[
    "This trial is testing the effectiveness of NucleomaxX and placebo in treating HIV patients with lipoatrophy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/3 trial for patients with unresectable cancer of the biliary tract, testing the efficacy of cisplatin, gemcitabine hydrochloride, and oxaliplatin, with eligibility criteria including WHO performance status, creatinine levels, and platelet count.",
    "The sample is a phase 2/phase 3 trial for type 2 diabetes, testing the efficacy of dapagliflozin and placebo in subjects receiving insulin and metformin and/or a thiazolidinedione, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for esophageal cancer and adenocarcinoma, testing the effectiveness of nimotuzumab, cisplatin, and fluorouracil, with eligibility criteria including age, cancer stage, performance status, and adequate body functions.",
    "The sample is a phase 2/phase 3 trial for generalized anxiety disorder, testing the efficacy of pexacerfont, escitalopram, and placebo, with inclusion criteria for outpatient women ages 18-65 meeting DSM-IV TR criteria for GAD, and exclusion criteria for males and patients with inadequate response to three or more adequate trials of any SSRIs for GAD within the last three years.",
    "The sample is a phase 2/phase 3 trial for idiopathic pulmonary fibrosis, testing the efficacy of bosentan and placebo, with inclusion and exclusion criteria listed.",
    "The sample is a phase 2/phase 3 trial for HIV infections, testing the efficacy of chloroquine phosphate and placebo drugs on HIV-1 infected adults with specific inclusion and exclusion criteria.",
    "This is a phase 2/phase 3 trial testing the efficacy of tonapofylline and placebo in treating acute decompensated heart failure in patients with a history of heart failure and clinical evidence of volume overload, with a list of inclusion and exclusion criteria, and a list of diseases including renal insufficiency and congestive heart failure.",
    "The sample is a phase 2/3 trial for metastatic breast cancer patients who have received prior taxane and anthracycline treatment, testing the efficacy of capecitabine and vinorelbine tartrate, with eligibility criteria including measurable lesions, specific patient characteristics, and prior concurrent therapy restrictions.",
    "The sample is a phase 2/phase 3 trial for type 2 diabetes mellitus, testing the efficacy of alogliptin and glimepiride drugs on patients who have been taking a sulfonylurea for at least 4 weeks, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/3 trial for HIV infected individuals, testing the efficacy of various anti-HIV drugs including nrtis, nnrtis, and pis, with eligibility criteria including age, HIV status, and previous anti-HIV drug use, and exclusion criteria including toxicity, infections, and certain medical conditions, while the diseases are limited to HIV infections and the icd-10 codes are limited to Z21.",
    "The sample is a phase 2/phase 3 trial for patients with colorectal carcinoma and liver metastases, testing the efficacy of folfox6 and bevacizumab in treating the disease, with specific eligibility and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial testing the drug alt-711 on sedentary elderly individuals with cardiovascular disease, aging, endothelial dysfunction, and physical activity as the diseases of interest, and with specific inclusion and exclusion criteria.",
    "This is a phase 2/phase 3 trial for adolescents and adults with mild to moderate asthma, testing the efficacy of the drug vr506 compared to placebo, with eligibility criteria including documented clinical history of asthma, ability to use the new inhaler correctly, and negative drug, alcohol, and urine cotinine screen.",
    "The sample is a phase 2/phase 3 trial for lupus nephritis, testing the efficacy of atacicept, mycophenolate mofetil, and corticosteroids compared to placebo, with inclusion criteria based on SLE diagnosis and active ISN/PRS class III or IV lupus nephritis, and exclusion criteria including prior treatment with certain medications and GFR less than or equal to 30 mL/min per 1.73 m^2.",
    "The sample is a phase 2/phase 3 trial for patients scheduled for elective cardiac or thoracic surgery with a history of deep venous thrombosis, testing the efficacy of desirudin and heparin as anticoagulants, with eligibility criteria and exclusion criteria listed.",
    "The sample is a phase 2/phase 3 trial for patients with stage IIIB or IV non-small cell lung cancer, testing the efficacy of vorinostat and several comparators, with eligibility criteria including confirmed diagnosis of NSCLC, adequate organ function, and ECOG performance status of 0 or 1.",
    "The sample is a phase 2/3 trial for previously untreated diffuse large B-cell or peripheral T-cell non-Hodgkin's lymphoma patients, testing the efficacy of chop and epoch regimens, cyclophosphamide, doxorubicin hydrochloride, etoposide, prednisone, and vincristine sulfate, with eligibility criteria including age over 70, WHO performance status 0-2, and various hematopoietic, hepatic, renal, and cardiovascular requirements.",
    "The sample is a phase 2/phase 3 trial for tobacco dependence, testing the effectiveness of s-adenosyl-l-methionine as a treatment, with inclusion and exclusion criteria listed.",
    "This trial is testing the drug ono-2506 for patients with acute cortical ischemic stroke, with specific inclusion and exclusion criteria based on patient characteristics and medical history.",
    "The sample is a phase 2/phase 3 trial for patients with HIV and chronic hepatitis B, testing the efficacy of Truvada (emtricitabine + tenofovir df) in reducing viral load, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for dry eye using carboxymethylcellulose sodium and glycerin as the drug, with inclusion criteria of mild, moderate, or severe dry eye symptoms and current eye drop use, and exclusion criteria of none, with a list of icd-10 codes for dry eye provided.",
    "The sample is a phase 2/phase 3 trial for patients with type 2 diabetes and dyslipidemia, testing the efficacy of fenofibrate, metformin, and placebo, with inclusion criteria being patients with type 2 diabetes mellitus and dyslipidemia, and exclusion criteria being type 1 diabetes.",
    "The sample is a phase 2/phase 3 trial for Huntington disease, testing the efficacy of minocycline and matching placebo as a treatment option, with inclusion criteria including age, clinical features of HD, and confirmatory family history or genetic confirmation, and exclusion criteria including hypersensitivity or intolerability to minocycline, vestibular disease, and underlying hematologic, hepatic or renal disease.",
    "The sample is a phase 2/3 trial for esophageal cancer, testing the efficacy of capecitabine and cisplatin in patients with localized, nonmetastatic disease who are not suitable for surgery, and have met specific eligibility criteria.",
    "The sample is a phase 2/phase 3 trial for pancreatic cancer using a combination of fluorouracil, gemcitabine hydrochloride, irinotecan hydrochloride, leucovorin calcium, and oxaliplatin, with eligibility criteria including confirmed adenocarcinoma of the pancreas, measurable disease, and specific patient characteristics.",
    "The trial is a phase 2/phase 3 study testing the drug indacaterol maleate on patients with chronic obstructive pulmonary disease (COPD) and obstructive lung diseases, with specific inclusion and exclusion criteria.",
    "This is a phase 2/phase 3 trial for endometriosis using pioglitazone as a drug, with eligibility criteria including regular cycles, pelvic pain, and scheduled surgery for endometriosis diagnosis.",
    "The sample is a phase 2/phase 3 trial for type 2 diabetes, testing the efficacy of rivoglitazone, pioglitazone, and placebo, with inclusion criteria of HbA1c between 7.5% and 10.5%, and exclusion criteria of insulin therapy and history of certain medications.",
    "The sample is a phase 2/phase 3 trial for previously untreated metastatic non-small cell lung cancer patients, testing the efficacy of chemotherapy +/- disulfiram, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for multiple sclerosis, testing the effectiveness of colecalciferol, with inclusion criteria of RRMS EDSS 0-5 and Betaferon use, and exclusion criteria including hypercalcaemia, kidney stones, and use of other IMD than interferon-beta.",
    "The sample is a phase 2/phase 3 trial for patients with active rheumatoid arthritis and incomplete response to methotrexate, testing the efficacy of ce-224,535 and placebo, with inclusion and exclusion criteria related to biologic therapies and recent infections.",
    "The sample is a phase 2/phase 3 trial for chronic myelogenous leukemia, malignant melanoma, and renal cell carcinoma, testing the efficacy of pegylated interferon alfa-2a and recombinant interferon alfa 2a, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/3 trial for breast neoplasm testing the efficacy of paclitaxel weekly in combination with capecitabine and docetaxel every 3 weeks in combination with capecitabine, with eligibility criteria including measurable and/or evaluable disease, adequate organ functions, and exclusion criteria including severe hepatic or renal impairment and known dihydropyrimidine dehydrogenase deficiency.",
    "The sample is a phase 2/phase 3 trial for patients with Parkinson's disease and troublesome dyskinesia following levodopa dosing, testing the drug ads-5102 (extended release amantadine hcl) and includes inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial testing the efficacy of lansoprazole and placebo in treating chronic cough and bronchoreactivity in patients with gastroesophageal reflux and asthma, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for venous thromboembolism, using fondaparinux sodium as the drug, with inclusion criteria based on risk factors for VTE and exclusion criteria including prisoners and pregnant patients.",
    "This is a phase 2/phase 3 trial for talsaclidine in Alzheimer's disease patients who completed the preceding talsaclidine trial within the last four weeks with adequate compliance, and have a relative or caregiver who is willing and capable of supporting the clinical trial, with a list of exclusion criteria and concomitant therapy exclusion.",
    "This trial is a phase 2/phase 3 study for systemic lupus erythematosus, testing the efficacy of corticosteroids, abatacept, and mycophenolate mofetil, with eligibility criteria including meeting at least 4 of the 11 classification criteria for SLE and having active proliferative lupus glomerulonephritis.",
    "The sample is a phase 2/phase 3 trial testing the efficacy of memantine in treating cognitive dysfunction in patients with multiple sclerosis, with inclusion criteria based on diagnosis and cognitive dysfunction, and exclusion criteria including history of depression, pregnancy, and use of certain medications.",
    "The sample is a phase 2/phase 3 trial for allergic rhinoconjunctivitis, testing the efficacy of avanz phleum pratense and placebo, with inclusion criteria including a history of grass pollen allergy and positive skin prick and Immunoglobulin E tests to grass, and exclusion criteria including severe asthma and other allergies overlapping the grass pollen season.",
    "The sample is a phase 2/phase 3 trial for cytomegalovirus infections, testing the drug valganciclovir (valcyte) in pediatric solid organ transplant recipients who are at risk of developing CMV disease, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/3 trial for type 2 diabetes mellitus, testing the efficacy of alogliptin and glimepiride or alogliptin and metformin as add-ons to sulfonylurea or metformin, with inclusion and exclusion criteria specified.",
    "The sample is a phase 2/phase 3 trial for systemic lupus erythematosus (SLE) using rituximab, placebo, prednisone, acetaminophen, and diphenhydramine as drugs, with inclusion and exclusion criteria listed.",
    "The sample is a phase 2/phase 3 trial for smoking cessation, testing the effectiveness of varenicline, bupropion, and nicotine patches in Duke employees and their dependents who smoke at least 10 cigarettes per day and express a desire to quit within 30 days, with exclusion criteria including various medical conditions and previous adverse reactions to smoking cessation aids.",
    "The sample is a phase 2/3 trial for allergy patients with a history of house dust mite induced asthma, testing the efficacy of various drugs including salbutamol inhaler, budesonide/formoterol inhaler, prednisone tablet, desloratadine tablet, and budesonide nasal spray, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for hypertension, testing the effectiveness of irbesartan and atenolol, with eligibility criteria including age, blood pressure, and left ventricular mass, and exclusion criteria including significant cardiac, renal, or gastrointestinal conditions, and uncontrolled diabetes mellitus.",
    "This trial is testing the efficacy of carboplatin, cediranib maleate, and paclitaxel in treating non-small cell lung cancer patients with measurable or nonmeasurable disease, who meet specific eligibility criteria.",
    "The sample is a phase 2/phase 3 clinical trial for patients with chronic sinusitis and nasal polyps, testing the efficacy of S8 Sinus Implant and mometasone furoate nasal spray as treatments, with specific eligibility criteria and exclusion criteria.",
    "This trial is for patients with newly diagnosed acute myeloid leukemia, testing the effectiveness of a combination of drugs including cytarabine, idarubicin, etoposide, all-trans retinoic acid, and pegfilgrastim, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for patients with atrial flutter, testing the efficacy of vernakalant injection 20 mg/ml, with inclusion criteria including age over 18, sustained atrial arrhythmia with dysrhythmic symptoms, and adequate anticoagulant therapy, and exclusion criteria including serious diseases/illnesses that could interfere with the study or compromise patient safety, and recent use of certain antiarrhythmic drugs.",
    "The sample is a phase 2/phase 3 trial for patients with inoperable or refused surgery stage I-III non-small cell lung cancer, testing the efficacy of cisplatin and vinorelbine tartrate, with eligibility criteria including ECOG 0-1 performance status, no prior chemotherapy or radiotherapy, and meeting various hematopoietic, hepatic, renal, cardiovascular, pulmonary, and other medical stability requirements.",
    "The sample is a phase 2/phase 3 trial for extended treatment of nicotine dependence in adolescents, with the inclusion criteria of age 14-18, smoking at least 10 cigarettes per day, and at least one quit attempt in the previous 6 months, and the exclusion criteria of current DSM-IV disorder, daily or heavy use of drugs, positive urine pregnancy test, current use of certain medications, and current formal treatment for substance abuse problem, depression or anxiety. The drug being tested is not specified.",
    "The sample is a phase 2/phase 3 trial for patients with colorectal cancer and liver metastases, testing the efficacy of various chemotherapy drugs (folfiri, folfox-4, folfiri-hd, folfox-7, folfirinox) with specific eligibility criteria for inclusion and exclusion.",
    "The sample is a phase 2/phase 3 trial for type 2 diabetes mellitus, testing the efficacy of alogliptin and metformin in patients who have been taking stable doses of metformin for at least 12 weeks, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial testing the efficacy of telmisartan and bisoprolol versus placebo in patients with diabetes mellitus, heart failure, and coronary artery disease, with inclusion criteria including age over 18, known diabetes mellitus for over 6 months, and increased Nt-proBNP above 125pg/ml, and exclusion criteria including chronic infection or malignant disease, history of cardiac disease, and systemic cortisone treatment.",
    "The sample is a phase 2/3 trial for patients with primary progressive multiple sclerosis, testing the efficacy of rituximab and placebo drugs, with specific eligibility criteria including disease duration, EDSS score, and CSF specimen results.",
    "The sample is a phase 2/phase 3 trial testing the efficacy of sertraline in treating depressive disorder, major, with specific inclusion and exclusion criteria listed, including the requirement of a HDRS score greater than 18.",
    "The sample is a phase 2/phase 3 trial for cardiac surgery patients using sodium bicarbonate and sodium chloride to prevent acute kidney injury, with eligibility criteria including age, preoperative plasma creatinine levels, and insulin dependent diabetes mellitus.",
    "This trial is testing the efficacy of s-1 + irinotecan and irinotecan in treating inoperable advanced gastric adenocarcinoma, with eligibility criteria including confirmed PD status after first-line chemotherapy and exclusion criteria including hypersensitivity to fluoropyrimidines and CPT-11.",
    "This trial is testing the effectiveness of caffeine and placebo in reducing excessive daytime somnolence in patients with Parkinson's disease, with specific inclusion and exclusion criteria for eligibility.",
    "This clinical trial is testing the efficacy of infliximab and placebo in treating lupus erythematosus and lupus nephritis, with eligibility criteria including biopsy-proven membranous glomerulonephritis and proteinuria > 3 g/day despite adequate therapy with ACE inhibitors and steroids.",
    "This trial is testing the efficacy of bosentan and placebo in treating patients with sarcoidosis and pulmonary arterial hypertension, with specific inclusion and exclusion criteria.",
    "This trial is for patients with relapsing multiple sclerosis and will test the effectiveness of mycophenolate mofetil (cellcept) as a treatment option, with inclusion and exclusion criteria listed.",
    "This clinical trial is testing the efficacy of eb-1010 and SSRIs in treating major depressive disorder in patients who have had an inadequate response to one or no adequate SSRI or SNRI treatment, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for metastatic colorectal cancer testing the efficacy of cmab009 plus irinotecan and irinotecan-only, with eligibility criteria including KRAS wild-type tumors and failure of fluoropyrimidine and oxaliplatin treatment, and exclusion criteria including previous irinotecan or anti-EGFR therapies and hematologic, liver, and renal function limitations.",
    "This trial is a phase 2/phase 3 study testing the efficacy of tadalafil and placebo in treating benign prostatic hyperplasia, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 2/phase 3 trial for vortioxetine and placebo in patients with major depressive disorder, with inclusion and exclusion criteria specified, and icd-10 codes provided for the disease.",
    "The sample is a phase 2/3 trial for multiple myeloma, CLL/SLL, non-Hodgkin's lymphoma, Waldenstroms, and mantle cell lymphoma, using fludarabine as a drug, with specific eligibility criteria including age, disease stage, and organ function.",
    "The sample is a phase 2/phase 3 trial for patients with chronic hepatitis C and liver fibrosis, testing the efficacy of ribavirin and ribavirin-placebo in combination with interferon, with eligibility criteria including previous non-response to antiviral treatment and a Metavir fibrosis score \u2265 2.",
    "The sample is a phase 2/phase 3 trial for heart and liver transplant patients with bone resorption, testing the effectiveness of zoledronic acid and alendronate, with eligibility criteria including age, exclusion criteria including hyperparathyroidism and Paget's disease.",
    "The sample is a phase 2/phase 3 trial for women with breast cancer and no sign of depression, testing the effectiveness of melatonin versus placebo as a sleep aid for patients undergoing lumpectomy or mastectomy, with a list of inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for persistent asthma, testing the drug indacaterol maleate, with inclusion criteria including daily treatment with a bronchodilator and daily dose of at least 100 \u00b5g beclomethasone dipropionate or equivalent, and exclusion criteria including use of tobacco products within 6 months prior to Visit 1 or a smoking history of more than 10 pack years.",
    "The sample is a phase 2/3 trial for type 2 diabetes mellitus, testing the efficacy of alogliptin and pioglitazone, with inclusion and exclusion criteria related to hepatic and renal impairment and cardiac failure.",
    "This is a phase 2/phase 3 trial for Parkinson's disease, testing the efficacy of cep-1347 at different doses, with specific inclusion and exclusion criteria, and requiring cancer screening before randomization.",
    "This clinical trial is testing the efficacy of tozadenant in treating Parkinson's disease, with a list of inclusion and exclusion criteria, and a variety of dosages of the drug being tested against a placebo and levodopa.",
    "The sample is a phase 2/phase 3 trial for low-grade B-cell lymphoma using rituximab in combination with standard chop or bi-weekly chop, with eligibility criteria including CD20 positivity, age between 20 and 69, and bidimensionally measurable disease >1.5cm, and exclusion criteria including CNS involvement, liver cirrhosis, and double cancer.",
    "This trial is testing the efficacy of tadalafil, a drug used to treat pulmonary hypertension, on patients with biopsy-proven sarcoidosis and specific eligibility criteria.",
    "The sample is a phase 2/phase 3 trial for anal cancer, testing the efficacy of cisplatin, fluorouracil, and mitomycin c, with eligibility criteria including confirmed squamous cell anal carcinoma and specific patient characteristics.",
    "The sample is a phase 2/phase 3 trial for relapsed or refractory diffuse large B-cell lymphoma, testing the efficacy of lenalidomide, gemcitabine, oxaliplatin, rituximab, and etoposide, with specific eligibility criteria for patients.",
    "The sample is a phase 2/phase 3 trial testing the efficacy of gabapentin in reducing pain after open unilateral inguinal herniorraphy surgery, with a focus on patients who are not currently on gabapentin therapy and do not have a history of alcohol or drug abuse, and with a list of diseases including pain, analgesia, and inguinal hernia.",
    "The sample is a phase 2/phase 3 trial for colorectal cancer, testing the efficacy of cediranib, bevacizumab, 5-fluorouracil, leucovorin, and oxaliplatin, with specific inclusion and exclusion criteria.",
    "This is a phase 2/phase 3 trial for chronic idiopathic constipation, testing the drug plecanatide, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 2/phase 3 trial for rheumatoid arthritis, testing the efficacy of rituximab in combination with methotrexate and prednisone, with specific inclusion and exclusion criteria for patient selection.",
    "The sample is a phase 2/phase 3 trial testing the efficacy of high dose multivitamin in patients with chronic kidney disease, cardiovascular disease, and death, with specific inclusion and exclusion criteria.",
    "This trial is testing the efficacy of duloxetine and placebo in treating daily pain attributed to multiple sclerosis, with inclusion and exclusion criteria specified.",
    "The sample is a phase 2/phase 3 trial for pancreatic cancer using the drug rubitecan, with inclusion criteria such as non-resectable Stage II-IV primary adenocarcinoma of the pancreas and a Karnofsky Performance Status between 50 and 100, and exclusion criteria such as any active, uncontrolled infection requiring antibiotics and surgery scheduled within 8 weeks following initiation of treatment.",
    "The sample is a phase 2/phase 3 trial for multiple myeloma, testing the efficacy of tanespimycin and bortezomib in patients who have had at least three prior treatment regimens for multiple myeloma that included both drugs, with specific eligibility criteria for enrollment.",
    "The sample is a phase 2/phase 3 trial for amyotrophic lateral sclerosis, testing the efficacy of memantine, riluzole, and placebo, with specific inclusion and exclusion criteria.",
    "This trial is testing the efficacy of 5-fluorouracil, leucovorin, and oxaliplatin in treating patients with neuroendocrine tumors, including gastrointestinal carcinoid tumor, islet cell tumor, lung cancer, and neoplastic syndrome, who meet specific eligibility criteria.",
    "The sample is a phase 2/phase 3 trial testing the efficacy of natural source vitamin E 400IU/day in diabetic patients aged 55 and above with a history of myocardial infarction, cardiovascular disease, and other related diseases, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial testing the efficacy of Lamictal in treating post-herpetic neuralgia, with inclusion criteria including a minimum score on the Likert Pain Scale and exclusion criteria including a history of Stevens-Johnson syndrome or TEN, and patients on Fibrates (Tricor and Lopid), and Lidocaine Patch, and use of hormonal contraceptives.",
    "The sample is a phase 2/3 trial testing the safety and efficacy of ati-5923 and coumadin in patients with various cardiovascular diseases, including atrial fibrillation, myocardial infarction, and cardiomyopathy, who require chronic anticoagulation, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for chronic lymphocytic leukemia testing the efficacy of bendamustine and fludarabine in patients who have not responded to initial chemotherapy, with specific inclusion and exclusion criteria.",
    "This trial is for HIV-infected individuals with measurable HIV Neurocognitive Impairment who are under consideration to initiate or change their HAART regimens and are willing to undergo at least 3 lumbar punctures safely during the course of the study. The trial will test the efficacy of FDA approved antiretroviral therapy in treating the disease.",
    "This trial is testing the effectiveness of rituximab for transplant rejection in pediatric renal allograft recipients with a decline in renal function, and includes eligibility criteria and exclusion criteria such as previous treatment with rituximab, ongoing use of high dose steroids, and significant cardiac or pulmonary disease.",
    "The sample is a phase 2/phase 3 trial for patients with primary or mixed dementia, testing the efficacy of megestrol acetate and placebo in treating weight loss and malnutrition, with inclusion and exclusion criteria listed.",
    "This trial is for patients with advanced and/or metastatic soft tissue sarcoma who have not received prior anticancer therapy, and will test the efficacy of doxorubicin hydrochloride and trabectedin as treatment options.",
    "The sample is a phase 2/phase 3 trial for type 2 diabetes mellitus, testing the efficacy of alogliptin and voglibose drugs, with eligibility criteria including completion of a phase 2 study and exclusion criteria related to hepatic and renal impairment.",
    "The sample is a phase 2/phase 3 trial testing the efficacy of moxaverine in treating macular degeneration, glaucoma, and regional blood flow, with eligibility criteria including age, ametropia, and clear ocular media, and exclusion criteria including hypersensitivity to moxaverine and presence of ocular pathology interfering with the study's aims.",
    "The sample is a phase 2/phase 3 trial for mild or moderate persistent asthma, testing the efficacy of rosiglitazone, theophylline, beclomethasone, and inhaled beclomethasone and oral theophylline, with eligibility criteria including a minimum 6-month history of asthma, current cigarette smoking, and a baseline FEV1 greater than 50% predicted.",
    "The sample is a phase 2/3 trial for postmenopausal women with estrogen and/or progesterone positive breast cancer, testing the efficacy of letrozole, with inclusion and exclusion criteria specified.",
    "The sample is a phase 2/phase 3 trial for pregnant women with documented HIV-1 infection without indication for ARV therapy, assessing the efficacy of kaletra (lopinavir/ritonavir) and kaletra (lopinavir/ritonavir) + combivir (zidovudine/lamivudine) in reducing mother-to-child transmission of HIV-1.",
    "This trial is a phase 2/phase 3 study testing the efficacy of oros methylphenidate and placebo in treating adults with attention deficit hyperactivity disorder who meet specific inclusion and exclusion criteria, including being in good health and not having other current DSM-IV Axis I Disorders or significant medical or psychiatric illnesses.",
    "The sample is a phase 2/phase 3 trial for atopic dermatitis, testing the drug fexofenadine/allegra (m016455), with inclusion criteria of patients aged 6 months through 11 years with atopic dermatitis and exclusion criteria of main itching scores of 4 or less than 2 on last three consecutive days before registration and patients who have itching only on face, head, or diaper area.",
    "This trial is a phase 2/phase 3 study testing the efficacy of anakinra and saline in treating type 1 diabetes with specific inclusion and exclusion criteria, including positive GAD auto-antibodies and peak C-peptide levels, and excluding patients with severe liver or renal disease, heart disease, malignancy, and immune-suppressive treatment.",
    "The sample is a phase 2/phase 3 trial for acute myocardial infarction, testing the efficacy of mesenchymal stem cell therapy versus a control group, with eligibility criteria including age, ischemic chest pain, and ST segment elevation, and exclusion criteria including cardiogenic shock, history of malignancy, and positive viral markers.",
    "The sample is a phase 2/phase 3 trial for patients with relapsed ovarian, fallopian tube or primary peritoneal cancer, testing the efficacy of paclitaxel and saracatinib compared to a matched placebo, with eligibility criteria including prior chemotherapy and adequate haematological and biochemical function.",
    "The sample is a phase 2/phase 3 trial for hematological malignancies, testing the efficacy of darbepoetin alpha and iron saccharate in patients who have undergone PBSC transplantation, with specific inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for locally advanced head and neck cancer, testing the efficacy of docetaxel, cisplatin, 5-fluorouracil (5-fu), radiotherapy and cisplatin, 5-fluorouracil (5-fu), radiotherapy, with eligibility criteria including good hematologic, hepatologic, and renal function, and exclusion criteria including previous treatment for the current disease and loss of weight greater than 10% within the last 3 months.",
    "The sample is a phase 2/phase 3 trial for patients with metastatic, recurrent or persistent squamous cell carcinoma of the head and neck region, testing the efficacy of erlotinib, with specific inclusion and exclusion criteria listed.",
    "This trial is a phase 2/phase 3 study testing the efficacy of various doses and combinations of valsartan and amlodipine in treating essential hypertension, with strict inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for patients with unresectable advanced gastric carcinoma and recurrent gastric carcinoma, testing the efficacy of tegafur/gimeracil/oteracil potassium (s-1), krestin (psk) and tegafur/gimeracil/oteracil potassium (s-1) drugs, with eligibility criteria including age, organ function, and performance status.",
    "The sample is a phase 2/3 trial for prostate cancer using celecoxib as a drug, with specific inclusion and exclusion criteria, and the trial is looking for participants who are either fully active and asymptomatic or symptomatic but fully ambulatory.",
    "This trial is testing the efficacy of AGI-1067, a drug for Type 2 diabetes, compared to a placebo, and has strict inclusion and exclusion criteria for participants.",
    "The sample is a phase 2/phase 3 trial for the treatment of recurrent respiratory papillomatosis using propranolol, with inclusion criteria including biopsy-proven disease and at least 4 previous surgeries, and exclusion criteria including heart failure, asthma, and hypersensitivity to propranolol.",
    "The sample is a phase 2/phase 3 trial for kidney transplantation, testing the effectiveness of rituximab and placebo drugs on renal transplant recipients with specific eligibility and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for heart failure patients, testing the effectiveness of relaxin and placebo drugs, with inclusion and exclusion criteria based on hospitalization, dyspnea, pulmonary congestion, blood pressure, and renal function.",
    "This trial is testing the effectiveness of zoledronic acid in treating metastatic breast cancer with bone metastases, and includes eligibility criteria such as confirmed invasive breast cancer, ECOG Performance Status of 0 to 2, and adequate organ function.",
    "The sample is a phase 2/phase 3 trial for rheumatoid arthritis, testing the efficacy of rosuvastatin and placebo in patients with a high risk profile, with specific inclusion and exclusion criteria based on disease duration, seropositivity, joint counts, and cholesterol levels.",
    "The sample is a phase 2/3 trial testing the efficacy of nitazoxanide and placebo in treating influenza in patients aged 12-65 with confirmed Influenza A or B infection, with specific inclusion and exclusion criteria, and a list of diseases and icd-10 codes.",
    "This trial is testing the use of atorvastatin in patients with advanced cancers who are undergoing lobectomy or pneumonectomy, with specific inclusion and exclusion criteria.",
    "This trial is testing the drug lbh589 on patients with cutaneous t-cell lymphoma who have had disease progression on or following treatment with an HDAC inhibitor, and have met certain eligibility criteria.",
    "The sample is a phase 2/3 clinical trial for patients with recurrent follicular lymphoma, testing the efficacy of cyclophosphamide and rituximab, filgrastim, non-myeloablative conditioning regimen, rituximab maintenance therapy, and gvhd prophylaxis, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for depression, testing the efficacy of trazodone and placebo, with inclusion criteria including age, DSM-IV criteria for depression, and HAM-D scores, and exclusion criteria including serious suicide attempts, bipolar disorder, and significant physical disorders.",
    "The sample is a phase 2/phase 3 trial for HIV-infected patients with tuberculosis, testing the efficacy of nevirapine and efavirenz-based therapy in combination with rifampicin, ethambutol, isoniazid, and pyrazinamide, with inclusion criteria including CD4 cell count < 250 cell/mm3 and exclusion criteria including ongoing psychiatric pathology.",
    "The sample is a phase 2/phase 3 trial for major depressive disorder, testing the efficacy of tasimelteon and placebo, with inclusion and exclusion criteria including diagnosis, episode duration, and history of certain disorders or substance abuse.",
    "The sample is a phase 2/phase 3 trial for chronic hepatitis C, testing the efficacy of nitazoxanide and ribavirin in patients with specific inclusion and exclusion criteria, including HCV genotype 4 and no history of failed peginterferon-ribavirin therapy.",
    "This trial is a phase 2/phase 3 study for patients with house dust mite-related allergic rhinitis, testing the efficacy of 300 ir and 500 ir house dust mites allergen extract tablets and placebo tablets, with eligibility criteria including sensitization to D. pteronyssinus or D. farinae and a baseline ARTSS > 5.",
    "The sample is a phase 2/phase 3 trial for chronic kidney disease using the drug zemplar, with inclusion criteria of eGFR 15-59 ml/m2 and exclusion criteria of current vitamin D treatment.",
    "The sample is a phase 2/phase 3 trial for type 2 diabetes mellitus, testing the efficacy of alogliptin and pioglitazone in patients who have been taking stable doses of pioglitazone for at least 16 weeks, with specific inclusion and exclusion criteria.",
    "This clinical trial will test the efficacy of sitagliptin, a DPPIV-inhibitor, in improving glucose metabolism in HIV-infected individuals with stable immunologic and virologic status, who are on antiretroviral therapy, and have diabetes or insulin resistance.",
    "This trial is a phase 2/phase 3 study testing the use of fluvastatin in combination with immunosuppression for renal transplantation patients with specific LDL-cholesterol levels and exclusion criteria, and the trial is focused on patients aged 18-65 with a history of myocardial infarction.",
    "The sample is a phase 2/phase 3 trial for patients with Philadelphia chromosome positive accelerated or blast phase chronic myeloid leukemia, testing the drug panobinostat, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for hyperlipidemia using simvastatin 20 mg/ezetimibe, with inclusion criteria of moderately obese patients and exclusion criteria of recent unstable heart or lung condition, current use of other lipid modifying drugs, hepatic disease, pregnancy or lactation.",
    "The sample is a phase 2/phase 3 trial for migraine, testing the efficacy of telcagepant and placebo, with inclusion and exclusion criteria related to menstrual cycles, migraine history, medication use, and medical history.",
    "The sample is a phase 2/phase 3 trial for type 2 diabetes mellitus with inadequate glycemic control, testing dapagliflozin and placebo, with inclusion criteria of moderate renal impairment and exclusion criteria of severe uncontrolled diabetes and serious cardiovascular, hepatic, hematological, oncological, endocrine, psychiatric, or rheumatic diseases.",
    "This clinical trial is testing the effectiveness of algeron, pegintron, and ribavirin in treating hepatitis C in patients who meet specific eligibility criteria.",
    "The sample is a phase 2/phase 3 trial for the drug cx516 (ampakine) in patients with schizophrenia, with inclusion criteria including stable dose of clozapine, olanzapine or risperidone for at least 6 months, and exclusion criteria including serious medical or neurological illness, current substance abuse, and serious suicidal or homicidal risk within the past six months.",
    "The sample is a phase 2/phase 3 trial testing the efficacy of pegylated interferon alfa-2a and ribavirin in treating HIV-infected patients with compensated liver cirrhosis caused by HCV genotype 1 or 4, with a list of inclusion and exclusion criteria.",
    "The sample is a phase 2/phase 3 trial for patients with type 2 diabetes, testing the efficacy of sitagliptin and metformin compared to placebo, with inclusion criteria including BMI 25-35 kg/m2 and HbA1c 6.5%-9% without OHA medication or 6%-8.5% with OHA monotherapy with metformin or sulfonylurea.",
    "The sample is a phase 2/phase 3 trial for patients with primary progressive multiple sclerosis (PP-MS) using hydroxyurea as the drug, with inclusion criteria based on age, diagnosis, and EDSS score, and exclusion criteria including hypersensitivity to the drug, recent treatment with immunosuppressive drugs or steroids, infections, malignancy, pregnancy or lactation, and low compliance to therapy.",
    "The sample is a phase 2/phase 3 trial for stroke patients testing the effectiveness of propranolol, with inclusion criteria including symptom onset within 18 hours and imaging evidence of MCA-infarction, and exclusion criteria including patients already receiving beta-blockers and major heart disease.",
    "This sample is a phase 2/phase 3 trial for diabetes mellitus type 2, testing the efficacy of ly2189265, sitagliptin, placebo solution, placebo tablet, and metformin, with inclusion criteria including a HbA1c value of \u22657.0% to \u22649.5% and a BMI between 25 and 40 kg/m^2.",
    "This is a phase 2/phase 3 trial for patients with moderate to severe ankylosing spondylitis, testing the effectiveness of rituximab, with inclusion and exclusion criteria including age, disease severity, medication history, and lab findings.",
    "The sample is a phase 3 trial testing the efficacy of multiple drugs, including aprepitant and dexamethasone, in reducing nausea caused by chemotherapy in cancer patients who are chemotherapy naive and meet specific eligibility criteria.",
    "The sample is a phase 3 trial for Parkinson's disease using istradefylline as a drug, with eligibility criteria including completion of previous studies, absence of certain illnesses and drug allergies, and ability to give informed consent.",
    "This phase 3 trial is testing the efficacy of rosiglitazone or placebo in patients with type 2 diabetes mellitus and ischemic heart disease who have undergone coronary artery bypass grafting, with eligibility criteria including age, disease history, and absence of certain medical conditions.",
    "The sample is a phase 3 trial for breast cancer patients with ER+ and/or PgR+ tumors, testing the efficacy of lapatinib and letrozole compared to placebo, with eligibility criteria including post-menopausal females with stage IV disease and archived tumor tissue available for comparison of tumor response with intra-tumoral expression of ErbB1 and ErbB2.",
    "The sample is a phase 3 trial for acute lymphoblastic leukemia (ALL) with a list of 14 drugs including asparaginase, cyclophosphamide, and methotrexate, and eligibility criteria including no prior disease that would preclude treatment with chemotherapy.",
    "The sample is a phase 3 trial for chronic renal anemia, testing the efficacy of methoxy polyethylene glycol-epoetin beta and epoetin alfa, with inclusion criteria of continuous iv maintenance epoetin alfa therapy and regular hemodialysis for >= 3 months, and exclusion criteria of transfusion of red blood cells during previous 2 months and poorly controlled hypertension requiring interruption of epoetin alfa treatment in previous 6 months.",
    "The sample is a phase 3 trial for age-related macular degeneration and choroidal neovascularization using ranibizumab as the drug, with eligibility criteria including age, diagnosis of active primary or recurrent CNV secondary to AMD, and BCVA score between 73 and 24 letters.",
    "The sample is a phase 3 trial for epilepsy, testing the drug lamotrigine, with inclusion criteria of a confident diagnosis of epilepsy and currently treated with one or two antiepileptic medications, and exclusion criteria of a history of hypersensitivity to lamotrigine and progressive diseases that would interfere with the study objectives.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of abatacept, non-biologic disease modifying anti-rheumatic drug (dmard), and anti-tumor necrosing factor (tnf) therapy, with inclusion criteria including completed double-blind portion of the IM101064 study, ACR functional class I, II, III, and previous use of anti-TNF therapy for at least 3 months.",
    "This phase 3 trial is testing the efficacy of pazopanib and sunitinib in treating locally advanced or metastatic renal cell carcinoma, with eligibility criteria including no prior systemic therapy, ECOG PS of 0 or 1, and adequate organ system functions.",
    "The sample is a phase 3 trial for the drug cetrorelix pamoate in patients with benign prostatic hypertrophy, with inclusion and exclusion criteria listed, and the disease is identified by its name and icd-10 codes.",
    "This phase 3 trial is testing the effectiveness of repaglinide and short-acting insulin in treating newly diagnosed diabetes mellitus in patients with cystic fibrosis, while excluding those with certain medical conditions and those already treated for diabetes.",
    "This phase 3 trial is testing the efficacy of aprepitant, ondansetron, dexamethasone, fosaprepitant dimeglumine, and placebos in treating chemotherapy-induced nausea and vomiting in patients with malignant disease who are scheduled to receive a single dose of moderately emetogenic chemotherapy, and have a Karnofsky score of 60 or greater, while excluding patients with certain medical conditions, allergies, or abnormal laboratory values.",
    "The sample is a phase 3 trial for locoregionally confined stage III or IV squamous cell carcinoma of the oral cavity, oropharynx, larynx, or hypopharynx, using cisplatin and fluorouracil as drugs, with eligibility criteria including ECOG performance status 0-1, WBC > 3,500/mm\u00b3, and serum creatinine < 2.0 mg/dL.",
    "This phase 3 trial is testing the efficacy of tiotropium respimat and placebo respimat in treating asthma in patients aged 18-75 who have been on maintenance treatment with a medium, stable dose of inhaled corticosteroids for at least 4 weeks prior to Visit 1, and meet other inclusion criteria.",
    "This phase 3 trial is testing the efficacy of ketoprofen in diractin\u00ae versus placebo for treating osteoarthritis of the knee in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of human insulin inhalation powder and insulin glargine in insulin-naive patients with HbA1c between 8.0% and 10.5%, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for Alzheimer's disease, testing the effectiveness of simvastatin as a treatment, with specific eligibility and exclusion criteria.",
    "The sample is a phase 3 trial for hypertension, testing the efficacy of telmisartan and amlodipine drugs in patients who failed to respond to amlodipine monotherapy, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for prostate cancer with bone metastases, testing the drugs zd4054 and placebo, and the eligibility criteria includes confirmed diagnosis of prostate cancer, increasing PSA, and currently receiving treatment with surgical or medical castration.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of methotrexate, ocrelizumab, and placebo, with inclusion criteria of inadequate response to methotrexate and exclusion criteria of prior biologic therapy or concurrent treatment with any DMARD.",
    "This phase 3 trial is testing the efficacy of a combination product (sumatriptan succinate/naproxen sodium) and placebo in treating migraine disorders, with eligibility criteria including 1-8 migraines per month and recent discontinuation of certain triptan medications due to nonresponse or intolerable adverse events.",
    "This phase 3 trial is testing the efficacy of azathioprine and infliximab in treating ulcerative colitis in patients who have not responded to corticosteroid treatment, with strict inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for epilepsy patients, testing the effectiveness of lamotrigine and levetiracetam as treatment options, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of tocilizumab sc and iv, along with other drugs, in patients with inadequate response to current DMARD therapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for chronic pain, testing the efficacy of tramadol hcl er and celecoxib as analgesics, with inclusion criteria including pain intensity score and exclusion criteria including diagnoses of inflammatory arthritis or fibromyalgia.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of formoterol fumurate inhalation solution and ipratropium bromide and albuterol sulfate inhalation solution, with inclusion criteria of COPD diagnosis and smoking history, and exclusion criteria of asthma diagnosis and pregnancy/lactation.",
    "The sample is a phase 3 clinical trial for patients with moderate to severe chronic kidney disease, testing the efficacy of ast-120 and placebo, with eligibility criteria including age, serum creatinine levels, urinary protein to creatinine ratio, and blood pressure, and exclusion criteria including previous kidney transplant and significant medical conditions.",
    "This phase 3 clinical trial aims to evaluate the efficacy of semuloparin sodium versus placebo in preventing venous thromboembolism in cancer patients with metastatic or locally advanced solid tumors of lung, pancreas, stomach, colon/rectum, bladder or ovary initiating a (new) course of chemotherapy with a minimum intent of 3 months therapy, while also excluding patients with high risk of bleeding, severe renal impairment, ECOG performance status 3 & 4, major surgery within 4 weeks before randomization, and known hypersensitivity to unfractionated heparin [UFH] or low molecular weight heparin [LMWH].",
    "This phase 3 clinical trial is testing the efficacy of mesalazine (asacol\u00ae) in maintaining remission in patients with ulcerative colitis who have had a symptomatic relapse within the past two years, and meet other eligibility criteria.",
    "This phase 3 trial is testing the effectiveness of various hypertension drugs, including amlodipine and olmesartan medoxomil, on patients with essential hypertension, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for non-small cell lung cancer patients who progressed after platinum-based chemotherapy and will test the drug icotinib, with eligibility criteria including ECOG performance status 0-2 and exclusion criteria including previous treatment with drugs targeting EGFR and history of interstitial lung disease.",
    "The sample is a phase 3 trial for acute ischemic stroke using ancrod and placebo drugs, with inclusion criteria of baseline NIHSS > 5 and exclusion criteria of hypertension, thrombocytopenia, recent use of thrombolytic agent or surgery, and baseline fibrinogen level < 100 mg/dL. The trial involves patients with stroke, cerebral ischemia, and brain infarction, with corresponding ICD-10 codes.",
    "This phase 3 trial is testing the efficacy of mp-376 and tis in treating cystic fibrosis patients with positive sputum culture for P. aeruginosa, who are clinically stable and have received at least 3 courses of inhaled tobramycin over the preceding 12 months, while meeting other inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for bladder cancer patients who have undergone radical cystectomy and bilateral pelvic lymphadenectomy, testing the efficacy of cisplatin, doxorubicin hydrochloride, methotrexate, and vinblastine as chemotherapy drugs, with eligibility criteria including p53 gene alteration and no metastatic disease, and patient characteristics such as ECOG 0-1 or Karnofsky 70-100% performance status and creatinine clearance of at least 50 mL/min.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of saxagliptin and metformin against a placebo, with inclusion criteria of inadequate blood sugar control and exclusion criteria of previous treatment for diabetes, current treatment with other medications to lower blood sugar, major heart, liver or kidney problems, and pregnancy or breastfeeding.",
    "The sample is a phase 3 trial for major depressive disorder using quetiapine as the drug, with inclusion criteria of patients 66 years or older and exclusion criteria of dementia, substance or alcohol abuse, and cancer or stroke diagnosis.",
    "The sample is a phase 3 trial for congestive heart failure, testing the efficacy of irbesartan and placebo, with inclusion and exclusion criteria based on age, heart function, recent hospitalization, and other health factors.",
    "This phase 3 trial is testing the efficacy of nevirapine and atazanavir in HIV-infected patients with specific inclusion and exclusion criteria, including no previous antiretroviral treatment and adequate renal function, and aims to assess the susceptibility of the drugs based on HIV-1 genotypic resistance report.",
    "This phase 3 trial is testing the efficacy of mometasone furoate nasal spray and placebo nasal spray in treating moderate/severe persistent allergic rhinitis with a history of intermittent asthma, with a list of inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of sitagliptin, pioglitazone, and metformin, with eligibility criteria including completion of a previous study and compliance with contraceptive methods for women of childbearing potential.",
    "The sample is a phase 3 clinical trial for atopic dermatitis, testing the efficacy of pimecrolimus and topical corticosteroids in children aged 3 to <12 months with a diagnosis of AD fulfilling the diagnostic criteria of Seymour, affecting at least 5% total body surface area, and with an IGA score of 2 or 3, with various inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for multiple myeloma and plasma cell neoplasm, testing the efficacy of thalidomide and zoledronic acid as treatment options, with specific eligibility criteria for patients.",
    "This is a phase 3 trial for the drug balaglitazone in patients with type 2 diabetes mellitus, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for chronic hepatitis B, testing the efficacy of lam group and adv group drugs, with specific inclusion and exclusion criteria based on disease status and previous treatments.",
    "This is a phase 3 clinical trial for the treatment of benign prostatic hyperplasia using tadalafil and placebo, with strict inclusion and exclusion criteria including restrictions on other BPH, ED, and OAB treatments, and a list of medical conditions and medications that would disqualify participants.",
    "The sample is a phase 3 trial for bacterial infections, testing the efficacy of iv vancomycin plus iv aztreonam and ceftaroline, with specific inclusion and exclusion criteria for subjects.",
    "The sample is a phase 3 trial for neuropathic pain, testing the efficacy of pregabalin (Lyrica) and placebo, with inclusion criteria requiring a diagnosis of peripheral neuropathic pain and a mean weekly pain score of 4 or greater, and exclusion criteria excluding certain diagnoses such as fibromyalgia.",
    "The sample is a phase 3 clinical trial for major depressive disorder with psychotic features, testing the efficacy of mifepristone and placebo, with inclusion and exclusion criteria listed.",
    "This is a phase 3 trial for complicated intra-abdominal infection, testing the efficacy of cxa-201 and metronidazole and meropenem as drugs, with eligibility criteria including surgical intervention within 24 hours and exclusion criteria such as severe renal impairment and allergy to certain antibiotics.",
    "This phase 3 trial is testing the efficacy of ketamine/amitriptyline np-h cream in treating chemotherapy-related peripheral neuropathy in patients with a history of cancer, with specific eligibility criteria and restrictions on concurrent medications.",
    "This phase 3 trial is testing the efficacy of a fixed combination ophthalmic suspension and other drugs in treating open-angle glaucoma and ocular hypertension, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin, canagliflozin, metformin, and sulphonylurea in controlling blood glucose levels, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for precancerous condition using eflornithine and sulindac as drugs, with eligibility criteria including history of surgically resected adenomatous polyp, negative pregnancy test, and no history of allergy to NSAIDs or eflornithine.",
    "This is a phase 3 clinical trial for venous thromboembolism, testing the efficacy of semuloparin sodium and enoxaparin compared to placebo in patients who have undergone knee replacement surgery or revision, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for major depressive disorder using quetiapine fumarate as the drug, with inclusion criteria including a clinical diagnosis of major depressive disorder and exclusion criteria including a known lack of response to previous treatment with quetiapine.",
    "The sample is a phase 3 trial for patients with cerebral infarction, testing the efficacy of aggrenox capsule in reducing the risk of recurrent stroke, with inclusion criteria including age over 50, stable neurological signs, and at least two risk factors such as hypertension or diabetes.",
    "This phase 3 trial is testing the efficacy of azli and placebo in treating cystic fibrosis patients with chronic Burkholderia spp. infection, with eligibility criteria including age, genetic mutations, and chronic infection status, among others.",
    "The sample is a phase 3 trial for the treatment of primary insomnia using eplivanserin and placebo, with inclusion criteria based on DSM-IV-TR criteria and nocturnal polysomnography recordings, and exclusion criteria including current psychiatric disturbances, use of sleep medication or substances affecting sleep/wake, and certain medical conditions. The trial will test the efficacy of the drugs in patients with sleep initiation and maintenance disorders and insomnia, as indicated by the icd-10 codes.",
    "The sample is a phase 3 trial for postmenopausal women experiencing vasomotor symptoms and hot flashes, testing the efficacy of various drugs including 0.5mg drsp / 0.5mg e2 (bay86-4891) and estradiol, with specific eligibility criteria for inclusion and exclusion.",
    "This phase 3 trial is testing the effectiveness of methylphenidate HCl, a drug used to treat attention deficit hyperactivity disorder, on patients who have completed earlier studies without significant drug-related adverse events and meet certain eligibility criteria.",
    "The sample is a phase 3 trial for asthma patients with positive skin prick tests to relevant aeroallergens, testing the efficacy of montelukast sodium and placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial called ACTIVE A, testing the efficacy of clopidogrel and placebo in patients with atrial fibrillation and high risk of vascular events who cannot take oral anticoagulant treatment, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of various drugs including sitagliptin phosphate, metformin hydrochloride, and pioglitazone, with eligibility criteria including age and recent medication history.",
    "The sample is a phase 3 trial for ADHD treatment with atomoxetine hydrochloride, where patients must meet inclusion criteria such as being aged 6 to 18 years old, having ADHD, and not having taken any medication for at least two weeks prior to beginning study treatment, and exclusion criteria such as not having received any treatment within the last 30 days with a drug that has not been approved by their country's appropriate government agency, not having previously experienced any unwanted effects or serious medical events during atomoxetine treatment, and not being judged by the study investigator to be at serious suicidal risk.",
    "This phase 3 trial focuses on de novo renal transplant recipients and tests the efficacy of everolimus, mycophenolate mofetil, basiliximab, cyclosporine a, and corticosteroid in preventing graft rejection.",
    "This phase 3 trial aims to test the effectiveness of ace inhibition, intensified blood pressure control, and add-on angiotensin receptor blockade in children with chronic renal failure, hypertension, and kidney diseases, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 3 trial for metastatic prostate cancer using chemotherapy (taxotere and prednisone) as the drug, with eligibility criteria including confirmed diagnosis of adenocarcinoma of the prostate, unresponsiveness to hormone therapy, and detectable metastases.",
    "The sample is a phase 3 trial for thromboembolism prevention in patients undergoing hip replacement surgery, using the drug exanta, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for osteoporosis, testing the efficacy of lasofoxifene and raloxifene compared to placebo, with eligibility criteria including postmenopausal women with low bone density and exclusion criteria including recent use of osteoporosis treatments or medication for blood clots or seizures.",
    "This phase 3 trial is testing the use of intravenous magnesium in patients undergoing coronary artery bypass surgery with or without valve procedure, who meet certain inclusion criteria and do not have any of the exclusion criteria, for the treatment of coronary artery disease and valvular heart disease.",
    "This phase 3 trial is testing the efficacy of LY2216684, an investigational drug, in treating major depressive disorder in patients who have had a partial response to SSRIs, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for liver cancer patients, testing the efficacy of carboplatin, cisplatin, and doxorubicin hydrochloride, with eligibility criteria including histologically proven hepatoblastoma or hepatocellular carcinoma and standard or high risk disease.",
    "This phase 3 trial is testing the efficacy of e2007, a drug for Parkinson's disease, in patients with predictable motor fluctuations and a good response to levodopa, while excluding patients with certain medical conditions and those taking certain medications.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of spd489 (lisdexamfetamine dimesylate) compared to placebo, with inclusion and exclusion criteria including age, diagnosis, medication history, and medical conditions.",
    "The sample is a phase 3 trial for patients with hyponatremia and congestive heart failure, testing the efficacy of lixivaptan and placebo, with inclusion criteria of patients 18 years or older.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus and cardiovascular disease, testing the efficacy of aliskiren and placebo, with eligibility criteria including specific kidney function and history of CV disease, and exclusion criteria including type 1 diabetes mellitus and recent cardiovascular events.",
    "The sample is a phase 3 trial for chronic pancreatitis, testing the efficacy of triamcinolone and bupivicaine alone, with inclusion criteria of chronic pancreatic-type abdominal pain and exclusion criteria of pregnancy, malignancy, recent acute pancreatitis, elevated INR or low platelet count, allergy to eggs or \"caine\" anesthetics or corticosteroids, and a Beck's depression score >20.",
    "This phase 3 trial is testing the efficacy of biphasic insulin aspart 30 and 50, along with metformin, in treating type 2 diabetes with specific eligibility criteria, including HbA1c levels between 7.5% - 12.0% and BMI between 23-40 kg/sq.m, in patients who are currently treated with premix human insulin twice daily with or without oral antidiabetic drugs for at least 3 months.",
    "The sample is a phase 3 trial for type 2 diabetes, testing the efficacy of dapagliflozin and metformin xr in patients with inadequate glycemic control, with inclusion and exclusion criteria specified.",
    "This is a phase 3 trial for emergency contraception using drugs cdb-2914 and levonorgestrel, with inclusion criteria including women aged 16 or older in the UK, presenting within 120 hours of unprotected intercourse, and with no current use of hormonal contraception.",
    "This phase 3 trial is testing the effectiveness of lacosamide, an antiepileptic drug, on patients with partial epilepsies and partial onset seizures who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This phase 3 trial is testing the efficacy of zonisamide, a drug used to treat partial seizures, in children aged 6 to 18 years who have completed a double-blind study, with specific inclusion and exclusion criteria.",
    "This phase 3 trial focuses on patients with reflux esophagitis and tests the effectiveness of esomeprazole and omeprazole, with eligibility criteria including endoscopic verification of the disease and exclusion criteria including recent use of any PPI or presence of gastric or duodenal ulcer.",
    "The sample is a phase 3 trial for liver transplantation patients using tacrolimus as the drug, with eligibility criteria and exclusion criteria listed, and the icd-10 codes for the disease are also provided.",
    "This is a phase 3 clinical trial for patients with essential hypertension, testing the effectiveness of losartan potassium (+) hydrochlorothiazide, with inclusion criteria of patients previously treated with antihypertensive medications for at least 4 weeks but did not reach the blood pressure goal.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of perindopril-indapamide and gliclazide mr-based glucose lowering drugs, with eligibility criteria including age, history of cardiovascular disease, and risk factors for vascular disease.",
    "This phase 3 trial is testing the efficacy of dalfampridine-er in patients with multiple sclerosis who meet specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for overactive bladder, testing the efficacy of alkalinized xylocaine and placebo, with inclusion and exclusion criteria specified.",
    "This is a phase 3 clinical trial for patients with moderate to moderately severe chronic active ulcerative colitis who are not responding to currently available therapies, and will test the efficacy of cobitolimod compared to placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial is testing the efficacy of aripiprazole and placebo in treating serious behavioral problems in children with autistic disorder, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 clinical trial for low back pain, testing the efficacy of active theramine and active naproxen and naproxen and theramine-like placebo, with inclusion criteria including back pain lasting greater than six weeks and analgesic medication used to treat pain at least 4 out of last 7 days and at least 10 days in the last month.",
    "The sample is a phase 3 trial for diabetes with saxagliptin, metformin, placebo, and pioglitazone as drugs, and the eligibility criteria include having type 2 diabetes and inadequate blood sugar control, while excluding major heart, liver, or kidney problems and pregnancy or breastfeeding.",
    "This phase 3 trial is testing the efficacy of ranibizumab in treating central retinal vein occlusion and macular edema, with strict inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of liraglutide and placebo in treating type 2 diabetes and obesity, with specific inclusion and exclusion criteria, and using a list of icd-10 codes to identify eligible patients.",
    "This phase 3 trial is testing the efficacy of octreotide acetate and tamoxifen citrate in postmenopausal women with potentially curable breast cancer, who have undergone prior treatment, and have specific disease and patient characteristics, as well as prior and concurrent therapy requirements.",
    "This phase 3 trial is testing the efficacy of fentanyl versus placebo in treating chronic pain, osteoarthritis, and low back pain, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for metastatic breast cancer patients with HER-2 overexpression, testing the efficacy of gemcitabine, herceptin, and capecitabine (xeloda) as well as eligibility criteria including prior chemotherapy, measurable disease, and adequate liver and cardiac function.",
    "This phase 3 trial is testing the effectiveness of alendronate and denosumab in treating osteoporosis and osteopenia in postmenopausal women with specific eligibility criteria, including BMD values and exclusion criteria such as certain disorders and medications.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin and metformin combination therapy versus placebo, with inclusion criteria of poorly controlled patients on one or two oral antidiabetic medications and exclusion criteria of patients with a history of type 1 diabetes mellitus or ketoacidosis, recent insulin therapy, or recent use of certain medications.",
    "This phase 3 trial is testing the efficacy of tacrolimus, everolimus, and corticosteroids in liver transplant recipients with confirmed hepatitis C virus status and functioning allografts, while excluding patients with certain medical conditions and those who have received multiple solid organ or islet cell tissue transplants.",
    "The sample is a phase 3 trial for cervical dystonia, testing the efficacy of placebo as a treatment option, with specific inclusion and exclusion criteria for patients who have previously been treated with botulinum toxin type A or B.",
    "This phase 3 trial is testing the efficacy of tiotropium + olodaterol in Japanese patients with chronic obstructive pulmonary disease who meet specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of glimepiride and linagliptin against placebos, with inclusion and exclusion criteria including HbA1c levels, age, BMI, and prior treatments.",
    "The sample is a phase 3 trial for deep venous thrombosis, testing the efficacy of idrabiotaparinux sodium, idraparinux sodium, avidin, and placebo, with inclusion criteria of confirmed acute symptomatic DVT of the lower limbs and exclusion criteria of severe concomitant diseases, active bleeding or high risk for bleeding, pregnancy or childbearing potential without proper contraceptive measures, breastfeeding, known allergy to idraparinux, SSR126517E, or egg proteins, indication of prolonged anticoagulation for other reason than DVT of the lower limbs, symptomatic pulmonary embolism (PE), and life expectancy < 6 months.",
    "This phase 3 trial is testing the efficacy of ipragliflozin, a drug used to treat type 2 diabetes mellitus, on patients who meet specific inclusion criteria, such as having a HbA1c value between 6.5% and 9.5%, and exclusion criteria, such as having type 1 diabetes mellitus or a history of treatment with ASP1941.",
    "The sample is a phase 3 trial for metastatic colorectal cancer using a combination of capecitabine, bevacizumab, and irinotecan, with eligibility criteria including confirmed adenocarcinoma, stage IV disease, and adequate hematologic function.",
    "This is a phase 3 trial for patients with unresectable and/or metastatic renal cell carcinoma, testing the efficacy of sorafenib (Nexavar) as a systemic therapy, with specific eligibility criteria and exclusion criteria for patient selection.",
    "The sample is a phase 3 trial for lung cancer patients with unresectable stage IIIA or IIIB non-small cell carcinoma, using carboplatin and paclitaxel as drugs, and with eligibility criteria including age, performance status, and absence of prior malignancy.",
    "The sample is a phase 3 trial for kidney transplantation and chronic kidney failure, testing the effectiveness of cyclosporine, belatacept li, and belatacept mi, with specific inclusion and exclusion criteria for subjects.",
    "This phase 3 trial is testing the efficacy of dacarbazine, fotemustine, and interferon alfa-2b in treating advanced or recurrent malignant melanoma patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for non-small cell lung cancer with squamous cell, large cell, or adenosquamous carcinoma, testing the drugs cp 751,871 (figitumumab) and erlotinib, with eligibility criteria including prior therapy exclusions and at least one measurable lesion.",
    "The sample is a phase 3 trial for Crohn's disease, testing the efficacy of infliximab and azathioprine in patients with moderate to severe disease activity and specific inclusion criteria, while excluding patients with recent abdominal surgery, ostomy, pregnancy, and other serious illnesses.",
    "The sample is a phase 3 trial for asthma patients, testing the efficacy of fluticasone propionate, fluticasone furoate, and placebo, with inclusion criteria such as pre-bronchodilator FEV1 of 40-90% predicted and exclusion criteria such as history of life threatening asthma and allergies to study drugs.",
    "The sample is a phase 3 trial for Friedreich's ataxia patients using idebenone as a drug, with inclusion and exclusion criteria listed.",
    "This is a phase 3 trial for antiretroviral-experienced adults with HIV-1, testing the efficacy of lopinavir/ritonavir tablets with nucleoside/nucleotide reverse transcriptase inhibitors, and the eligibility criteria includes plasma HIV-1 RNA levels and laboratory analyses for hemoglobin, neutrophil count, platelet count, and ALT/AST levels.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of mra(tocilizumab) and mtx compared to placebos, with specific inclusion and exclusion criteria for patients, including disease duration and previous treatments.",
    "This phase 3 trial is testing the efficacy of ff/gw642444 inhalation powder, ff inhalation powder, gw642444 inhalation powder, and placebo in treating chronic obstructive pulmonary disease (COPD) in patients who meet specific inclusion criteria and do not meet any of the exclusion criteria.",
    "The sample is a phase 3 trial for lymphoblastic lymphoma, testing a combination of 12 drugs including asparaginase, cyclophosphamide, and methotrexate, with eligibility criteria including confirmed LBL diagnosis, negative pregnancy test, and no prior chemotherapy or radiotherapy.",
    "This phase 3 trial is testing the efficacy of menatetranone and alfacalcidol in postmenopausal women with osteoporosis, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for smoking cessation, testing the effectiveness of nicotine patch, placebo, and varenicline on smokers with tobacco dependence and using icd-10 codes F17.220, F17.221, F17.223, F17.290, F17.291, F17.293, Z81.2, Y36.881S, Y36.891S, Y36.880S, Y36.881A, Y36.881D, Y36.890S, Y36.891A, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of dolutegravir, atripla, abacavir/lamivudine, and their placebos in treating human immunodeficiency virus (HIV) infection, with eligibility criteria including antiretroviral-na\u00efve patients with a screening plasma HIV-1 RNA \u22651000 c/mL, negative HLAB*5701 allele assessment, and absence of certain exclusion criteria such as malignancy within the past 5 years and recent history of upper or lower gastrointestinal bleed.",
    "The sample is a phase 3 trial for gastroesophageal reflux disease (GERD) using pantoprazole as the drug, with specific inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of exenatide and placebo in treating type 2 diabetes mellitus patients with suboptimal glycemic control, with inclusion and exclusion criteria including stable doses of certain medications and exclusion of previous participation in similar studies.",
    "This phase 3 trial is testing the efficacy of tocilizumab and placebo in treating moderate to severe rheumatoid arthritis, with specific inclusion and exclusion criteria for patients.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of er niacin/laropiprant and placebo, with inclusion criteria of stable antidiabetic medication for at least 3 months and exclusion criteria of certain medications and medical conditions.",
    "This phase 3 trial is testing the efficacy of aclidinium bromide/formoterol fumarate and aclidinium bromide alone, compared to placebo, in patients with stable moderate to severe chronic obstructive pulmonary disease (COPD) who are at least 40 years old, current or former smokers with a smoking history of at least 10 pack-years, and have a postbronchodilator FEV1/FVC ratio < 70%, with a list of exclusion criteria.",
    "The sample is a phase 3 trial for liver transplantation patients receiving tacrolimus, with inclusion and exclusion criteria listed, and the icd-10 codes for the diseases involved include Z52.6, K71.8, K71.7, A06.4, C22.0, C22.3, and K70.0.",
    "This phase 3 trial is testing the efficacy of daptomycin and vancomycin or semi-synthetic penicillins (ssps) in treating Gram-positive complicated Skin and Soft Tissue Infections (cSSTIs) in patients 65 years or older with infections of sufficient severity to require in-patient hospitalization, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for metastatic breast cancer, testing the efficacy of pegylated liposomal doxorubicin and capecitabine, with inclusion criteria including clinically or pathologically proven metastatic breast cancer and adequate bone marrow, renal and liver functions, and exclusion criteria including prior chemotherapy for metastatic disease and history of cardiac disease with New York Heart Association Class II or greater.",
    "The sample is a phase 3 trial for seasonal allergic rhinitis and SAR, testing the efficacy of bdp hfa and placebo nasal aerosol, with inclusion criteria including a documented history of SAR and sensitivity to seasonal allergens, and exclusion criteria including recent respiratory infections or disorders and active asthma requiring treatment with corticosteroids.",
    "The sample is a phase 3 trial for patients undergoing high-risk non-cardiovascular surgeries, testing the use of esmolol as a beta-blocker, with specific inclusion and exclusion criteria based on medical history and other factors.",
    "This phase 3 trial is testing the efficacy of azli and placebo in treating cystic fibrosis patients with lung infection caused by pseudomonas aeruginosa, with inclusion criteria including age, CF diagnosis, PA presence, FEV1, and chronic/interrupted CF symptoms, and exclusion criteria including administration of any investigational drug or device within 28 days prior to Visit 1 or within 6 half-lives of the investigational drug, administration of any IV, oral, or inhaled antipseudomonal antibiotic within 28 days prior to Visit 1, and history of lung transplantation.",
    "The sample is a phase 3 trial for osteoarthritis of the hand, testing the efficacy of diclofenac sodium gel 1%, with specific inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of Combivent CFC-MDI, Combivent Respimat 20/100 mcg, and Atrovent HFA 42 mcg + albuterol HFA 200 mcg in patients with chronic obstructive pulmonary disease (COPD) who meet specific spirometric criteria and have a smoking history of 10 pack-years or more.",
    "This is a phase 3 trial for chronic hepatitis C infection testing the efficacy of abt-450/r/abt-267, abt-333, ribavirin, and placebo for ribavirin, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of insulin degludec/liraglutide, insulin degludec, and liraglutide in treating type 2 diabetes with specific inclusion and exclusion criteria, including stable doses of 1-2 OADs and a BMI maximum of 40 kg/m^2.",
    "The sample is a phase 3 trial for the treatment of clostridium infections and diarrhea using par-101/opt-80 and vancomycin, with inclusion criteria including CDAD and signed informed consent, and exclusion criteria including life-threatening CDAD, toxic megacolon, pregnancy, concurrent use of diarrheal agents, and participation in other trials.",
    "The sample is a phase 3 trial for severe pneumonia in children aged 2 months to 59 months, testing the efficacy of amoxicillin and benzyl penicillin, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial testing the effectiveness of tolvaptan, a drug used to treat hyponatremia, in patients with cirrhosis, hepatic encephalopathy, and hyponatremia, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of modafinil in treating sleepiness caused by opioids in patients with cancer or pain, with specific inclusion and exclusion criteria, and the drug being the only one listed in the table.",
    "The sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) testing the efficacy of four different inhalers, including atrovent respimat and combivent mdi, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for chronic heart failure patients, testing the effectiveness of olmesartan medoxomil, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for the drug nrp104 in treating attention deficit hyperactivity disorder (ADHD), with inclusion criteria including meeting DSM-IV-TR\u2122 criteria for ADHD and having a baseline ADHD-RS score greater than or equal to 28.",
    "The sample is a phase 3 trial for patients with inoperable stage III non-small cell lung cancer, testing the efficacy of radical radiotherapy treatment with platinum-based chemotherapy, with eligibility criteria including ECOG performance status, life expectancy, and various laboratory values, and the drugs being tested are a control arm and an experimental arm.",
    "This phase 3 trial is testing the drug picoplatin for patients with refractory small cell lung cancer who have had one prior cisplatin or carboplatin-containing chemotherapy regimen, and meet specific eligibility criteria.",
    "The sample is a phase 3 trial for age-related macular degeneration using bevacizumab as the drug, with inclusion criteria of na\u00efve subfoveal choroidal neovascularization and best-corrected visual acuity less than 20/200, and exclusion criteria of previous treatments and any other condition able to limit the visual improvement.",
    "The sample is a phase 3 trial for open-angle glaucoma and ocular hypertension, testing the efficacy of brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension, brinzolamide ophthalmic suspension, 1%, and brimonidine tartrate ophthalmic solution, 0.2%, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with Bipolar I Disorder, Most Recent Episode Manic, using risperidone as the drug, and the eligibility criteria includes a history of at least one documented manic or mixed episode that required treatment prior to study initiation, and exclusion criteria includes patients who meet DSM-IV criteria for Schizoaffective Disorder or for rapid cycling.",
    "The sample is a phase 3 trial for non-small cell lung cancer, testing the efficacy of cisplatin, ifosfamide, gemcitabine, and docetaxel, with eligibility criteria including advanced stage III or IV disease and no prior chemotherapy treatment.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of olodaterol (bi 1744) and placebo in patients with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of galiximab and rituximab in treating relapsed or progressive non-Hodgkin's lymphoma, with specific eligibility criteria and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of lixisenatide, basal insulin, and metformin in treating insufficiently controlled type 2 diabetes mellitus, with a list of exclusion criteria including history of hypoglycemia unawareness, uncontrolled hypertension, and history of allergic reaction to GLP-1 agonist.",
    "The sample is a phase 3 trial for asthma, testing the efficacy of montelukast and placebo in non-smoking participants aged 6 to 14 years with a history of asthma exacerbation associated with a cold within the past year, and a documented history of asthma that required treatment with any asthma medication within 6 months prior to Visit 1. The trial has inclusion and exclusion criteria, and the diseases are limited to asthma with specific ICD-10 codes.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of ly2963016, lantus, and oams, with inclusion criteria including a BMI of less than or equal to 45 kg/m^2 and exclusion criteria including significant liver, cardiac, or gastrointestinal disease.",
    "This is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of insulin degludec/insulin aspart and biphasic insulin aspart 30, with inclusion criteria including HbA1c levels between 7.0-10.0% and exclusion criteria including recent treatment with oral antidiabetic drugs (OADs) and cardiovascular disease within the last 6 months.",
    "This phase 3 trial is testing the efficacy of ramelteon and placebo in treating chronic insomnia, with specific inclusion and exclusion criteria, and a list of disallowed medications.",
    "The sample is a phase 3 trial for the treatment of Lennox-Gastaut syndrome, testing the efficacy of rufinamide and placebo drugs, with inclusion and exclusion criteria for participants.",
    "This is a phase 3 clinical trial for patients with multiple myeloma, testing the drug bortezomib, with inclusion criteria including adequate renal function and exclusion criteria including hypersensitivity to bortezomib or other serious medical or psychiatric illness likely to interfere with participation in the study.",
    "This phase 3 clinical trial is testing the efficacy of placebo, aflibercept, and folfiri drugs on patients with metastatic colorectal neoplasms and neoplasm metastasis who have had one prior line of treatment with oxaliplatin-based chemotherapy, and the eligibility criteria includes prior treatment with bevacizumab.",
    "The sample is a phase 3 trial for urinary incontinence, detrusor overactivity, and urinary urgency, testing the efficacy of botulinum toxin a, bladder detrusor muscle injection and vehicle saline as placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing multiple drugs, including dexamethasone and cisplatin, on patients with symptomatic multiple myeloma who have had at least one prior line of chemotherapy, and have met certain eligibility criteria.",
    "This phase 3 trial is testing the efficacy of tacrolimus, leflunomide, and prednisone in treating lupus nephritis in patients who meet specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for ulcerative colitis, testing the effectiveness of mesalamine, with inclusion criteria for patients aged 18-75 with moderately active flare of the disease, and exclusion criteria for patients with isolated proctitis or comorbidities that may compromise safety or interpretation of study results.",
    "The sample is a phase 3 trial for pasireotide, a drug used to treat Cushing's disease, with specific inclusion and exclusion criteria, and the disease is confirmed by ACTH-dependent diagnosis.",
    "This phase 3 trial is testing the effectiveness of lurasidone in treating schizophrenia, with eligible subjects being 18-60 years old, diagnosed with schizophrenia or schizoaffective disorder, and able to safely have an MRI, while exclusion criteria include being treatment resistant or intolerant to lurasidone, having tremors or shaking of the limbs, being pregnant or breastfeeding, and having a history of alcohol, cannabis or cocaine abuse within two weeks prior to the study.",
    "This phase 3 trial is testing the efficacy of Grazax and Aerius in treating grass pollen induced allergic rhinoconjunctivitis, with eligibility criteria including a clinical history of the disease, positive skin prick test response to Phleum pratense, and absence of certain exclusion criteria.",
    "The sample is a phase 3 trial for patients with breast, lung, or prostate cancer and bone metastases, testing the efficacy of zoledronic acid and sm-153, with eligibility criteria including a minimum diagnostic workup and adequate bone marrow function, and exclusion criteria including brain metastases, spinal cord compression, and prior treatment with Strontium-89 or Samarium-153 for bone metastases.",
    "This phase 3 trial is testing the efficacy of GSK1349572 and raltegravir in antiretroviral-na\u00efve patients with HIV-1 infection, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 1 diabetes, testing the efficacy of human insulin inhalation powder, injectable insulin, and insulin glargine, with inclusion criteria of non-smokers with normal lung function and exclusion criteria of significant pulmonary, hepatic, or renal disease, severe congestive heart failure, active malignancy, and systemic glucocorticoid therapy.",
    "This phase 3 trial is testing the drug azli on patients with cystic fibrosis and positive lower respiratory tract culture for pseudomonas aeruginosa, with eligibility criteria including stable respiratory symptoms and exclusion criteria including hypersensitivity to aztreonam and beta-agonists.",
    "This phase 3 trial is testing the efficacy of testosterone gel and placebo gel in treating hypoactive sexual desire disorder in postmenopausal females with cardiovascular risk factors and a clinical diagnosis of HSDD.",
    "The sample is a phase 3 trial for type 2 diabetes, testing the efficacy of dapagliflozin and metformin, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of vortioxetine and venlafaxine extended release, with inclusion criteria including a MADRS total score \u226526 and a CGI-S score \u22654, and exclusion criteria including non-compliance with the protocol or unsuitability for any reason.",
    "The sample is a phase 3 trial for the treatment of bipolar disorder with asenapine and olanzapine, with inclusion criteria requiring completion of previous studies and exclusion criteria excluding patients with unstable medical conditions or significant laboratory abnormalities.",
    "The sample is a phase 3 trial for hypertension using amlodipine as the drug, with eligibility criteria based on completion of a preceding study and treatment compliance rate, and exclusion criteria based on meeting discontinuation criteria in the preceding study.",
    "This phase 3 trial is testing the drug lonidamine on males aged 50-80 with benign prostatic hyperplasia and enlarged prostate, with inclusion criteria including LUTS, prostate volume >30cc, and I-PSS >12, and exclusion criteria including prior treatment with alpha-blockers and/or herbal supplements in the past 2 weeks, and active cardiac, renal or hepatic disease.",
    "The sample is a phase 3 trial for idiopathic restless legs syndrome using the drug rotigotine, with inclusion criteria requiring completion of a previous maintenance and taper period, and exclusion criteria including ongoing serious adverse events related to the trial medication or any medical or psychiatric condition that could compromise participation.",
    "The sample is a phase 3 trial for the treatment of painful diabetic peripheral neuropathy using pregabalin, with inclusion criteria being patients who completed a 13-week treatment of the same disease in a previous study and exclusion criteria being patients who experienced serious adverse events or treatment non-compliance in the previous study.",
    "This is a phase 3 trial for heart failure patients with impaired renal function, testing the efficacy of rolofylline and placebo, with a list of exclusion criteria including various medical conditions and allergies.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of linagliptin versus placebo, with eligibility criteria including HbA1c levels and exclusion criteria including prior use of DPP-4 inhibitors and GLP-1 agonists.",
    "The sample is a phase 3 trial testing the drug tolvaptan for the treatment of hyponatremia in patients with specific inclusion and exclusion criteria, including clinically significant symptoms of hyponatremia and no recent prior treatment with certain medications.",
    "This phase 3 trial is testing the effectiveness of Prograf and LCP-tacro in treating tremors in kidney transplant recipients who are taking stable doses of the drugs, and have symptomatic drug-induced hand tremors associated with the use of these drugs.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) with a list of drugs including budesonide/formoterol pmdi, budesonide pmdi, and formoterol turbuhaler, and eligibility criteria including a clinical diagnosis of COPD, smoking history of 10 or more pack years, and a history of at least one COPD exacerbation requiring a course of oral steroids and/or antibiotics within 1-12 months before first visit.",
    "The sample is a phase 3 trial for thromboembolism, testing the efficacy of dabigatran etexilate 150 mg and warfarin, with eligibility criteria including acute DVT or PE and exclusion criteria such as contraindications to anticoagulant therapy and recent unstable cardiovascular disease.",
    "This phase 3 trial is testing the efficacy of opc-34712 + adt and placebo + adt in treating major depressive disorder with inadequate response to no more than three adequate antidepressant treatments, with a list of diseases and icd-10 codes provided as well as inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of peginesatide and epoetin alfa in treating anemia in patients with chronic renal failure on hemodialysis, with specific inclusion and exclusion criteria. The trial includes patients with chronic kidney disease and anemia, and the icd-10 codes for these diseases are provided.",
    "The sample is a phase 3 trial for HIV infections and AIDS, testing the efficacy of vicriviroc and placebo in ART-experienced patients with resistance to at least 2 drug classes, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for Crohn's disease testing the efficacy of infliximab or placebo on single or multiple draining fistulas, with inclusion criteria of Crohn's disease of at least 3 months' duration and exclusion criteria of Crohn's disease complications for which surgery might be indicated and positive stool culture.",
    "The sample is a phase 3 trial for pregnant women with newborn diseases, sepsis, and puerperal infection, testing the effectiveness of chlorhexidine as a topical antiseptic solution, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for schizophrenia with icd-10 codes F20.0, F20.1, F20.2, F20.3, F20.5, F20.89, and F20.9, using asenapine and olanzapine as drugs, and the eligibility criteria includes meeting demographic and procedural criteria of a previous trial and demonstrating compliance.",
    "The sample is a phase 3 trial for bipolar I disorder, testing the efficacy of inhaled loxapine 5mg and 10mg as compared to placebo, with inclusion criteria of adult patients with acute agitation and exclusion criteria of drug or alcohol dependence and recent use of benzodiazepines or other hypnotics.",
    "This phase 3 trial is testing the efficacy of Visanne and placebo in treating endometriosis-associated pelvic pain, with a list of specific ICD-10 codes for endometriosis, and eligibility criteria including exclusion of pregnant or lactating women and those with hormone dependent tumors.",
    "This phase 3 trial is testing the effectiveness of PENNSAID, a topical medication, in treating moderate to severe osteoarthritis of the knee and coagulopathy in adults over 55 who are on stable anticoagulant therapy and meet other eligibility criteria.",
    "This phase 3 trial is testing the efficacy of Generex Oral-Lyn and regular human insulin in type 1 diabetes mellitus patients with specific inclusion and exclusion criteria, including a BMI <27 and HbA1c of 8.5% or less, while excluding patients with unstable retinopathy, nephropathy, or neuropathy, and those with a history of drug or alcohol abuse.",
    "This is a phase 3 clinical trial for venous thromboembolism using open-label semuloparin sodium, placebo, and semuloparin sodium as drugs, with eligibility criteria including standard surgery for fracture of the upper third of the femur and exclusion criteria including high risk of bleeding and end stage renal disease or patient on dialysis.",
    "The sample is a phase 3 trial for patients with acute symptoms of Bipolar I Disorder, using aripiprazole as the drug, and the eligibility criteria is not specified.",
    "The sample is a phase 3 trial for hypertension, testing the efficacy of various drug combinations (valsartan + amlodipine, valsartan + hctz, amlodipine + hctz, valsartan + amlodipine + hctz) with specific eligibility criteria based on blood pressure levels, and exclusion criteria based on the number of antihypertensive drugs taken and arm circumference.",
    "This is a phase 3 trial for lixisenatide and placebo in patients with type 2 diabetes mellitus, with a list of exclusion criteria including uncontrolled hypertension, history of myocardial infarction or stroke, and use of systemic glucocorticoids within the previous 3 months.",
    "This is a phase 3 trial for overactive bladder syndrome, testing the efficacy of fesoterodine and placebo in men aged 40 and above who have persistent symptoms of OAB with urinary frequency and micturition-related urgency episodes, and are on a stable and well-tolerated dose of an alpha-blocker prescribed for LUTS for at least 6 weeks prior to screening, with exclusion criteria including contraindication to fesoterodine, previous history of acute urinary retention requiring catheterization or severe voiding difficulties, and inability to follow study procedures.",
    "This phase 3 trial is testing the effectiveness of eplerenone, a drug, in treating chronic kidney disease, with specific inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of pentoxyphilline and tocopherol in treating chronic hepatitis C and liver fibrosis in patients who are non-responders to interferon alfa or ribavirin, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for attention deficit hyperactivity disorder using the drug Vyvanse (lisdexamfetamine dimesylate) and includes eligibility criteria for subjects such as age, medical history, and previous exposure to NRP104.",
    "This phase 3 trial is testing the effectiveness of azilsartan medoxomil and placebo in treating essential hypertension, with inclusion and exclusion criteria outlined.",
    "The sample is a phase 3 trial for hypertension and high blood pressure, testing the effectiveness of ramipril and hydrochlorothiazide, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of dapagliflozin and placebo, with inclusion and exclusion criteria based on insulin regimen and renal function.",
    "This phase 3 trial is testing the effectiveness of megestrol acetate and oxandrolone 20 mg in treating patients with unspecified adult solid tumor and weight changes, with specific eligibility criteria including confirmed solid tumor, weight loss history, and normal serum creatinine and bilirubin levels.",
    "This phase 3 trial is testing the efficacy of fluticasone propionate/formoterol fumarate 100/10, fluticasone propionate 100, and formoterol fumarate 10 in treating asthma, with eligibility criteria including a history of asthma for at least 12 months and FEV-1 of 60-85% of predicted normal values, while exclusion criteria include life-threatening asthma within the past year and history of systemic corticosteroid medication within 3 months before the Screening Visit.",
    "This phase 3 trial aims to test the efficacy of trimethoprim-sulfamethoxazole and placebo in treating vesicoureteral reflux and urinary tract infections in children aged 2 months to 6 years, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for patients with diffuse large B-cell non-Hodgkin's lymphoma, testing the effectiveness of the CHOP regimen, with eligibility criteria including age, disease characteristics, and prior concurrent therapy restrictions.",
    "The sample is a phase 3 trial for postmenopausal females with oestrogen and/or progesterone receptor positive breast cancer, testing the efficacy of fulvestrant and anastrozole, with specific inclusion and exclusion criteria, and a list of icd-10 codes for the disease.",
    "The sample is a phase 3 trial for non small cell lung carcinoma, testing the efficacy of pemetrexed, gemcitabine, and cisplatin, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for hepatocellular carcinoma testing the efficacy of sirolimus and other drugs, with specific inclusion and exclusion criteria listed.",
    "This is a phase 3 trial for restless legs syndrome, testing the efficacy of ropinirole extended release (xr) in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This phase 3 clinical trial is testing the efficacy of mesalazine slow-release granules and mesalazine liquid enema in treating newly diagnosed or relapsing mild to moderate ulcerative colitis patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "The sample is a phase 3 trial for hepatocellular carcinoma, testing the efficacy of sunitinib malate and sorafenib, with eligibility criteria including histologically-confirmed diagnosis, measurable disease, Child-Pugh class A, ECOG PS 0 or 1, and adequate organ function.",
    "This phase 3 trial is testing the efficacy of vi-0521, topiramate, and phentermine in treating obesity in patients with specific inclusion and exclusion criteria, including age, BMI, and absence of certain medical conditions.",
    "This phase 3 trial is testing the efficacy of idelalisib, rituximab, and placebo in treating previously treated recurrent chronic lymphocytic leukemia patients who are not fit for cytotoxic therapy due to chemotherapy-induced bone marrow damage or comorbidities.",
    "This phase 3 trial is testing the efficacy of dolutegravir, darunavir, and ritonavir in treating HIV-1 infected adults with a screening plasma HIV-1 RNA greater than or equal to 1000copies/mL, and includes eligibility criteria and exclusion criteria.",
    "The sample is a phase 3 trial testing the efficacy of enoxaparin and apixaban in preventing deep vein thrombosis and pulmonary embolism in patients undergoing hip replacement surgery, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of lamotrigine in treating epilepsy with partial seizures, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD), testing the efficacy of aclidinium bromide and tiotropium compared to placebo, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for pain, with icd-10 codes including N50.82, R07.2, R07.82, R10.13, R10.33, R14.1, and R52, testing the drugs 4975 and placebo for patients undergoing bunionectomy surgery, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for graft versus host disease, testing the efficacy of methylprednisolone and placebo as treatments, with specific inclusion and exclusion criteria for patients.",
    "This phase 3 trial is testing the efficacy of formoterol/fluticasone, foraseq\u00ae, and fluticasone in treating persistent asthma in patients aged 12 and above, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing intensive management or tight control versus standard management in patients with psoriatic arthritis, with inclusion criteria including less than 24 months disease duration and active disease, and exclusion criteria including previous treatment with DMARDs and use of investigational agents within 4 weeks prior to randomisation.",
    "The sample is a phase 3 trial testing the drug rebamipide for the treatment of keratoconjunctivitis sicca, with specific inclusion and exclusion criteria listed in the eligibility criteria section.",
    "This phase 3 trial is testing the efficacy of 0.15% azelastine hydrochloride and placebo in treating moderate to severe seasonal allergic rhinitis, with eligibility criteria including a positive skin test to a prevalent Texas Mountain Cedar allergen and exclusion criteria such as the presence of nasal mucosal erosion or chronic sinusitis.",
    "This is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of candesartan in reducing blood pressure, with specific inclusion and exclusion criteria, and using retinal photograph grading as a measure of severity.",
    "This phase 3 trial is testing the effectiveness of valganciclovir and ganciclovir in treating cytomegalovirus infections in patients receiving allogeneic peripheral blood stem cell transplant, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for tesamorelin and placebo for tesamorelin in treating lipodystrophy and HIV infections, with inclusion criteria of completing a previous study and signed informed consent, and exclusion criteria of fasting blood glucose >8.33 mmoL at the end of the previous study.",
    "The sample is a phase 3 trial for asthma and lung diseases, testing the effectiveness of albuterol, colchicine, adrenal cortex hormones, and adrenergic-beta agonists, with specific eligibility criteria varying for each study.",
    "This phase 3 trial aims to test the efficacy of various doses and combinations of glimepiride and atorvastatin in treating type 2 diabetes mellitus patients with cardiovascular risk factors, with eligibility criteria including stable metformin monotherapy and HbA1c levels between 7.0% and 9.5%.",
    "The sample is a phase 3 trial for major depressive disorder using quetiapine fumarate as the drug, with inclusion criteria including a clinical diagnosis of major depressive disorder and exclusion criteria including a known lack of response to previous treatment with quetiapine.",
    "The sample is a phase 3 trial for non-Hodgkin's lymphoma using rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone/prednisolone, with specific eligibility criteria including CD20-positive follicular lymphoma and no prior treatment.",
    "The sample is a phase 3 trial for thromboembolism, testing the effectiveness of warfarin and dabigatran etexilate as anticoagulant therapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for overactive bladder using fesoterodine fumarate as the drug, with inclusion criteria of OAB symptoms and dissatisfaction with tolterodine therapy, and exclusion criteria of contraindications to fesoterodine usage and significant hepatic and renal disease or other significant unstable diseases.",
    "The sample is a phase 3 trial testing the efficacy of sitagliptin and glipizide, along with their placebos, in treating type 2 diabetes mellitus and chronic renal insufficiency, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for migraine without aura, testing the efficacy of sumatriptan succinate / naproxen sodium versus placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the efficacy of methylphenidate 20 mg long-acting capsules in treating Attention-Deficit Hyperactivity Disorder (ADHD) in children aged 6-12, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for pediatric patients with refractory partial onset seizures, testing the efficacy of levetiracetam, with inclusion and exclusion criteria listed, and the diseases are epilepsy with partial onset, and the drug is levetiracetam.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus using the drug ipragliflozin, with inclusion criteria including HbA1c value between 6.5 and 9.5% and BMI between 20.0 and 45.0kg/m2, and exclusion criteria including type 1 diabetes mellitus and significant renal, hepatic or cardiovascular diseases.",
    "The sample is a phase 3 trial for patients with schizophrenia and acute agitation, testing the efficacy of inhaled loxapine 5 mg and 10 mg compared to placebo, with inclusion and exclusion criteria listed.",
    "This phase 3 clinical trial is testing the efficacy of fimasartan and fimasartan/hctz combination in treating essential hypertension in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of abatacept and methotrexate, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of three drugs (Leo 90105, Dovonex, and Rinderon-DP) on psoriasis patients with specific eligibility criteria, including a minimum m-PASI score and a target lesion size, and exclusion criteria such as recent systemic treatments and other skin conditions.",
    "This phase 3 trial is testing the effectiveness of ziprasidone oral capsules on schizophrenia patients who participated in a previous study, with specific inclusion and exclusion criteria, and the disease is identified by the icd-10 codes.",
    "The sample is a phase 3 trial for ocular hypertension using bimatoprost/timolol fixed combination as the drug, with inclusion criteria of clinical diagnosis of glaucoma or ocular hypertension in both eyes and exclusion criteria of uncontrolled medical conditions and contraindication to beta-adrenoceptor antagonist therapy.",
    "The sample is a phase 3 clinical trial for patients with B-cell chronic lymphocytic leukemia, testing the efficacy of rituximab, cyclophosphamide, and fludarabine phosphate, with eligibility criteria including specific disease characteristics and patient characteristics.",
    "The sample is a phase 3 trial for acute coronary syndrome, testing the efficacy of ticagrelor and clopidogrel, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of carboplatin, cisplatin, doxorubicin hydrochloride, and paclitaxel in treating patients with primary stage III or stage IV or recurrent endometrial carcinoma, with specific eligibility criteria, including platelets >= 100,000/mcl and a Gynecologic Oncology Group (GOG) performance status of 0, 1, or 2.",
    "This phase 3 trial is testing the efficacy of infliximab and placebo in treating diabetic macular edema and retinopathy, with specific inclusion and exclusion criteria for eligible patients.",
    "The sample is a phase 3 trial for the treatment of bipolar disorder with quetiapine fumarate (seroquel) sr, targeting patients with a documented diagnosis of bipolar disorder and exclusion criteria including substance or alcohol abuse or dependence, and current suicide risk or suicide attempt within last 6 months.",
    "This phase 3 trial is testing the efficacy of zonisamide and carbamazepine in treating newly diagnosed epilepsy patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This phase 3 trial is testing the efficacy of docetaxel, capecitabine, epirubicin, and cyclophosphamide in treating operable invasive adenocarcinoma of the breast with HER2 negative tumors, and includes eligibility criteria such as age, performance status, and laboratory results.",
    "This is a phase 3 trial for major depressive disorder, testing the efficacy of an antidepressant combined with spd489 (lisdexamfetamine dimesylate) compared to placebo, with strict inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for fibromyalgia, testing the drug pregabalin, with inclusion criteria based on ACR criteria for fibromyalgia and exclusion criteria for patients who experienced serious adverse events during a previous fibromyalgia study.",
    "The sample is a phase 3 trial for cystic fibrosis using tobramycin as the drug, with eligibility criteria including successful completion of the core study, at least 6 years of age, and both males and females being eligible.",
    "This phase 3 trial is testing the efficacy of cisplatin, etoposide, and docetaxel in treating non-small cell lung cancer patients with unresectable Stage IIIA or Stage IIIB disease, and determining eligibility for consolidation therapy based on various criteria.",
    "This phase 3 trial is testing the efficacy of sr34006 and vitamin K antagonist in patients with atrial fibrillation and risk factors for stroke, with eligibility criteria including ECG-documented AF and exclusion criteria including active bleeding or high risk of bleeding.",
    "This phase 3 trial is testing the effectiveness of pramlintide in treating type 2 diabetes mellitus in obese patients who are on stable insulin doses, with a list of inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for acute coronary syndrome, testing the efficacy of clopidogrel, prasugrel, and commercially-available aspirin, with specific eligibility and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of docetaxel, estramustine phosphate sodium, ketoconazole, and therapeutic hydrocortisone in treating prostate cancer patients with rising PSA levels and Gleason score 7 or higher, while meeting specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of mometasone furoate/formoterol combination and formoterol mdi compared to placebo in treating moderate to severe chronic obstructive pulmonary disease (COPD) in patients with a smoking history of at least 10 pack years, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for the treatment of opioid-induced constipation (OIC) using the drugs NKTR-118 and placebo, with inclusion criteria including confirmed OIC and stable opioid regimen, and exclusion criteria including cancer-related pain and gastrointestinal issues.",
    "The sample is a phase 3 trial for chronic hepatitis C infection, testing the efficacy of abt-450/r/abt-267, abt-333, and ribavirin, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for bipolar disorder using ziprasidone hcl (oral) as the drug, with inclusion criteria based on risk factors for metabolic syndrome and exclusion criteria including contraindications to ziprasidone and pre-existing medical conditions that may confound the evaluation of the study drug.",
    "The sample is a phase 3 trial for hyperparathyroidism and chronic kidney disease, testing the efficacy of sevelamer carbonate and placebo in patients with eGFR < 60 ml/min and excluding those with primary parathyroid disease.",
    "This phase 3 trial is testing the effectiveness of adriamycin, cyclophosphamide, and taxol in treating HER2-positive invasive adenocarcinoma in breast cancer patients who meet specific eligibility criteria.",
    "This is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of insulin degludec in combination with metformin and other OADs, with specific inclusion and exclusion criteria, and the trial will include patients with specific icd-10 codes for diabetes.",
    "The sample is a phase 3 trial for patients with moderate to severe stable chronic obstructive pulmonary disease (COPD), testing the efficacy of nva237 and placebo drugs, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for a combination of drugs, hzt-501 and ibuprofen, for the treatment of multiple types of chronic pain, with specific eligibility criteria including a requirement for daily NSAID use and completion of a previous treatment period.",
    "This phase 3 trial is testing the efficacy of gsk2118436 and dacarbazine in treating advanced or metastatic melanoma that is BRAF mutation positive, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for HIV infections, testing the efficacy of darunavir and ritonavir as antiretroviral treatments, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of indacaterol and placebo to indacaterol, with inclusion criteria including a smoking history of at least 10 pack-years and post-bronchodilator FEV1 <80% and \u226530% of the predicted normal value, and exclusion criteria including a history of lung cancer and certain cardiovascular comorbid conditions.",
    "The sample is a phase 3 trial for breast cancer patients testing the effectiveness of exemestane drug in reducing the risk of developing breast cancer in postmenopausal women with certain risk factors and eligibility criteria.",
    "The sample is a phase 3 trial for major depressive disorder using vortioxetine (lu aa21004) as the drug, with inclusion criteria of patients who completed a short-term treatment study for MDD and exclusion criteria of any current psychiatric disorder other than MDD, female patients of childbearing potential who are not using effective contraception, and use of any psychoactive medication.",
    "The sample is a phase 3 clinical trial testing the efficacy of single-dose iv oritavancin diphosphate and iv vancomycin in treating acute bacterial skin and skin structure infections caused by Gram-positive pathogens, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing tocilizumab and DMARDs against placebo, with inclusion and exclusion criteria listed, and the trial includes patients who have been on stable doses of permitted DMARDs for at least 8 weeks.",
    "This is a phase 3 trial for HIV-associated neuropathic pain, testing the efficacy of pregabalin and placebo, with inclusion criteria including confirmed HIV diagnosis, moderate to severe pain, and exclusion criteria including use of neuroregenerative agents or neurotoxic chemotherapeutic agents.",
    "The sample is a phase 3 trial for psoriasis, testing the drugs cp-690,550 and placebo/cp-690,550, with inclusion criteria of moderate to severe plaque psoriasis and a PASI score of 12, and exclusion criteria of non-plaque or drug induced forms of psoriasis and uncontrolled significant medical conditions.",
    "This phase 3 trial is testing the efficacy of insulin degludec/insulin aspart in insulin-naive patients with type 2 diabetes who are currently on metformin or metformin in combination with one or two additional oral anti-diabetic drugs, and have an HbA1c between 7.0-10.0%, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for patients with ocular hypertension or glaucoma, testing the efficacy of bimatoprost/timolol fixed combination ophthalmic solution in lowering intraocular pressure, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for tiotropium in patients with chronic obstructive pulmonary disease (COPD), with inclusion criteria based on age, smoking history, and lung function, and exclusion criteria based on cardiac and pulmonary conditions, malignancy, tuberculosis, and hypersensitivity to anticholinergic drugs.",
    "The sample is a phase 3 trial for hypercholesterolemia and dyslipidemia, testing the efficacy of abt-335 and rosuvastatin calcium, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for schizophrenia, testing the efficacy of asenapine and olanzapine, with inclusion criteria including a diagnosis of schizophrenia and persistent negative symptoms, and exclusion criteria including other psychiatric disorders and unstable medical conditions.",
    "This phase 3 trial is testing the efficacy of maxalt 10mg mlt plus caffeine 75mg and maxalt 10mg mlt plus placebo compared to placebo + placebo in treating migraine with or without aura in subjects aged 18-65 with a 1 year history of 1-6 migraine attacks per month, who have successfully treated a migraine attack with a triptan medication, and meet other inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for renal transplantation patients, testing the efficacy of enteric-coated mycophenolate sodium (ec-mps) and includes inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial is testing the efficacy of BMS-790052, pegylated-interferon alfa 2a, and ribavirin in treating chronic HCV genotype 4 infection in participants with no previous exposure to interferon, RBV, or HCV direct antiviral agents, and with a liver biopsy demonstrating the absence of cirrhosis.",
    "This phase 3 trial is testing the efficacy of lixisenatide, exenatide, and metformin in treating type 2 diabetes mellitus that is insufficiently controlled with metformin, with a list of exclusion criteria including various medical conditions and medication use.",
    "This phase 3 trial is testing the efficacy of Exparel 266 mg and placebo in reducing postoperative pain in patients undergoing thoracotomy, with specific inclusion and exclusion criteria related to medication use, medical history, and body weight.",
    "The sample is a phase 3 trial for chronic hepatitis B, testing the efficacy of pegylated interferon alpha-2b, with inclusion criteria including positive hepatitis B surface antigen and e antigen, and exclusion criteria including recent antiviral treatment and significant hepatic disease from other etiologies.",
    "The sample is a phase 3 trial for iron deficiency anemia, testing the efficacy of ferumoxytol and iron sucrose in participants with specific inclusion and exclusion criteria, including a history of unsatisfactory oral iron therapy and a hemoglobin level below 10.0 g/dL.",
    "The sample is a phase 3 trial for lupus nephritis and membranous glomerulonephritis, testing the efficacy of prednisolone and mycophenolate mofetil or prednisolone and tacrolimus, with eligibility criteria including abnormal urine protein excretion and biopsy-proven membranous lupus nephritis.",
    "The sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) testing the efficacy of multiple drugs including gsk573719/gw642444 and tiotropium bromide, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of folate, methotrexate, methylprednisolone, placebo, and rituximab, with inclusion criteria including RA for \u2265 2 months and patients naive to methotrexate treatment.",
    "The sample is a phase 3 trial for partial seizure disorder, epilepsy, and seizures, using topiramate and placebo as drugs, with eligibility criteria including age, weight, and antiepileptic drug use.",
    "This phase 3 trial is testing the drug Nexavar (sorafenib) on patients with advanced renal cell carcinoma who have failed prior systemic therapy, with eligibility criteria including age, performance status, and use of adequate birth control methods.",
    "The sample is a phase 3 trial for preladenant and rasagiline in patients with moderate to severe idiopathic Parkinson's disease who are experiencing motor fluctuations, with inclusion and exclusion criteria listed, and the study will test the efficacy of the drugs listed.",
    "This phase 3 trial is testing the efficacy of docetaxel and gemcitabine in treating unresectable, locally recurrent, or metastatic breast cancer in pre-treated female patients with specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of sitagliptin and placebo in treating type 2 diabetes mellitus in patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for locally advanced breast cancer, testing the drugs trastuzumab, doxorubicin, paclitaxel, and cmf, with eligibility criteria including female patients over 18 years old and exclusion criteria of previous therapy for any invasive malignancy.",
    "The sample is a phase 3 trial for bacterial pneumonia, testing the efficacy of ceftaroline fosamil for injection, ceftriaxone, and placebo, with inclusion criteria of initial hospitalization or treatment in an emergency room or urgent care setting and exclusion criteria of infections resistant to ceftriaxone and history of any hypersensitivity or allergic reaction to any \u00df-lactam antimicrobial.",
    "The sample is a phase 3 trial for rheumatoid arthritis patients who have had a disease flare after initial response to infliximab, with drugs including infliximab increased frequency, infliximab increased dose, and infliximab control, and eligibility criteria including ACR criteria for RA and DAS28 score improvement.",
    "The sample is a phase 3 trial for allergic asthma, testing the efficacy of omalizumab, placebo, and fluticasone as drugs, with eligibility criteria including a positive prick skin test to at least one perennial allergen and a diagnosis of moderate or severe persistent asthma.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of abatacept and infliximab in combination with methotrexate, with inclusion criteria including a diagnosis of rheumatoid arthritis and prior treatment with methotrexate, and exclusion criteria including previous treatment with an approved biologic drug and severe or recurrent bacterial infection.",
    "The sample is a phase 3 trial for overactive bladder, using normal saline (placebo) as the drug, with specific inclusion and exclusion criteria related to neurogenic overactive bladder due to spinal cord injury or multiple sclerosis, and inadequate response to anticholinergic medication.",
    "This phase 3 trial is testing the efficacy of sorafenib, paclitaxel, and carboplatin versus placebo, paclitaxel, and carboplatin in patients with non-small-cell lung carcinoma who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for generalized anxiety disorder, testing the effectiveness of quetiapine fumarate and escitalopram oxylate, with inclusion and exclusion criteria listed, including the requirement for a clinical diagnosis of GAD and the exclusion of pregnant or lactating females and those with a history of stroke or TIA.",
    "This phase 3 trial is testing the effectiveness of obinutuzumab, rituximab, and chlorambucil in treating previously untreated chronic lymphocytic leukemia in adults with CD20+ B-cell CLL, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of clarithromycin and placebo in treating active Crohn's disease in patients who meet specific inclusion criteria, while excluding those with certain complications or sensitivities to the drug, and who have not made any changes to their medication for Crohn's disease in the previous month.",
    "The sample is a phase 3 trial for restless legs syndrome, testing the drug rotigotine, with inclusion criteria of idiopathic RLS and exclusion criteria of secondary RLS, history of sleep disturbances, and symptomatic orthostatic hypotension.",
    "This phase 3 trial is testing the effectiveness of valsartan and enalapril, two blood pressure medications, in treating hypertension in children ages 6-17 who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for patients with ongoing significant hemorrhage, testing the effectiveness of tranexamic acid and sodium chloride 0.9%, with eligibility criteria based on age and uncertainty of antifibrinolytic therapy.",
    "The sample is a phase 3 trial for asthma patients aged 6 months to 5 years, testing the efficacy of montelukast sodium and placebo, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for patients with partial epilepsy and the drug being tested is levetiracetam, with inclusion criteria including confirmed diagnosis and stable anti-epileptic drug treatment, and exclusion criteria including treatable seizure etiology and history of status epilepticus.",
    "This phase 3 trial focuses on kidney transplantation and uses tacrolimus, mycophenolate mofetil, and steroids as drugs, with eligibility criteria including patients over 60 years old and donors over 60 years old.",
    "The sample is a phase 3 trial for refractory epilepsy, testing the efficacy of keppra\u00ae extended release formulation - xr and placebo in patients receiving 1-3 concomitant Anti-Epileptic Drugs, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for patients with type 1 diabetes, testing the efficacy of insulin degludec, insulin detemir, and insulin aspart, with specific inclusion and exclusion criteria, and icd-10 codes for diabetes.",
    "This phase 3 trial aims to improve libido disorder and menopausal syndrome in women using dehydroepiandrosterone and placebo, with eligibility criteria including age, sexual activity, BMI, and baseline DHEAS level.",
    "The sample is a phase 3 trial for chronic hepatitis C virus (HCV) infection, testing the efficacy of eltrombopag and placebo as antiviral therapy, with eligibility criteria including platelet count, haemoglobin level, and history of infections, and exclusion criteria including non-responders to previous treatment, decompensated liver disease, and serious cardiac, cerebrovascular, or pulmonary disease.",
    "This is a phase 3 trial for major depressive disorder, testing the efficacy of DVS-233 SR and venlafaxine ER, with inclusion criteria of outpatients with a primary diagnosis of major depressive disorder and exclusion criteria of previous treatment with DVS-233 SR or venlafaxine, or known hypersensitivity to venlafaxine.",
    "This phase 3 trial is testing the efficacy of talactoferrin and placebo in treating non-small cell lung cancer patients who have failed at least 2 prior systemic anti-cancer regimens, with inclusion criteria including confirmed stage IIIB or IV NSCLC, at least one unirradiated and measurable target lesion, and adequate hematologic, renal and hepatic function.",
    "The sample is a phase 3 trial for asthmatic children aged 12 months to 8 years, testing the efficacy of 0.135mg and 0.25mg map0010 and placebo, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of mesalamine, canasa, and placebo in treating active, mild to moderate ulcerative proctitis in adults, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of donepezil and placebo in treating drowsiness/sedation caused by opiate in patients with advanced cancer, with inclusion criteria including intact cognition and regular dose of strong opioids, and exclusion criteria including hypersensitivity to donepezil and ongoing arrhythmia.",
    "The sample is a phase 3 trial for qva149 and placebo in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD), with inclusion criteria including age, smoking history, and lung function, and exclusion criteria including respiratory tract infection, pulmonary disease, and certain cardiovascular co-morbid conditions.",
    "This phase 3 trial is testing the effectiveness of vilazodone, an antidepressant, in treating major depressive disorder in patients aged 18-65 with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for multiple sclerosis, testing the efficacy of glatiramer acetate (db) and glatiramer acetate (ol) compared to placebo, with eligibility criteria including a single clinical attack, unifocal clinical presentation, and 2 or more cerebral lesions highly suspicious of MS on MRI.",
    "The sample is a phase 3 trial for heartburn treatment using esomeprazole, with inclusion criteria including experiencing heartburn at least 2 days a week and exclusion criteria including a history of erosive esophagitis or GERD diagnosed by a physician.",
    "The sample is a phase 3 trial for schizophrenia with bifeprunox and quetiapine as drugs, and the eligibility criteria includes a diagnosis of schizophrenia, age between 18-65 years, and no hospitalization for an exacerbation of schizophrenia within two months prior to screening and during the screening period.",
    "The sample is a phase 3 trial for knee osteoarthritis, testing the efficacy of smc021 oral calcitonin and placebo, with inclusion and exclusion criteria based on medical history and symptoms of knee osteoarthritis and other diseases or medications affecting bone or cartilage.",
    "The sample is a phase 3 trial for hospitalized men and women with confirmed or suspected intra-abdominal infection, testing the efficacy of moxifloxacin and ertapenem intravenous as intravenous antibiotics for 5-14 days.",
    "The sample is a phase 3 trial for gastric cancer patients who have undergone potentially curative resection of tumor, and the trial will test the efficacy of capecitabine and oxaliplatin as chemotherapy drugs, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with congestive heart failure or acute respiratory failure, testing the efficacy of apixaban and enoxaparin in preventing venous thromboembolism, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for a drug called placebo, testing its efficacy in treating hyperlipidemia in patients with heterozygous familial hypercholesterolemia, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial testing the drug memantine on patients with brain metastases visible on contrast-enhanced MRI or CT scan, with stable systemic disease, and with specific patient characteristics and prior concurrent therapy criteria.",
    "This phase 3 trial is testing the efficacy of bosentan, an endothelin receptor antagonist, in treating pulmonary hypertension and sickle cell anemia patients who have completed a 16-week treatment period in a previous study, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for pulmonary embolism, testing the efficacy of rivaroxaban and enoxaparin followed by VKA, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with chronic heart failure and iron deficiency anemia, testing the efficacy of ferinject and normal saline, with eligibility criteria including NYHA II-III functional class and LVEF 40% or lower, and exclusion criteria including active infection, active malignancy, and recent blood transfusion or iron therapy.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of vildagliptin am and pm versus placebo, with inclusion criteria including stable metformin use and BMI range, and exclusion criteria including pregnancy, lactation, and significant diabetic complications.",
    "The sample is a phase 3 clinical trial for adolescents with acute schizophrenia, testing the effectiveness of risperidone, with inclusion and exclusion criteria listed, and the diseases are limited to schizophrenia with specific ICD-10 codes.",
    "The sample is a phase 3 trial for psoriasis, testing the efficacy of ustekinumab compared to placebo, with inclusion criteria including a PASI score of 12 or greater and exclusion criteria including current nonplaque forms of psoriasis and recent use of investigational drugs or biologics.",
    "The sample is a phase 3 trial for patients with acute or primary HIV-1 infection, testing the efficacy of raltegravir, maraviroc, darunavir, ritonavir, and tenofovir/emtricitabine and darunavir, ritonavir, and emtricitabine/tenofovir drugs, with inclusion criteria such as symptomatic primary infection or CD4 <500/mm3 and exclusion criteria such as prior post-exposure antiretroviral treatment within six months before enrollment and pregnancy or breastfeeding.",
    "The sample is a phase 3 trial for the prevention of venous thromboembolism in patients undergoing unilateral total hip arthroplasty, using edoxaban and enoxaparin sodium as drugs, with eligibility criteria including risks of hemorrhage and thromboembolic risks, and exclusion criteria including pregnancy and weight less than 40 kg.",
    "The sample is a phase 3 trial for patients who experienced a heart attack, testing the effectiveness of omega-3 fatty acids (fish oil supplements) compared to placebo, with inclusion and exclusion criteria based on medical history and location.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) patients with a smoking history of at least 20 pack years, testing the efficacy of indacaterol, salmeterol/fluticasone, and salbutamol compared to placebos, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for ADHD, testing the efficacy of the drugs nwp09 and placebo, with inclusion criteria of children aged 6 to 12 years requiring pharmacologic treatment for ADHD, and exclusion criteria of other serious illnesses or conditions that would interfere with treatment/assessment of ADHD.",
    "This phase 3 trial is testing the efficacy of various antiretroviral drugs, including tenofovir/emtricitabine and nevirapine, for HIV-infected patients with CD4 cell count over 50 cells per mm3 and other inclusion criteria, while excluding patients with certain opportunistic infections or serious pathologies, ongoing pregnancy or breastfeeding, and those taking contra-indicated drugs.",
    "This phase 3 trial is testing the effectiveness of nilotinib and imatinib in treating chronic myelogenous leukemia in chronic phase patients with specific inclusion and exclusion criteria, including confirmation of Philadelphia chromosome translocations and no prior treatment with certain medications.",
    "The sample is a phase 3 trial for non-small cell lung cancer using the drug hycamtin, with eligibility criteria including measurable brain lesions, previous chemotherapy, and adequate organ function, and exclusion criteria including previous whole brain radiation therapy and concomitant therapy with certain drugs.",
    "This is a phase 3 clinical trial for type 2 diabetes mellitus patients treated with basal insulin and at least two OADs including an insulin secretagogue and metformin, testing the efficacy of insulin glargine and insulin glulisine in combination with other drugs.",
    "This is a phase 3 trial for postmenopausal women with osteoporosis, testing the efficacy of denosumab and placebo drugs, with eligibility criteria including bone mineral density values and exclusion criteria including previous metabolic bone disease and medications used to treat osteoporosis.",
    "This is a phase 3 trial for the treatment of epilepsy using brivaracetam tablets, bolus, and infusion, with specific inclusion and exclusion criteria for subjects.",
    "This phase 3 trial is testing the efficacy of lafutidine and famotidine in treating patients with mild reflux oesophagitis who have complained of heartburn symptoms within the past week, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 trial is testing the efficacy of quetiapine fumarate (seroquel) extended release and placebo in treating bipolar depression in patients aged 18 to 65 years who meet DSM-IV criteria for bipolar disorder I or bipolar II, with a Hamilton Rating Scale for Depression (HAM-D) total score of \u2265 20 and HAM-D item 1 (depressed mood) score \u2265 2 at enrolment and randomisation.",
    "This phase 3 trial is testing the efficacy of switching from fondaparinux to bivalirudin or unfractionated heparin in patients with acute coronary syndromes who meet certain eligibility criteria.",
    "This phase 3 trial is testing the efficacy of various topical medications, including calcipotriol plus betamethasone and betamethasone-17,21-dipropionate, in treating stable plaque psoriasis vulgaris, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial testing the efficacy of ospemifene 60 mg and placebo in treating moderate to severe symptoms of vaginal atrophy in menopausal women with specific inclusion and exclusion criteria, and the trial includes patients with atrophy and vaginal diseases with specific ICD-10 codes.",
    "The sample is a phase 3 trial for idiopathic pulmonary fibrosis using bosentan as the drug, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for breast cancer patients with metastatic disease that has progressed after combination treatment of a taxane and an anthracycline, testing the efficacy of gemcitabine, capecitabine, and vinorelbine, with specific eligibility criteria and exclusion criteria.",
    "This is a phase 3 trial for the drug brivaracetam in patients with focal epilepsy, who have at least 2 partial onset seizures per month and are uncontrolled while treated by 1 to 2 permitted concomitant antiepileptic drugs.",
    "This phase 3 trial is testing the efficacy of metformin and cj-30001/cj-30002 in treating Type 2 Diabetes Mellitus with specific inclusion and exclusion criteria, including BMI, HbA1c levels, and medical history.",
    "This phase 3 trial is testing the efficacy of tadalafil, placebo, and finasteride in treating benign prostatic hyperplasia and enlarged prostate, with specific inclusion and exclusion criteria for participants.",
    "This is a phase 3 trial for kidney transplantation patients testing the efficacy of Prograf-xl, Prograf, and MMF drugs, with eligibility criteria including a negative pregnancy test and exclusion criteria including a history of malignancy or hypersensitivity to certain drugs.",
    "This phase 3 trial is testing the efficacy of vi-0521 and placebo matched phentermine/topiramate in treating obesity, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for metastatic breast cancer patients with estrogen receptor positive and/or progesterone receptor positive, HER2 negative breast cancer, testing the efficacy of exemestane and everolimus (rad001) drugs, with specific eligibility and exclusion criteria.",
    "This is a phase 3 trial for prostate cancer patients with specific disease characteristics and patient characteristics, testing the drugs bicalutamide and goserelin acetate, with eligibility criteria including PSA levels and no prior local curative therapy.",
    "The sample is a phase 3 trial for overactive bladder, testing the efficacy of fesoterodine fumarate, tolterodine tartrate, and placebo, with inclusion criteria of urinary frequency and urgency urinary incontinence, and exclusion criteria of contraindications to fesoterodine use and significant hepatic and renal disease or other significant unstable diseases.",
    "The sample is a phase 3 clinical trial for pediatric patients with allergic rhinitis, testing the efficacy of levocetirizine and including eligibility criteria such as age range, symptoms, and laboratory results.",
    "This phase 3 trial is testing the efficacy of zoledronic acid, teriparatide, and placebo in postmenopausal women with osteoporosis, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of budesonide/formoterol pmdi and formoterol turbuhaler, with inclusion criteria including a clinical diagnosis of COPD, smoking history of 10 or more pack years, and a history of at least one COPD exacerbation requiring a course of oral steroids and/or antibiotics within 1-12 months before first visit.",
    "This phase 3 trial will investigate the efficacy of cangrelor p2y12 inhibitor, clopidogrel, and clopidogrel post cangrelor in patients with atherosclerosis, percutaneous coronary intervention, and acute coronary syndrome, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of candesartan cilexetil, hydrochlorothiazide, and candesartan/hct 32/25 mg in treating primary hypertension with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for seasonal allergic rhinitis, testing the efficacy of bilastine, desloratadine, and placebo drugs, with inclusion and exclusion criteria based on clinical diagnosis and medical history.",
    "The sample is a phase 3 trial for osteoporosis testing the efficacy of zoledronic acid and placebo, with inclusion criteria of patients who have received 3 infusions in the HORIZON-Pivotal Fracture (PFT) Study and exclusion criteria of poor kidney, eye, or liver health, use of certain therapies for osteoporosis in the HORIZON-PFT study (other than the study medication), and abnormal calcium levels in the blood.",
    "This phase 3 trial is testing the efficacy of biphasic insulin aspart, insulin detemir, and insulin aspart in insulin-naive patients with type 2 diabetes and a BMI below or equal to 40.0 kg/m2, who have been on OAD treatment for at least 4 months with metformin, a sulphonylurea or a combination, and have an HbA1c between 7.0%-10%, while excluding patients with proliferative retinopathy, recurrent major hypoglycaemia, cardial problems, uncontrolled hypertension, and impaired hepatic or renal function.",
    "The sample is a phase 3 trial for heart failure patients with intolerance to first-line medication, testing the efficacy of losartan 50 mg and 150 mg, with inclusion criteria including symptomatic heart failure and alternative/additional drug treatment.",
    "The sample is a phase 3 trial for prostate cancer testing the drugs amg 162 and placebo, with eligibility criteria not specified.",
    "This phase 3 trial is testing the efficacy of vildagliptin and placebo in patients with type 2 diabetes mellitus who have received a stable dose of SU for at least 12 weeks prior to Visit 1, with HbA1c levels between \u22657.5% to \u2264 11.0% at Visit 1 and Visit 3, and meet other inclusion/exclusion criteria.",
    "The sample is a phase 3 trial for locally advanced or metastatic HER2-positive breast cancer, testing the efficacy of docetaxel, vinorelbine, and trastuzumab, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for hypertension using a combination pill of losartan and hydrochlorothiazide, with eligibility criteria including age, blood pressure levels, and ability to commence combination therapy, and exclusion criteria including previous adverse events, contraindications, and current participation in another clinical trial.",
    "This is a phase 3 trial for aneurysmal subarachnoid hemorrhage, testing the efficacy of clazosentan and placebo, with eligibility criteria including age, aneurysm confirmation, and certain WFNS grades, and exclusion criteria including certain medical conditions and drug use.",
    "The sample is a phase 3 trial for patients with schizophrenia, testing the effectiveness of risperidone and ziprasidone, with specific inclusion and exclusion criteria based on PANSS score and previous treatment with risperidone.",
    "The sample is a phase 3 clinical trial for platinum-sensitive recurrent ovarian cancer using topotecan as the drug, with eligibility criteria including age, performance status, and history of chemotherapy, and exclusion criteria including hypersensitivity to certain drugs and infection.",
    "The sample is a phase 3 trial testing the efficacy of methylphenidate and placebo in reducing fatigue in patients with breast, gastrointestinal, lymphoma, myeloma or lung cancer undergoing chemotherapy or hormonal treatment, with specific inclusion and exclusion criteria, and a list of diseases and icd-10 codes.",
    "The sample is a phase 3 trial for non-small cell lung cancer, testing the efficacy of alimta or taxotere and erlotinib [tarceva] in patients with measurable disease and disease progression during 1-4 cycles of platinum-based chemotherapy, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of canagliflozin, sitagliptin, and metformin immediate release compared to placebo, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the effectiveness of Foster and Seretide Accuhaler in treating chronic obstructive pulmonary disease (COPD) in patients aged 40 or older with a smoking history of at least 10 pack years, post-bronchodilator FEV1 less than 60% of predicted normal value, and a history of no more than one COPD exacerbation in the previous 12 months.",
    "The sample is a phase 3 trial for HIV patients with hyperlipidemia, testing the efficacy of atazanavir and current antiretroviral regimen, with inclusion criteria including HIV-1 RNA < 500 copies/ml and fasting LDL cholesterol >130 mg/dl OR fasting triglycerides >200 mg/dl.",
    "The sample is a phase 3 trial for prostatitis, testing the effectiveness of alfuzosin and placebo, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for hypertension using valsartan and amlodipine as drugs, with inclusion criteria for patients with moderate essential hypertension and exclusion criteria for severe hypertension and history of cardiovascular disease.",
    "The sample is a phase 3 trial for non-small cell lung cancer patients with measurable or evaluable disease, testing the efficacy of carboplatin, gemcitabine hydrochloride, and paclitaxel, with eligibility criteria including ECOG 0-1 performance status and no prior chemotherapy for advanced NSCLC.",
    "This phase 3 trial is testing the efficacy of ibandronate sodium, zoledronic acid, and zolendronic acid in treating metastatic breast cancer patients with multiple bone metastases, who meet specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of ranibizumab injection and sham injection in treating macular edema and retinal vein occlusion, with strict inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the efficacy of Sativex, a drug used to relieve spasticity in patients with multiple sclerosis, compared to a placebo, and requires participants to meet specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for advanced and/or metastatic gastric cancer, testing the efficacy of 5-fluorouracil, capecitabine, and cisplatin, with eligibility criteria including adults aged 18 to 75 with at least 1 measurable lesion, and exclusion criteria including uncontrolled infection, evidence of CNS metastases, and previous chemotherapy.",
    "This phase 3 trial is testing the efficacy of TC-5214, a drug for major depressive disorder, compared to placebo, with specific inclusion and exclusion criteria for patients.",
    "The sample is a phase 3 trial for breast neoplasms and hormone-dependent neoplasms, using atamestane, toremifene, and letrozole as drugs, with eligibility criteria for continued treatment and survival follow-up.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of antidepressant + placebo and antidepressant + aripiprazole in patients who have had an inadequate response to at least one and no more than three antidepressants, with inclusion criteria of men and women aged 18-65 who have experienced a current episode of MDD lasting at least 8 weeks.",
    "This phase 3 trial is testing the efficacy of carboplatin and paclitaxel in treating patients with various types of ovarian, peritoneal, or fallopian tube cancer, with specific eligibility criteria including histologic diagnosis, stage, and performance status.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of indacaterol and glycopyrronium (qva149) and fluticasone/salmeterol against placebos, with inclusion criteria including smoking history and post-bronchodilator FEV1, and exclusion criteria including recent respiratory tract infection and concomitant pulmonary disease.",
    "The sample is a phase 3 trial for Alzheimer's disease, testing the efficacy of dimebon and placebo drugs on patients with mild-to-moderate Alzheimer's disease, with inclusion and exclusion criteria specified.",
    "This is a phase 3 trial for patients with chronic obstructive pulmonary disease, testing the efficacy of various drugs including tiotropium and olodaterol, with strict inclusion and exclusion criteria.",
    "This phase 3 trial is testing the drug gefitinib on patients with non-small cell lung cancer who have not progressed after prior chemotherapy, and have met certain disease and patient characteristics criteria.",
    "The sample is a phase 3 trial for bipolar disorder, testing the efficacy of olanzapine, haloperidol, and placebo, with inclusion and exclusion criteria based on DSM-IV-TR and Young Mania Rating Scale, and icd-10 codes provided for the disease.",
    "The sample is a phase 3 trial for osteoarthritis, testing the efficacy of hydrocodone/acetaminophen extended release and placebo, with inclusion criteria including sufficient pain to justify around-the-clock opioids and exclusion criteria including allergy to hydrocodone or acetaminophen, history of drug or alcohol abuse, and pregnancy or breastfeeding.",
    "The sample is a phase 3 trial for restless legs syndrome, testing the efficacy of ropinirole extended release (xr) with specific inclusion and exclusion criteria based on the International RLS Study Group Diagnostic Criteria, while the icd-10 code for the disease is G25.81.",
    "This phase 3 trial is testing the efficacy of tadalafil in patients with pulmonary hypertension who have previously discontinued a placebo-controlled study due to clinical worsening, and have completed week 16 of the previous study without worsening on placebo or tadalafil 2.5mg, 10mg, or 20mg, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for systemic lupus erythematosus, testing the effectiveness of premarin and provera in postmenopausal women with SLE, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with moderate to severe rheumatoid arthritis, testing the efficacy of methotrexate and tocilizumab, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for macular edema and retinal vein occlusion, testing the efficacy of intravitreal triamcinolone injection, with eligibility criteria including age and diagnosis, and exclusion criteria available on the SCORE Study website.",
    "This phase 3 trial is testing the efficacy of ciclesonide nasal aerosol versus placebo in treating perennial allergic rhinitis in children aged 6 to 11 years old with a history of PAR to a relevant perennial allergen, and a demonstrated sensitivity to at least one allergen known to induce PAR.",
    "The sample is a phase 3 trial for patients with advanced non-small cell lung cancer, testing the efficacy of erlotinib hydrochloride and matched placebo as second-line treatment, with eligibility criteria including performance status, laboratory values, and prior therapy history.",
    "The sample is a phase 3 trial for type 2 diabetes, testing the efficacy of exenatide and insulin glargine in patients with specific eligibility criteria, including HbA1c between 7.5% and 10.0% and BMI >27.",
    "The sample is a phase 3 trial for hypertension, testing the efficacy of losartan potassium, hydrochlorothiazide, and amlodipine besylate, along with placebos, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of TMC278 and efavirenz in treating HIV-1 infections in patients who have not previously received ARV drugs, with specific inclusion and exclusion criteria, and the diseases and icd-10 codes listed include HIV infections and HIV-1.",
    "The sample is a phase 3 trial for autistic disorder, testing the efficacy of fluoxetine and placebo, with inclusion and exclusion criteria based on DSM-IV criteria and CYBOCS-PDD score, and patients with previous fluoxetine use or planning to commence cognitive behavior therapy are excluded.",
    "The sample is a phase 3 trial for type 2 diabetes using human insulin inhalation powder and insulin, with inclusion criteria of insulin-naive non-smokers and exclusion criteria of significant pulmonary, hepatic or renal disease, severe congestive heart failure, active malignancy or malignancy within the last 5 years, and systemic glucocorticoid therapy.",
    "The sample is a phase 3 trial testing the effectiveness of tiotropium inhalation solution on patients with pulmonary disease, chronic obstructive, with the icd-10 codes J44.9, J44.1, and J44.0, and with no specified eligibility criteria.",
    "The sample is a phase 3 trial for epilepsy patients who completed the N165 Clinical Trial of L059 and wish to continue treatment with levetiracetam, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial testing duloxetine hydrochloride for painful sensory chemotherapy-induced peripheral neuropathy resulting from prior treatment with single-agent taxane or platinum agents in patients with cancer, with specific eligibility criteria including neuropathic pain score and exclusion of certain illnesses and medications.",
    "This phase 3 trial is testing the efficacy of lixisenatide, metformin, and placebo in treating insufficiently controlled type 2 diabetes mellitus, with a list of exclusion criteria including uncontrolled hypertension, history of drug or alcohol abuse, and clinically significant diabetic retinopathy.",
    "This phase 3 clinical trial is testing the efficacy of lc15-0444 and sitagliptin in patients with type 2 diabetes mellitus who are currently on metformin monotherapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease, testing the efficacy of aclidinium bromide/formoterol fixed-dose combination (fdc), aclidinium bromide, formoterol fumarate, and placebo, with inclusion criteria of completion of the lead-in study, written informed consent, no medical contraindication, and compliance with study procedures and IP dosing. There are no specific exclusion criteria.",
    "The sample is a phase 3 trial testing the drug IDEA-033 on patients with joint pain, musculoskeletal pain, stiffness, or soft tissue inflammation, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for hypercholesterolemia, testing the efficacy of various drug comparators including ezetimibe/simvastatin and niacin (er), with inclusion criteria of LDL-C of 130-190 mg/dL and triglycerides \u2264500 mg/dL, and exclusion criteria including sensitivity or intolerance to the drugs being tested.",
    "The sample is a phase 3 trial for Parkinson's disease dementia, testing the efficacy of rivastigmine capsule and transdermal patch, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with colorectal and liver neoplasms, testing the efficacy of irinotecan + 5 fu + folinic acid and folinic acid + 5 fu, with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for major depressive disorder, testing the efficacy of vortioxetine (lu aa21004) compared to placebo, with eligibility criteria including confirmed diagnosis of recurrent MDD, MADRS total score \u226526, and resistance to 2 adequate antidepressant treatments.",
    "The sample is a phase 3 trial for patients with major depression or partially remitted depression, using risperidone as the drug, and with exclusion criteria including bipolar disorder, psychotic features, and substance dependence or abuse in the past three months.",
    "This phase 3 trial is testing the efficacy of vortioxetine and placebo in treating major depressive disorder, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for bipolar disorder using ziprasidone oral capsules, with inclusion criteria of participation in a specific double-blind treatment study and exclusion criteria of imminent risk of suicide or homicide, serious adverse events related to study medication, and significant prolongation of QT interval.",
    "The sample is a phase 3 trial for Parkinson's disease, testing the efficacy of carbidopa/levodopa/entacapone and immediate release carbidopa/levodopa, with inclusion criteria of clinical diagnosis of idiopathic Parkinson's disease and diagnosis for no more than 5 years, and exclusion criteria of atypical or secondary parkinsonism, drug-related wearing-off symptoms, dyskinesia or other motor complications, and levodopa exposure of more than 30 days or anytime within 8 weeks prior to visit 1.",
    "The sample is a phase 3 trial for pulmonary hypertension using sildenafil citrate, with inclusion criteria based on right heart catheterization and 6-Minute Walk test distance, and exclusion criteria including significant hepatic and/or renal disorder and current use of nitrates or nitric oxide donors, ritonavir, ketoconazole, and itraconazole.",
    "The sample is a phase 3 trial for patients with schizophrenia or schizoaffective disorder, testing the efficacy and safety of switching to lurasidone hcl as the antipsychotic medication, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of insulin lispro protamine suspension and insulin glargine, with inclusion criteria including a minimum of 1 year with type 2 diabetes, stable doses of at least 2 oral antihyperglycemic medications, and a hemoglobin A1c between 7.5% and 10.0%.",
    "The sample is a phase 3 trial for smoking cessation using varenicline tartrate and placebo, with inclusion criteria for current smokers aged 18-75 and exclusion criteria for patients with depression, psychosis, panic disorder, bipolar disorder, or severe COPD.",
    "This is a phase 3 trial for social anxiety disorder using quetiapine as the drug, with inclusion criteria including meeting DSM IV criteria for generalized social anxiety disorder and a score \u2265 60 on the LSAS, and exclusion criteria including presence of any primary axis I diagnosis other than social anxiety disorder and patients at risk of suicide.",
    "The sample is a phase 3 trial for venous thromboembolism using edoxaban and enoxaparin sodium as drugs, with eligibility criteria including patients undergoing unilateral total knee arthroplasty and exclusion criteria including subjects with risks of hemorrhage and thromboembolic risks.",
    "This is a phase 3 trial for breast cancer patients with specific disease characteristics and patient characteristics, testing the efficacy of a combination of cyclophosphamide, docetaxel, epirubicin hydrochloride, fluorouracil, goserelin acetate, and tamoxifen citrate, with eligibility criteria including age, sex, performance status, and prior therapy.",
    "This phase 3 trial is testing the efficacy of ara-c, mitoxantrone, daunorubicin, and thioguanin in treating newly diagnosed acute myeloid leukemia patients who meet certain eligibility criteria.",
    "The sample is a phase 3 trial for the treatment of diabetic peripheral neuropathy using pregabalin, with inclusion criteria of diagnosis of painful diabetic peripheral neuropathy and pain on walking, and exclusion criteria of inability to walk 50 feet on a flat surface or pain on walking due to conditions other than diabetic peripheral neuropathy.",
    "This phase 3 trial is testing the efficacy of leuprolide acetate formulations A and B in treating prostate cancer patients with rising PSA levels following radical prostatectomy or irradiation, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of pioglitazone and metformin, pioglitazone, and metformin in treating type 2 diabetes mellitus with specific eligibility and exclusion criteria.",
    "This is a phase 3 trial for breast cancer patients with specific eligibility criteria, testing the efficacy of fluorouracil, doxorubicin, cyclophosphamide, and paclitaxel as adjuvant chemotherapy.",
    "This is a phase 3 clinical trial for hospital-acquired pneumonia, testing the efficacy of levofloxacin and piperacillin/tazobactam, with eligibility criteria including specific signs and symptoms, microbiological documentation, and exclusion criteria such as concomitant pulmonary diseases and impaired renal function.",
    "The sample is a phase 3 clinical trial for previously untreated B-cell chronic lymphocytic leukemia patients with specific disease and patient characteristics, testing the efficacy of fludarabine and cyclophosphamide as treatment options.",
    "The sample is a phase 3 trial for hypercholesterolemia, testing the efficacy of atorvastatin and ezetimibe as lipid-lowering therapy, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of sildenafil citrate and placebo in treating pulmonary arterial hypertension in children, with specific eligibility criteria and exclusion criteria listed.",
    "The sample is a phase 3 trial for Parkinson's disease using rasagiline mesylate as the drug, with inclusion criteria being completion of week 52 of a previous protocol and exclusion criteria being adverse effects in the previous study.",
    "This phase 3 trial is testing the efficacy of tezosentan versus placebo in treating acute heart failure, with inclusion criteria including dyspnea at rest and elevated BNP or N terminal pro-BNP, and exclusion criteria including ongoing myocardial ischemia and concomitant treatment with cyclosporin A or tacrolimus.",
    "This phase 3 trial is testing the effectiveness of candesartan, a drug used to treat hypertension, in patients with type 1 diabetes who meet specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for hypertension, testing the efficacy of amlodipine and manidipine with delapril, with inclusion criteria of mild to moderate hypertension and exclusion criteria of severe hypertension and pregnancy/lactation.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of indacaterol 75 \u03bcg and placebo to indacaterol, with inclusion criteria based on smoking history, post-bronchodilator forced expiratory volume in 1 second (FEV1), and post-bronchodilator FEV1/FVC, and exclusion criteria including recent COPD exacerbation, respiratory tract infection, concomitant pulmonary disease, history of asthma, diabetes Type I or uncontrolled diabetes Type II, lung cancer or history of lung cancer, and certain cardiovascular co-morbid conditions.",
    "The sample is a phase 3 trial for the treatment of hepatitis B with lamivudine, with inclusion criteria such as liver biopsy acceptance and DNA HBV greater than 100000 copies/mL, and exclusion criteria such as HCV, HDV, and HIV positivity.",
    "The sample is a phase 3 trial for chronic hepatitis B with inclusion criteria of lamivudine treatment, HBV DNA > 6 log10 copies/mL, and evidence of viral breakthrough, and exclusion criteria of pregnancy, co-infection with HCV, HDV, or HIV, and previous anti-HBV treatment other than lamivudine, with telbivudine and adefovir dipivoxil as the tested drugs.",
    "This phase 3 trial is testing the efficacy of various drugs, including tamsulosin hydrochloride and solifenacin succinate, in treating lower urinary tract symptoms associated with benign prostatic hyperplasia, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for the treatment of hyperphosphatemia in end-stage renal disease patients using ferric citrate as a phosphate binder, with inclusion criteria including age >18, serum phosphorus levels between 3.5-8.0 mg/dL, and taking 3-15 tablets/capsules per day of calcium acetate or sevelamer, and exclusion criteria including parathyroidectomy within six months prior to screening visit, history of multiple drug allergies or intolerances, and inability to tolerate oral drug intake.",
    "The sample is a phase 3 clinical trial for low back pain, testing the efficacy of thiocolchicoside+ketoprofen and thiocolchicoside drugs, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with metastatic progressive or locally recurrent inoperable breast cancer, testing the effectiveness of exemestane and anastrozole, with eligibility criteria including confirmed breast cancer at original diagnosis and exclusion criteria including prior hormonal or chemotherapy treatment for advanced/recurrent breast cancer.",
    "The sample is a phase 3 trial for patients with diabetes mellitus type 2, testing the efficacy of taspoglutide and placebo, with inclusion criteria including HbA1c levels and BMI, and exclusion criteria including type 1 diabetes and severe hypoglycemia.",
    "The sample is a phase 3 trial for patients with venous thromboembolism, testing the efficacy of rivaroxaban and placebo as anticoagulant treatments, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for rheumatoid arthritis patients who have inadequate response to methotrexate, and the trial will test the efficacy of rituximab in treating the disease. The eligibility criteria and exclusion criteria are also provided.",
    "The sample is a phase 3 trial for a drug called oxycodone naloxone prolonged release tablets (oxn) for moderate to severe pain caused by opioids, with constipation as a side effect, and the study includes patients with the disease of pain and exclusion criteria for pregnant or lactating females, unstable disease, impaired liver/kidney function, and significant structural abnormalities of the gastrointestinal tract.",
    "This phase 3 trial will test the efficacy of didanosine, lamivudine, and efavirenz or nevirapine in treating tuberculosis and human immunodeficiency virus infections in patients with CD4 cell counts less than 250 cells/mm3, along with eligibility criteria including age, residency, and willingness to use contraception.",
    "The sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of insulin glargine new formulation and insulin glargine in combination with oral antihyperglycemic drugs, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for seasonal allergic rhinitis using four different concentrations of epinastine nasal spray and includes inclusion and exclusion criteria, with the disease being seasonal allergic rhinitis and the drugs being epinastine nasal spray.",
    "The sample is a phase 3 trial for sepsis treatment with drotrecogin alfa (activated) and placebo, with inclusion and exclusion criteria based on age, infection, systemic inflammatory response syndrome, and vasopressor-dependent septic shock, and exclusion criteria based on prior vasopressor therapy, sepsis-induced organ dysfunction, recent surgery, active bleeding, or preexisting uncorrectable medical condition.",
    "This phase 3 trial is testing the efficacy of BEMA\u2122 and placebo drugs on patients with pain associated with cancer or cancer treatment, who are on a stable current regimen of oral opioids, and regularly experience 1-4 breakthrough pain episodes per day that require additional opioids for pain control.",
    "This phase 3 trial is testing the efficacy of atorvastatin and placebo in patients with atrial fibrillation and inflammation, with a list of inclusion and exclusion criteria, and a list of diseases and icd-10 codes.",
    "The sample is a phase 3 trial for patients with type II diabetes mellitus, testing the efficacy of vildagliptin and glimepiride, with inclusion criteria of stable metformin use and exclusion criteria of other antidiabetic treatment and significant diabetic organ disease or complications.",
    "The sample is a phase 3 trial for patients with biliary tract cancer who have undergone radical surgery, and the drug being tested is capecitabine, with eligibility criteria including specific disease characteristics and patient characteristics.",
    "The sample is a phase 3 trial for type 2 diabetes testing the efficacy of liraglutide, glimepiride, and placebo, with inclusion criteria including HbA1c levels between 6.5-9.0% and BMI less than or equal to 40 kg/m^2, and exclusion criteria including previous treatment with insulin or GLP-1 analogues/mimetics, and evidence of overt cardiovascular disease.",
    "This phase 3 trial is testing the efficacy of inhaled mannitol and placebo comparator in patients with cystic fibrosis who meet specific eligibility criteria, including confirmed diagnosis and lung function requirements.",
    "This phase 3 trial will test the efficacy of COV795 and placebo in managing postoperative pain and bunion in patients undergoing primary unilateral first metatarsal bunionectomy, with eligibility criteria including age, health status, and absence of certain medical conditions or allergies.",
    "This phase 3 trial is testing the effectiveness of clevidipine and placebo in lowering SBP by at least 15% from baseline in patients with hypertension undergoing cardiac surgery, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of dexpramipexole and placebo in treating amyotrophic lateral sclerosis, with specific inclusion and exclusion criteria for patients, including a requirement for a diagnosis of ALS and a minimum upright slow vital capacity of 65%.",
    "This phase 3 trial is testing the efficacy of bosentan and placebo in treating idiopathic pulmonary fibrosis, with strict inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for advanced Parkinson's disease, testing the efficacy of rotigotine in combination with levodopa and a non-ergot dopamine agonist, with inclusion criteria including motor fluctuations and nocturias, and exclusion criteria including therapy with tolcapone or budipine and a history of symptomatic orthostatic hypotension.",
    "This phase 3 trial is testing the efficacy of vortioxetine and duloxetine compared to placebo in treating major depressive disorder, with specific inclusion and exclusion criteria, and the use of ICD-10 codes to identify the disease.",
    "The sample is a phase 3 trial for hypertension, testing the effectiveness of aliskiren, amlodipine, and hydrochlorothiazide, with inclusion criteria based on blood pressure levels, and exclusion criteria based on history of hypertension-related conditions.",
    "This phase 3 trial is testing the efficacy of liraglutide versus placebo in treating type 2 diabetes in patients who have been treated with stable basal insulin analogue dose of minimum 20 U/day with or without stable metformin equal to or above 1500 mg/day for at least 8 weeks prior to screening, with inclusion criteria including HbA1c 7.0-10.0% and BMI 20-45 kg/m^2, and exclusion criteria including impaired liver or renal function and known or suspected abuse of alcohol or narcotics.",
    "The sample is a phase 3 trial for painful diabetic neuropathy, testing the drug lacosamide, with inclusion criteria of the disease and exclusion criteria of no relevant liver enzyme abnormalities, impaired renal function, cardiac abnormalities, and pregnancy or nursing.",
    "The sample is a phase 3 clinical trial for acute schizophrenia, testing the efficacy of er oros paliperidone and olanzapine, with inclusion criteria including a DSM-IV diagnosis of schizophrenia and a total PANSS score between 60 and 120, and exclusion criteria including a lack of response to any antipsychotic and significant risk of suicidal or violent behavior.",
    "The sample is a phase 3 trial for the drug NKTR-118 and placebo in treating opioid-induced constipation (OIC) in patients who completed a 12-week study, with inclusion criteria including a stable maintenance opioid regimen and willingness to abstain from laxatives and other bowel regimens, and exclusion criteria including cancer-related pain, recent history of cancer, and gastrointestinal issues.",
    "The sample is a phase 3 trial for cystic fibrosis patients with Pseudomonas aeruginosa infection, testing the efficacy of tobramycin inhalation powder, with inclusion criteria of age between 6 and 21 and FEV1 between 25% and 80% of normal predicted values, and exclusion criteria of hypersensitivity to aminoglycosides or inhaled antibiotics.",
    "The sample is a phase 3 trial for men with an elevated prostate specific antigen, testing the effectiveness of ciprofloxacin as a treatment, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for cardiovascular disease, testing the efficacy of simvastatin 20 mg and 80 mg daily versus placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of gemcitabine, docetaxel, and capecitabine in treating breast cancer with locally advanced and/or metastatic disease, with specific eligibility and exclusion criteria.",
    "This is a phase 3 trial for patients with invasive breast cancer with stage IV disease, testing the efficacy of lapatinib, paclitaxel, and trastuzumab, with specific eligibility criteria and exclusion criteria.",
    "This is a phase 3 trial for bipolar disorder using quetiapine as the drug, with eligibility criteria including a lifetime diagnosis of bipolar spectrum disorder and exclusion criteria including known intolerance or lack of response to quetiapine fumarate.",
    "The sample is a phase 3 trial for COPD patients of Asian ancestry, testing the efficacy of fluticasone furoate/vilanterol versus placebo, with inclusion criteria including a COPD diagnosis and dyspnea score of 2 or higher, and exclusion criteria including asthma, lung volume reduction surgery within 12 months, and use of prohibited medications.",
    "The sample is a phase 3 trial for the treatment of chronic hepatitis C with vaniprevir and ribavirin in Japanese patients who have failed prior IFN-based therapy, with specific inclusion and exclusion criteria, and the presence of certain diseases and icd-10 codes.",
    "The sample is a phase 3 trial for migraine patients, testing the efficacy of frovatriptan 2.5mg qd and frovatriptan 2.5 mg bid compared to placebo, with pre-menopausal females diagnosed as suffering from MRM aged 15 years and over as the inclusion criteria.",
    "This phase 3 trial is testing the efficacy of naproxcinod, naproxen, and placebo in treating primary osteoarthritis of the hip in men and women over 40 who are chronic users of NSAIDs or acetaminophen, with a list of inclusion and exclusion criteria.",
    "This phase 3 clinical trial is testing the efficacy of GSK1358820 and placebo in treating post-stroke spasticity and cerebrovascular accident, with eligibility criteria including upper limb spasticity, specific muscle tone and functional disability ratings, and exclusion criteria such as previous botulinum toxin therapy and clinically significant severe reduction of muscle strength.",
    "This phase 3 trial is testing the efficacy of SPM 962 and ropinirole, along with a placebo, in treating Parkinson's disease in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "The sample is a phase 3 trial for glaucoma and ocular hypertension, testing the effectiveness of brimonidine as an IOP-lowering therapy, with inclusion criteria including current treatment with brimonidine and exclusion criteria including known allergy or sensitivity to the drug.",
    "The sample is a phase 3 trial for non-small cell lung cancer, testing the efficacy of erlotinib and pemetrexed, with eligibility criteria including confirmed adenocarcinoma, failure of prior chemotherapy, and adequate bone marrow, liver, and renal function.",
    "The sample is a phase 3 clinical trial for patients with prostate cancer, testing the efficacy of docetaxel, mitoxantrone, and prednisone, with eligibility criteria including documented progressive disease, normal organ function, and no prior treatment with cytotoxic agents.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of insulin degludec in combination with stable doses of OADs, with inclusion criteria including HbA1c between 7.0-10.0% and BMI below or equal to 45 kg/m^2.",
    "The sample is a phase 3 trial for major depressive disorder, with a list of drugs including quetiapine, amitriptyline, and sertraline, and eligibility criteria including a documented diagnosis of MDD and exclusion of patients with certain Axis I and II disorders.",
    "The sample is a phase 3 clinical trial for previously untreated chronic lymphocytic leukemia (CLL) using obinutuzumab, rituximab, and chlorambucil, with eligibility criteria including CD20+ B-Cell CLL and a Total Cumulative Illness Rating Scale (CIRS) > 6 and/or creatinine clearance < 70 ml/min.",
    "This phase 3 trial is testing the effectiveness of iogen (molecular iodine) in treating fibrocystic breast disease, with inclusion criteria including premenopausal females with clinical breast pain and at least 25% involvement of at least one breast surface, and exclusion criteria including prior thyroid disease and current treatment with iodine-containing medications.",
    "This phase 3 trial is testing the efficacy of entecavir, tenofovir, adefovir, and lamivudine in treating chronic hepatitis B with evidence of lamivudine resistance, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for locally advanced or metastatic colorectal cancer, testing the efficacy of fluorouracil and leucovorin calcium as treatment options, with eligibility criteria including age, performance status, hematopoietic and hepatic function, and prior concurrent therapy.",
    "The sample is a phase 3 trial for moderate to severe scalp psoriasis, testing the efficacy of various corticosteroids, with inclusion and exclusion criteria for subjects, and the presence of icd-10 codes for the disease.",
    "This phase 3 trial is testing the efficacy of piribedil, pramipexole or ropinirole in treating idiopathic Parkinson's disease in patients aged 35 to 80 years with Hoehn & Yahr stages 1 to 4, who have significant daytime sleepiness and are compliant to the study regimen, while excluding patients with certain medical conditions and those who are pregnant or lactating.",
    "This phase 3 trial is testing the efficacy of sitagliptin, sulfonylurea, and metformin in Muslim patients with type 2 diabetes mellitus who intend to fast during Ramadan, and have stable doses of SU drugs for at least three months, with or without metformin therapy, and have HbA1c \u226410% at screening, while excluding patients with type 1 diabetes mellitus, gestational diabetes, hypersensitivity or contraindication to DPP-4 treatment, serum creatinine \u22651.5 mg/dL (males), \u22651.4 mg/dL (females), history of severe hypoglycemia, any use of insulin, use of any class of oral antidiabetic therapy other than an SU or metformin, and current participation in another interventional study.",
    "The sample is a phase 3 trial for hypercholesterolemia, testing the efficacy of ezetimibe (+) simvastatin, rosuvastatin calcium, and two placebos, with inclusion criteria of current statin use and LDL-C level between 100-190 mg/dl, and exclusion criteria of pregnancy/nursing and any condition/medication that may pose a risk or interfere with participation.",
    "This phase 3 trial is testing the efficacy of insulin degludec and insulin glargine in insulin-na\u00efve subjects with type 2 diabetes who are currently on metformin monotherapy or metformin in combination with an insulin secretagogue, DPP-4 inhibitor, or alpha-glucosidase-inhibitor, and have an HbA1c of 7.0-10.0%, with exclusion criteria including recent use of thiazoledinediones, exenatide, or liraglutide, and cardiovascular disease within the last 6 months.",
    "The sample is a phase 3 clinical trial for patients with extensive stage small cell lung cancer, testing the efficacy of cisplatin, etoposide, and irinotecan hydrochloride, with eligibility criteria including age, performance status, hematopoietic, hepatic, renal, and other factors.",
    "This phase 3 trial is testing the effectiveness of cetirizine, an antihistamine, in treating allergic rhinitis in children, with a list of exclusion and inclusion criteria.",
    "This phase 3 clinical trial is testing the efficacy of volinanserin and placebo in treating primary insomnia in participants with type II diabetes mellitus, with strict inclusion and exclusion criteria based on sleep patterns, medical history, and substance use.",
    "The sample is a phase 3 trial for gastric cancer, testing the efficacy of cisplatin, fluorouracil, and leucovorin calcium in patients with locally resectable disease and specific eligibility criteria.",
    "The sample is a phase 3 trial for cystic fibrosis patients, testing the efficacy of denufosol tetrasodium inhalation solution and placebo, with inclusion criteria including confirmed diagnosis of cystic fibrosis and FEV1 of greater than or equal to 75% of predicted normal, and exclusion criteria including abnormal renal or liver function and colonization with Burkholderia cepacia.",
    "This is a phase 3 trial for postmenopausal women with osteoporosis, testing the efficacy of denosumab and placebo, with eligibility criteria including bone mineral density values and exclusion criteria including medications used to treat osteoporosis and malignancy within 5 years.",
    "This phase 3 trial is testing the efficacy of various drugs, including bicalutamide and goserelin, in treating prostate cancer patients who meet specific eligibility criteria, such as having rising PSA levels and no evidence of metastatic disease.",
    "The sample is a phase 3 trial for patients with open angle glaucoma or ocular hypertension, testing the effectiveness of xalacom, xalatan, and timolol, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of azilsartan medoxomil, a drug used to treat hypertension, and its placebo on participants with essential hypertension, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of methotrexate, placebo, and tocilizumab, with inclusion criteria including inadequate response to current anti-rheumatic therapies and intolerance to treatment with 1 or more anti-TNF therapies, while exclusion criteria include major surgery within 8 weeks before screening and women who are pregnant or breast-feeding.",
    "The sample is a phase 3 trial for patients with Generalised Anxiety Disorder (GAD), testing the efficacy of quetiapine xr and placebo, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for epilepsy with the drugs usl255 and placebo, and the eligibility criteria includes having a confirmed diagnosis of partial-onset seizures and being on a stable dosing regimen of 1 to 3 AEDs for at least 4 weeks prior to Visit 1.",
    "The sample is a phase 3 trial for epilepsy with partial-onset seizures, testing the efficacy of lacosamide and levetiracetam as adjunctive treatment, with specific inclusion and exclusion criteria, and the diseases are identified by their ICD-10 codes.",
    "The sample is a phase 3 trial for macular degeneration and choroidal neovascularization, testing the effectiveness of verteporfin photodynamic therapy and ranibizumab, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for Alzheimer's disease, testing the efficacy of galantamine and placebo drugs on patients with mild to moderately-severe AD, with inclusion and exclusion criteria specified, and icd-10 codes provided; while the second sample is a study testing the ability of extended release nifedipine to decrease the dose of glucocorticoid medication for children with congenital adrenal hyperplasia.",
    "The sample is a phase 3 trial for patients with HER-2 negative adenocarcinoma of the breast, testing the efficacy of bevacizumab and taxane-based chemotherapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for familial hypercholesterolaemia, testing the efficacy of rosuvastatin calcium, with inclusion criteria for children and adolescents aged 6 to less than 18 years and exclusion criteria for history of muscle or sensitivity reactions to any statin medicines and current active liver disease or dysfunction.",
    "This phase 3 trial is testing the efficacy of an induction dose of infliximab followed by a combination of pegylated interferon alfa-2b and ribavirin, as well as a combination of pegylated interferon alfa-2b and ribavirin, in treating chronic hepatitis C in patients who meet specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of tacrolimus and placebo in treating myasthenia gravis patients whose symptoms are well-controlled by prednisone, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for Parkinson's disease, testing the efficacy of rasagiline compared to placebo, with inclusion criteria of idiopathic PD and Modified Hoehn and Yahr stage <3, and exclusion criteria of clinically significant medical or surgical conditions, unstable vascular disease, major depression, MMSE score \u226424, and history of melanoma.",
    "The sample is a phase 3 trial for Parkinson's disease using the drug rotigotine, with inclusion criteria including PD greater than 3 years and off time, and exclusion criteria including previous use of rotigotine, atypical Parkinson's syndrome, and dementia.",
    "The sample is a phase 3 clinical trial for major depressive disorder using lurasidone as the drug, with inclusion criteria including completion of previous studies and exclusion criteria including suicidal ideation or imminent risk of harm.",
    "This is a phase 3 trial for refractory status epilepticus, testing the efficacy of propofol and thiopental/pentobarbital in inducing coma for clinical management, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for smoking cessation using dianicline, with inclusion criteria of outpatients over legal age smoking at least 10 cigarettes per day for at least 2 months, and exclusion criteria of insufficient motivation, another participant in the household, and current psychotic or major depressive disorder.",
    "This phase 3 trial is testing the efficacy of bibf 1120 and placebo in treating pulmonary fibrosis, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for gastroesophageal reflux disease, testing the efficacy of lansoprazole microgranules suspension and placebo, with inclusion and exclusion criteria for infants with reflux symptoms.",
    "The sample is a phase 3 trial for adults with moderate to severe rheumatoid arthritis, testing the efficacy of cp-690,550 and disease-modifying antirheumatic drugs, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of rotigotine, a drug used to treat Parkinson's disease, in patients who are not satisfactorily controlled on a total daily dose of ropinirole from 3mg to 12mg, inclusive.",
    "This phase 3 trial is testing the efficacy of doxepin hydrochloride in relieving oral pain related to mucositis in patients undergoing radiation therapy for head and neck cancer, mucositis, oral complications of radiation therapy, and pain, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 3 clinical trial for patients with refractory prostate cancer, testing the efficacy of cabazitaxel, mitoxantrone, and prednisone, with eligibility criteria including documented disease progression and ECOG performance status 0-2.",
    "This phase 3 trial is testing the efficacy of reslizumab and placebo in treating eosinophilic asthma in patients with a history of asthma exacerbation, elevated blood eosinophil levels, and other inclusion criteria.",
    "This phase 3 trial is testing the effectiveness of lisinopril and atenolol in treating hypertension and left ventricular hypertrophy in patients on chronic hemodialysis, with specific eligibility criteria including compliance with hemodialysis treatments and presence of LVH on echocardiogram.",
    "This phase 3 trial is testing the efficacy of fluticasone furoate, a drug used to treat perennial allergic rhinitis, in children aged 2 to <15 years with a positive test response to house dust and/or dust mites on serum antigen-specific IgE antibody test, and a history of at least six months of clinical symptoms.",
    "The sample is a phase 3 clinical trial for the treatment of migraine disorders using np101 - sumatriptan iontophoretic transdermal patch and placebo, with inclusion criteria such as a diagnosis of migraine headache and exclusion criteria such as a history of epilepsy or conditions associated with a lowered seizure threshold.",
    "The sample is a phase 3 trial for HIV postexposure prophylaxis, testing the efficacy of darunavir/ritonavir, lopinavir/ritonavir, zidovudine, nrtis, and efavirenz, with inclusion criteria for occupational or non-occupational exposure to HIV and exclusion criteria for positive HIV rapid test and various medical conditions.",
    "This phase 3 trial is testing the efficacy of desoximetasone spray 0.25% and placebo comparator in treating stable plaque psoriasis involving \u2265 10% of the body surface area (BSA) with a combined total lesion severity score (TLSS) of \u2265 7 for the Target Lesion, and a plaque elevation score \u2265 3 of (moderate) for the Target Lesion, with inclusion criteria of male or non-pregnant, non-lactating female 18 years of age or older, and exclusion criteria of current diagnosis of other types of psoriasis other than stable plaque psoriasis or history of psoriasis that has been unresponsive to topical corticosteroid therapy.",
    "This phase 3 trial is testing the efficacy of mirabegron and solifenacin succinate in treating overactive bladder symptoms in patients who have previously received antimuscarinic agents, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for the drug xp13512 (gsk1838262) in patients with primary restless legs syndrome, with inclusion criteria including documented RLS symptoms and a total RLS severity score of 15 or greater, and exclusion criteria including neurologic disease or movement disorder and abnormal laboratory results or physical findings.",
    "The sample is a phase 3 trial for bipolar disorder using aripiprazole as the drug, with inclusion criteria including a Y-MRS score >20 and exclusion criteria including previous failure on aripiprazole and hypersensitivity to the drug.",
    "The sample is a phase 3 trial for osteoporosis, testing the efficacy of lasofoxifene, with inclusion criteria of postmenopausal women with low bone mineral density and exclusion criteria of other metabolic bone diseases or recent osteoporotic fractures.",
    "The sample is a phase 3 trial for cytomegalovirus infections in lung transplant recipients, testing the efficacy of valganciclovir, with inclusion and exclusion criteria for both phase I and phase II.",
    "The sample is a phase 3 trial for osteoporosis, testing the efficacy of teriparatide and placebo drugs on Japanese patients aged 55 or older who are at high risk for fracture, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for esophageal cancer, testing the efficacy of cisplatin and fluorouracil in patients with stage I or II thoracic esophageal cancer who are deemed resectable with curative intent and meet a variety of eligibility criteria.",
    "The sample is a phase 3 trial for premature infants with respiratory distress syndrome or bronchopulmonary dysplasia, testing the efficacy of infasurf and sham drugs, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes, testing the efficacy of saxagliptin and sitagliptin, with eligibility criteria including stable metformin treatment and exclusion criteria including previous DPP-4 inhibitor treatment.",
    "The sample is a phase 3 trial for asthma patients, testing the efficacy of fluticasone propionate/formoterol fumarate 100/10, fluticasone propionate 100, formoterol fumarate 10, and placebo, with eligibility criteria including a history of asthma, FEV-1 of 60-85% of predicted normal values, and exclusion criteria including life-threatening asthma within the past year and history of systemic corticosteroid medication within 3 months before screening visit.",
    "The sample is a phase 3 trial for cardiovascular disease using rimonabant and placebo, with inclusion criteria based on waist circumference and major risk factors, and exclusion criteria including severe medical or psychological conditions and prior participation in a rimonabant trial.",
    "The sample is a phase 3 trial for chronic hepatitis C using telaprevir, pegylated interferon alfa-2a, and ribavirin, with specific inclusion and exclusion criteria for patient selection.",
    "The sample is a phase 3 clinical trial testing the efficacy of mifepristone, a drug, in treating major depressive disorder with psychotic features, and includes inclusion and exclusion criteria for eligible patients.",
    "This phase 3 trial is testing the efficacy of rivaroxaban and enoxaparin followed by VKA in treating confirmed acute symptomatic proximal DVT without symptomatic PE in patients who meet the inclusion criteria and do not meet any of the exclusion criteria. The trial is focused on patients with venous thrombosis and the icd-10 codes associated with it.",
    "The sample is a phase 3 trial for schizophrenia with blonanserin and risperidone as drugs, and the eligibility criteria includes meeting DSM-IV-TR criteria for schizophrenia, PANSS total score \u226570 and \u2264120, and willingness to comply with study protocol.",
    "The sample is a phase 3 trial for partial seizures and epilepsies, partial, with patients taking stable dosages of 1 to 3 anti-epilepsy medicines, testing the effectiveness of pregabalin and placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for ADHD patients aged 8-10 years old, testing the effectiveness of atomoxetine, with inclusion criteria of being medication naive and exclusion criteria of having certain disorders, such as bipolar disorder or autism.",
    "The sample is a phase 3 trial for breast cancer patients, testing the efficacy of capecitabine and taxotere drugs, with eligibility criteria including female patients aged 18-70 with adenocarcinoma of the breast and no evidence of metastatic disease.",
    "This phase 3 trial is testing the efficacy of pegylated interferon alpha 2b in treating chronic hepatitis B in patients who meet specific eligibility criteria and do not have any exclusion criteria.",
    "The sample is a phase 3 trial for multiple sclerosis with two drugs, interferon beta-1b (betaseron, bay86-5046), and eligibility criteria for patients who have completed the BENEFIT study.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin phosphate and placebo as monotherapy, with inclusion criteria of glimepiride and exclusion criteria of type 1 diabetes mellitus.",
    "The sample is a phase 3 trial for leukemia and lymphoma patients, testing a combination of drugs including asparaginase, cyclophosphamide, and vincristine sulfate, with eligibility criteria based on disease characteristics and risk factors.",
    "The trial is a phase 3 study testing the efficacy of four different drugs, including triamcinolone acetonide and ranibizumab, in treating diabetic retinopathy and diabetic macular edema, with specific inclusion and exclusion criteria for study eye eligibility.",
    "The sample is a phase 3 trial for metastatic prostate cancer patients receiving androgen deprivation therapy, testing the efficacy of risedronate and placebo, with specific eligibility and exclusion criteria.",
    "The sample is a phase 3 trial for patients with stage 3-5 chronic kidney disease and anemia, testing the efficacy of darbepoetin alfa versus placebo, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for gout patients with hyperuricemia, testing the efficacy of febuxostat and allopurinol, with inclusion and exclusion criteria listed.",
    "This phase 3 trial will test the effectiveness of dutasteride and placebo in treating prostatic hyperplasia in male patients aged 50 or older with an estimated prostate volume of at least 30cc, an I-PSS Symptom Score of at least 8 points, and a maximum flow rate of no more than 15mL/sec, among other eligibility criteria.",
    "The sample is a phase 3 trial for Crohn's disease testing the efficacy of GSK1605786A and placebo, with inclusion criteria including achieving clinical response or remission in a previous GSK study, stable doses of Crohn's disease medications, and willingness to undergo corticosteroid dose tapering, and exclusion criteria including pregnancy, small bowel strictures, and hepatic dysfunction.",
    "The sample is a phase 3 trial testing the efficacy of enoxaparin and apixaban in preventing deep vein thrombosis and pulmonary embolism in patients undergoing knee replacement surgery, with eligibility criteria including age 18 or older and exclusion criteria including bleeding disorders and need for ongoing anticoagulation.",
    "The sample is a phase 3 trial for kidney transplant patients, testing the efficacy of enteric-coated mycophenolate sodium, tacrolimus, and corticosteroids, with specific inclusion and exclusion criteria, for patients with certain kidney diseases.",
    "This phase 3 trial is testing the efficacy of carboplatin, cyclophosphamide, mitoxantrone hydrochloride, and paclitaxel in treating stage III or IV ovarian epithelial carcinoma, with eligibility criteria including prior chemotherapy response and specific patient characteristics.",
    "The sample is a phase 3 trial for patients with ovarian, fallopian tube, or primary peritoneal cancer who have had only one prior chemotherapy regimen and have a biochemical recurrence, and will test the effectiveness of tamoxifen citrate and thalidomide as treatment options.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of levomilnacipran er and placebo, with inclusion and exclusion criteria specified, and the icd-10 codes for the disease listed.",
    "The sample is a phase 3 trial for male osteoporosis, testing the efficacy of zoledronic acid 5 mg iv versus placebo, with inclusion and exclusion criteria based on bone density, previous treatments, and medical history.",
    "The sample is a phase 3 trial for dry eye, testing the efficacy of dexamethasone phosphate ophthalmic solution and sodium citrate buffer solution, with inclusion criteria of reported history of dry eye and response to Controlled Adverse Environment model, and exclusion criteria of contraindications to test articles, ocular infections or inflammation, and current contact lens wearers.",
    "The sample is a phase 3 trial for previously untreated metastatic colon or rectal cancer using bevacizumab and fluoropyrimidine-based chemotherapy, with specific inclusion and exclusion criteria.",
    "This is a phase 3 clinical trial for individuals with Down syndrome and Alzheimer's disease, testing the effectiveness of vitamin E, multivitamin, and placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for chemotherapy-induced nausea and vomiting (CINV) with a list of drugs including fosaprepitant dimeglumine, aprepitant, dexamethasone, and ondansetron, and eligibility criteria including age, predicted life expectancy, and contraception use.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of aclidinium bromide and placebo, with inclusion criteria based on GOLD guidelines and exclusion criteria including respiratory tract infection, asthma, and cardiovascular conditions.",
    "The sample is a phase 3 trial for Caucasian infants born small for gestational age, testing the efficacy of genotropin and control (no treatment) in promoting growth, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of cxa-201 and levofloxacin in treating complicated urinary tract infections and pyelonephritis, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of insulin degludec and sitagliptin in combination with metformin, sulfonylurea or pioglitazone, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 3 trial for patients with schizophrenia and psychotic disorders, using risperidone as the drug, with inclusion criteria including a diagnosis of schizophrenia and expected benefit from risperidone treatment, and exclusion criteria including substance dependence and hypersensitivity to risperidone.",
    "The sample is a phase 3 trial for hypercholesterolemia and hyperlipidemia, testing the efficacy of torcetrapib/atorvastatin and atorvastatin, with specific inclusion and exclusion criteria for subjects.",
    "The sample is a phase 3 trial for Parkinson's disease and dyskinesias, testing the efficacy of ropinirole controlled-release (Requip CR) for restless leg syndrome, with specific inclusion and exclusion criteria related to levodopa therapy and cognitive function.",
    "This phase 3 trial is testing the efficacy of lidocaine in treating neuropathic pain in patients who have undergone cancer surgery, with specific eligibility criteria and restrictions on concurrent therapies.",
    "This is a phase 3 clinical trial for the drug paliperidone er in patients with schizophrenia, with inclusion criteria including a PANSS score between 70 and 120 and willingness to be hospitalized for at least 14 days, and exclusion criteria including a history of lack of response to any antipsychotic and significant risk of suicidal or violent behavior.",
    "The sample is a phase 3 trial for asthma patients with positive skin prick test response to house dust mites, testing the efficacy of three drugs: alk hdm ait placebo, alk hdm ait 6 du, and alk hdm ait 12 du, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing consolidation chemotherapy with docetaxel plus cisplatin and ccrt arm without consolidation chemotherapy for patients with non-small cell lung cancer who meet specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of granulocyte colony-stimulating factor plus plerixafor and placebo in patients with multiple myeloma who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for patients undergoing knee replacement surgery, testing the efficacy of enoxaparin and apixaban in preventing deep vein thrombosis and pulmonary embolism, with eligibility criteria including no bleeding disorders or recent major surgery.",
    "This is a phase 3 trial for epilepsy patients, testing the efficacy of brivaracetam, with inclusion criteria including well-characterized focal epilepsy or epileptic syndrome and at least 2 but not exceeding 40 partial onset seizures per 4 weeks, while exclusion criteria include seizure type IA non-motor as only seizure type and other serious uncontrolled disease.",
    "The sample is a phase 3 trial for patients with unresectable non-small cell lung cancer, testing the efficacy of carboplatin and cisplatin, with eligibility criteria including specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "The sample is a phase 3 trial for head and neck cancer using placebo, palifermin, and cisplatin chemotherapy, with eligibility criteria including histologically documented squamous cell carcinoma and locally advanced stage head and neck cancer, and exclusion criteria including presence or history of any other primary malignancy.",
    "This phase 3 trial is testing the efficacy of paclitaxel in treating advanced ovarian, fallopian tube, or primary peritoneal cancer in patients who have achieved complete remission following platinum-based chemotherapy, and have met specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of insulin degludec/insulin aspart and biphasic insulin aspart 30 in treating type 2 diabetes mellitus with specific inclusion and exclusion criteria, including HbA1c levels and cardiovascular disease history.",
    "This phase 3 trial is testing the drug letrozole on postmenopausal women with estrogen and/or progesterone-receptor positive breast cancer, who are not eligible for breast-conserving surgery, and have measurable tumours, while excluding patients with multifocal disease, inflammatory breast cancer, or distant metastasis, and prohibiting simultaneous anti-cancer treatments, hormone replacement therapy, and radiation therapy.",
    "This phase 3 trial is testing the efficacy of lenalidomide, melphalan, and prednisone in treating newly diagnosed multiple myeloma patients who meet specific inclusion criteria.",
    "The sample is a phase 3 clinical trial for ulcerative colitis, testing the drugs spd476 and asacol, with inclusion criteria including confirmed remission for at least 30 days and exclusion criteria including proctitis, previous resective colonic surgery, Crohn's disease, hypersensitivity to salicylates, and moderate/severe renal impairment.",
    "The sample is a phase 3 trial for diabetes mellitus, testing the efficacy of alogliptin and insulin, with inclusion and exclusion criteria specified.",
    "This phase 3 trial focuses on renal transplantation and tests the efficacy of everolimus + cyclosporine, everolimus + enteric-coated mycophenolate sodium (ec-mps), and steroids as drugs, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for female patients with locally recurrent or metastatic breast cancer, testing the efficacy of vinflunine plus capecitabine and capecitabine, with eligibility criteria including prior treatments with anthracycline and taxane, and exclusion criteria including history of severe hypersensitivity to vinca alkaloids and/or fluoropyrimidine.",
    "The sample is a phase 3 trial for patients with graft versus host disease, leukemia, or lymphoma, testing the efficacy of anti-thymocyte globulin, cyclophosphamide, cyclosporine, methotrexate, and methylprednisolone, with specific eligibility criteria for patients based on disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This phase 3 trial is testing the efficacy of pd 0332334 and placebo in treating generalized anxiety disorder, with specific inclusion and exclusion criteria based on DSM-IV diagnoses and symptom scores.",
    "The sample is a phase 3 trial for vortioxetine and placebo in patients with major depressive disorder, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of topiramate and placebo in treating Tourette Syndrome, with strict inclusion and exclusion criteria, and a focus on patient health and safety.",
    "This is a phase 3 trial for venous thromboembolism using rivaroxaban and enoxaparin as drugs, with specific inclusion and exclusion criteria for patients undergoing elective THR.",
    "This phase 3 trial is testing elacytarabine and investigator's choice drugs for patients with acute myeloid leukemia who have received previous induction/re-induction regimens and have certain eligibility criteria.",
    "This phase 3 trial is testing the efficacy of methylphenidate hydrochloride in improving quality of life and reducing symptoms such as depression and fatigue in patients with various brain tumors who are undergoing external beam cranial radiotherapy, and meet specific eligibility criteria.",
    "The sample is a phase 3 trial for glaucoma and ocular hypertension, testing the efficacy of brimonidine 0.2%/timolol 0.5% fixed combination ophthalmic solution and concurrent brimonidine 0.2% and 0.5% timolol, with inclusion criteria of requiring IOP-lowering therapy in both eyes and exclusion criteria of uncontrolled medical conditions or contraindication to \u03b2-adrenoceptor antagonist therapy or brimonidine therapy.",
    "This phase 3 trial is testing the efficacy of zegerid and losec in treating gastroesophageal reflux disease in patients who have responded to standard PPI therapy in the past 12 months, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of paliperidone extended-release in treating bipolar disorder and mood disorders, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for schizophrenia with bifeprunox, placebo, and quetiapine as drugs, and the inclusion criteria require a primary diagnosis of schizophrenia, clinically significant symptoms, stable medication for 8 weeks, and being in the post-acute maintenance phase of the disease.",
    "The sample is a phase 3 trial for patients with acute coronary syndrome and coronary artery disease, testing the effectiveness of atorvastatin in reducing the need for direct revascularization techniques, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with metastatic germ cell tumors who have previously been treated with etoposide and cisplatin, and the study will test the efficacy of cisplatin, ifosfamide, paclitaxel, and vinblastine in treating the disease.",
    "The sample is a phase 3 trial for asthma treatment in children aged 6-14, using montelukast sodium and placebo as drugs, with specific inclusion and exclusion criteria based on respiratory conditions, and the icd-10 codes for asthma are provided.",
    "This is a phase 3 trial for asthma patients using budesonide/formoterol turbuhaler, budesonide turbuhaler (pulmicort), and terbutaline turbuhaler, with inclusion criteria of a diagnosis of asthma for at least 6 months and prescribed daily use of glucocorticosteroids for at least 3 months prior to visit one.",
    "The sample is a phase 3 trial for seasonal allergic rhinitis, testing the efficacy of mometasone furoate nasal spray and placebo, with inclusion and exclusion criteria for eligible participants.",
    "The sample is a phase 3 clinical trial for hypertension, testing the efficacy of irbesartan/amlodipine combination therapy, with eligibility criteria including uncontrolled systolic BP and exclusion criteria including severe hepatic or renal impairment and contraindications or hypersensitivity to the drugs.",
    "This is a phase 3 trial for patients with stable plaque psoriasis failing at least one systemic treatment regimen or where other systemic therapies are contraindicated or where tolerability is an issue, testing the efficacy of voclosporin, ciclosporin, and placebo.",
    "This phase 3 trial is testing the efficacy of tegafur and uracil in treating rectal cancer with specific disease characteristics and patient eligibility criteria.",
    "This phase 3 trial is testing the efficacy of amrubicin and topotecan in treating small cell lung cancer patients who have had no more than one prior chemotherapy regimen and meet specific inclusion criteria, while excluding those who have had prior anthracycline, topotecan, or irinotecan treatment.",
    "The sample is a phase 3 trial for kidney transplantation using alemtuzumab and tacrolimus, with eligibility criteria including endstage renal failure and exclusion criteria including previous treatment with Campath-1H and active systemic infection.",
    "The sample is a phase 3 trial for the treatment of invasive candidiasis using caspofungin acetate, with inclusion criteria of clinical and laboratory evidence of blood stream and/or systemic candida infections and exclusion criteria of possible candida contamination, candida colonization, acute or moderately severe liver disease, abnormal liver function tests, and abnormal blood clotting for patients on blood thinners.",
    "The sample is a phase 3 trial for eltrombopag and placebo in patients with chronic liver disease who require a platelet transfusion to manage the risk of bleeding associated with an elective invasive procedure, and have a baseline platelet count <50,000/\u00b5L, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for the treatment of bipolar disorder with asenapine and olanzapine, with inclusion criteria requiring completion of a 3-week asenapine study and exclusion criteria excluding patients with unstable medical conditions or clinically significant laboratory abnormalities.",
    "This phase 3 trial will test the efficacy of dexlansoprazole and placebo in treating gastroesophageal reflux with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for systemic lupus erythematosus, testing the efficacy of belimumab at two different doses and including eligibility criteria such as clinical diagnosis of SLE, active disease, and autoantibody positivity.",
    "This phase 3 trial is testing the efficacy of pertuzumab, trastuzumab, and docetaxel in treating HER2-positive metastatic breast cancer, with eligibility criteria including confirmed adenocarcinoma of the breast, LVEF \u226550%, and ECOG PS 0 or 1.",
    "This is a phase 3 trial for breast cancer patients who are candidates for hormonal therapy, testing the efficacy of zd9393 (zoladex) 10.8 mg and 3.6 mg, with eligibility criteria including pre-menopausal women with hormone sensitivity and exclusion criteria including prior hormonal therapy for breast cancer.",
    "The sample is a phase 3 clinical trial for metastatic pancreatic cancer using bevacizumab (Avastin) as a drug, with eligibility criteria including good liver, kidney, and bone marrow function, and exclusion criteria including previous systemic treatment for metastatic pancreatic cancer and recent participation in another investigational study.",
    "This phase 3 trial focuses on the use of s-adenosylmethionine and placebo in patients with alcoholic liver disease, with inclusion criteria including a history of chronic alcoholism and clinical and laboratory features of established liver disease, while exclusion criteria include viral hepatitis B or C, hemochromatosis, Wilson disease, sclerosing cholangitis, primary biliary cirrhosis, other chronic disease, and renal insufficiency.",
    "The sample is a phase 3 trial for patients with coronary heart disease, testing the efficacy of dalcetrapib, evidence-based medical care, and placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of dapagliflozin and metformin in treating type 2 diabetes, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for patients with fallopian tube or ovarian cancer, testing the drugs TCG and TC, with eligibility criteria including age, performance status, hematopoietic, hepatic, renal, and cardiovascular health, as well as prior concurrent therapy.",
    "The sample is a phase 3 trial for the treatment of retinal vein occlusion and macular edema using the drugs Ozurdex, with eligibility criteria including prior treatment with anti-VEGF injections, age over 18, and specific visual acuity and foveal thickness requirements.",
    "This phase 3 trial for breast cancer patients will test the efficacy of cyclophosphamide, docetaxel, gemcitabine, paclitaxel, and doxorubicin, and has strict eligibility criteria including tumor size, nodal staging, and hormone receptor status.",
    "The sample is a phase 3 trial for chronic hepatitis B, testing the efficacy of pegylated interferon and lamivudine, with specific inclusion and exclusion criteria, and the presence of certain icd-10 codes.",
    "The sample is a phase 3 trial for asthma patients, testing the efficacy of budesonide/formoterol and budesonide HFA inhalers, with inclusion criteria of Hispanic patients over 12 years old with moderate to severe asthma and exclusion criteria of subjects requiring systemic corticosteroids or with significant diseases or disorders.",
    "The sample is a phase 3 trial for psoriasis, testing the efficacy of u0267 foam and vehicle foam as treatments, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for diabetes mellitus, asthma, and chronic obstructive pulmonary disease, testing human insulin inhalation powder and injected insulin, with inclusion criteria of type 1 or type 2 diabetes and asthma or COPD, and exclusion criteria of current smoking habit.",
    "The sample is a phase 3 trial for non-small cell lung cancer using carboplatin and paclitaxel as drugs, with inclusion criteria including NSCLC, stages IB, IIA, IIB, IIIA/T3, lung function test allowing surgery, and age 18-75 years, and exclusion criteria including poor lung function, performance status 3-4, and mediastinal lymph node involvement.",
    "This is a phase 3 trial for patients with schizophrenia and associated cannabis abuse and/or psychotic disorders, testing the efficacy of quetiapine xr, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the effectiveness of abetimus sodium and/or placebo solution in treating lupus erythematosus and lupus nephritis, with eligibility criteria including a diagnosis of SLE and weekly IV administration of study treatment.",
    "The sample is a phase 3 trial for mixed dyslipidemia, testing the efficacy of fenofibrate/simvastatin and atorvastatin, with inclusion criteria of mixed dyslipidemia and exclusion criteria of hypersensitivity to the drugs, pregnancy/lactation, contra-indication to the drugs, and unstable/severe cardiac disease.",
    "The sample is a phase 3 trial for liver transplantation patients using the drugs Prograf and MR4, with eligibility criteria including negative pregnancy test, end-stage liver failure, and exclusion criteria including multi-organ transplant, allergy to macrolide antibiotics or tacrolimus, and serum creatinine > 1.5mg/Dl.",
    "The sample is a phase 3 clinical trial for safinamide, a drug used to treat Parkinson's disease, and includes eligibility criteria such as a diagnosis of idiopathic Parkinson's disease, levodopa responsiveness, and motor fluctuations.",
    "This phase 3 trial is testing the efficacy of alisporivir, peginterferon alfa-2a, and ribavirin in treating chronic HCV infection with genotype 1, and the eligibility criteria includes having a serum HCV RNA level \u2265 1000 IU/ml and liver evaluation prior to baseline, while exclusion criteria includes co-infection with Hepatitis B or HIV and presence or history of hepatic decompensation.",
    "This phase 3 trial is testing the efficacy of adalimumab and mtx versus placebo in treating moderate to severe chronic plaque psoriasis, with specific inclusion and exclusion criteria for subjects.",
    "This phase 3 trial is testing the efficacy of albumin-bound paclitaxel, paclitaxel, and carboplatin in treating stage IIIB or IV non-small cell lung cancer patients who have not received prior chemotherapy for metastatic disease, and meet specific eligibility criteria.",
    "The sample is a phase 3 trial for patients with inadequately controlled acromegaly, testing the efficacy of pasireotide, octreotide lar 30mg, and lanreotide atg 120mg, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of flibanserin, a drug used to treat sexual dysfunctions, in premenopausal women with HSDD, and includes eligibility criteria such as regular menstrual periods, minimum cut-off scores on questionnaires, and a stable, monogamous, heterosexual relationship.",
    "The sample is a phase 3 trial for patients with osteoarthritis of the knee, testing the efficacy of pg201 tablet and celebrex capsule as compared to NSAIDs/Cyclooxygenase-2 inhibitor, with eligibility criteria including age, radiographic diagnosis, pain VAS scores, and exclusion criteria including surgery or arthroscopy of the study joint within the previous 6 months, trauma of study joint within the previous 12 months, and any other type of arthritis, active malignancies or any active GI, cardiovascular, renal, hepatic, neurologic, or psychiatric disease.",
    "The sample is a phase 3 trial for patients with gastrointestinal stromal tumors who are currently receiving imatinib mesylate and meet certain eligibility criteria, with the goal of testing the efficacy of the drug.",
    "The sample is a phase 3 trial for chronic hepatitis C infection with the drugs telaprevir, peg-ifn-alfa-2a, ribavirin, and placebo, and the eligibility criteria includes having failed at least 1 prior course of Peg-IFN/RBV therapy and using 2 effective methods of birth control for up to 7 months after last dose of study medication.",
    "This phase 3 trial is testing the efficacy of saxagliptin and placebo in treating type 2 diabetes in patients who have inadequate glycaemic control despite being on a combination of metformin and sulfonylurea for at least 8 weeks prior to Visit 1.",
    "The sample is a phase 3 trial for seasonal allergic rhinitis, testing the efficacy of olopatadine hydrochloride nasal spray 0.6% and vehicle, with inclusion criteria of a minimum age of 6 years and a 2-year history of seasonal allergic rhinitis, and exclusion criteria including chronic or intermittent use of corticosteroids and known non-responder to antihistamines.",
    "The sample is a phase 3 trial for linagliptin and placebo in patients with type 2 diabetes mellitus, with inclusion criteria of HbA1c >= 7.0% and age >= 70 years, and exclusion criteria of recent myocardial infarction or stroke, impaired hepatic function, and treatment with certain diabetes medications.",
    "The sample is a phase 3 trial for Parkinson's disease using istradefylline (kw-6002) as a drug, with inclusion criteria such as UK Parkinson's Disease Society brain bank criteria and predictable end of dose wearing off, and exclusion criteria such as neurosurgical treatment for PD and history of psychosis.",
    "The sample is a phase 3 trial for Parkinson's disease, testing the efficacy of placebo and Azilect\u00ae in patients with motor fluctuations, taking optimized levodopa therapy, and meeting specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of zoledronic acid in prostate cancer patients undergoing androgen deprivation therapy with low bone mineral density, and excludes patients with bone metastases, prior bisphosphonate therapy, and other confounding conditions.",
    "This phase 3 trial is testing the efficacy of celecoxib and placebo in palliative chemotherapy for non-small cell lung cancer patients with specific eligibility criteria, including disease stage, performance status, and blood count levels.",
    "The sample is a phase 3 trial for invasive breast cancer patients with HER2-positive tumors, testing the efficacy of a combination of doxorubicin, cyclophosphamide, paclitaxel, trastuzumab, and lapatinib, with eligibility criteria including specific disease characteristics and health status, and exclusion criteria including prior therapy with certain drugs and certain medical conditions.",
    "The sample is a phase 3 trial for migraine headache, testing the efficacy of sumatriptan and placebo, with inclusion criteria of age, diagnosis, and frequency of migraine attacks, and exclusion criteria of medication use and history of resistance to sumatriptan.",
    "This phase 3 trial is testing the efficacy of desvenlafaxine succinate sustained-release (dvs sr), duloxetine, and placebo in treating Major Depressive Disorder, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for breast cancer and osteoporosis patients, testing the effectiveness of alendronate sodium, calcium gluconate, and risedronate sodium in postmenopausal women with acceptable DEXA scans and no other bone diseases, and who have not taken certain medications for a specified period of time.",
    "This phase 3 trial is testing the efficacy of indacaterol, salmeterol, and placebo in treating moderate-to-severe chronic obstructive pulmonary disease (COPD) in patients with a smoking history of at least 20 pack-years, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the drugs abt-874 and methotrexate for the treatment of psoriasis, with eligibility criteria including a diagnosis of psoriasis for 6 months, BSA 10%, PASI 12 or above, and PGA 3 or above, and exclusion criteria including previous exposure to anti-IL 12.",
    "The sample is a phase 3 trial for mixed hyperlipidemia, testing the efficacy of mk-0524a, atorvastatin, and simvastatin, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial focuses on kidney transplantation and uses drugs such as fk506mr, prograf, mycophenolate mofetil, methylprednisolone, and prednisolone, with eligibility criteria including age, negative pregnancy test, and absence of certain medical conditions.",
    "This phase 3 trial is testing the efficacy of insulin glargine, omega-3 polyunsaturated fatty acids, and placebo in individuals with impaired glucose tolerance, impaired fasting glucose, or early type 2 diabetes and at least one cardiovascular risk factor.",
    "This phase 3 trial is testing the efficacy of budesonide-mmx\u00ae and asacol\u00ae in treating mild to moderate ulcerative colitis in patients aged 18-75, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of vortioxetine and duloxetine compared to placebo, with inclusion and exclusion criteria including duration and severity of symptoms, previous participation in clinical studies, and presence of other psychiatric or medical disorders.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the effectiveness of budesonide/formoterol, budesonide, and terbutaline sulfate, with inclusion criteria of out-patient clinical diagnosis of COPD and age 40 or over, and exclusion criteria of a history of asthma or significant/unstable heart disease.",
    "This is a phase 3 trial for acute coronary syndrome patients, testing the efficacy of a-002 and varespladib methyl drugs against placebo, with eligibility criteria including age, diagnosis, risk factors, and exclusion criteria such as severe liver or renal disease, pregnancy, and drug abuse.",
    "The sample is a phase 3 clinical trial for participants with type 2 diabetes mellitus, testing the efficacy of hoe901-u300 and lantus insulin glargine, with eligibility criteria including completion of a 6-month study period and exclusion criteria such as age less than 18 years and contraindications to insulin glargine use.",
    "The sample is a phase 3 trial for advanced non-small cell lung cancer, testing the efficacy of docetaxel, vinorelbine, gemcitabine, and capecitabine, with specific eligibility and exclusion criteria.",
    "The sample is a phase 3 clinical trial for type 2 diabetes mellitus, testing the efficacy of bi10773 and sitagliptin compared to placebos, with eligibility criteria including HbA1c levels, age, BMI, and exclusion criteria including liver disease, cancer, and drug use.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of alogliptin, metformin, and pioglitazone, with inclusion and exclusion criteria, and a list of associated icd-10 codes.",
    "This phase 3 trial is testing the effectiveness of aliskiren, ramipril, hydrochlorothiazide, and amlodipine in treating essential hypertension in patients over 65 years old with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of aprepitant and ondansetron in preventing chemotherapy-induced nausea and vomiting in children aged 6 months to 17 years with a documented malignancy, and who are expected to receive ondansetron as part of their antiemetic regimen.",
    "This is a phase 3 clinical trial for the treatment of primary insomnia using volinanserin and placebo, with specific inclusion and exclusion criteria based on sleep patterns and medical history.",
    "The sample is a phase 3 trial for head and neck cancer patients, testing the efficacy of erlotinib and placebo drugs, with inclusion criteria of curatively treated T3-T4 and/or N2-N3 pathology and ECOG status of 0 to 2, and exclusion criteria of previous anti-EGFR targeted therapies.",
    "The sample is a phase 3 trial for advanced renal cell carcinoma, testing the efficacy of bevacizumab, temsirolimus, and interferon-alfa 9mu, with specific eligibility criteria including histological confirmation and measurable lesions, and exclusion criteria such as prior systemic treatment and CNS metastases.",
    "The sample is a phase 3 trial for patients with non-valvular atrial fibrillation, testing the efficacy of rivaroxaban and warfarin as anticoagulants, with inclusion criteria of age 20 or older, Japanese nationality, and risk of stroke and non-CNS systemic embolism, and exclusion criteria of significant mitral stenosis and contraindication to anticoagulants.",
    "This phase 3 trial is testing the efficacy of various doses and combinations of pioglitazone and linagliptin in treating type 2 diabetes mellitus, with a list of inclusion and exclusion criteria, including contraindications to pioglitazone and other medications, and a list of diseases and drugs being studied.",
    "This phase 3 trial is testing the efficacy of bosentan, an endothelin receptor antagonist, in patients diagnosed with type 2 diabetes and overt nephropathy who are on current treatment with angiotensin II receptor blockers for at least 3 months, and have stable medication for at least 3 months prior to screening.",
    "This phase 3 trial focuses on infertility and involves testing the efficacy of two placebo drugs, sch 900962 and recfsh, on female participants who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for patients with malignancy who will be treated with highly emetogenic chemotherapeutic agents, testing the effectiveness of ramosetron and ondansetron as antiemetics, with specific inclusion and exclusion criteria.",
    "This phase 3 trial will test the efficacy of lpv/r, peg-ifna 2a, ribavirin, and nucs in treating HIV and HCV infections in patients with chronic hepatitis and/or compensated cirrhosis, who meet specific eligibility criteria and do not have any exclusion criteria.",
    "The sample is a phase 3 trial for fibromyalgia patients using pregabalin, with inclusion criteria requiring prior participation in a fibromyalgia study and exclusion criteria related to serious adverse events from previous medication.",
    "The sample is a phase 3 clinical trial for children with atopic dermatitis, testing the efficacy of broncho-vaxom and placebo-cap drugs, with inclusion criteria including affected body surface area and SCORAD score, and exclusion criteria including immunodeficiency and previous intolerance to trial drugs.",
    "The sample is a phase 3 trial for asthma, testing the efficacy of elpenhaler active and diskus placebo, with inclusion and exclusion criteria including age, diagnosis, FEV1, inhaled steroids, and history of pulmonary disease or medication use.",
    "This phase 3 trial is testing the efficacy of lapaquistat acetate and stable statin therapy in treating hypercholesterolemia, with strict inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for non-prior chemotherapy treated advanced gastric adenocarcinoma, testing the efficacy of drugs including s-1, s-1 plus cddp, and 5-fu plus cddp, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 3 trial for venous thromboembolism, testing the efficacy of enoxaparin and dabigatran etexilate as prophylaxis for patients undergoing total hip arthroplasty, with specific inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of cyclophosphamide, doxorubicin hydrochloride, etoposide, ifosfamide, irinotecan hydrochloride, and vincristine sulfate in treating high-risk rhabdomyosarcoma or ectomesenchymoma, with eligibility criteria including prior enrollment on COG-D9902, metastatic disease, and specific patient characteristics such as ECOG or Zubrod performance status and platelet count.",
    "This phase 3 trial is testing the efficacy of glatiramer acetate (GA) versus placebo in treating relapsing-remitting multiple sclerosis, with inclusion criteria including confirmed MS diagnosis, ambulatory with EDSS score of 0-5.5, and experiencing at least one documented relapse in the 12 months prior to screening.",
    "The sample is a phase 3 trial for breast neoplasms, testing the efficacy of capecitabine and sunitinib malate in patients who have previously been treated with anthracyclines and taxanes, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for smoking cessation, testing the efficacy of placebo and varenicline tartarate in patients with mild to moderate COPD, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for moderate to severe plaque-type psoriasis, testing the efficacy of secukinumab 150 mg versus placebo, with inclusion and exclusion criteria based on disease severity, prior treatment, and medical history.",
    "This phase 3 trial is testing the drug ast-120 in patients with inflammatory bowel disease and intestinal fistula, with specific inclusion and exclusion criteria for eligibility.",
    "This phase 3 trial is testing the efficacy of hyoscine butylbromide and placebo in treating abdominal pain in patients with occasional or recurrent episodes of gastric or intestinal spasm-like pain, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of tramadol hcl/acetaminophen extended release and placebo in treating low back pain, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for asthma, testing the drug ciclesonide (xrp1526), with inclusion criteria including persistent bronchial asthma and FEV1 60 to 90% of predicted, and exclusion criteria including history of life-threatening asthma and use of systemic steroids within 6 months before screening.",
    "The sample is a phase 3 trial for attention deficit hyperactivity disorder (ADHD) testing the efficacy of methylphenidate hydrochloride and placebo, with inclusion criteria including a diagnosis of ADHD and exclusion criteria including various medical conditions and recent participation in other clinical trials.",
    "This phase 3 trial is testing the efficacy of ly2216684 (edivoxetine) and SSRIs in treating major depressive disorder in adults who have had a partial response to SSRIs, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of azilsartan medoxomil and chlorthalidone in treating essential hypertension, with strict inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of fluticasone propionate/formoterol fumarate and other drugs in treating asthma, with eligibility criteria including a history of asthma, documented use of inhaled corticosteroid, and reversible FEV-1 levels, while exclusion criteria include life-threatening asthma, recent systemic corticosteroid medication, and significant pulmonary disease.",
    "The sample is a phase 3 trial for HIV infections using the drug maraviroc, with inclusion criteria including virologic suppression failure and R5 HIV-1, and exclusion criteria including prior treatment with any CCR5 antagonist or premature discontinuation of maraviroc in trials.",
    "This phase 3 trial will test the efficacy of paricalcitol and placebo in patients with coronary artery disease, chronic kidney disease, hypovitaminosis D, and secondary hyperparathyroidism, who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for graft vs host disease and kidney transplantation, testing the effectiveness of sirolimus, cyclosporine, mycophenolate mofetil, corticosteroids, and daclizumab, with inclusion criteria of kidney transplantation and a donor age of at least 60, and exclusion criteria of current systemic infection, unstable angina or treatment for serious arrhythmia, and cancer within the previous 5 years.",
    "The sample is a phase 3 trial for glaucoma patients, testing the drugs t2345 and prostaglandin, with inclusion criteria being adult patients diagnosed with glaucoma and exclusion criteria being patients under 18.",
    "The sample is a phase 3 trial for non-constipation irritable bowel syndrome, testing the efficacy of rifaximin and placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for non-valvular atrial fibrillation, testing the efficacy of du-176b 15mg, 30mg, and 60mg, with inclusion criteria of patients with NVAF and SRI or Normal/MiRI, and exclusion criteria of patients on hemodialysis, high risk for bleeding, receiving treatment with certain anticoagulant drugs, or evidence of hepatic function test abnormalities.",
    "The sample is a phase 3 trial for chondroitin sulphate (condrosan) versus placebo in patients with primary osteoarthritis of the knee with synovitis criteria, and the eligibility criteria include radiological stages 2 and 3 according to Kellgren-Lawrence, minimum joint space width \u22652 mm in the medial femorotibial compartment on standing knee X-ray, and VAS of pain while walking \u226540 mm.",
    "The sample is a phase 3 trial for chronic moderate to severe pain caused by a nonmalignant condition, using the drug alo-01 (morphine sulfate plus naltrexone hydrochloride er), with inclusion criteria of age 18-70 and exclusion criteria including drug abuse/dependence/misuse within five years prior to the Baseline Visit and BMI>45kg/m2.",
    "The sample is a phase 3 trial for locally advanced or metastatic breast neoplasms, testing the efficacy of sunitinib + capecitabine and capecitabine drugs, with eligibility criteria including previous treatment with an anthracycline and a taxane, and exclusion criteria including brain metastases.",
    "This is a phase 3 trial for patients at risk of venous thromboembolic events, testing the efficacy of rivaroxaban and enoxaparin, with inclusion criteria including heart failure, active cancer, acute ischemic stroke, and reduced mobility.",
    "This is a phase 3 clinical trial for acute bacterial rhinosinusitis in children, testing the efficacy of amoxicillin-potassium clavulanate combination, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for metastatic colorectal cancer using fluorouracil, irinotecan hydrochloride, and leucovorin calcium as drugs, with eligibility criteria including confirmed adenocarcinoma, measurable disease, and certain patient characteristics.",
    "This is a phase 3 trial for acute coronary syndrome patients, testing the effectiveness of bivalirudin and heparin as drugs, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of bevacizumab, placebo, and standard chemotherapy in treating metastatic breast cancer patients who have progressed after first-line chemotherapy, with specific eligibility and exclusion criteria.",
    "The sample is a phase 3 trial for advanced Parkinson's disease, testing the efficacy of levodopa carbidopa intestinal gel, levodopa carbidopa oral encapsulated immediate release tablets, and their respective placebos, with inclusion criteria of idiopathic Parkinson's disease and severe motor fluctuations, and exclusion criteria of contraindications to levodopa and other neurological deficits.",
    "This phase 3 trial is testing the efficacy of palonosetron and ondansetron, among other drugs, in treating chemotherapy-induced nausea and vomiting in pediatric patients with confirmed malignant disease who are scheduled to receive at least one of the moderately or highly emetogenic chemotherapeutic agents on Study Day 1.",
    "This phase 3 trial is testing the efficacy of buprenorphine and placebo in treating moderate to severe low back pain in patients who have been on stable non-opioid analgesic medication for at least 4 weeks, with a list of inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for advanced breast cancer patients, testing the efficacy of sunitinib, paclitaxel, and bevacizumab in combination with paclitaxel, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for rheumatoid arthritis patients who completed phase II and cannot take MTX, testing the efficacy of abatacept, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for acute lymphoblastic leukemia (ALL) with a list of 15 drugs including dexamethasone, asparaginase, and vincristine, and eligibility criteria including confirmed ALL and no prior disease that would preclude treatment with chemotherapy.",
    "The sample is a phase 3 trial for hypertension, testing the efficacy of azilsartan medoxomil and valsartan, with eligibility criteria including specific blood pressure ranges and exclusion criteria such as recent history of cardiovascular events or drug/alcohol abuse.",
    "The sample is a phase 3 trial for patients with breast neoplasm, testing the effectiveness of taxol and tocosol paclitaxel, with eligibility criteria including stage IV disease and exclusion criteria including recent taxane treatment and HER2/neu overexpression.",
    "This phase 3 trial is testing the efficacy of rituximab and anti-inflammatory drugs in treating active rheumatoid arthritis in patients who have had an inadequate response to non-biological disease-modifying anti-rheumatic drugs, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for chronic osteoarthritis and pain assessment, testing the efficacy of cg5503 ir and tapentadol as analgesic medication, with inclusion criteria for joint replacement surgery and exclusion criteria for certain medical conditions and medications.",
    "This phase 3 trial is testing the efficacy of tezosentan and placebo in patients undergoing complex cardiac surgery or with pre-operative pulmonary hypertension due to left heart disease, with a list of inclusion and exclusion criteria, and diseases including heart diseases and pulmonary hypertension.",
    "The sample is a phase 3 trial for venous thromboembolism, testing the efficacy of 15mg and 30mg du-176b and fondaparinux as antithrombotic therapy for patients undergoing orthopedic surgery of the lower limbs, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for restless legs syndrome, testing the drug asp8825, with inclusion criteria based on IRLS score and exclusion criteria including recent use of dopamine agonists or gabapentin, low creatinine clearance, pregnancy or lactation, low serum ferritin, and movement disorders or abnormal neurological findings.",
    "The sample is a phase 3 trial for obesity and type 2 diabetes mellitus, testing the drugs taranabant and placebo, with inclusion criteria of BMI between 27-43 kg/m2 and HbA1c between 7.0-10%, and exclusion criteria including history of major psychiatric disorder, blood pressure greater than 160/100, use of any antihyperglycemic agent other than metformin, and triglycerides greater than 600 mg/dL.",
    "The sample is a phase 3 trial for gastric cancer patients with metastatic or unresectable disease, testing the efficacy of placebo and paclitaxel as second-line therapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for ulcerative colitis testing the efficacy of abatacept and placebo in patients who have had an inadequate response or intolerance to standard treatment, with inclusion criteria including a diagnosis of ulcerative colitis for at least 3 months and moderate to severe active disease.",
    "The sample is a phase 3 trial testing the efficacy of epoetin alfa in treating anemia in female patients with metastatic breast cancer who are predicted to start chemotherapy for the first time, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of consensus interferon and ribavirin in treating chronic hepatitis C, with specific inclusion and exclusion criteria for eligible patients.",
    "This phase 3 trial is testing the efficacy of mepolizumab, placebo, and oral corticosteroids in treating eosinophilic asthma, with inclusion criteria including regular treatment with high dose inhaled corticosteroids and persistent airflow obstruction, and exclusion criteria including current or former smokers with a smoking history of >=10 pack years and a known allergy or intolerance to a monoclonal antibody or biologic.",
    "The sample is a phase 3 trial for patients with schizophrenia or bipolar I disorder, testing the efficacy of quetiapine fumarate, with inclusion criteria including previous enrollment in related studies and exclusion criteria including pregnancy or lactation and previous participation in this study.",
    "The sample is a phase 3 trial for patients with chronic kidney disease and insulin resistance, testing the effectiveness of rosiglitazone, with inclusion criteria of CKD stage 4, BMI \u2264 30, and fasting glucose < 7 mmol/l, and exclusion criteria including a diagnosis of diabetes mellitus for which the patient uses insulin, significant co-morbidities, and allergy for PPAR's.",
    "This is a phase 3 clinical trial for patients with schizophrenia, testing the efficacy of cariprazine, aripiprazole, and placebo, with specific inclusion and exclusion criteria. The trial will use ICD-10 codes to identify patients with schizophrenia.",
    "This phase 3 trial is testing the efficacy of cisplatin, epirubicin hydrochloride, fluorouracil, and leucovorin calcium in treating patients with adenocarcinoma of the stomach or gastroesophageal junction who have had en bloc resection of all known tumor with a curative intent and meet other eligibility criteria.",
    "The sample is a phase 3 trial for breast cancer patients, testing the efficacy of capecitabine, cyclophosphamide, docetaxel, doxorubicin hydrochloride, and gemcitabine hydrochloride, with eligibility criteria including age, performance status, tumor size, and various lab values, while excluding patients with certain medical histories or conditions.",
    "This phase 3 trial is testing taxane, avastin, and xeloda in patients with locally advanced or metastatic breast cancer who have already undergone (neo)adjuvant chemotherapy, adjuvant endocrine therapy, or palliative endocrine treatments, and meet other eligibility criteria.",
    "The sample is a phase 3 trial for left-sided uncomplicated diverticular disease, testing the efficacy of mesalazine and placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for chronic hepatitis B infection, testing the efficacy of tdf and ftc/tdf drugs in patients with lamivudine resistance, with inclusion criteria including positive HBsAg, HBV DNA \u2265 10^3 IU/mL, and exclusion criteria including decompensated liver disease and coinfection with hepatitis C virus, HIV, or hepatitis D virus.",
    "The sample is a phase 3 trial for metastatic melanoma using dacarbazine and temozolomide as drugs, with specific inclusion and exclusion criteria for potential study participants.",
    "This phase 3 trial is testing the efficacy of modified release and immediate release formulations of oxcarbazepine in treating partial epilepsy, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial aims to investigate the effect of vitamin D supplementation on patients with coronary artery disease, postprandial hyperglycemia, and vitamin D deficiency, with inclusion criteria including age, glucose levels, and angiographically verified coronary artery disease, and exclusion criteria including acute coronary syndrome, heart failure, and ongoing chemotherapy. The drug being tested is vitamin D.",
    "The sample is a phase 3 trial testing the efficacy of eplivanserin and placebo in treating primary insomnia, with specific inclusion and exclusion criteria, and involving patients with sleep initiation and maintenance disorders and insomnia.",
    "The sample is a phase 3 trial for seasonal allergic rhinitis, testing the efficacy of montelukast and placebo drugs, with inclusion and exclusion criteria based on weight, height, ability to record symptoms, and medical history.",
    "This phase 3 trial is testing the safety of azilsartan medoxomil and chlorthalidone and olmesartan medoxomil and hydrochlorothiazide in treating hypertension in patients with moderate renal impairment and includes eligibility criteria and exclusion criteria.",
    "This is a phase 3 trial for patients with type 2 diabetes, testing the drug bi 10773, with eligibility criteria including a minimum dose of metformin and sulfonylurea, HbA1c levels, and exclusion criteria such as liver disease and recent cancer treatment.",
    "The sample is a phase 3 trial for colorectal cancer patients with measurable disease progression after prior fluorouracil therapy, testing the efficacy of cyclosporine and irinotecan hydrochloride, with eligibility criteria including performance status, blood counts, renal function, and absence of certain conditions or medications.",
    "The sample is a phase 3 trial for anemia patients undergoing platinum-based chemotherapy, testing the efficacy of epoetin beta and placebo, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 clinical trial for amyotrophic lateral sclerosis (ALS) testing the efficacy of MCI-186 and its placebo, with inclusion criteria based on diagnostic criteria and functional limitations, and exclusion criteria including severe complications, pregnancy, and recent participation in other clinical trials.",
    "The sample is a phase 3 trial for kidney transplantation using the drugs Prograf and MR4, with inclusion and exclusion criteria listed, and the disease being studied is kidney transplantation with associated ICD-10 codes.",
    "The sample is a phase 3 trial for the treatment of bilateral blepharospasm using incobotulinumtoxina (xeomin) and placebo, with eligibility criteria including a Jankovic Rating Scale severity subscore >= 2 and stable therapeutic response to BOTOX\u00ae injections, and exclusion criteria including hypersensitivity to human serum albumin, sucrose, or Botulinum toxin A.",
    "This phase 3 trial is testing the efficacy of cisplatin, docetaxel, fluorouracil, and paclitaxel in treating unresectable, locally recurrent squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx in patients who have had prior radiotherapy for SCC of the head and neck with > 75% of the present tumor volume in areas irradiated at doses \u2265 45 Gy but \u2264 75 Gy.",
    "The sample is a phase 3 clinical trial for hypercholesterolemia, testing the efficacy of alirocumab and ezetimibe, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial testing the efficacy of NGX-4010, a capsaicin patch, in treating painful HIV-associated distal symmetric polyneuropathy, with a list of diseases and their corresponding icd-10 codes, and eligibility criteria for the study.",
    "This is a phase 3 trial for non-small cell lung cancer patients with measurable or evaluable disease, who have not received prior systemic chemotherapy, and meet specific eligibility criteria, using carboplatin and paclitaxel as drugs.",
    "The sample is a phase 3 trial testing the efficacy of modafinil and placebo in treating mild to moderate stage probable Alzheimer's disease with clinically elevated levels of apathy, and the inclusion and exclusion criteria for the trial include specific diagnoses and medical history.",
    "This phase 3 trial is testing the efficacy of aripiprazole im depot and placebo in treating acute relapse of schizophrenia in subjects who have received previous outpatient antipsychotic treatment, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 3 trial for ovarian neoplasms using caelyx and paclitaxel hcl as drugs, with eligibility criteria including histologically proven epithelial ovarian carcinoma and measurable disease, and exclusion criteria including prior therapy with DOXIL or paclitaxel.",
    "This phase 3 trial is testing the efficacy of cyclophosphamide, cyclosporine, etoposide, methotrexate, busulfan, and mesna in treating childhood acute lymphoblastic leukemia in second hematologic remission or greater, with specific eligibility criteria for patients and donors.",
    "The sample is a phase 3 trial for patients with gastrointestinal stromal tumor who have progressed on imatinib, testing the efficacy of sunitinib malate and imatinib mesylate, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is testing the efficacy of lesinurad and placebo in treating gout patients who meet specific inclusion criteria, while excluding those with certain medical conditions or taking certain medications.",
    "This is a phase 3 clinical trial for Alzheimer's disease, testing the efficacy of DHA (docosahexaenoic acid) compared to placebo, with eligibility criteria including age, MMSE score, language fluency, and neuroimaging consistent with AD diagnosis. Exclusion criteria include non-AD dementia, history of stroke, and significant clinical disorders or laboratory findings.",
    "This phase 3 trial is testing the efficacy of insulin glargine and insulin glulisine in patients with type 1 or type 2 diabetes mellitus who are currently using premix insulin or Lantus with short acting insulin, and have a screening HbA1c level of \u2265 7.0 and \u2264 9.0 %, while also meeting other inclusion criteria and not meeting any exclusion criteria.",
    "The sample is a phase 3 trial for pulmonary hypertension, testing the efficacy of bosentan and placebo, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for glaucoma and ocular hypertension, testing the effectiveness of brimonidine ophthalmic solution 0.1% and 0.2%, with inclusion criteria of having the diseases in both eyes and exclusion criteria of uncontrolled systemic disease or allergy to brimonidine.",
    "This phase 3 trial is testing the efficacy of brivaracetam, a drug used to treat partial onset seizures, in subjects with well-characterized focal epilepsy or epileptic syndrome according to the International League Against Epilepsy (ILAE) classification, who are uncontrolled while treated by 1 to 2 permitted concomitant antiepileptic drug(s) (AEDs).",
    "This phase 3 trial is testing the efficacy of imatinib mesylate and imatinib in treating GIST, a type of sarcoma, with specific eligibility criteria including tumor size and mitotic count, organ function, and exclusion criteria such as inoperable or metastatic GIST and severe medical conditions.",
    "The sample is a phase 3 trial for psoriasis patients with a minimum PASI score of 10, testing the effectiveness of etanercept, and requiring previous failure or contraindication to other systemic or phototherapies.",
    "The sample is a phase 3 trial for hyperlipidemia and mixed dyslipidemia, testing the efficacy of niacin er/simvastatin tablets and atorvastatin, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of prazosin, a drug used to treat hypertension, in reducing symptoms of PTSD and sleep disorders in veterans who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for acute ischemic stroke with the inclusion criteria of first symptoms within 6 hours, baseline NIHSS > 5, and the exclusion criteria of no intracranial, extravascular blood on CT, hypertension, baseline fibrinogen level < 100 mg/dL, thrombocytopenia, recent or anticipated use of a thrombolytic agent, and recent or anticipated surgery. The drug being tested is a placebo.",
    "The sample is a phase 3 trial for post-menopausal women with urogenital ageing and recurrent urinary tract infections, testing the efficacy of estradiol, 25 mcg, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of leflunomide, methotrexate, and ocrelizumab, along with placebo, in treating rheumatoid arthritis patients who have had inadequate response to anti-TNF-alpha agents, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with schizoaffective disorder or psychotic disorder, testing the efficacy of paliperidone er and placebo, with inclusion and exclusion criteria based on DSM-IV diagnosis, PANSS score, and history of treatment resistance.",
    "The sample is a phase 3 trial for schizophrenia, testing the efficacy of asenapine and olanzapine compared to placebo, with inclusion criteria of acute exacerbation of schizophrenia and exclusion criteria of other psychiatric disorders or unstable medical conditions.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of mk0869 and aprepitant drugs compared to placebo, with eligibility criteria being major depressive disorder.",
    "The sample is a phase 3 trial for rheumatoid arthritis patients receiving outpatient treatment with inadequate response or intolerance to etanercept, infliximab or adalimumab, and ongoing treatment with methotrexate, using rituximab as the drug, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of linagliptin and placebo, with inclusion and exclusion criteria related to diabetes medication and recent cardiovascular events.",
    "The sample is a phase 3 trial for basal cell carcinoma using imiquimod 5% cream as the drug, with inclusion criteria of basal cell carcinoma and exclusion criteria of psoriasis.",
    "This phase 3 trial is testing the efficacy of vortioxetine and agomelatine in treating Major Depressive Disorder in patients who have an inadequate response to current SRI treatment, with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for patients with estrogen receptor positive or unknown stage I or II primary operable breast cancer, testing the drug fulvestrant, with eligibility criteria including age, sex, menopausal status, and prior concurrent therapy restrictions.",
    "This phase 3 trial is testing the efficacy of conjugated estrogens in treating endometrial cancer in patients who have had a total hysterectomy and bilateral salpingo-oophorectomy within the past 20 weeks, with specific eligibility criteria for disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This is a phase 3 clinical trial for patients with gastric adenocarcinoma who underwent curative D2 lymphadenectomy resection, testing the efficacy of capecitabine and oxaliplatin as adjuvant chemotherapy.",
    "The sample is a phase 3 trial for breakthrough pain in cancer patients, testing the drug oravescent fentanyl citrate, with inclusion criteria including age, opioid tolerance, and a malignant solid tumor or hematological malignancy diagnosis.",
    "The sample is a phase 3 trial for bipolar disorder and mood disorders, with icd-10 codes provided, testing the efficacy of placebo, quetiapine, and paliperidone er, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for COPD patients testing the efficacy of tiotropium+salmeterol, salmeterol, and tiotropium, with specific inclusion and exclusion criteria, and the presence of chronic obstructive pulmonary disease as the disease of interest.",
    "The sample is a phase 3 trial for Crohn's Disease testing the efficacy of abatacept and placebo, with inclusion criteria including moderate to severe disease and inadequate response to other treatments.",
    "The sample is a phase 3 trial for fibromyalgia, testing the efficacy of placebo and milnacipran 100mg, with inclusion criteria based on ACR diagnosis and exclusion criteria including various medical conditions and psychiatric illnesses.",
    "The sample is a phase 3 trial for hepatocellular carcinoma non-resectable and recurrent, testing the drugs abt-869 and sorafenib, with inclusion criteria including Child Pugh Class A and ECOG performance status 0-1, and exclusion criteria including prior systemic treatment for HCC and current treatment on another clinical trial.",
    "The sample is a phase 3 trial for perennial allergic rhinitis, testing the efficacy of bepotastine besilate and placebo, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for HIV infection using fosamprenavir and ritonavir, with eligibility criteria including prior participation in certain studies and exclusion criteria including intolerance to GW433908 and any condition that would preclude participation.",
    "This phase 3 trial is testing the efficacy of tipranavir, darunavir, and ritonavir in treating HIV infections in patients who have resistance to multiple PIs and are three-class treatment-experienced, with specific eligibility criteria for their optimized background regimen.",
    "The sample is a phase 3 trial for diabetic retinopathy using octreotide acetate in microspheres, with inclusion criteria of successful completion of a previous study and willingness to comply with all study requirements.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin, rosiglitazone, metformin, and glipizide as compared to placebo, with eligibility criteria including inadequate control on two oral antidiabetic medications.",
    "The sample is a phase 3 trial for venous thromboembolism, testing the effectiveness of fondaparinux and enoxaparin, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of golimumab, placebo, and methotrexate, with inclusion criteria of a diagnosis of rheumatoid arthritis for at least 6 months, a stable dose of methotrexate for 4 weeks, and at least 4 swollen and 4 tender joints.",
    "This phase 3 trial is testing the efficacy of ezetimibe (plus simvastatin) versus placebo (plus simvastatin) in treating patients with heterozygous familial hypercholesterolemia and high LDL-C levels, with inclusion criteria including tendinous xanthoma and family history of hypercholesterolemia, and exclusion criteria including use of certain drugs known to alter cholesterol levels.",
    "The sample is a phase 3 trial for postmenopausal women with breast cancer and osteoporosis, testing the efficacy of letrozole and zoledronic acid in reducing the risk of bone fractures, with eligibility criteria including completed adjuvant tamoxifen therapy and a total baseline lumbar spine or femoral neck bone mineral density T-score below -2.0 standard deviation.",
    "The sample is a phase 3 trial for patients with malignant bone disease and moderate to severe pain, testing the effectiveness of ibandronate and zoledronic acid, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with partial epilepsy, using pregabalin and lamotrigine as drugs, with inclusion criteria requiring at least 2 partial seizures in the past year and exclusion criteria including primary generalized seizures and treatable causes of seizures.",
    "This phase 3 trial is testing the efficacy of darbepoetin alfa and placebo in treating anemia in patients with chronic kidney disease, diabetes mellitus, and anemia, with specific inclusion and exclusion criteria based on hemoglobin levels, eGFR, and transferrin saturation.",
    "The sample is a phase 3 trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD), testing the efficacy of aclidinium bromide compared to placebo, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for bipolar disorder, testing the efficacy of quetiapine fumarate, with inclusion criteria including a diagnosis of Bipolar I Disorder and a current manic, depressed or mixed episode, and exclusion criteria including pregnancy and substance or alcohol dependence at enrollment.",
    "This phase 3 trial is testing the efficacy of fimasartan and candesartan cilexetil in treating mild to moderate essential hypertension, with strict inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of methylphenidate transdermal system (MTS) in treating adults with attention deficit hyperactivity disorder (ADHD), with inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "The sample is a phase 3 clinical trial for cervical cancer patients with specific inclusion and exclusion criteria, using cisplatin as the drug of interest.",
    "The sample is a phase 3 trial for metastatic prostate cancer using calcitriol and docetaxel, with eligibility criteria including documented progression while on androgen ablation therapy and adequate hematologic, renal and hepatic function.",
    "This is a phase 3 trial for carpal tunnel syndrome, testing the effectiveness of gabapentin, with inclusion and exclusion criteria based on symptoms and electrophysiological results, and excluding patients with severe CTS, accompanying conditions, epilepsy, or previous steroid treatment.",
    "The sample is a phase 3 trial for chronic osteoarthritis of the hip or knee, testing the efficacy of buprenorphine transdermal patch and placebo, with inclusion and exclusion criteria related to opioid analgesics and acetaminophen use.",
    "This is a phase 3 clinical trial for pancreatic cancer patients with no previous chemotherapy or radiation, testing the efficacy of gemcitabine, capecitabine, and erlotinib, with eligibility criteria including age, disease stage, performance status, and adequate organ function.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of bi 10773 and sitagliptin, with eligibility criteria including completion of a previous trial and exclusion criteria including liver disease and drug abuse.",
    "The sample is a phase 3 trial for advanced hepatocellular carcinoma, testing the efficacy of sorafenib and placebo drugs, with eligibility criteria including age, life expectancy, tumor lesion measurements, and ECOG performance status.",
    "The sample is a phase 3 trial for sepsis with shock and/or respiratory failure, testing the efficacy of resatorvid and placebo drugs, with eligibility criteria including clinical evidence of infection and meeting SIRS criteria.",
    "This is a phase 3 clinical trial for patients with schizophrenia, testing the efficacy of paliperidone palmitate as an alternative to previous antipsychotic medication, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the effectiveness of pitavastatin and atorvastatin in reducing LDL-C levels in patients with hyperlipidemia, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of gtx-024 and placebo in treating muscle wasting and non-small cell lung cancer, with specific eligibility criteria including BMI, cancer stage, and chemotherapy regimen.",
    "This is a phase 3 trial for patients with human immunodeficiency virus (HIV) infections, testing the efficacy of atazanavir + ritonavir as a treatment, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of fluticasone propionate/salmeterol combination diskus in treating pulmonary disease, chronic obstructive, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for non-small cell lung cancer, testing the efficacy of gemcitabine and cisplatin in patients who meet specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of alga dunaliella bardawil and placebo in treating moderate to severe plaque or guttate psoriasis in male and female subjects aged 18 to 75 who meet specific inclusion criteria, including having a Psoriasis Area and Severity Index (PASI) score of \u226512 or psoriasis covering \u226510% of body surface area (BSA), and being a candidate for phototherapy treatment.",
    "The sample is a phase 3 trial for the treatment of clostridium infections and diarrhea using fidaxomicin, vancomycin, and a matching placebo, with eligibility criteria including CDAD and exclusion criteria including toxic megacolon and concurrent use of diarrheal agents.",
    "The sample is a phase 3 trial for esophageal cancer using cisplatin and fluorouracil as drugs, with eligibility criteria including histologically documented untreated squamous cell carcinoma or adenocarcinoma of the thoracic esophagus or gastro-esophageal junction, and less than 2 cm distal spread into the gastric cardia.",
    "The sample is a phase 3 trial for ferumoxytol, a drug used to treat iron deficiency anemia, with key inclusion criteria being completion of a previous study and use of effective birth control, and key exclusion criteria being previous serious adverse events related to ferumoxytol and pregnancy or intent to become pregnant.",
    "This phase 3 trial is testing the effectiveness of azithromycin versus placebo in patients over 40 years old with chronic cough and COPD, with inclusion and exclusion criteria specified, and the diseases and icd-10 codes listed include cough, chronic obstructive pulmonary disease, and chronic bronchitis.",
    "This phase 3 trial aims to test the efficacy of azithromycin and placebo in treating asthma exacerbation or mild persistent asthma symptoms in adults with reversible airway obstruction, with inclusion criteria including physician-diagnosed asthma and exclusion criteria including chronic use of macrolides, tetracyclines or quinolones, and specified co-morbidities likely to interfere with study assessments or follow up.",
    "This phase 3 trial is testing the efficacy of cladribine 5.25 mg/kg and cladribine 3.5 mg/kg in treating relapsing-remitting multiple sclerosis, with eligibility criteria including definite MS according to the McDonald criteria, relapse within 12 months prior to Study Day 1, and MRI consistent with MS at the pre-study evaluation according to the Fazekas criteria.",
    "The sample is a phase 3 trial for metastatic breast cancer patients with HER2/neu overexpressing and/or amplified disease, testing the efficacy of docetaxel, lapatinib ditosylate, and paclitaxel, with eligibility criteria including confirmed adenocarcinoma of the breast, no CNS metastases, and no serious cardiac illness or condition.",
    "The sample is a phase 3 clinical trial for HIV patients, testing the efficacy of NNRTI, FTC/TDF, and Stribild drugs, with eligibility criteria including undetectable plasma HIV 1 RNA levels, normal ECG, and adequate hematologic function.",
    "This is a phase 3 trial for patients with moderate persistent asthma, testing the efficacy of beclomethasone plus formoterol and fluticasone plus salmeterol fixed combinations, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of morphine, cg5503 ir, and placebo in managing moderate to severe pain following hysterectomy in female patients with uterine leiomyomas, dysfunctional uterine bleeding, or endometrial hyperplasia, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is testing the efficacy of glucosamine sulfate/chondroitin sulfate and cosamin ds\u00ae in treating knee osteoarthritis, with specific inclusion and exclusion criteria, and icd-10 codes provided for the disease.",
    "The sample is a phase 3 trial testing the drug bosentan for patients with sickle cell disease and symptomatic pulmonary arterial hypertension, with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for chronic hepatitis C patients with compensated liver disease, testing the efficacy of ribavirin in combination with interferon, with strict inclusion and exclusion criteria, including age, genotype, and previous treatment history.",
    "This phase 3 trial is testing the efficacy of mirabegron and placebo in treating overactive bladder symptoms in patients who meet specific inclusion and exclusion criteria, including experiencing frequency of micturition and urgency, and not having significant stress incontinence or mixed stress/urge incontinence.",
    "The sample is a phase 3 trial for osteoarthritis and postoperative pain, testing the efficacy of pregabalin and placebo as part of the standard of care, with specific inclusion and exclusion criteria for subjects.",
    "This phase 3 trial is testing the effectiveness of esomeprazole, a proton pump inhibitor, in reducing nausea in female breast cancer patients receiving anthracycline-based chemotherapy, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of telmisartan and telmisartan/hctz in treating mild-to-moderate essential hypertension, with eligibility criteria including a mean seated DBP between 95 and 109 mmHg and exclusion criteria including hepatic and/or renal dysfunction and congestive heart failure.",
    "The sample is a phase 3 trial for chronic hepatitis C, testing the drugs sofosbuvir, rbv, and peg, with specific inclusion and exclusion criteria for subjects.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus with inadequate glycaemic control, testing the efficacy of dapagliflozin versus placebo, with inclusion criteria of stable dose combination of metformin and sulfonylurea and HbA1c \u22657.7% and \u226411.0%.",
    "The sample is a phase 3 trial for chronic kidney disease and end-stage renal disease patients, testing the efficacy of somatropin and placebo, with eligibility criteria including stable and adequate haemodialysis treatment and malnourishment based on serum albumin value below 40 g/L.",
    "This phase 3 trial is testing the efficacy of ff/gw642444 inhalation powder in treating chronic obstructive pulmonary disease (COPD) in patients who are at least 40 years old, have a history of smoking, and have experienced at least one COPD exacerbation in the past year.",
    "This phase 3 trial is testing the effectiveness of insulin glargine, ly2189265, and insulin lispro in treating type 2 diabetes with specific eligibility criteria, including a BMI between 23 and 45 kg/m^2 and a stable weight for 3 months prior to screening.",
    "This phase 3 trial will test the efficacy of vildagliptin, a drug used to treat type 2 diabetes, in combination with metformin in patients with stable HbA1c levels between 6.5-8.0%.",
    "This phase 3 trial is testing the efficacy of mycophenolate mofetil, cyclophosphamide, azathioprine, and corticosteroid, as well as placebos, in treating lupus nephritis in patients with systemic lupus erythematosus, who have had a kidney biopsy within 6 months and laboratory evidence of active nephritis.",
    "The sample is a phase 3 trial for patients with genotype 1 hepatitis C infection who have previously received peginterferon-based therapy and relapsed within 1 year, testing the efficacy of tmc435, placebo, peginterferon alpha-2a, and ribavirin, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the effectiveness of a combination of six drugs, including carmustine and doxorubicin hydrochloride, in treating stage III or IV Hodgkin's disease in patients aged 15 to 65 who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for type 2 diabetes, testing the efficacy of dapagliflozin, glimepiride, metformin hydrochloride, pioglitazone hydrochloride, and rosiglitazone, with eligibility criteria including inadequate glycaemic control and treatment with a stable sulphonylurea monotherapy dose, and exclusion criteria including type 1 diabetes, hepatic impairment, and renal failure or dysfunction.",
    "This phase 3 trial is testing the effectiveness of omalizumab, placebo, corticosteroids, and long-acting beta-agonists in treating inadequately controlled asthma in patients with a history of moderate to severe asthma, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with ocular hypertension or open-angle glaucoma using latanoprost 0.005% as prior medication, testing the efficacy of tafluprost, with inclusion criteria requiring ocular surface related symptoms and/or signs.",
    "The sample is a phase 3 trial for lamictal extended-release in patients with epilepsy, including those with partial seizures, with specific inclusion and exclusion criteria, and lists the diseases and icd-10 codes as well as the drug being tested.",
    "The sample is a phase 3 trial for metastatic colorectal cancer testing the efficacy of folfiri regimen, capecitabine, celecoxib, fluorouracil, irinotecan hydrochloride, and leucovorin calcium, with eligibility criteria including confirmed adenocarcinoma, measurable disease, and specific hematopoietic, hepatic, renal, and cardiovascular requirements.",
    "The sample is a phase 3 clinical trial testing the efficacy of budesonide and placebo in treating active, mild to moderate ulcerative proctitis and proctosigmoiditis, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for asthma patients, testing the efficacy of budesonide/formoterol, budesonide, and theophylline, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes with two drugs, insulin aspart and glibenclamide, and eligibility criteria including HbA1c between 7.5% and 10.0% and BMI below 30.0 kg/m2.",
    "The sample is a phase 3 trial for type 1 diabetes patients with a BMI below or equal to 35 kg/m^2 and HbA1c below or equal to 12%, testing the efficacy of insulin detemir, insulin aspart, insulin nph, and human soluble insulin, with inclusion and exclusion criteria including no proliferative retinopathy or maculopathy requiring acute treatment and no known hypoglycaemic unawareness.",
    "The sample is a phase 3 trial for advanced pancreatic cancer patients who have been previously treated with gemcitabine, testing the efficacy of larotaxel, 5-fluorouracil, and capecitabine, with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for patients with essential hypertension, testing the efficacy of telmisartan/amlodipine fixed combination drugs, with eligibility criteria including failure to respond to Amlodipine 5 mg and exclusion criteria including mean seated Systolic Blood Pressure => 180 mmHg and/or mean seated Diastolic Blood Pressure => 120 mmHg at any visit.",
    "This phase 3 clinical trial is testing the efficacy of ipilimumab and placebo in treating high risk stage III melanoma patients who have undergone complete and adequate resection, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for dry eye syndrome, testing the efficacy of various carboxymethylcellulose-based eye drops, with inclusion criteria of current use of eye drops for dry eye and exclusion criteria of recent eye surgeries or active ocular allergy.",
    "This is a phase 3 trial for non-small-cell lung carcinoma patients, testing the efficacy of sorafenib, placebo, gemcitabine, and cisplatin, with specific eligibility criteria including age, disease stage, and laboratory requirements.",
    "This phase 3 clinical trial is testing the efficacy of docetaxel, leuprolide, and bicalutamide in treating prostate adenocarcinoma with specific eligibility criteria, including PSA doubling time and organ function requirements.",
    "The sample is a phase 3 trial testing the efficacy of sertraline and placebo pill in treating depression in patients with a history of coronary heart disease, with specific inclusion and exclusion criteria, and the presence of depression and heart diseases as the main diseases of interest.",
    "This phase 3 trial is testing the efficacy of quetiapine xr versus placebo for treating bipolar disorder, anxiety, anxiety disorders, and substance use disorders, with specific inclusion and exclusion criteria, and the study will not include patients with certain medical conditions or those taking certain medications.",
    "This is a phase 3 clinical trial for patients with newly diagnosed acute promyelocytic leukemia, testing the efficacy of a combination of drugs including arsenic trioxide, idarubicin, and methotrexate, with eligibility criteria including confirmation of diagnosis at genetic level and exclusion criteria such as other active malignancy and uncontrolled infections.",
    "This phase 3 trial will test the efficacy of valsartan and placebo in treating atrial fibrillation in patients with underlying cardiovascular diseases/comorbidities, with inclusion criteria including documented history of stroke or peripheral vascular disease, and exclusion criteria including recent acute myocardial infarction or bypass surgery, and serum creatinine level above 2.5 mg/dL.",
    "The sample is a phase 3 trial for bipolar disorder, affective disorders, and mood disorders, testing the efficacy of topiramate versus placebo, with inclusion criteria including a DSM-IV diagnosis of Bipolar I Disorder and a YMRS score greater than or equal to 20, and exclusion criteria including a diagnosis of autistic disorder, schizophrenia, or other psychotic disorders not otherwise specified, and chronic antidepressant treatment within 4 weeks of randomization.",
    "This phase 3 trial is testing the drug gw873140 on HIV-infected patients with specific eligibility criteria, including prior antiretroviral experience and resistance, and exclusion criteria such as acute laboratory abnormalities and recent participation in an experimental drug trial.",
    "This phase 3 trial focuses on kidney transplant recipients and compares the effectiveness of two drug combinations, everolimus and tacrolimus, and mycophenolate mofetil and tacrolimus, in preventing organ rejection, with specific eligibility and exclusion criteria.",
    "The sample is a phase 3 trial for hypertension and metabolic syndrome, testing the efficacy of olmesartan medoxomil and placebo, with eligibility criteria including age, blood pressure, and metabolic traits, and exclusion criteria including diabetes and secondary hypertension.",
    "This is a phase 3 clinical trial for patients with breast cancer and metastasis expressing HER2-NEU, testing the efficacy of trastuzumab in association with chemotherapy, with eligibility criteria including good general conditions, age between 18 and 70 years, and no cerebral metastasis, while exclusion criteria include prior cerebral radiotherapy and positive serology, among others.",
    "This phase 3 trial is testing the efficacy of tmc125 and darunavir/ritonavir in HIV patients with drug resistance or antiretroviral failure, and eligibility criteria include a history of drug resistance, HIV-1 positivity, and continuous use of the same PI regimen for 4 months prior to screening.",
    "This phase 3 trial is testing the use of heparin in patients with end stage renal disease who meet specific eligibility criteria and do not have any exclusion criteria.",
    "The sample is a phase 3 trial for hypertension, testing the efficacy of telmisartan and ramipril, with inclusion and exclusion criteria listed.",
    "This phase 3 trial will test the efficacy of everolimus, cyclosporine, and prednison in de novo kidney transplant recipients and renal transplantation patients, with specific inclusion and exclusion criteria.",
    "This is a phase 3 clinical trial for patients with glioblastoma multiforme, testing the efficacy of il13-pe38qqr and GLIADEL\u00ae Wafer drugs, with specific eligibility criteria including previous cytoreductive surgery or biopsy for GBM, and adequate hematologic status.",
    "This is a phase 3 clinical trial for ulcerative colitis patients, testing the efficacy of asacol 400 mg, with eligibility criteria including a documented history of UC, a baseline PUCAI score < 10, and a stable maintenance dose of oral mesalamine for at least 1 month prior to entry in the study.",
    "This phase 3 trial is testing the effectiveness of Xalacom and unfixed latanoprost and timolol in treating open-angle glaucoma and ocular hypertension, with specific inclusion and exclusion criteria related to the patient's eye health history.",
    "The sample is a phase 3 trial for the drug fasudil in patients with scleroderma and definite Raynaud's, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for colorectal cancer testing the efficacy of fluorouracil and leucovorin calcium in patients with resectable adenocarcinoma of the rectum, with eligibility criteria including age under 80, WHO 0-1 performance status, and no prior biologic, chemotherapy, endocrine, radiotherapy, or surgery for adenocarcinoma of the rectum.",
    "The sample is a phase 3 trial for female patients with metastatic breast cancer, testing the efficacy of vinflunine and alkylating agent of physician choice registered in cancer, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for hormone refractory prostate cancer using satraplatin and prednisone as drugs, with eligibility criteria including stage D2 metastatic prostate cancer and progression after one prior chemotherapy.",
    "This phase 3 trial is testing the efficacy of leucovorin, oxaliplatin, and 5-fluorouracil in treating pancreatic neoplasms, with specific eligibility criteria including previous treatment with gemcitabine-based chemotherapy and adequate liver and kidney function.",
    "The sample is a phase 3 trial for the treatment of overactive bladder in children, testing the efficacy of solifenacin succinate suspension and placebo, with inclusion criteria including symptoms of urgency and daytime incontinence, and exclusion criteria including urinary tract infections and congenital anomalies affecting lower urinary tract function.",
    "The sample is a phase 3 clinical trial for schizophrenia using quetiapine xr as the drug, with inclusion criteria based on age, diagnosis, and PANSS score, and exclusion criteria including other Axis I disorders, pregnancy/lactation, and intolerance to quetiapine IR.",
    "The sample is a phase 3 trial for ranirestat in patients with diabetic neuropathy, with inclusion and exclusion criteria listed, and the important values include the drug name and disease being studied.",
    "This phase 3 trial is testing the efficacy of androgen-deprivation therapy and docetaxel in treating metastatic hormone-sensitive prostate cancer, with eligibility criteria including confirmed prostate cancer, metastatic disease, and Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-2.",
    "This phase 3 trial is testing the efficacy of depigoid, omalizumab, and placebo in treating allergic asthma in patients with concomitant seasonal allergic rhinoconjunctivitis and a positive RAST result for grass pollen and/or rye pollen specific IgE, with inclusion criteria including a total serum IgE level between 30 and 700 IU/ml and FEV1 > 80% of predicted normal value, and exclusion criteria including hypersensitivity to study medication ingredients or related drugs.",
    "The sample is a phase 3 trial for cystic fibrosis patients, testing the efficacy of denufosol tetrasodium inhalation solution compared to placebo, with inclusion criteria including confirmed diagnosis of cystic fibrosis and FEV1 of 75-110% predicted normal, and exclusion criteria including abnormal renal or liver function and lung transplant.",
    "This phase 3 trial is testing the efficacy of mesalazine and placebo in treating left-sided uncomplicated diverticular disease, with specific inclusion and exclusion criteria, and the disease is identified by a list of icd-10 codes.",
    "The sample is a phase 3 trial for osteoarthritis knee pain, testing the efficacy of duloxetine and placebo, with inclusion criteria being outpatients with the disease and exclusion criteria being serious medical or psychiatric conditions or previous exposure to duloxetine.",
    "This is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of exenatide versus placebo in patients with specific eligibility criteria, including HbA1c levels and BMI, and excluding those who have previously received exenatide or certain other medications.",
    "This phase 3 trial is testing the efficacy of brinzolamide 1%/brimonidine tartrate 0.2% fixed combination ophthalmic suspension, brinzolamide 1% ophthalmic suspension, and brimonidine tartrate 0.2% ophthalmic solution in treating open-angle glaucoma and ocular hypertension in patients who are insufficiently controlled on monotherapy or are currently on multiple IOP-lowering medications, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes, testing the efficacy of dapagliflozin, metformin, and pioglitazone, with eligibility criteria including inadequate glycemic control, C-peptide \u2265 1.0 ng/mL, and BMI \u2264 45.0 kg/m\u00b2.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of exenatide and rosiglitazone in patients with specific inclusion and exclusion criteria, including HbA1c and BMI ranges, and restrictions on previous medication use.",
    "This phase 3 trial is testing the efficacy of mometasone furoate/formoterol fumarate combination mdi 100/10 mcg bid, mometasone furoate mdi (mf mdi), formoterol fumarate 10 mcg, and placebo in treating asthma in patients who have been using low daily doses of inhaled corticosteroid (ICS) for at least 12 weeks and have been on a stable asthma regimen for at least 2 weeks prior to screening.",
    "The sample is a phase 3 trial for rheumatoid arthritis patients who have inadequate response to methotrexate, and the study will test the efficacy of folate, methotrexate, methylprednisolone, placebo, and rituximab as drugs, with eligibility criteria including age, disease duration, joint count, and previous treatment history.",
    "This phase 3 trial aims to test the efficacy of varenicline, placebo, and transdermal nicotine in treating nicotine addiction, with eligibility criteria including smoking at least 10 cigarettes/day for the past 6 months and exclusion criteria including current use of certain medications and history of certain medical and psychiatric conditions.",
    "The sample is a phase 3 clinical trial for relapsing remitting multiple sclerosis, testing the efficacy of glatiramer acetate (ga) 40 mg and 20 mg, with inclusion criteria including confirmed diagnosis of MS, relapse history, and ambulatory status, and exclusion criteria including previous use of Copaxone and corticosteroid treatment.",
    "The sample is a phase 3 trial for schizophrenia and schizoaffective disorder, testing the effectiveness of asenapine and olanzapine, with inclusion criteria requiring completion of 12 months of treatment under protocol 25517 and written informed consent.",
    "The sample is a phase 3 trial for asthma patients using fluticasone furoate/gw642444 and fluticasone furoate drugs, with inclusion criteria such as clinical diagnosis of asthma and history of asthma exacerbations, and exclusion criteria such as history of life-threatening asthma and taking another investigational medication or prohibited medication.",
    "This phase 3 trial will test the efficacy of aliskiren and losartan in treating hypertension, left ventricular hypertrophy, and overweight patients with specific inclusion and exclusion criteria, using ICD-10 codes to identify diseases and a placebo control group.",
    "This is a phase 3 trial for pneumonia patients, testing the effectiveness of levofloxacin and nemonoxacin, with specific inclusion and exclusion criteria for patient eligibility.",
    "This is a phase 3 clinical trial for schizophrenia using paliperidone er as the drug, with inclusion criteria such as DSM-IV diagnosis of schizophrenia and experiencing an acute schizophrenic episode, and exclusion criteria such as preexisting severe gastrointestinal narrowing and significant risk of suicidal or violent behavior.",
    "The sample is a phase 3 trial for macular edema resulting from retinal vein occlusion, testing the efficacy of 700 \u00b5g and 350 \u00b5g dexamethasone, with inclusion criteria including a decrease in visual acuity and exclusion criteria including a history of glaucoma or use of systemic steroids.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus patients, testing the efficacy of asp1941 and placebo drugs, with inclusion criteria such as stable diet or one oral hypoglycemic agent, estimated GFR value, HbA1C value, and BMI range, and exclusion criteria such as type 1 diabetes mellitus, proliferative diabetic retinopathy, and chronic diseases requiring continuous use of certain medications.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of aclidinium bromide 200 \u00b5g and 400 \u00b5g, with inclusion criteria based on GOLD guidelines and exclusion criteria including respiratory tract infection, asthma, and cardiovascular conditions.",
    "This phase 3 trial is testing the efficacy of ranibizumab and sham injection in treating diabetic macular edema in patients with diabetes mellitus, with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for mild to moderate asthma patients using budesonide/formoterol turbuhaler, with inclusion criteria of FEV1 \u00b3 60% and daily use of inhaled GCS during the last 3 months, and exclusion criteria of regular need of >4 inhalations of a short-acting b2-agonist/day, known or suspected hypersensitivity to any of the investigational drugs or inhaled lactose, use of any b-blocking agent, and having smoked \u00b310 pack-years.",
    "This phase 3 trial is testing the efficacy of pramipexole immediate release and extended release tablets in Chinese patients with idiopathic Parkinson's disease who meet specific inclusion criteria and do not have any of the listed exclusion criteria.",
    "This phase 3 trial is testing the efficacy of bicalutamide, leuprolide, goserelin, and flutamide in treating prostate cancer patients who meet specific inclusion criteria, including biopsy-proven prostate cancer within the last 12 months, AJCC clinical stage T1c-2b, and PSA < 20 ng/mL.",
    "The sample is a phase 3 trial for women with menorrhagia, testing the efficacy of tranexamic acid tablets and placebo tablets, with inclusion criteria of women aged 18-49 with regularly occurring menstrual periods and exclusion criteria of clinically significant disease or abnormalities that may confound the study, history of bilateral oophorectomy or hysterectomy, and hormone therapy for birth control.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of placebo and sitagliptin phosphate as drugs, with inclusion criteria of patients on diet/exercise therapy and metformin as monotherapy, and exclusion criteria of patients with type 1 diabetes mellitus.",
    "This phase 3 trial is testing the efficacy of bibf 1120 and placebo in treating pulmonary fibrosis, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the effectiveness of lapatinib, a drug, in treating squamous cell carcinoma of the head and neck, and includes eligibility criteria such as pathological stage and ECOG performance status.",
    "This is a phase 3 trial for patients with type 2 diabetes mellitus, testing two different insulin inhalation powder regimens, with eligibility criteria including HbA1c levels and previous medication history, and exclusion criteria including pregnancy, smoking, and certain medical conditions.",
    "This phase 3 trial is testing the efficacy of chf1535 200/6 \u00b5g and bdp 100 \u00b5g in treating persistent asthma not optimally controlled on high doses of ICS or medium dose of ICS+LABA, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for refractory multiple myeloma patients undergoing stem cell harvest for possible allogeneic stem cell transplant, using plerixafor as the drug, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of gabapentin in reducing hot flashes in women with breast cancer, who meet specific eligibility criteria, and have no clinical evidence of disease, while excluding those with a history of alcohol or drug abuse, allergy to gabapentin, or seizure disorder.",
    "This is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of er oros paliperidone, placebo, and olanzapine, with inclusion criteria including a DSM-IV diagnosis of schizophrenia and acute symptoms, and exclusion criteria including a history of cerebrovascular accident or diabetes mellitus.",
    "The sample is a phase 3 trial for type 2 diabetes using bromocriptine mesylate as a drug, with specific inclusion and exclusion criteria, and the presence of certain diseases and icd-10 codes.",
    "This phase 3 trial is testing the efficacy of two drugs, 23 mg sr and 10 mg ir, in treating Alzheimer's disease, with specific inclusion and exclusion criteria for patients and caregivers.",
    "This is a phase 3 trial for eosinophilic asthma, testing the efficacy of reslizumab and placebo, with eligibility criteria including ACQ score, airway reversibility, and stable baseline asthma therapy regimens.",
    "The sample is a phase 3 trial for diffuse large B-cell lymphoma using a combination of rituximab, doxorubicin, cyclophosphamide, vindesine, bleomycin, and prednisone, with eligibility criteria including age, disease stage, and negative HIV/HBV/HCV serologies.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of bi 10773 and its placebo in patients who are pre-treated with metformin or metformin plus sulfonylurea, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for lupus nephritis and systemic lupus erythematosus, testing the efficacy of corticosteroids, cyclophosphamide, mycophenolate mofetil, ocrelizumab, azathioprine, and placebo, with eligibility criteria including age, diagnosis of SLE, and active lupus nephritis, and exclusion criteria including severe renal impairment, pregnancy or breastfeeding, and history of cancer or drug abuse.",
    "The sample is a phase 3 trial for patients with type 2 diabetes and hypertension, testing the efficacy of bi 10773 compared to placebo, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 clinical trial for non small cell lung cancer (NSCLC) patients with EGFR expression, testing the efficacy of cetuximab, cisplatin, and vinorelbine combination therapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of methotrexate and tocilizumab, with inclusion and exclusion criteria, and the icd-10 codes for the disease listed as well.",
    "The sample is a phase 3 clinical trial for dry eye disease, testing the efficacy of 3% de-089 ophthalmic solution and 0.1% sodium hyaluronate ophthalmic solution, with inclusion criteria of keratoconjunctival disorder and abnormal Schirmer score results, and exclusion criteria of needing therapy for other eye diseases or wearing contact lenses during the study.",
    "The sample is a phase 3 trial for erosive esophagitis using the drugs tak-438, with eligibility criteria including endoscopically confirmed reflux esophagitis and good compliance to the study medication.",
    "This phase 3 trial is testing the efficacy of ibuprofen/famotidine and ibuprofen in treating ulcer patients who require daily administration of an NSAID for at least six months, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for cilomilast in patients with chronic obstructive pulmonary disease (COPD) and a history of cigarette smoking, with inclusion and exclusion criteria specified, and the icd-10 codes for COPD listed as J44.9, J44.1, and J44.0.",
    "The sample is a phase 3 trial for postmenopausal women with vaginal atrophy, testing the effectiveness of estradiol, 10 mcg, with the inclusion criteria being postmenopausal women whose last menstruation was at least two years previously.",
    "This phase 3 trial will test the efficacy of high and low dose aspirin and placebo in reducing persistent fatigue in patients with relapsing-remitting or secondary progressive multiple sclerosis, who meet specific inclusion and exclusion criteria, and are not taking certain medications or have certain medical conditions.",
    "The sample is a phase 3 trial for patients with limited or no approved treatment options for acquired immunodeficiency syndrome and HIV infection, using the drug maraviroc, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of ramucirumab and docetaxel in treating non-small cell lung cancer patients who have progressed after one prior platinum-based chemotherapy, with eligibility criteria including confirmed NSCLC, adequate organ function, and a life expectancy of at least 3 months.",
    "This is a phase 3 trial for patients with chronic obstructive pulmonary disease, testing the efficacy of various drugs including tiotropium and olodaterol, with strict inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with plaque-type psoriasis, testing the efficacy of ustekinumab and placebo, with inclusion and exclusion criteria related to medical history and current health status.",
    "The sample is a phase 3 trial for metastatic colorectal cancer, testing the efficacy of erlotinib and bevacizumab, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of cyclophosphamide, doxorubicin hydrochloride, octreotide pamoate, and tamoxifen citrate in treating estrogen receptor positive breast cancer patients who have undergone total mastectomy or lumpectomy followed by an axillary dissection or sentinel node resection.",
    "The sample is a phase 3 trial testing the efficacy of rivaroxaban and warfarin in preventing stroke and embolism in patients with atrial fibrillation and a history of stroke or other risk factors, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for asthma patients, testing the effectiveness of Symbicort and budesonide drugs, with inclusion criteria such as clinical diagnosis of asthma and daily use of inhaled corticosteroids for at least 3 months, and exclusion criteria such as history of life-threatening asthma and intake of oral, rectal or parenteral glucocorticosteroid within 30 days of enrolment.",
    "This is a phase 3 clinical trial for primary biliary cirrhosis testing the efficacy of obeticholic acid (oca) compared to placebo, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for breast cancer patients aged 40-70, testing the efficacy of anastrozole versus placebo in reducing the risk of breast cancer recurrence, with eligibility criteria based on family history, prior breast conditions, and hormone receptor status.",
    "The sample is a phase 3 trial for essential hypertension, testing the efficacy of lcz696 and amlodipine compared to placebo, with specific eligibility criteria for patients to be included in the study.",
    "The sample is a phase 3 trial for anemia and cancer patients with a screening hemoglobin level of </= 11.0 g/dL for men or </= 10.0 for women, testing the drug epoetin alfa, with eligibility criteria including age, weight, and ECOG score, and exclusion criteria including history of or concurrent second malignancy and evidence of primary or metastatic malignancy involving the Central Nervous System.",
    "This is a phase 3 trial for patients with biopsy-proven esophagus cancer who are not candidates for radical treatment, and will receive cisplatin and 5-fluorouracil chemotherapy if they meet the eligibility criteria.",
    "The sample is a phase 3 trial for knee pain due to osteoarthritis, testing the efficacy of duloxetine and placebo, with inclusion and exclusion criteria including history of intolerance to duloxetine, major depressive disorder, substance abuse, and other medical conditions.",
    "This is a phase 3 trial for the treatment of benign prostatic hypertrophy, testing the efficacy of cetrorelix and placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for schizophrenia with the drugs haloperidol and asenapine, and the eligibility criteria includes completing a short-term trial and demonstrating compliance with trial medication.",
    "The sample is a phase 3 trial for painful diabetic neuropathy, testing the efficacy of pregabalin versus placebo, with inclusion criteria of VAS pain score >40mm and diagnosis of type 1 or 2 diabetes mellitus for at least 1 year, and exclusion criteria of malignancy within the past 2 years and neurologic disorders unrelated to diabetic neuropathy that may confuse the assessment of neuropathy pain.",
    "This phase 3 trial is testing the efficacy of pemetrexed, gemcitabine, and cisplatin in treating non-squamous non-small cell lung cancer patients with specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of insulin degludec/insulin aspart in insulin-na\u00efve subjects with type 2 diabetes mellitus who are currently on metformin monotherapy or metformin in combination with one of the following oral anti-diabetic drugs: insulin secretagogue, dipeptidyl peptidase IV (DPP-IV) inhibitor, or alpha-glucosidase inhibitors, and have an HbA1c between 7.0-10.0%, with exclusion criteria including recent treatment with thiazolidinediones or glucagon like peptide 1 (GLP-1) receptor agonists, and cardiovascular disease within the last 24 weeks prior to trial start.",
    "This is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) testing the efficacy of multiple drugs including gsk 573719 +gw642444 and eligibility criteria including age, smoking history, dyspnea score, and lung volume measurements.",
    "The sample is a phase 3 clinical trial testing the efficacy of single-dose iv oritavancin diphosphate and iv vancomycin in treating acute bacterial skin and skin structure infections caused by Gram-positive pathogens, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of azelastine hydrochloride nasal spray and placebo in treating seasonal allergic rhinitis, with eligibility criteria including a history of fall pollen allergy, positive skin prick or intradermal test, and absence of certain medical conditions or medication use.",
    "The sample is a phase 3 trial for bipolar I disorder, testing the efficacy of aripiprazole and placebo in subjects who completed a previous study and meet specific criteria, with exclusion criteria including allergies to aripiprazole and other medical conditions.",
    "This phase 3 trial is testing the efficacy of switching to Myfortic and continuing azathioprine in patients with systemic lupus erythematosus who meet specific inclusion criteria, while excluding those with certain medical conditions or who have received certain prior treatments.",
    "The sample is a phase 3 trial for non-small cell lung cancer testing the efficacy of bevacizumab, carboplatin, and paclitaxel in combination with placebo, with specific eligibility and exclusion criteria.",
    "The sample is a phase 3 trial for patients with ovarian, fallopian tube, or primary peritoneal cancer who achieved complete remission with normal CA 125 after first-line platinum-containing chemotherapy, and will test the efficacy of chemotherapy for these patients.",
    "The sample is a phase 3 trial for metastatic breast cancer (MBC) patients, testing the efficacy of gemcitabine, docetaxel, and paclitaxel, with eligibility criteria including prior taxanes regimen and relapse after anthracycline-containing chemotherapy, and exclusion criteria including previous chemotherapy for MBC and gemcitabine treatment in any setting of disease.",
    "The sample is a phase 3 trial for non-small-cell lung cancer patients, testing the efficacy of zoledronic acid 4 mg, with specific inclusion and exclusion criteria, and the trial will use ICD-10 codes to identify patients.",
    "This phase 3 trial is testing the efficacy of brivaracetam and placebo in treating patients with well-characterized localization-related or generalized epilepsy who are uncontrolled while treated by 1 to 3 permitted concomitant Antiepileptic Drugs (AEDs).",
    "This phase 3 trial is testing the efficacy of velcade, thalidomide, and dexamethasone, and velcade, melphalan, and dexamethasone in treating multiple myeloma patients who have relapsed or progressed after at least one autologous transplant, with specific eligibility criteria for inclusion and exclusion.",
    "This phase 3 trial is testing the efficacy of regorafenib, placebo, and best supportive care in treating gastrointestinal stromal tumors in patients who have previously undergone treatment with imatinib and sunitinib, with specific eligibility criteria for inclusion and exclusion.",
    "The sample is a phase 3 trial for HIV-1 infection testing the efficacy of atazanavir/ritonavir monotherapy, with inclusion criteria such as virological suppression and CD4 cells nadir >100 cells/\u00b5L, and exclusion criteria such as previous virological failure and use of contraindicated medications.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of viaject\u2122 and regular human insulin, with inclusion criteria including established diagnosis of type 2 diabetes, HbA1c values of not more than 10.5%, and three months on a stable insulin regimen that meets the current standard of care.",
    "This is a phase 3 trial for non-small cell lung cancer patients with eligibility criteria including no prior systemic antineoplastic treatment, WHO Performance Status of 0-1, and lab values within a certain range, and the drugs being tested are asa404, placebo, carboplatin, and paclitaxel.",
    "This phase 3 trial is testing the efficacy of arbaclofen placarbil at different doses versus placebo in treating spasticity in multiple sclerosis patients who meet specific inclusion criteria and do not take certain medications, with the primary outcome being the change in the Ashworth Scale score.",
    "The sample is a phase 3 trial for locally advanced, unresectable pancreatic cancer using a combination of capecitabine, erlotinib hydrochloride, and gemcitabine hydrochloride, with eligibility criteria including ECOG performance status 0-2 and exclusion criteria such as prior radiotherapy or chemotherapy.",
    "The sample is a phase 3 trial for left ventricular hypertrophy, testing the effectiveness of carvedilol mr, atenolol, and lisinopril, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for osteogenesis imperfecta, testing the efficacy of risedronate sodium (actonel) and placebo in reducing fracture risk, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of tadalafil and placebo in treating pulmonary hypertension associated with various conditions, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for type 2 diabetes mellitus, testing the efficacy of two insulin glargine drugs (lantus and hoe901-u300) on participants who meet specific inclusion criteria and do not meet any of the exclusion criteria.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of sitagliptin phosphate compared to placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for osteoarthritis, testing the efficacy of glucosamine, chondroitin sulfate, glucosamine and chondroitin sulfate combined, and celecoxib, with eligibility criteria of patients aged 40 and above with clinical and radiographic osteoarthritis symptomatic for at least six months.",
    "This phase 3 trial is testing the efficacy of ivacaftor and placebo in treating cystic fibrosis patients with at least one R117H CFTR mutation, with specific inclusion and exclusion criteria, including age, weight, and liver function.",
    "The sample is a phase 3 trial for children aged 1 to 5 years old with upper respiratory tract infection, testing the efficacy of montelukast and placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for non-small-cell lung carcinoma patients, testing the efficacy of gemcitabine and cisplatin as chemotherapy drugs, with specific eligibility criteria including clinical stage, age, performance status, and adequate organ function.",
    "This phase 3 trial is testing the efficacy of pramipexole and placebo in patients with early idiopathic Parkinson's disease who meet specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for postmenopausal women with locally recurrent, locally advanced, or metastatic breast cancer, testing the efficacy of atamestane, toremifene, letrozole, aromatase inhibition, and estrogen receptor blocker, with eligibility criteria including measurable tumor localization, estrogen receptor and/or progesterone receptor positivity, and predicted life expectancy of 12 weeks or more.",
    "The sample is a phase 3 trial for allergic rhinitis, testing the efficacy of mometasone furoate nasal spray and placebo nasal spray, with inclusion criteria including a positive skin prick test response to an appropriate seasonal allergen and exclusion criteria including a history of severe local reaction(s) or anaphylaxis to skin testing and participation in any other clinical study.",
    "This phase 3 trial is testing the efficacy of suvorexant high and low dose compared to placebo in treating primary insomnia, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the efficacy of 323u66 SR, a drug containing bupropion, in treating major depressive disorder in outpatients who meet specific eligibility criteria.",
    "This phase 3 trial is testing the effectiveness of inhaled insulin for patients with diabetes mellitus type 2 who have failed two or more oral anti-diabetic agents, and the inclusion and exclusion criteria are specified.",
    "The sample is a phase 3 trial for postmenopausal women with osteoporosis, back pain, and spinal fractures, testing the efficacy of teriparatide, risedronate, and placebo, with inclusion and exclusion criteria for eligibility.",
    "This phase 3 trial is testing the efficacy of letrozole, bevacizumab, and fulvestrant in treating HER2-negative breast cancer patients with positive hormone receptors and who are candidates for first-line treatment with letrozole, while also allowing treatment with bisphosphonates.",
    "The sample is a phase 3 trial for partial seizures, testing the effectiveness of pregabalin and levetiracetam in patients who have been unresponsive to prior antiepileptic drugs, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with proliferative diabetic retinopathy and diabetic macular edema, testing the efficacy of ranibizumab and triamcinolone acetonide, with eligibility criteria including age, diagnosis of diabetes mellitus, and visual acuity score.",
    "This is a phase 3 trial for bipolar disorder using quetiapine as the drug, with eligibility criteria including moderate-to-severe hypomanic symptoms and exclusion criteria including severe depressive symptoms and serious general medical illnesses.",
    "The sample is a phase 3 trial for patients with schizophrenia, testing the effectiveness of olanzapine and olanzapine pamoate depot, with specific inclusion and exclusion criteria, and using ICD-10 codes to identify eligible patients.",
    "The sample is a phase 3 trial for schizophrenia, testing the efficacy of ziprasidone oral capsules and placebo, with inclusion criteria including DSM-IV criteria for schizophrenia, a Brief Psychiatric Rating Scale score \u226535, and age 13-17 years, and exclusion criteria including imminent risk of suicide or homicide and any history of serious or unstable medical illness.",
    "The sample is a phase 3 trial testing the efficacy of azilsartan medoxomil, a blood pressure medication, in combination with metformin for type 2 diabetes patients with inadequate glycemic control and hypertension.",
    "This phase 3 trial is testing the efficacy of a placebo for sch 39641 in treating ragweed-induced allergic rhinoconjunctivitis, with inclusion criteria including a positive skin prick test response to Ambrosia artemisiifolia and a forced expiratory volume in 1 second (FEV1) of at least 70% of predicted value, and exclusion criteria including unstable asthma, history of anaphylaxis with cardio-respiratory symptoms, and participation in any other clinical trial.",
    "The sample is a phase 3 clinical trial for psoriasis vulgaris, testing the efficacy of LEO 90100 and vehicle as treatments, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the efficacy of a combination of enfuvirtide, raltegravir, darunavir, tipranavir, etravirine, and maraviroc in treating HIV-1 infection in patients with triple-class drug experience or resistance, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for gastric cancer using uft (uracil, tegafur) as the drug, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the drug alogliptin on patients with type 2 diabetes mellitus who completed one of seven controlled Phase III studies, and the eligibility criteria includes having alanine aminotransferase less than or equal to 3 times the upper limit of normal and serum creatinine less than or equal to 2.0 mg per dL.",
    "This phase 3 trial is testing the efficacy of docetaxel + estramustine + hydrocortisone and docetaxel + prednisone in treating advanced prostate carcinoma with eligibility criteria including previous hormone treatment and testosterone levels < 50 ng/dL.",
    "The sample is a phase 3 trial for osteoporosis, testing the effectiveness of phylloquinone and menatetranone, with eligibility criteria including postmenopausal females who are ambulatory, community dwelling, able to ingest calcium and vitamin D supplements, and willing to restrict vitamin K intake, among other requirements.",
    "The sample is a phase 3 trial for patients with mixed dyslipidemia and qualifying cIMT thickness, testing the drugs abt-335 and placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus testing the efficacy of exenatide once weekly and insulin detemir in patients with suboptimal glycaemic control and a BMI of 25-45 kg/m2 who are receiving metformin at a stable dose or metformin and sulphonylurea, with various inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of Stribild, a combination of antiretroviral drugs, in treating patients with acquired immunodeficiency syndrome and HIV infections who meet specific eligibility criteria.",
    "The sample is a phase 3 clinical trial testing the efficacy of iv dalbavancin and vancomycin/linezolid in treating abscess, wound infection, surgical site infection, and cellulitis caused by Gram-positive bacteria, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of cilostazol in treating atherosclerosis-related peripheral vascular diseases, with eligibility criteria including symptoms of intermittent claudication and positive noninvasive evaluation for significant aortoiliac PAD, while exclusion criteria include allergy or intolerance to cilostazol and presence of critical limb ischemia or acute limb ischemia.",
    "This phase 3 trial is testing the efficacy of tapentadol extended release in treating pain, osteoarthritis, and low back pain, with inclusion criteria including completion of previous trials and willingness to take the drug, and exclusion criteria including certain medical conditions and medication use.",
    "This phase 3 trial is testing the efficacy of COV155 and placebo in managing postoperative pain in patients undergoing primary unilateral first metatarsal bunionectomy, with specific inclusion and exclusion criteria, and a requirement for a postoperative pain intensity score \u22655 on a 0 to 10 Numerical Pain Rating Score (NPRS) for randomization into the Double-Blind Phase.",
    "The sample is a phase 3 trial for neoplasms of the prostate, testing the effectiveness of dutasteride and placebo, with specific eligibility criteria including PSA levels and previous medical history.",
    "The sample is a phase 3 trial for asthma patients, testing the efficacy of montelukast and salmeterol/fluticasone propionate inhalation powder, with specific inclusion and exclusion criteria, and a list of icd-10 codes for asthma.",
    "The sample is a phase 3 trial testing the efficacy of irinotecan, leucovorin, 5-fluorouracil, docetaxel, cisplatin and leucovorin, 5-fluorouracil in treating adenocarcinoma of the stomach or gastroesophageal junction, with specific eligibility criteria for patients.",
    "This phase 3 trial is testing the effectiveness of losartan potassium (+) hydrochlorothiazide in treating patients with metabolic disorder and untreated hypertension, with specific inclusion and exclusion criteria.",
    "This is a phase 3 clinical trial for patients with neurogenic urinary bladder, testing the efficacy of alfuzosin and placebo drugs, with specific eligibility and exclusion criteria.",
    "This is a phase 3 trial for urinary bladder overactivity, testing the efficacy of mirabegron and tolterodine compared to placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for patients with metastatic colorectal cancer, testing the efficacy of capecitabine, floxuridine, and oxaliplatin, with eligibility criteria including specific disease characteristics and patient characteristics, and excluding prior concurrent therapy.",
    "This is a phase 3 clinical trial for major depressive disorder (MDD) patients who have a partial response to SSRI treatment, and will test the efficacy of ly2216684 and placebo in combination with SSRI. The eligibility criteria include a clinical diagnosis of MDD, use of reliable birth control, and meeting pre-defined psychiatric scales. Exclusion criteria include presence of other primary psychiatric illness, diagnosed medical condition that could be exacerbated by noradrenergic agents, and history of treatment-resistant depression.",
    "This phase 3 trial is testing the efficacy of pregabalin for central neuropathic pain after spinal cord injury, stroke, or multiple sclerosis, with inclusion criteria including pain VAS at least 40mm in Visit 1 and Visit 2, and exclusion criteria including creatinine clearance < 60 mL/min and platelet count < 100 \u00d7 103/mm3, among others.",
    "The sample is a phase 3 trial for liver transplant patients, testing the effectiveness of mycophenolate mofetil and tacrolimus as immunosuppressive treatment, with inclusion criteria including primary liver transplantation and exclusion criteria including autoimmune hepatitis and treated hypertension.",
    "The sample is a phase 3 trial for hypertension using valsartan plus hydrochlorothiazide as the drug, with inclusion criteria based on blood pressure levels and written informed consent, and exclusion criteria not provided.",
    "The sample is a phase 3 trial for postmenopausal osteoporosis using arzoxifene and placebo, with inclusion criteria of female participants aged 60-85 years and exclusion criteria including history of certain cancers and medication use, and the trial is testing the ability of extended release nifedipine to decrease the dose of glucocorticoid medication in children with congenital adrenal hyperplasia.",
    "This phase 3 trial is testing the efficacy of naltrexone sr 32 mg/bupropion sr 360 mg/day versus placebo in treating obesity and overweight patients with specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of high and low dose dexamethasone in treating vomiting and headache in children undergoing radiation therapy for brain tumors, with inclusion criteria including age, tumor size, and prior enrollment in the dexamethasone study.",
    "The sample is a phase 3 trial for smoking cessation, testing the efficacy of placebo and varenicline (cp-526,555) in patients with schizophrenia or schizoaffective disorder who are motivated to quit smoking and meet certain inclusion and exclusion criteria. The trial includes patients between the ages of 18 and 75 who smoke at least 15 cigarettes per day and have been stable on psychiatric treatment for at least 6 months.",
    "The sample is a phase 3 trial for osteoarthritis of the knee, testing the efficacy of diclofenac topical sodium gel 1%, with eligibility criteria including exclusion of other rheumatic diseases and allergies to analgesic drugs.",
    "This phase 3 trial is testing the efficacy of 1mg and 4mg triamcinolone acetonide in treating diabetic macular edema, with eligibility criteria including age, diabetes diagnosis, and willingness to provide informed consent.",
    "This phase 3 trial is testing the effectiveness of daptomycin and vancomycin in treating MRSA infected foot ulcers in patients with Type 1 and Type 2 Diabetes mellitus, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of ciclosporin in treating chronic hepatitis C patients who have undergone liver transplantation and meet specific eligibility criteria.",
    "The sample is a phase 3 trial for patients with stage I or II non-small cell lung cancer who are current smokers, testing the effectiveness of bupropion hydrochloride and nicotine in helping patients quit smoking within 30 days after registration, while also meeting various eligibility criteria.",
    "The sample is a phase 3 trial for patients undergoing allogenic stem cell or bone marrow transplantation with a history of leukemia or graft-versus-host disease, testing the efficacy of budesonide as a prophylaxis for GVHD, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of ACR16 and placebo in treating Huntington's disease, with specific inclusion and exclusion criteria for patients, and the trial will take place in France.",
    "This phase 3 trial is testing the efficacy of sevelamer carbonate and placebo in reducing serum phosphorus levels in patients with chronic kidney disease on hemodialysis, with inclusion criteria including a minimum of 30 days on hemodialysis and a central laboratory serum iPTH measurement less than 1000 pg/mL at Visit 1.",
    "This is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of insulin glulisine and insulin glargine, with eligibility criteria including A1c levels between 7.5% and 10%, negative GAD autoantibodies, and ability to perform self-monitoring of blood glucose.",
    "The sample is a phase 3 trial for previously untreated head and neck squamous cell carcinoma using tirapazamine and cisplatin, with specific eligibility criteria including stage III or IV disease and ECOG performance status less than or equal to 2.",
    "The sample is a phase 3 trial for bipolar disorder, testing the efficacy of Risperdal Consta and placebo, with inclusion criteria including a current diagnosis of bipolar disorder and at least four episodes of mood disorder in the last year that required psychiatric intervention.",
    "The sample is a phase 3 trial for patients with schizophrenia or schizoaffective disorder, testing the effectiveness of lurasidone hcl and risperidone, with eligibility criteria including meeting DSM-IV criteria for the primary diagnosis, being 18-75 years old, and not having a chronic organic disease of the central nervous system.",
    "This is a phase 3 clinical trial for the drug memantine hcl in treating major depression, with specific inclusion and exclusion criteria based on DSM-IV diagnosis and medical history.",
    "This phase 3 trial is testing the efficacy of pegfilgrastim in breast cancer patients undergoing chemotherapy with an increased risk of febrile neutropenia, with eligibility criteria including age, liver function, and prior chemotherapy.",
    "The sample is a phase 3 trial for hypertension, testing the efficacy of carvedilol controlled release/lisinopril and lisinopril + placebo, with inclusion criteria of age 18-80 and mean sitting systolic blood pressure >/=140mmHg to </=170mmHg, and exclusion criteria of taking two or more antihypertensive medications or having Type 1 or Type 2 diabetes.",
    "The sample is a phase 3 trial testing the effects of bifidobacterium lactis (bb-12) and placebo on healthy children aged 1-3 attending daycare or preschool centers, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for patients with non-myeloid cancer receiving chemotherapy-related anemia, testing the efficacy of sodium ferric gluconate complex in sucrose, with eligibility criteria including ECOG performance status, ferritin levels, and absence of certain hematologic disorders or gastrointestinal conditions.",
    "The sample is a phase 3 trial for chronic hepatitis C, testing the efficacy of pegylated-interferon alfa-2a and ribavirin, with specific inclusion and exclusion criteria based on genotype and liver disease status.",
    "This phase 3 trial is testing the drug bc1036 on patients with a persistent cough, with inclusion criteria including confirmed diagnosis of cough and Leicester Cough Questionnaire score of \u2264 17 at baseline, while exclusion criteria include treatment with systemic oral steroids within 7 days prior to randomisation at Visit 2 and any pulmonary co-morbidity such as COPD.",
    "The sample is a phase 3 trial for patients with ocular hypertension or open-angle glaucoma using latanoprost 0.005% as prior medication, testing the efficacy of tafluprost, with inclusion criteria of ocular surface related symptoms and/or signs.",
    "This phase 3 trial is testing the efficacy of insulin glulisine and insulin glargine in treating type 2 diabetes mellitus, with inclusion criteria including stable insulin regimen and HbA1c between 7.5% and 11.0%.",
    "This phase 3 trial is testing the efficacy of xaliproden and placebo in treating colorectal neoplasms, with eligibility criteria including completion of oxaliplatin-containing chemotherapy and Grade \u2265 1 PSN, and exclusion criteria including pre-existing peripheral neuropathy and receiving any further anti-cancer treatment.",
    "This phase 3 trial is testing the drug cf101 for the treatment of moderate-to-severe Aqueous-Deficient Dry Eye, with eligibility criteria including positive corneal fluorescein staining, Schirmer Test score, and OSDI score, and exclusion criteria including use of certain medications and presence of certain ocular diseases.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of canagliflozin and antihyperglycemic agents versus placebo, with inclusion criteria of HbA1c between >=7 and <=10.0%, FPG <270 mg/dL, and exclusion criteria of history of diabetic ketoacidosis, type 1 diabetes mellitus, pancreas or beta cell transplantation, or severe hypoglycemic episode within 6 months before screening.",
    "This phase 3 trial is testing the efficacy of tivozanib and sorafenib in treating advanced renal cell carcinoma in subjects who have undergone prior nephrectomy and have measurable disease, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of insulin degludec/insulin aspart and insulin glargine in combination with metformin and other oral antidiabetic drugs for patients with type 2 diabetes mellitus, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for ferumoxytol, a drug used to treat iron deficiency anemia, with eligibility criteria including low hemoglobin and transferrin saturation levels, unsatisfactory oral iron therapy, and exclusion criteria including allergy to IV iron and pregnancy.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) with a list of drugs including beclomethasone and budesonide, and eligibility criteria including FEV1 levels and smoking history.",
    "This phase 3 trial is testing the efficacy of safinamide and placebo in treating idiopathic Parkinson's disease in patients who are levodopa-responsive and have motor fluctuations, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of rosuvastatin calcium and atorvastatin in treating non-ST segment elevation acute coronary syndromes, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of vortioxetine and duloxetine compared to placebo, with inclusion criteria of moderate to severe depression and exclusion criteria of any current psychiatric or substance disorder, and use of any psychoactive medication 2 weeks prior to screening and during the study.",
    "This phase 3 trial is testing the efficacy of doxorubicin hydrochloride, etoposide, and ifosfamide in treating high-risk soft tissue sarcoma patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus patients using ipragliflozin and DPP-4 inhibitor drugs, with inclusion criteria including HbA1c value between 6.5 and 9.5% and BMI between 20.0 and 45.0 kg/m2, and exclusion criteria including type 1 diabetes mellitus and significant renal, hepatic or cardiovascular diseases.",
    "This phase 3 trial is testing the effectiveness of lopinavir/ritonavir plus nucleoside(s) in treating HIV infection, with strict inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of various drugs, including fluticasone furoate and salbutamol, on patients with chronic obstructive pulmonary disease (COPD) who meet specific inclusion criteria, such as being former or current smokers with a clinical history of COPD and a post-albuterol spirometry criteria of FEV1/FVC ratio \u2264 0.70 and FEV1 \u2264 70% of predicted normal (NHANES III).",
    "This phase 3 trial is testing the efficacy of bicalutamide, buserelin, flutamide, goserelin, leuprolide acetate, and docetaxel in treating localized prostate cancer with high risk of recurrence, and patients must meet certain eligibility criteria.",
    "This phase 3 trial is testing the efficacy of umeclidinium/vilanterol and fluticasone propionate/salmeterol compared to placebo in treating chronic obstructive pulmonary disease (COPD) in patients who are current or former smokers with a history of at least 10 pack-years, and have a pre and post-salbutamol FEV1/Forced Vital Capacity (FVC) ratio of <0.70 and a post-salbutamol FEV1 of >=30% and <=70% of predicted normal values calculated using National Health and Nutrition Examination Survey (NHANES) III reference equations.",
    "This phase 3 trial is testing the effectiveness of ir methylphenidate, modafinil, and sr methylphenidate in treating cognitive decline in patients with brain tumors who have had prior radiation treatment, and have a Karnofsky performance status of 70 or higher, while also excluding patients with certain medical conditions or taking certain medications.",
    "The sample is a phase 3 trial for the drug GSK573719 in patients with chronic obstructive pulmonary disease (COPD), with inclusion criteria including a diagnosis of COPD, a history of cigarette smoking, and a dyspnea score of 2 or greater, and exclusion criteria including use of certain medications and a history of alcohol or drug abuse.",
    "This is a phase 3 trial for prostate cancer with the drugs rofecoxib and placebo, requiring regular PSA testing and study biopsies, and the icd-10 codes for the disease include C61, D29.1, D40.0, Z15.03, Z80.42, Z85.46, and Z12.5.",
    "This phase 3 trial is testing the efficacy of liraglutide and oral anti-diabetic drugs in Japanese patients with type 2 diabetes, who meet specific inclusion and exclusion criteria, and have not been treated with GLP-1 receptor agonist or DPP-4 inhibitor within 12 weeks prior to Visit 1.",
    "The sample is a phase 3 trial for patients with mild abnormalities of the aortic valve, testing the efficacy of ezetimibe (+) simvastatin and placebo drugs, with inclusion criteria of patients aged 45 to 85 and exclusion criteria of previous trial participation or current use of disallowed medications.",
    "The sample is a phase 3 trial for non-small-cell lung carcinoma, lung cancer, and anemia, testing the effectiveness of epoetin alfa in increasing hemoglobin levels in patients with lung cancer who have not received platinum-based chemotherapy in the past two months or plan to receive it in the next three months.",
    "This phase 3 trial is testing the efficacy of vincristine sulfate, carmustine, melphalan, cyclophosphamide, and prednisone in treating multiple myeloma patients who meet specific eligibility criteria, including measurable disease and no prior chemotherapy treatment.",
    "The sample is a phase 3 trial for infertility, testing the drugs dr-2011 and crinone 8%, with inclusion criteria including pre-menopausal age, specific types of infertility, and semen analysis, and exclusion criteria including contraindication to progesterone therapy and history of failed IVF cycles or miscarriages.",
    "The sample is a phase 3 trial for Alzheimer's disease and dementia, testing the efficacy of mpc-7869, with inclusion criteria including a diagnosis of probable Alzheimer's disease, age 55 or older, and a reliable caregiver, and exclusion criteria including evidence of other causes of dementia and active malignancy.",
    "This phase 3 trial is testing the efficacy of gsk1120212 and chemotherapy in treating BRAF V600E/K mutation-positive cutaneous melanoma, with specific eligibility criteria and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of methylphenidate hydrochloride extended-release tablets in treating attention deficit hyperactivity disorder (ADHD) in adults, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of telmisartan+amlodipine fixed dose combination in treating hypertension, with inclusion criteria including age over 18 and mean seated diastolic blood pressure equal or more than 100 mmHg, and exclusion criteria including current treatment with any antihypertensive agents that cannot be safely stopped.",
    "The sample is a phase 3 trial for HIV-1 infections, testing the efficacy of tenofovir disoproxil fumarate (tdf), emtricitabine/tenofovir disoproxil fumarate (ftc/tdf), and placebo, with eligibility criteria for both HIV-1 infected and uninfected partners in a discordant heterosexual relationship.",
    "The sample is a phase 3 trial for vildagliptin, a drug used to treat type 2 diabetes, with inclusion criteria including stable metformin dose, specific blood glucose levels, and BMI range, and exclusion criteria including type 1 diabetes, pregnancy or lactation, and significant diabetic complications.",
    "The sample is a phase 3 trial for type 2 diabetes patients with HbA1C between 7.0% and 11.0%, testing the efficacy of liraglutide and exenatide, with inclusion criteria including stable treatment with oral anti-diabetic drugs and BMI lower than 45.0 kg/m2, and exclusion criteria including previous treatment with insulin and impaired liver or/and renal function.",
    "This phase 3 trial is testing the effectiveness of velcade, thalidomide, and dexamethasone in treating relapsing or progressive multiple myeloma, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of avlocardyl and placebo in treating posttraumatic stress disorder in patients who meet specific inclusion and exclusion criteria, including having a diagnosis of PTSD according to DSM IV-TR criteria and not being treated with certain substances or having certain psychiatric or somatic pathologies.",
    "The sample is a phase 3 trial for preventing graft rejection in heart transplant patients using a combination of everolimus, mycophenolate mofetil, cyclosporine, and corticosteroids, with eligibility criteria including age and functional graft status, and exclusion criteria including previous organ transplants and ABO incompatibility.",
    "The sample is a phase 3 trial for the treatment of benign prostatic hypertrophy, testing the efficacy of cetrorelix 78+78 and cetrorelix 78 + placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of peginterferon alfa-2a and ribavirin in treating chronic hepatitis C infection, with specific inclusion and exclusion criteria, and requires the use of two forms of effective contraception during and after treatment.",
    "The sample is a phase 3 trial for patients with sickle cell disease and pulmonary hypertension, testing the effectiveness of bosentan, with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for diabetic neuropathies, testing the efficacy of duloxetine hydrochloride and placebo drugs, with inclusion and exclusion criteria listed.",
    "This phase 3 trial aims to treat atherosclerosis and acute coronary syndrome with drugs such as cangrelor and clopidogrel, and the eligibility criteria includes angiography demonstrating atherosclerosis amenable to treatment by PCI and diagnosis of ACS by elevated cardiac markers or ischemic chest discomfort.",
    "The sample is a phase 3 trial testing the efficacy of loteprednol etabonate and its vehicle in reducing inflammation and pain in patients undergoing cataract surgery, with inclusion criteria of age over 18 and candidacy for routine surgery, and exclusion criteria of hypersensitivity to the study drug, severe ocular or medical conditions, elevated intraocular pressure, and poor visual acuity in the non-study eye.",
    "This is a phase 3 trial for HIV infections testing the efficacy of raltegravir and placebo in patients with sustained HIV RNA < 50 copies/ml, with inclusion and exclusion criteria including CD4 count, pregnancy status, and previous use of integrase inhibitors.",
    "The sample is a phase 3 trial for soft tissue sarcoma, testing the efficacy of doxorubicin in combination with palifosfamide-tris or placebo, with eligibility criteria including age, disease type, prior treatment, performance status, and organ function.",
    "This phase 3 trial is testing the efficacy of a combination tablet of treximet (sumatriptan/naproxen sodium) in treating migraine disorders in adolescents aged 12-17 years old with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for breast cancer patients with locally recurrent or metastatic disease, testing the efficacy of docetaxel and bevacizumab, with eligibility criteria including HER2-negative cancer and ECOG performance status of 0-1.",
    "The sample is a phase 3 trial for non-small cell lung cancer, testing the efficacy of docetaxel and carboplatin, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for smoking cessation using nicotine as the drug, with inclusion criteria based on BMI and smoking habits, and exclusion criteria based on intolerance to nicotine or suspected smoking during the sequestration period.",
    "The sample is a phase 3 trial for HIV infections in Abidjan, testing the effectiveness of a combination of antiretroviral drugs including zidovudine, lamivudine, efavirenz, ritonavir, and indinavir, with specific inclusion and exclusion criteria for participants.",
    "This is a phase 3 clinical trial for patients with chronic myelogenous leukemia, testing the efficacy of hydroxyurea and homoharringtonine as treatment options, with eligibility criteria including prior treatment failure with alpha-Interferon and age \u2265 16 years.",
    "The sample is a phase 3 trial for a drug called pf-00345439, which is being tested for its effectiveness in treating moderate to severe pain caused by osteoarthritis or low back pain, and the eligibility criteria includes age, gender, and contraceptive use.",
    "This phase 3 trial is testing chlorambucil and fludarabine for the treatment of Waldenstr\u00f6m macroglobulinemia, lymphoplasmacytic lymphoma, and splenic marginal zone lymphoma, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of duloxetine and placebo in treating generalized social anxiety disorder, with specific inclusion and exclusion criteria, and a list of icd-10 codes for the disease.",
    "This is a phase 3 trial for diabetes mellitus testing the efficacy of acarbose and placebo drugs on patients with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 3 clinical trial for Crohn's disease patients who are steroid-dependent and in clinical remission, testing the efficacy of dexamethasone as a treatment option, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for painful diabetic neuropathy, testing the efficacy of pregabalin (lyrica) versus placebo, with inclusion criteria requiring patients to be receiving treatment for the condition and exclusion criteria excluding patients with other pain conditions.",
    "The sample is a phase 3 clinical trial for ovarian cancer patients receiving platinum-based chemotherapy and interval debulking surgery, with eligibility criteria including residual macroscopic disease and no concurrent or prior malignancy likely to interfere with protocol treatments or comparison, and the drug being tested is chemotherapy.",
    "The sample is a phase 3 trial for Chinese patients with relapsing remitting or secondary progressive multiple sclerosis, testing the effectiveness of interferon beta-1b (betaseron, bay86-5046), with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of oxaliplatin+capecitabine and oxaliplatin+capecitabine+bevacizumab in treating patients with colorectal cancer and liver metastases who have undergone R0 resection, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of gemcitabine in treating locally advanced or regional pancreatic cancer, with specific eligibility criteria including age, performance status, and adequate bone marrow reserve, liver and renal function.",
    "The sample is a phase 3 trial for ovarian cancer, testing liposomal doxorubicin, carboplatin, and paclitaxel, with inclusion criteria including a diagnosis of stage Ic-IV ovarian cancer and indication for chemotherapy treatment, and exclusion criteria including previous chemotherapy treatment and heart disease.",
    "The sample is a phase 3 trial for diabetes mellitus and hypercholesterolemia, testing the efficacy of atorvastatin and its placebo, with inclusion criteria including stable insulin therapy and fasting LDL-C>100mg/dl, and exclusion criteria including severe dyslipidemia and current use of lipid lowering or antidiabetic drugs.",
    "This phase 3 trial is testing the efficacy of resatorvid and placebo in treating sepsis in patients who meet specific eligibility criteria, including having a suspected or proven bacterial or fungal infection and having developed at least 3 of 4 systemic inflammatory response syndrome criteria within 36 hours prior to study drug administration.",
    "The sample is a phase 3 trial for CD20+ low-grade lymphoma using rituximab and interferon-a-2a as drugs, with eligibility criteria including stage II-IV lymphoma and exclusion criteria including prior treatment with rituximab or an interferon.",
    "This phase 3 trial is testing the efficacy of tiotropium respimat\u00ae and salmeterol hfa mdi in treating asthma, with inclusion criteria including confirmed diagnosis of asthma, use of inhaled corticosteroids, and symptomatic at screening, while exclusion criteria include recent use of certain medications and history of significant diseases.",
    "This phase 3 trial is testing the efficacy of RAD001 and placebo in treating metastatic renal cell carcinoma patients who have previously received sunitinib and/or sorafenib, with various eligibility criteria including measurable lesions, Karnofsky Performance Status \u226570%, and adequate bone marrow, liver and renal function.",
    "This phase 3 trial is testing the effectiveness of Sativex and placebo in treating central neuropathic pain in patients with multiple sclerosis who have been on analgesic therapy, with inclusion criteria including at least two years of MS and at least three months of stable CNP.",
    "The sample is a phase 3 trial for depression, testing the efficacy of risperidone and placebo comparator in patients with severe depression and suicidality, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of levomilnacipran er and placebo, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for non small cell lung carcinoma, testing the drug iressa (gefitinib) in combination with chemotherapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for metastatic breast cancer, testing the drugs ct-p6, herceptin, and paclitaxel, with eligibility criteria including Her 2 over-expression and ECOG 0 or 1, and exclusion criteria including current CNS metastases and infection, and no pregnant or nursing mothers allowed.",
    "The sample is a phase 3 trial for ovarian cancer patients with specific disease characteristics and patient characteristics, testing the effectiveness of carboplatin and paclitaxel drugs, with eligibility criteria including complete surgical staging and no prior treatment for this malignancy except surgical staging.",
    "The sample is a phase 3 trial for the treatment of epithelial ovarian cancer, primary peritoneal cancer, and fallopian tube cancer using paclitaxel+carboplatin, with eligibility criteria including confirmed cancer diagnosis, no prior chemotherapy, and specific blood count and liver function requirements.",
    "The sample is a phase 3 trial for insulin-naive patients with type 2 diabetes mellitus, testing the efficacy of insulin degludec/insulin aspart and insulin glargine in combination with oral antidiabetic drugs, with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for HIV infections testing the effectiveness of enfuvirtide and an optimized background antiretroviral regimen (OB) in participants previously treated with drugs of 2 or 3 different antiretroviral classes, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with unresectable metastatic colorectal cancer, testing the efficacy of bevacizumab, capecitabine, and oxaliplatin, with eligibility criteria including age, cancer confirmation, measurable lesion, and ECOG performance status, and exclusion criteria including previous treatment with Avastin, previous systemic treatment for advanced or metastatic disease, clinically significant cardiovascular disease, and daily chronic treatment with high doses of aspirin or non-steroidal anti-inflammatory drugs.",
    "The sample is a phase 3 trial for ovarian cancer patients with resistance to platinum/taxane-based chemotherapy, testing the efficacy of karenitecin and topotecan, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for postmenopausal women with primary invasive breast carcinoma resected at time of original diagnosis, testing the efficacy of letrozole as adjuvant therapy after completing at least 4.5 years of adjuvant tamoxifen or aromatase inhibitor therapy, with eligibility criteria including specific disease characteristics, patient characteristics, and prior concurrent therapy.",
    "The sample is a phase 3 clinical trial for osteoarthritis, testing the efficacy of diclofenac and placebo in patients with chronic NSAID use and documented osteoarthritis flare, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of high and low dose fdc, bi 10773, and linagliptin in treating type 2 diabetes mellitus, with eligibility criteria including a diagnosis of type 2 diabetes mellitus, HbA1c levels between 7.0% and 10.5%, and absence of any oral antidiabetic therapy, glucagon like peptide-1 analog or insulin for 12 weeks prior to randomization.",
    "The sample is a phase 3 trial for endometriosis-associated pelvic pain, testing the drug Visanne (sh t00660aa, bay86-5258), with inclusion criteria being female patients with endometriosis-associated pelvic pain and exclusion criteria including pregnancy, lactation, hormone dependent tumor history or suspicion, therapy resistant endometriosis or need for primary surgical treatment, and any other conditions which forbid participation.",
    "This phase 3 trial is testing the efficacy of high and low dose clonidine hcl sustained release and placebo in treating attention deficit disorder with hyperactivity in children between 6 and 17 years old, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of corifollitropin alfa and ganirelix in females undergoing controlled ovarian stimulation for in vitro fertilization, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for asthma patients, testing the effectiveness of ciclesonide and placebo drugs, with inclusion and exclusion criteria listed, and the diseases are represented by ICD-10 codes.",
    "This phase 3 trial is testing the efficacy of bortezomib, lenalidomide, and dexamethasone in treating symptomatic multiple myeloma patients who have received a minimum of 1 cycle, maximum of 6 cycles, of a dexamethasone-based regimen and have met specific eligibility criteria.",
    "The sample is a phase 3 trial for Alzheimer's disease, testing the drugs ly450139 and placebo, with inclusion criteria based on MMSE score, Hachinski Ischemia Scale score, and Geriatric Depression Scale score, and exclusion criteria including inability to swallow medication, serious illnesses, lack of reliable caregiver, chronic alcohol or drug abuse, and prior active vaccination for AD.",
    "This phase 3 trial is testing the efficacy of cyclosporine, hydroxychloroquine, prednisone, and tacrolimus in treating extensive chronic graft-versus-host disease in patients who have undergone allogeneic bone marrow, peripheral blood stem cell, or cord blood transplantation, with specific eligibility criteria for disease characteristics, patient characteristics, and prior concurrent therapy.",
    "The sample is a phase 3 trial for restless legs syndrome (RLS) using ropinirole as the drug, with inclusion and exclusion criteria listed, and disease names and corresponding ICD-10 codes provided.",
    "The sample is a phase 3 trial for the drug sitaxentan in patients with symptomatic pulmonary arterial hypertension, with specific inclusion and exclusion criteria related to blood pressure and previous exposure to endothelin receptor antagonists.",
    "The sample is a phase 3 trial for schizophrenia and cognition, testing the effectiveness of sertindole and quetiapine, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of mesalazine and placebo in treating irritable bowel syndrome patients who meet the Rome III criteria, with exclusion of any organic or metabolic disease.",
    "The sample is a phase 3 trial testing the efficacy of retapamulin ointment and placebo ointment in treating bacterial skin infections, with specific inclusion and exclusion criteria for subjects.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of abatacept and methotrexate in combination with a stable dose of methotrexate for at least 3 months, with key inclusion criteria being RA diagnosis for over a year and key exclusion criteria being active or latent bacterial or viral infections.",
    "The sample is a phase 3 trial for metastatic colorectal cancer using xaliproden, placebo, oxaliplatin, 5-fluorouracil, and leucovorin as drugs, with eligibility criteria including histologically or cytologically-proven metastatic cancer of the colon or rectum, measurable disease, and no prior chemotherapeutic regimen for metastatic disease.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus testing the efficacy of exenatide once weekly and liraglutide in patients with suboptimal glycemic control and BMI \u226445 kg/m^2 who have been treated with lifestyle modification and one of the specified oral antidiabetic agents, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of bi 1356 and glimepiride compared to placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for pneumonia treatment with drugs including avelox and ceftriaxone, and eligibility criteria including hospitalization, clinical signs, and radiological evidence.",
    "The sample is a phase 3 trial for patients with chronic kidney disease and anemia, testing the efficacy of epoetin alfa, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the drug lapatinib for patients with non-metastatic operable primary invasive adenocarcinoma of the breast, who have received at least four cycles of an approved anthracycline-based (neo-) adjuvant chemotherapy regimen, and have over expression and/or amplification of HER2 in the invasive component of the primary tumour.",
    "This phase 3 trial is testing the efficacy of pegylated liposomal doxorubicin and capecitabine in treating metastatic breast cancer patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for bipolar disorder, testing the efficacy of asenapine and placebo, with inclusion criteria of bipolar I disorder and treatment with lithium or valproic acid, and exclusion criteria of unstable medical condition, clinically significant laboratory abnormality, and primary diagnosis other than bipolar I disorder.",
    "The sample is a phase 3 trial for schizophrenia using paliperidone palmitate as the drug, with inclusion criteria including a diagnosis of schizophrenia and a total PANSS score of 60 to 120, and exclusion criteria including active substance dependence and pregnancy.",
    "The sample is a phase 3 trial for Alzheimer's disease and dementia, testing the efficacy of rivastigmine transdermal patch, with inclusion criteria including a diagnosis of Alzheimer's and a primary caregiver, and exclusion criteria including unstable cardiovascular disease and active, uncontrolled seizure disorder.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of anagliptin and sitagliptin, with inclusion criteria including FPG \u2264 270 mg/dL and exclusion criteria including BMI < 20 kg/m2 or > 40.0kg/m2.",
    "This is a phase 3 clinical trial for patients with Parkinson's disease, testing the efficacy of 2 mg and 4 mg perampanel compared to a placebo, with eligibility criteria including a good response to levodopa and predictable motor fluctuations of the wearing \"OFF\" type.",
    "The sample is a phase 3 clinical trial for patients aged 6 to 18 years with chronic motor or vocal tic disorder or Tourette's disorder, testing the efficacy of aripiprazole and placebo, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for HIV infections, testing the efficacy of tenofovir df and placebo in patients with prior antiretroviral treatment experience and absence of K65R mutation, with inclusion criteria including weight \u2265 35 kg and documented laboratory diagnosis of HIV infection.",
    "The sample is a phase 3 trial for major depressive disorder, testing the effectiveness of quetiapine fumarate and duloxetine, with inclusion criteria of a documented clinical diagnosis of major depressive disorder and exclusion criteria of pregnancy or lactation and current or past diagnosis of stroke or transient ischemic attack (TIA).",
    "The sample is a phase 3 trial for patients with non-insulin-dependent diabetes mellitus, testing the efficacy of sitagliptin phosphate and voglibose as drugs, with eligibility criteria including type 2 diabetes mellitus on diet/exercise therapy and exclusion criteria including type 1 diabetes mellitus.",
    "This phase 3 trial is testing the efficacy of saredutant succinate in treating major depressive disorder, with specific inclusion and exclusion criteria, and the use of the Montgomery-Asberg Depression Rating Scale to measure outcomes.",
    "The sample is a phase 3 trial for chronic stable angina pectoris, using ivabradine as the drug, with inclusion criteria including documented coronary artery disease and previous treatment with atenolol or other beta-blocker agent, and exclusion criteria including heart rate < 60 bpm and congestive heart failure.",
    "The sample is a phase 3 trial for patients with coronary artery disease undergoing on-pump, elective coronary artery bypass grafting with at least 2 free grafts, testing the efficacy of aspirin and clopidogrel, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease, testing the effectiveness of budesonide/formoterol and formoterol drugs, with inclusion criteria of COPD diagnosis, symptoms for more than 2 years, and a smoking history of at least 10 pack years, and exclusion criteria of asthma and atopic diseases.",
    "The sample is a phase 3 trial for HIV-associated Distal Symmetrical Polyneuropathy (DSP) with pain in the feet, testing the efficacy of pregabalin and placebo, with inclusion and exclusion criteria including vitamin B12 deficiency and diabetes mellitus.",
    "This phase 3 trial is testing the efficacy of insulin lispro and insulin aspart in patients with type 2 diabetes mellitus who have been treated with CSII therapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for advanced non-small cell lung cancer with squamous cell, large cell, or adenosquamous carcinoma, testing the effectiveness of cp-751,871 (figitumumab), carboplatin, and paclitaxel as drugs, with eligibility criteria including no prior systemic treatment for NSCLC and ECOG performance status (PS) 0 or 1.",
    "The sample is a phase 3 trial for HIV prevention using acyclovir and placebo, with inclusion criteria for MSM and WSM, and exclusion criteria for those with adverse reactions to acyclovir or current enrollment in another HIV prevention trial.",
    "The sample is a phase 3 trial for patients with defibrillators or ventricular tachycardia, testing the effectiveness of amiodarone as a prophylaxis against sudden cardiac death, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of different doses of valsartan, a hypertension medication, in children aged 6 months to 5 years with documented history of hypertension, and the eligibility criteria includes MSSBP \u2265 95th percentile for age, gender and height, while exclusion criteria includes patients with background ARB therapy and clinically significant abnormalities or lab values.",
    "The sample is a phase 3 trial testing the efficacy of olmesartan medoxomil and placebo tablets in patients with type 2 diabetes, cardiovascular disease, and kidney disease, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for inflammation, using difluprednate as the drug, with eligibility criteria including no systemic administration of corticosteroids or immunosuppressive drugs in the 2 weeks prior to study enrollment.",
    "The sample is a phase 3 clinical trial for ulcerative colitis using encapsulated mesalamine granules (emg) as the drug, with eligibility criteria including confirmed diagnosis of mild to moderate UC in remission for greater than 1 month and less than 12 months.",
    "The sample is a phase 3 trial for lupus nephritis patients who are resistant or relapsed to IVCY, testing the efficacy of mycophenolate sodium and cyclophosphamide as drugs, with eligibility criteria including biopsy-proven active lupus nephritis and a lifetime cumulative dose of IVCY > 6 grams.",
    "The sample is a phase 3 trial for previously untreated children with chronic hepatitis C, using ribavirin (sch 18908) as the drug, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for Parkinson's disease, testing the efficacy of Requip PR and Mirapex in patients currently taking pramipexole, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of oxycodone and naloxone in treating moderate to severe non-malignant pain, with specific inclusion and exclusion criteria, and a focus on discontinuing current analgesics.",
    "This phase 3 trial is testing the efficacy of carboplatin in treating ovarian, fallopian tube, or primary peritoneal cancer in patients who are unsuitable or unwilling to receive platinum-taxane combination therapy, and meet specific eligibility criteria.",
    "The sample is a phase 3 trial for non-small cell lung cancer, testing the efficacy of pemetrexed and docetaxel, with specific eligibility criteria including prior chemotherapy and Eastern Cooperative Oncology Group performance status 0 to 2.",
    "This phase 3 trial is testing the efficacy of pomalidomide and dexamethasone in treating multiple myeloma patients who have undergone prior treatment with at least 2 lines of anti-myeloma therapy and have failed treatment with both lenalidomide and bortezomib, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial testing the efficacy of duloxetine and pregabalin compared to placebo in treating painful diabetic neuropathy, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for allergic rhinoconjunctivitis with grass pollen sensitivity, testing the efficacy of sublivac\u00ae grasses/placebo treatment and sublivac\u00ae grasses treatment, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with moderate to severe COPD, testing the efficacy of nva237 and indacaterol compared to placebo, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of beclomethasone dipropionate and albuterol sulfate in treating asthma in children who meet specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of fluticasone propionate/formoterol fumarate in treating asthma, with eligibility criteria including a history of asthma, documented use of inhaled corticosteroids, and reversible FEV-1 levels, while exclusion criteria include life-threatening asthma, recent systemic corticosteroid medication, and significant pulmonary disease.",
    "This phase 3 trial is testing the efficacy of various inhalation powders, including ff inhalation powder and placebo, in treating chronic obstructive pulmonary disease (COPD) in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "The sample is a phase 3 trial for hypertension using aliskiren as the drug, with inclusion criteria of mild to moderate essential hypertension and exclusion criteria of secondary hypertension or malignant hypertension.",
    "The sample is a phase 3 trial for postmenopausal osteoporosis, testing the efficacy of ibandronate and placebo drugs, with eligibility criteria including postmenopausal status and osteoporosis at specific sites, and exclusion criteria including pregnancy, drug/alcohol abuse, and certain medical conditions.",
    "This phase 3 trial is testing the efficacy of ly2189265, liraglutide, and placebo in treating type 2 diabetes mellitus in participants who are OAM-na\u00efve or taking OAM monotherapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for the treatment of migraine with almotriptan malate, with inclusion criteria such as having a history of migraine for at least one year and exclusion criteria such as having an allergy to almotriptan malate or experiencing more than 6 non-migraine headaches per month.",
    "The sample is a phase 3 trial for seasonal allergic rhinitis, testing the efficacy of placebo, azelastine hcl, azelastinehcl/fluticasone propionate, and fluticasone propionate, with inclusion criteria including a positive skin test to a prevalent spring allergen and exclusion criteria including hypersensitivity to the drugs, nasal disease likely to affect medication deposition, and use of medications that could affect the study results.",
    "The sample is a phase 3 trial for patients with liver metastases secondary to uveal melanoma or metastatic cancer, testing the efficacy of fotemustine and isolated perfusion, with eligibility criteria including various medical conditions and restrictions on prior concurrent therapies.",
    "This phase 3 trial is testing the efficacy of glargine, ly2605541, and insulin lispro in treating type 1 diabetes mellitus with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for preoperative chemotherapy and radiation therapy in patients with gastric or rectal cancer, using epoetin alfa as a drug to increase hemoglobin levels, with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for hypertension patients, testing the effectiveness of telmisartan and amlodipine, with specific eligibility and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of s-1/cisplatin and 5-fu/cisplatin in treating unresectable, locally advanced or metastatic gastric cancer patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for asthma, testing the efficacy of ciclesonide and placebo, with inclusion and exclusion criteria including reversible airway obstruction and contraindications for inhaled steroids.",
    "The sample is a phase 3 trial for kidney cancer patients who underwent surgical resection of primary tumor within the past month and have no evidence of metastatic disease, testing the efficacy of fluorouracil, with eligibility criteria including age, performance status, hematopoietic, hepatic, renal, and cardiovascular conditions, and excluding prior chemotherapy, concurrent immunotherapy, corticosteroids, hormonal therapy, radiotherapy, major organ allografts, and other concurrent investigational drugs, agents, or devices.",
    "This phase 3 trial will test the efficacy of human albumin in treating patients with cirrhosis, sepsis, and renal failure, with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for upper limb spasticity post-stroke, testing the efficacy of gsk1358820 (botulinum toxin type a) compared to placebo, with eligibility criteria including specific muscle tone and functional disability ratings, stable medication and physical therapy use, and exclusion criteria including previous botulinum toxin therapy and certain medical conditions.",
    "The sample is a phase 3 trial for major depressive disorder using vortioxetine (lu aa21004) as the drug, with inclusion criteria being patients who completed a short-term treatment study for MDD and exclusion criteria including any current psychiatric disorder other than MDD, use of any psychoactive medication, and significant risk of suicide.",
    "The sample is a phase 3 trial for bladder cancer, transitional cell cancer of the renal pelvis and ureter, and urethral cancer, testing the efficacy of carboplatin, cisplatin, doxorubicin hydrochloride, methotrexate, paclitaxel, and vinblastine, with eligibility criteria including confirmed transitional cell carcinoma of the urothelium and specific patient characteristics.",
    "The sample is a phase 3 trial for osteoporosis, testing the efficacy of osteoform and shelcal drugs, with inclusion criteria for postmenopausal women with osteoporosis and exclusion criteria for various medical conditions and medication use.",
    "The sample is a phase 3 trial for patients with hyperglycemia and leukemia, testing the effectiveness of therapeutic insulin while undergoing chemotherapy treatment, with specific eligibility criteria including blood sugar levels and ECOG performance status.",
    "The sample is a phase 3 trial for patients with both heart failure and type 2 diabetes, testing the efficacy of metformin as a treatment, with specific inclusion and exclusion criteria, and using ICD-10 codes to identify the diseases.",
    "The sample is a phase 3 trial for eosinophilic asthma, testing the efficacy of reslizumab and placebo, with inclusion criteria including ACQ score, airway reversibility, fluticasone dosage, blood eosinophil count, and contraception use for female patients.",
    "The sample is a phase 3 trial for metastatic melanoma patients with BRAF V600E mutation, testing the efficacy of vemurafenib and dacarbazine, with eligibility criteria including age, disease stage, and negative pregnancy test.",
    "The sample is a phase 3 trial for knee osteoarthritis pain, testing the efficacy of tapentadol er, matching placebo, and oxycodone cr, with inclusion criteria including a diagnosis of knee osteoarthritis and dissatisfaction with current analgesic therapy, and exclusion criteria including a history of alcohol or drug abuse, malignancy within the past 2 years, and treatment with certain medications.",
    "This phase 3 trial is testing the efficacy of single low dose cyclophosphamide and placebo in treating unresectable stage III non-small cell lung cancer patients who have completed primary thoracic chemo-radiotherapy, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of duloxetine and placebo in treating generalized anxiety disorder (GAD) in male and female outpatients, with specific inclusion and exclusion criteria, and using various diagnostic scales to measure severity.",
    "This phase 3 trial is testing the efficacy of travoprost ophthalmic solution, 0.003% and 0.004%, in treating open-angle glaucoma and ocular hypertension, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of disodium clodronate injections for postmenopausal osteoporosis in patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for the treatment of nocturia using desmopressin and placebo, with inclusion criteria including male sex and at least 2 voids every night, and exclusion criteria including urologic malignancies, obstructive sleep apnea, and previous desmopressin treatment for nocturia.",
    "The sample is a phase 3 clinical trial for osteoporosis, testing the efficacy of risedronate and its placebo on osteopenic, postmenopausal women with specific inclusion and exclusion criteria, and with a list of icd-10 codes for the disease.",
    "The sample is a phase 3 trial for asthma patients using ciclesonide as a drug, with inclusion criteria of persistent bronchial asthma and FEV1 50-90% of predicted, and exclusion criteria including concomitant severe diseases or diseases which are contraindications for the use of inhaled steroids, COPD, and respiratory tract infection or asthma exacerbation within the last 30 days prior to entry into the study.",
    "This is a phase 3 clinical trial for Friedreich's Ataxia, testing the efficacy of idebenone and placebo in patients aged 8-17 with confirmed FRDA mutations, who are able to walk at least 10 meters without assistance and meet other eligibility criteria.",
    "The sample is a phase 3 trial for type 1 diabetes patients with HbA1c below or equal to 8.5%, testing the efficacy of insulin degludec and insulin glargine, with inclusion and exclusion criteria specified.",
    "This is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of exenatide and placebo in combination with sulfonylurea, biguanide, or thiazolidinedione, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of balsalazide disodium, a drug used to treat inflammatory bowel disease and ulcerative colitis, in patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for osteoarthritis patients, testing the effectiveness of shinbaro capsule and celebrex, with inclusion criteria including age, diagnosis, duration of symptoms, and WOMAC score, and exclusion criteria including comorbid orthopedic disease or significant trauma/surgery to the index knee.",
    "The sample is a phase 3 trial for patients with hyperphosphatemia and kidney failure, testing the efficacy of ferric citrate, calcium acetate, sevelamer carbonate, and placebo as phosphate binders, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial testing the drug eszopiclone for sleep maintenance insomnia in patients with Parkinson's disease, with specific eligibility criteria and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of bendamustine and rituximab in treating CD20+ B-cell non-Hodgkin's lymphomas, including mantle cell lymphoma, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial aims to test the efficacy of naltrexone sr 32 mg/bupropion sr 360 mg/day versus placebo in reducing weight and improving glycemic control in overweight and obese patients with type 2 diabetes mellitus, who are on stable doses of oral hypoglycemic medications and have no injectable antidiabetes medication or inhaled insulin for more than 3 months prior to randomization.",
    "The sample is a phase 3 trial for primary hypercholesterolemia and dyslipidemia, testing the effectiveness of pitavastatin and atorvastatin, with eligibility criteria including age, diet restrictions, and exclusion criteria including certain medical conditions and drug use.",
    "The sample is a phase 3 trial for hypertension using eplerenone as the drug, with eligibility criteria for 6-16 year old males and females with high blood pressure, and exclusion criteria for chronic kidney disease and high potassium levels.",
    "This phase 3 trial is testing the efficacy of indacaterol and salmeterol, along with placebos, in treating moderate to severe chronic obstructive pulmonary disease (COPD) in patients who meet specific inclusion criteria, including a smoking history of at least 20 pack years and post-bronchodilator FEV1/FVC < 70%.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) patients, testing the efficacy of roflumilast and placebo drugs, with inclusion and exclusion criteria based on exacerbation history and lung function.",
    "This phase 3 trial is testing the efficacy of pregabalin in treating bothersome hot flashes in women with a history of breast cancer or those who wish to avoid estrogen, with specific eligibility criteria and restrictions on concurrent therapies.",
    "The sample is a phase 3 trial for hyperlipidemia using ezetimibe as the drug, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) testing the efficacy of tiotropium/salmeterol qd, placebo, salmeterol, tiotropium/salmeterol qd+ salmeterol, and tiotropium, with inclusion criteria of post-bronchodilator FEV1<80% predicted and FEV1/FVC<70% predicted and exclusion criteria of significant other diseases, recent MI, unstable or life-threatening arrhythmia, hospitalization for cardiac failure in past year, and history of asthma.",
    "The sample is a phase 3 trial for the drug vortioxetine in patients with major depressive disorder, with inclusion criteria including completion of a prior double-blind treatment period and a primary diagnosis of major depressive episode, and exclusion criteria including other psychiatric disorders, significant suicide risk, and ongoing adverse events related to study medication.",
    "The sample is a phase 3 trial for postherpetic neuralgia, testing the efficacy of pregabalin compared to placebo, with inclusion criteria of pain lasting more than 3 months and a VAS score higher than 40mm, and exclusion criteria including malignancy within the past 2 years and skin conditions that could alter sensation.",
    "This phase 3 trial is testing the efficacy of lapatinib and paclitaxel in treating invasive breast cancer with stage IV disease and amplification of ErbB2, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin phosphate and metformin hydrochloride as antihyperglycemic therapy, with eligibility criteria including inadequate control and exclusion criteria including recent use of insulin or oral antihyperglycemic therapy.",
    "The sample is a phase 3 trial for systemic lupus erythematosus (SLE) using rituximab, methylprednisolone, acetaminophen, and diphenhydramine as drugs, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for head and neck cancer patients, testing the efficacy of placebo and palifermin drugs, with specific eligibility criteria including histologically documented squamous cell carcinoma and a planned dose of at least 50Gy to the area of the oral cavity/oropharynx mucosa that can be visualized.",
    "The sample is a phase 3 trial testing the efficacy of ibandronate sodium in treating metastatic cancer, pain, and prostate cancer, with eligibility criteria including confirmed bone metastases and hormone receptor status not specified.",
    "The sample is a phase 3 trial for depressive disorders, using risperidone as the drug, with inclusion criteria based on DSM-IV and a history of resistance to antidepressant medication, and exclusion criteria including substance dependence and pregnancy/nursing.",
    "This is a phase 3 trial for osteoporosis testing the efficacy of teriparatide and risedronate in ambulatory men with a BMD of at least 1.5 SD below the corresponding normal young adult men average BMD, who have received glucocorticoid therapy at an average dose of at least 5.0 milligrams per day of prednisone or its equivalent for a minimum of 3 consecutive months immediately preceding screening, and meet other inclusion criteria.",
    "The sample is a phase 3 clinical trial for the treatment of diverticulitis using spd476, mmx\u2122 mesalazine, and placebo drugs, with eligibility criteria including confirmation of diverticulosis and exclusion criteria such as previous colorectal surgery and use of other investigational products within 30 days of baseline.",
    "This phase 3 trial is testing the efficacy of Requip PR, a dopamine agonist, versus placebo in treating idiopathic Parkinson's Disease in patients who have demonstrated lack of control with L-dopa therapy, and have a minimum of 3 hours awake time \"off\" for each diary day recorded during the Placebo Run-In Period.",
    "The sample is a phase 3 trial for patients with multiple sclerosis, testing the efficacy of fampridine-sr and placebo on a timed 25 foot walk, with inclusion and exclusion criteria including clinically defined multiple sclerosis and no pregnant or breastfeeding female patients.",
    "This phase 3 trial is testing the efficacy of BF2.649 (Pitolisant) in treating narcolepsy and cataplexy, with inclusion criteria including a diagnosis of narcolepsy, EDS with an ESS score of at least 12, and previous participation in a Bioprojet narcolepsy study assessing BF2.649 efficacy, while exclusion criteria include untreated sleep apnea syndrome, substance abuse or dependence disorder, and known hypersensitivity to the tested treatment.",
    "This phase 3 trial will test the efficacy of Sativex\u00ae versus placebo in treating spasticity due to multiple sclerosis, with inclusion criteria including a diagnosis of MS and spasticity not wholly relieved by current therapy, and exclusion criteria including significant cardiac, renal or hepatic disease and hypersensitivity to cannabinoids.",
    "The sample is a phase 3 trial for hypertension using the drug valsartan/amlodipine, with inclusion criteria of uncomplicated essential hypertension and exclusion criteria of severe hypertension, history of stroke or heart disease, liver/kidney/pancreas disease, insulin dependent diabetes, and allergies to certain medications.",
    "The sample is a phase 3 trial for osteoarthritis of the knee, testing the efficacy of placebo, hyruan plus, and lbsa0103, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for non-CF bronchiectasis using azli and placebo drugs, with inclusion and exclusion criteria listed, and the disease is identified by icd-10 codes J47.9, Q33.4, J47.1, and J47.0.",
    "This phase 3 trial is testing the efficacy of sitagliptin phosphate, acarbose, and glimepiride in treating type 2 diabetes mellitus patients who are on stable doses of acarbose, with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for growth hormone deficiency, testing the effectiveness of placebo and somatropin drugs, with eligibility criteria including age and isolated growth hormone deficiency, and exclusion criteria including childhood onset and diabetes mellitus type 1 or 2.",
    "The sample is a phase 3 trial for Alzheimer's disease and dementia patients with a specific set of inclusion and exclusion criteria, using galantamine hydrobromide as the drug being tested.",
    "The sample is a phase 3 trial for venous thromboembolism using du-176b (edoxaban) and enoxaparin sodium 20mg as drugs, with eligibility criteria including subjects scheduled for surgery for femoral neck fracture within 10 days and exclusion criteria including subjects with risks of hemorrhage or thrombolic risks, weighing less than 40 kg, pregnant or suspecting pregnancy, or wanting to become pregnant.",
    "The sample is a phase 3 trial for breast cancer patients receiving the AT regimen, testing the efficacy of chemotherapy in treating chemotherapy-induced neutropenia, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of aripiprazole, a drug used to treat bipolar I disorder, on subjects who meet specific inclusion criteria and do not meet any of the exclusion criteria listed in the eligibility criteria section.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of quetiapine fumarate sustained release, with inclusion and exclusion criteria based on DSM-IV diagnosis and current episode duration.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of mk0653a and ezetimibe (+) simvastatin compared to atorvastatin, with inclusion and exclusion criteria including stable weight and no recent history of cancer or heart disease.",
    "The sample is a phase 3 trial for small cell lung cancer, testing the efficacy of pemetrexed, etoposide, and carboplatin, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the efficacy of octreotide acetate 30 mg suspension in treating patients with biochemically documented active acromegaly who are currently receiving somatostatin-analogues in a conventional treatment regimen for at least 6 months and have uncontrolled disease, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with non-erosive reflux disease or erosive gastroesophageal reflux disease, testing the effectiveness of pantoprazole, with eligibility criteria including symptomatic patients and exclusion criteria including previous acid-lowering surgery or inflammatory bowel diseases.",
    "The sample is a phase 3 clinical trial for patients with primary peritoneal carcinoma, epithelial ovarian carcinoma or fallopian tube carcinoma, using gemcitabine, paclitaxel, and carboplatin as drugs, with eligibility criteria including histologic diagnosis and exclusion criteria including prior radiotherapy or chemotherapy.",
    "The sample is a phase 3 trial for major depressive disorder (MDD) using extended-release bupropion hydrochloride as the drug, with inclusion criteria including a primary diagnosis of MDD and normal orgasmic function, and exclusion criteria including previous failure to respond to two adequate trials of antidepressants and positive urine test for illicit drug use at screening.",
    "This phase 3 trial is testing the effectiveness of armodafinil and placebo in treating excessive sleepiness in patients with narcolepsy who meet specific eligibility criteria, including having a mean sleep latency of 6 minutes or less and a CGI-S rating of 4 or more.",
    "This phase 3 trial is testing the efficacy of rituximab in treating previously untreated patients with follicular lymphoma who meet specific eligibility criteria, including having at least one symptom requiring treatment, adequate hematological function, and no major underlying medical conditions.",
    "The sample is a phase 3 trial for gastroesophageal reflux disease (GERD) using pantoprazole as the drug, with inclusion criteria of 12-16 years old and clinical diagnosis of GERD, and exclusion criteria of GI or malabsorption disorders, chronic use of warfarin, and positive pregnancy test.",
    "The sample is a phase 3 trial for non-seminomatous germ cell tumors with poor prognosis, using drugs such as cisplatin and etoposide, and eligibility criteria including clinical stage II-III disease and high serum HCG or AFP levels.",
    "This is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of alogliptin and glipizide as antidiabetic agents, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus patients using ipragliflozin and alpha glucosidase inhibitor drugs, with inclusion criteria of HbA1c value between 6.5 and 9.5% and BMI between 20.0 and 45.0 kg/m2, and exclusion criteria of type 1 diabetes mellitus, serum creatinine > upper limit of normal, proteinuria, dysuria and/or urinary tract infection, significant renal, hepatic or cardiovascular diseases, and severe gastrointestinal diseases.",
    "This phase 3 trial is testing the efficacy of ckd-828 and telmisartan in treating essential hypertension that is not adequately controlled, with specific inclusion and exclusion criteria.",
    "This phase 3 trial focuses on breast cancer patients and tests the efficacy of various drugs including epirubicin, paclitaxel, cyclophosphamide, methotrexate, 5 fu, and darbepoetin alfa, with eligibility criteria including age, organ function, and absence of systemic metastasis.",
    "The sample is a phase 3 trial for metastatic breast cancer patients who have received previous treatment with anthracyclines and taxanes, and are now being tested with larotaxel and capecitabine, with eligibility criteria including age, pregnancy status, and other medical assessments.",
    "The sample is a phase 3 trial for type 2 diabetes with liraglutide, glibenclamide, and placebos as drugs, and the eligibility criteria include HbA1c levels, BMI, and exclusion of insulin treatment and other interfering drugs.",
    "This phase 3 trial is testing the efficacy of pancrecarb\u00ae (pancrelipase) versus placebo in patients with cystic fibrosis and pancreatic insufficiency, with eligibility criteria including confirmed diagnosis of CF, adequate nutritional status, and ability to swallow capsules.",
    "The sample is a phase 3 trial for patients with metastatic malignant melanoma or neoplasm metastasis, testing the drug cc-5013, with eligibility criteria including negative pregnancy test and exclusion of patients with active brain disease or newly diagnosed brain metastases.",
    "The sample is a phase 3 trial for major depressive disorder using quetiapine fumarate as the drug, with inclusion criteria of a clinical diagnosis of major depressive disorder and exclusion criteria of pregnancy or lactation and past diagnosis of stroke or TIA.",
    "The sample is a phase 3 trial for patients with stable, symptomatic Chronic Obstructive Pulmonary Disease (COPD) testing the efficacy and safety of nva237 and placebo, with inclusion and exclusion criteria defined, including smoking history, FEV1 levels, and contraindications for treatment with certain medications.",
    "The sample is a phase 3 trial for asthma patients, testing the effectiveness of budesonide/formoterol, budesonide, and formoterol drugs, with inclusion criteria of age, asthma diagnosis, and previous treatment with inhaled corticosteroids, and exclusion criteria of non-inhaled corticosteroid treatment, sensitivity to drugs specified in the protocol, and cancer or other significant disease or disorder.",
    "This is a phase 3 trial for patients with metastatic colorectal cancer who have failed prior irinotecan and oxaliplatin-containing regimens, and are K-Ras wild type, testing the efficacy of brivanib alaninate, with specific eligibility criteria including disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This phase 3 trial is testing the efficacy of fentanyl, an opioid, in treating breakthrough pain in cancer patients who are already on a stable background opioid regimen.",
    "The sample is a phase 3 trial for juvenile rheumatoid arthritis, testing the drugs celecoxib and naproxen, with inclusion criteria of 2-18 year olds with active JRA and exclusion criteria of recent changes in arthritis meds or other experimental meds.",
    "The sample is a phase 3 trial for diabetes mellitus using the drugs tak-875 and placebo, with inclusion and exclusion criteria specified, and icd-10 codes provided for the disease.",
    "The sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) testing the efficacy of aclidinium bromide/formoterol fumarate and formoterol fumarate, with inclusion criteria including a smoking history of at least 10 pack-years and stable moderate to severe COPD, and exclusion criteria including recent hospitalization for COPD exacerbation and clinically significant respiratory or cardiovascular conditions.",
    "This phase 3 trial is testing the effectiveness of olmesartan medoxomil, amlodipine, and hydrochlorothiazide in treating hypertension, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for chronic heart failure, testing the efficacy of ivabradine and placebo, with inclusion and exclusion criteria listed, and icd-10 codes provided for the disease.",
    "The sample is a phase 3 trial for migraine, with a list of icd-10 codes and eligibility criteria, comparing the drugs rizatriptan benzoate and placebo.",
    "The sample is a phase 3 trial for breast cancer patients with metastatic or multiple sites of new disease, testing the efficacy of anastrozole and fulvestrant, with eligibility criteria including postmenopausal women with hormone receptor positive cancer and no prior chemotherapy for recurrent or metastatic disease.",
    "The sample is a phase 3 trial for bipolar disorder patients treated with lithium or valproic acid, testing the efficacy of asenapine and placebo, with inclusion criteria of completion of a 12-week lead-in trial and exclusion criteria of unstable medical condition or primary diagnosis other than bipolar I disorder.",
    "The sample is a phase 3 trial for patients with non-muscle invasive urothelial bladder carcinoma, testing the efficacy of mitomycin c (mmc) as a treatment option, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with type 1 diabetes, testing the efficacy of insulin lispro protamine suspension and insulin levemir, with inclusion criteria including a clinical diagnosis of type 1 diabetes for one year or more, age 18 years or older, and a BMI less than or equal to 35 kg/m2.",
    "This phase 3 trial is testing the effectiveness of raltegravir, an HIV-1 integrase inhibitor, in patients with documented HIV-1 infection and a stable antiretroviral regimen, while excluding patients with certain conditions or prior therapy with MK-0518 or any other HIV-1 integrase inhibitor.",
    "The sample is a phase 3 trial for lupus erythematosus, systemic, testing the effects of atorvastatin and placebo atorvastatin on patients who meet certain eligibility criteria and do not have certain exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of exenatide and glimepiride in patients with specific inclusion and exclusion criteria, including HbA1c levels and BMI.",
    "This phase 3 trial is testing the efficacy of fluticasone furoate/gw642444 inhalation powder in treating chronic obstructive pulmonary disease (COPD) in patients who are at least 40 years old, have a history of smoking, and have a post-albuterol/salbutamol FEV1/FVC ratio of \u22640.70 and a post-albuterol/salbutamol FEV1 \u2264 70% of predicted normal values, among other inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for the drug paliperidone er in patients with schizophrenia, with inclusion and exclusion criteria listed, and the diseases are schizophrenia, schizophrenic disorders, psychotic disorders, and dementia praecox, with corresponding icd-10 codes.",
    "This phase 3 trial is testing the effectiveness of palonosetron and granisetron hydrochloride in treating chemotherapy-induced nausea and vomiting in patients with malignant disease who meet specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of ASP1941, in combination with metformin and placebo, in treating patients with type II diabetes mellitus who meet specific inclusion criteria and do not meet any of the exclusion criteria.",
    "The sample is a phase 3 trial for small cell lung carcinoma, testing the efficacy of etoposide + cisplatin and irinotecan + cisplatin, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of fluticasone furoate/vilanterol and tiotropium in treating chronic obstructive pulmonary disease (COPD) in patients with a history of smoking and exacerbation, with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for rheumatoid arthritis patients using DMARDs, with specific inclusion and exclusion criteria, including evidence of erosive disease by x-ray at baseline.",
    "The sample is a phase 3 trial for bipolar disorder, testing the efficacy of placebo and geodon (ziprasidone) with specific inclusion and exclusion criteria, and using a structured Mini International Neuropsychiatric Interview (MINI) to confirm diagnosis.",
    "This phase 3 trial is testing the efficacy of 5-mg desloratadine and placebo tablet in treating persistent allergic rhinitis, with eligibility criteria including a 2-year history of symptoms and a positive skin-prick test to relevant allergens.",
    "This phase 3 trial is testing the efficacy of docetaxel, 5-fluorouracil, doxorubicin, and cyclophosphamide in operable breast cancer patients with negative axillary lymph nodes and high risk criteria according to St. Gallen consensus criteria.",
    "The sample is a phase 3 trial for small cell lung cancer, testing the efficacy of carboplatin, etoposide & thalidomide and carboplatin, etoposide & placebo, with eligibility criteria including confirmed diagnosis, ECOG performance status, and renal function.",
    "The sample is a phase 3 trial for follicular lymphoma patients who have achieved complete or partial remission after first-line induction therapy including rituximab, and the trial will test the efficacy of rituximab in treating the disease.",
    "The sample is a phase 3 trial for patients with colorectal cancer and neurotoxicity, testing the efficacy of adjuvant treatment with FOLFOX chemotherapy regimens, comprising leucovorin calcium, fluorouracil, and oxaliplatin, along with calcium gluconate and magnesium sulfate, with eligibility criteria including confirmed adenocarcinoma of the colon or rectum, curative resection for stage II or III disease, and various patient characteristics and prior concurrent therapy restrictions.",
    "The sample is a phase 3 trial for hypertension using telmisartan 80 mg + hydrochlorothiazide 25 mg, with inclusion criteria including essential hypertension and inadequate blood pressure control on current medication, and exclusion criteria including severe hepatic or renal impairment and previous symptoms of angioedema after ACE inhibitors or angiotensin-II receptor antagonists.",
    "The sample is a phase 3 trial for non-Hodgkin lymphoma, testing the efficacy of multiple drugs including pixantrone, cyclophosphamide, and rituximab, with eligibility criteria including relapse after 2 or more prior regimens of chemotherapy and adequate hematologic, renal, and hepatic function.",
    "The sample is a phase 3 trial for tiotropium in patients with chronic obstructive pulmonary disease (COPD) who meet specific eligibility criteria, including moderate to severe airway obstruction, smoking history, and history of exacerbation, with the goal of improving lung function.",
    "The sample is a phase 3 trial for newly diagnosed advanced anaplastic large cell lymphoma, using a combination of doxorubicin hydrochloride, mercaptopurine, methotrexate, prednisone, vinblastine sulfate, and vincristine sulfate, with specific eligibility criteria for patients.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of linagliptin compared to placebo, with specific inclusion and exclusion criteria, and a list of diseases and icd-10 codes.",
    "The sample is a phase 3 trial for hypertension, testing the effectiveness of carvedilol phosphate modified release formulation and metoprolol succinate, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing chemotherapy, exemestane, tamoxifen, and triptorelin in premenopausal women with estrogen and/or progesterone receptor positive breast cancer who have undergone surgery within the past 12 weeks and have no known clinical residual locoregional disease.",
    "This phase 3 trial is testing the efficacy of apremilast 20mg and 30mg compared to placebo in treating psoriatic arthritis in patients who have been inadequately treated by DMARDs, with inclusion criteria including a diagnosis of PsA of \u2265 6 months duration and meeting the CASPAR criteria for PsA at time of screening.",
    "This phase 3 trial is testing the efficacy of two drugs, fluticasone furoate 100mcg/vilanterol 25mcg and fluticaosne propionate 500mcg/salmeterol 50mcg, in treating chronic obstructive pulmonary disease (COPD) in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "The sample is a phase 3 trial for patients with type 1 diabetes, testing the efficacy of human insulin inhalation powder, injectable insulin, and insulin glargine, with specific inclusion and exclusion criteria.",
    "This is a phase 3 clinical trial for patients with gastrointestinal stromal tumor who have undergone 6-12 months of treatment with imatinib mesylate and have surgically resectable residual disease, testing the efficacy of imatinib mesylate in achieving complete response, partial response, or stable disease without progression, and assessing patient eligibility criteria including performance status, blood counts, liver function, and medical history.",
    "The sample is a phase 3 trial for hyperlipidemia, testing the efficacy of evolocumab and ezetimibe against a placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the efficacy of ustekinumab and placebo in treating psoriasis, with inclusion criteria including a PASI score of \u226512 and exclusion criteria including a history of tuberculosis infection or malignant tumors.",
    "The sample is a phase 3 trial for graft rejection, using everolimus as the drug, with inclusion criteria including established cardiac allograft vasculopathy and being on statins, and exclusion criteria including serum creatinine value >2.0 mg/dL and recent use of investigational drugs.",
    "The sample is a phase 3 trial for non-Hodgkin's lymphoma using rituximab as a drug, with eligibility criteria including patients who are 5-6 months post an autologous stem cell transplant and are in CR, and exclusion criteria including uncontrolled active infection and severe concomitant medical or psychiatric illness.",
    "The sample is a phase 3 trial for osteoporosis, testing the efficacy of ed-71 and alfacalcidol compared to their placebos, with inclusion criteria based on fragility fractures and bone mineral density, and exclusion criteria including certain disorders and recent use of bone-affecting medications.",
    "This phase 3 trial is testing the efficacy of ezetimibe (+) simvastatin and two comparators, atorvastatin and rosuvastatin, in treating hypercholesterolemia in patients with established CVD, diabetes, or at high risk of CVD, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of capecitabine and lapatinib in treating refractory breast cancer with ErbB2 overexpression, with eligibility criteria including prior treatment with trastuzumab and disease progression following hormonal therapy.",
    "This phase 3 trial is testing the efficacy of ustekinumab, a drug used to reduce interleukin-12 and interleukin-23, in treating psoriatic arthritis, with inclusion criteria including a diagnosis of active PsA and exclusion criteria including the use of any therapeutic agent targeted at reducing IL-12 or IL-23.",
    "The sample is a phase 3 trial for attention deficit hyperactivity disorder, testing the drug atomoxetine, with inclusion criteria of patients aged 12-18 with a diagnosis of ADHD and normal intelligence, and exclusion criteria including severe allergies, drug abuse within the past 3 months, and pregnancy or breastfeeding in female patients.",
    "The sample is a phase 3 trial for basal cell carcinoma using imiquimod as the drug, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with anaplastic astrocytoma or glioblastoma, testing the effectiveness of temozolomide as a treatment, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 3 trial for irritable bowel syndrome with diarrhea, testing the efficacy of rezular and placebo drugs, with specific eligibility criteria including fulfilling Rome III criteria for IBS-D and excluding major cardiovascular disease, psychiatric illness, pregnancy, and other GI diseases.",
    "This phase 3 trial is testing the efficacy of extended-release guanfacine hydrochloride in treating attention-deficit/hyperactivity disorder in adolescents aged 13-17 years, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for ventilator-associated pneumonia, testing the efficacy of doripenem and imipenem-cilastatin compared to placebo, with inclusion criteria including new or worsening radiographic infiltrates and baseline CPIS score of 6 or higher.",
    "The sample is a phase 3 trial for the drug tolvaptan in treating hyponatremia, with inclusion and exclusion criteria listed, and the important values being the disease (hyponatremia) and drug (tolvaptan).",
    "This phase 3 trial is testing the efficacy of rt-pa 0.9 mg/kg verum or placebo intravenous in treating ischemic stroke patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of technosphere insulin and metformin in combination with eligibility criteria including stable metformin regimen and HbA1c levels, while excluding patients with certain medical histories and recent anti-diabetic therapy.",
    "The sample is a phase 3 trial for patients with severe sepsis and hypotension, testing the efficacy of drotrecogin alfa (activated) versus placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the drug temozolomide on patients with unresectable metastatic melanoma and concurrent visceral/soft tissue metastases, with eligibility criteria including no neurological symptoms and specific hematopoietic, hepatic, and renal levels.",
    "This phase 3 trial is testing the efficacy of rebetol (ribavirin) in combination with Pegasys for the treatment of chronic hepatitis C genotype 1, with specific eligibility criteria including liver function tests, prior treatment response, and contraceptive use.",
    "This phase 3 clinical trial is testing the effectiveness of rasburicase and allopurinol in reducing uric acid concentrations in patients with hyperuricemia who are at high risk of malignancy and/or chemotherapy-induced hyperuricemia, and have non-Hodgkin's lymphoma Stage more than III, or acute lymphoblastic leukemia with peripheral with blood cell count more than 25,000/mm3, or any lymphoma or leukemia.",
    "The sample is a phase 3 trial for non-small cell lung cancer, testing the efficacy of erlotinib and placebo drugs, with eligibility criteria including age, disease stage, and previous chemotherapy, and exclusion criteria including unstable systemic disease and other malignancies in the last 5 years.",
    "This phase 3 trial is testing two arms of drugs for the treatment of recurrent and/or metastatic head and neck cancer, with eligibility criteria including confirmed diagnosis, measurable and non-measurable disease, and ECOG performance status of 0 or 1.",
    "This is a phase 3 clinical trial for Alzheimer's disease, testing the effectiveness of dl-alpha-tocopherol, memantine, and placebo drugs, with eligibility criteria including a diagnosis of Alzheimer's disease, presence of a caregiver, and administration of a maintenance dosage of certain drugs for at least 4 weeks prior to randomization.",
    "The sample is a phase 3 trial for breast cancer patients, testing the efficacy of tab premarin and placebo drugs, with inclusion criteria including operable breast cancer and eligibility for adjuvant chemotherapy, and exclusion criteria including a known second cancer.",
    "This is a phase 3 trial for patients with epilepsy and non-controlled partial seizures, testing the efficacy of rufinamide and placebo, with strict inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of valsartan and amlodipine in treating essential hypertension in patients over 55 years old, with strict inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of insulin degludec/insulin aspart in combination with up to 3 oral antidiabetic drugs, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the effectiveness of insulin detemir and insulin nph, with inclusion criteria of HbA1C greater than 7.5% and less than or equal to 11.0% and exclusion criteria of previous acute treatment with insulin for more than 7 days and known hypoglycaemia unawareness or recurrent major hypoglycaemia.",
    "This phase 3 trial is testing the efficacy of GSK1605786A and placebo in treating moderately-to-severely active Crohn's disease, with eligibility criteria including confirmed diagnosis, inadequate response to previous treatments, and specific exclusion criteria such as recent biologic use or chronic narcotic use.",
    "This phase 3 trial is testing the efficacy of albumin interferon alfa-2b, peginterferon alfa-2a, and ribavirin in treating chronic hepatitis C in patients who are treatment na\u00efve and have compensated liver disease, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of ff/gw642444 inhalation powder in treating chronic obstructive pulmonary disease (COPD) in patients who are at least 40 years old, have a history of smoking, and have experienced at least one COPD exacerbation in the past year.",
    "The sample is a phase 3 clinical trial for Alzheimer's disease, testing the efficacy of rivastigmine transdermal patch and placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of tapentadol extended release and placebo in treating painful diabetic peripheral neuropathy, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial will test the efficacy of ciclesonide HFA nasal aerosol and placebo in treating seasonal allergic rhinitis in subjects with a history of SAR to Mountain Cedar, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the effectiveness of abacavir/lamivudine and atazanavir/ritonavir in antiretroviral-na\u00efve patients with HIV-1 infection, who meet specific eligibility criteria, and will continue for 144 weeks if successfully completed.",
    "The sample is a phase 3 trial for patients with locally advanced, recurrent, or metastatic colorectal adenocarcinoma, testing the efficacy of oxaliplatin, leucovorin calcium, capecitabine, and fluorouracil, with eligibility criteria including specific disease characteristics and medical conditions.",
    "The sample is a phase 3 trial for patients with systemic sclerosis and ulcers, testing the efficacy of macitentan 3mg and 10mg versus placebo, with eligibility criteria including age, diagnosis of SSc, and active ischemic digital ulcers, and exclusion criteria including substance abuse, treatment with certain medications, and severe organ failure.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of placebo + pioglitazone and linagliptin + pioglitazone, with eligibility criteria including HbA1c levels and exclusion criteria such as recent myocardial infarction or stroke.",
    "This is a phase 3 trial for chronic hepatitis C virus (HCV) infection, testing the efficacy of eltrombopag and placebo as antiviral therapy, with eligibility criteria including evidence of HCV infection, appropriate candidacy for pegIFN and ribavirin therapy, and platelet count of <75,000/mcL.",
    "This phase 3 trial is testing the efficacy of injectable risperidone or oral antipsychotic drugs in treating bipolar I disorder, with eligibility criteria including a DSM-IV-TR diagnosis of bipolar disorder, age 18-70, and a Young-Mania rating scale total score > 15, among others.",
    "The sample is a phase 3 clinical trial for patients with rheumatoid arthritis who have inadequate response to methotrexate treatment, and will test the efficacy of ofatumumab compared to placebo, with inclusion criteria based on joint inflammation and disease activity measures, and exclusion criteria based on medical history and comorbidities.",
    "The sample is a phase 3 trial for metastatic breast cancer patients undergoing treatment with ixabepilone, calcium gluconate, and magnesium sulfate, with eligibility criteria including no prior exposure to ixabepilone and no more than 2 prior chemotherapy regimens for metastatic disease, and exclusion criteria including pre-existing history of peripheral neuropathy >= grade 2 and concurrent treatment with anticonvulsants, tricyclic antidepressants, or other neuropathic pain medications.",
    "This phase 3 trial is testing the effectiveness of dutasteride and tamsulosin in treating prostatic hyperplasia, with eligibility criteria including age, diagnosis, and various medical factors.",
    "The sample is a phase 3 trial for hyperlipidemia, testing the efficacy of ezetimibe, atorvastatin, rosuvastatin, and simvastatin, with inclusion criteria based on LDL-C levels and exclusion criteria including statin intolerance and uncontrolled hypertension or cardiac arrhythmia.",
    "This phase 3 trial is testing the drug vandetanib on patients with locally advanced or metastatic medullary thyroid cancer, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for the treatment of locally advanced or metastatic prostate cancer using triptorelin (decapeptyl\u00ae) as the drug, with inclusion criteria including confirmed diagnosis of prostate cancer and estimated survival time of at least twelve months.",
    "This is a phase 3 trial for Parkinson's disease, testing the eligibility and exclusion criteria for subjects taking rasagiline mesylate, with a focus on early idiopathic PD of less than 1\u00bd years duration, and excluding subjects with certain medical conditions or previous use of rasagiline or selegiline.",
    "This phase 3 trial is testing the efficacy of cisplatin and docetaxel in combination with surgery for patients with stage IIIA non-small cell lung cancer, with specific eligibility criteria including confirmed primary NSCLC, measurable disease, and no distant metastases, among other requirements.",
    "This phase 3 trial is testing the efficacy of liraglutide versus placebo in treating type 2 diabetes in patients with stable diabetes treatment, with inclusion criteria including HbA1c 7-10%, moderate renal impairment, and BMI 20-45 kg/m^2, and exclusion criteria including impaired liver function, history of chronic pancreatitis, and heart failure.",
    "The sample is a phase 3 trial for obesity using taranabant and placebo as drugs, with inclusion criteria based on BMI and age, and exclusion criteria including psychiatric disorders, neurological disorders, and high blood pressure.",
    "The sample is a phase 3 trial for breakthrough pain in cancer patients using nasal fentanyl as the drug, with specific inclusion criteria such as a minimum of three breakthrough pain episodes per week and previous use of Actiq being accepted.",
    "This is a phase 3 trial for pulmonary hypertension patients with confirmed IPAH or FPAH, testing the efficacy of inhaled iloprost, sildenafil, bosentan, and placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for relapsing-remitting multiple sclerosis, testing bg00012 and glatiramer acetate against placebo, with eligibility criteria including confirmed diagnosis of RRMS, baseline EDSS between 0.0 and 5.0, and exclusion criteria including other chronic diseases of immune system, malignancies, urologic, pulmonary, gastrointestinal disease, and pregnancy or nursing women.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of linagliptin compared to placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of aripiprazole and placebo in treating Tourette's disorder and tic disorder in children and adolescents, with strict inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for erosive esophagitis, testing the efficacy of tak-438, lansoprazole, and placebos, with eligibility criteria including endoscopically confirmed erosive esophagitis of Grade A to D and exclusion criteria including esophagus-related complications and previous or current history of Zollinger-Ellison syndrome.",
    "This phase 3 trial is testing the efficacy of incobotulinumtoxina and placebo in treating cervical dystonia, with specific inclusion and exclusion criteria, and patients must have a clinical diagnosis of cervical dystonia with a need for injection, and be on stable medication for at least 3 months prior to the trial.",
    "The sample is a phase 3 trial for hypertension, testing the efficacy of darusentan and guanfacine, with eligibility criteria including age, blood pressure levels, and adherence to antihypertensive drugs from three different classes.",
    "The sample is a phase 3 trial for type 1 diabetes, testing the daily intranasal administration of insulin in children with genetic risk and specific autoantibodies, with exclusion criteria of severe disease and age above 15 years.",
    "This phase 3 trial is testing the efficacy of topical analgesic and oral intake drugs for treating neuropathic pain in subjects with controlled, treated type 1 or 2 diabetes mellitus or postherpetic neuralgia, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with hemodialysis and hyperphosphatemia, testing the effectiveness of pa21 and sevelamer hydrochloride as phosphate binder agents, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of esmirtazapine versus placebo in treating chronic primary insomnia in patients over 65 years old with specific PSG criteria, and who do not have other sleep disorders or significant medical or psychiatric illnesses.",
    "The sample is a phase 3 trial for venous thrombosis using apixaban and placebo drugs, with inclusion criteria including a clinical diagnosis of DVT or PE and exclusion criteria including indications for long-term treatment with a vitamin K antagonist and active bleeding or high risk for serious bleeding.",
    "The sample is a phase 3 trial for non-small-cell lung cancer patients with no prior chemotherapy, testing the efficacy of docetaxel and gemcitabine, with eligibility criteria including measurable disease, adequate organ function, and informed consent.",
    "The sample is a phase 3 trial for low back pain, testing the efficacy of acetylsalicylic acid, ibuprofen, and placebo, with inclusion criteria for ambulatory patients aged 18-70 with normal blood pressure and exclusion criteria for hypersensitivity to the drugs, serious physical illness, pregnancy or lactation, and substance abuse.",
    "This phase 3 trial aims to test the efficacy of fluticasone propionate and placebo in treating seasonal allergic rhinitis in participants with a positive skin test reaction to mountain cedar pollen, with eligibility criteria including moderate severity of symptoms and geographical residence, while exclusion criteria include nasal disorders and uncontrolled diseases.",
    "The sample is a phase 3 trial for aclidinium bromide and placebo in patients with stable moderate to severe chronic obstructive pulmonary disease (COPD), with inclusion criteria including post-levalbuterol FEV1 >=30% and < 80% predicted and FEV1/FVC<70% predicted, and exclusion criteria including a history of asthma, allergic rhinitis, or atopy, and chronic use of oxygen therapy >= 15 hours a day.",
    "The sample is a phase 3 clinical trial for ocular hypertension and open-angle glaucoma, testing the efficacy of timolol and tafluprost, and a fixed dose combination of tafluprost and timolol, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for transitional cell carcinoma and bladder cancer, using vinflunine and best supportive care as drugs, with specific eligibility criteria for inclusion and exclusion.",
    "This phase 3 trial is testing the efficacy of irinotecan hydrochloride, leucovorin calcium, and fluorouracil in treating metastatic colorectal cancer with specific eligibility criteria, including wild type KRAS and no prior treatment with irinotecan or cetuximab.",
    "The sample is a phase 3 trial for small cell lung cancer, testing the efficacy of intravenous topotecan/cisplatin and intravenous etoposide/cisplatin, with inclusion criteria including evaluable extensive small cell lung cancer and ECOG performance status < 2, and exclusion criteria including prior chemotherapy and concurrent severe medical problems other than small cell lung cancer.",
    "This phase 3 trial is testing the efficacy of lapatinib, capecitabine, and oxaliplatin in treating locally advanced or metastatic gastric, esophageal, or gastro-esophageal junction adenocarcinoma in patients with adequate organ function and cardiac ejection fraction, and who have not had certain prior treatments or have certain medical conditions.",
    "The sample is a phase 3 trial for previously untreated classical Hodgkin's lymphoma, testing a combination of doxorubicin, bleomycin, vinblastine, dacarbazine, vincristine, mechlorethamine, etoposide, prednisone, and cyclophosphamide, with eligibility criteria including measurable or evaluable disease, age of 16 and over, and ECOG Performance status 0-2.",
    "The sample is a phase 3 trial for immune thrombocytopenic purpura, testing the efficacy of dexamethasone and prednisone as drugs, with inclusion criteria including platelet count and age, and exclusion criteria including previous exposure to prednisone and ongoing use of treatments that inhibit platelet function.",
    "The sample is a phase 3 trial for idiopathic pulmonary fibrosis and chronic cough, testing the efficacy of thalidomide and placebo, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for major depressive disorder with inadequate response to one antidepressant, testing the efficacy of tc-5214 compared to placebo, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 clinical trial for ulcerative colitis, testing the effectiveness of mesalazine, with inclusion criteria including confirmed active ulcerative colitis and disease activity at baseline, and exclusion criteria including Crohn's disease and current use of immunosuppressants or corticosteroids.",
    "The sample is a phase 3 trial for contraception, testing flexible, fixed, and standard treatments of ee20/drsp (yaz, bay86-5300) in healthy women who desire contraception and are smokers \u2264 30 years old, with exclusion criteria of contraindication against use of hormonal contraceptives.",
    "The sample is a phase 3 trial for kidney transplantation patients, testing the efficacy of mycophenolate mofetil, anti-IL-2R, methylprednisolone, and cyclosporine as immunosuppressive treatment, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for pancreatic cancer patients who have undergone potentially curative gross resection, and the study will test the efficacy of fluorouracil and gemcitabine hydrochloride as treatment options. The eligibility criteria include specific disease characteristics, patient characteristics, and prior concurrent therapy restrictions.",
    "The sample is a phase 3 trial for bipolar disorder, testing the efficacy of geodon (ziprasidone) and placebo, with inclusion and exclusion criteria based on DSM-IV TR diagnosis and comorbid conditions.",
    "The sample is a phase 3 trial for the drug adalimumab in patients with interstitial cystitis, with inclusion and exclusion criteria listed in the eligibility criteria column.",
    "The sample is a phase 3 trial for non-small-cell lung carcinoma, testing the efficacy of kd019 and erlotinib as treatment options for patients who have failed previous therapy and have no active brain metastasis, with eligibility criteria including no prior use of epidermal growth factor receptor inhibitors and demonstrated progressive disease.",
    "This phase 3 trial is testing the effectiveness of telcagepant and acetaminophen/paracetamol in treating migraine disorders in patients with stable coronary artery disease, with a list of exclusion criteria including age, psychiatric conditions, and malabsorption.",
    "The sample is a phase 3 trial for psoriasis, testing the drugs u0267 and vehicle, with inclusion criteria of mild to moderate plaque-type psoriasis and exclusion criteria including allergies to calcipotriene or vitamin D analogs, history of hypercalcemia or vitamin D toxicity, and use of certain medications or therapies within a certain timeframe.",
    "This phase 3 trial is testing the efficacy of ziprasidone in treating schizophrenia, with inclusion criteria including age 18-65, moderate PANSS positive symptom subscale score, and previous treatment with ziprasidone, while exclusion criteria include significant cardiac disease, abnormal laboratory tests, and substance dependence within the past 12 months.",
    "The sample is a phase 3 trial for chronic kidney disease patients, testing the efficacy of n-acetylcysteine versus placebo, with inclusion criteria including eGFR range, age, no allergies to NAC, no scheduled radio-contrast procedures, and no medications affecting creatinine secretion.",
    "The sample is a phase 3 trial for amyotrophic lateral sclerosis (ALS) testing the efficacy of mci-186 and its placebo, with inclusion and exclusion criteria based on previous drug administration and medical history.",
    "The sample is a phase 3 trial for diffuse large b-cell lymphoma and follicular nhl grade 3b, using rituximab as a drug, with specific eligibility criteria including 4-8 cycles of R-CHOP/like and CR or CRu response, and exclusion criteria such as transformed lymphoma and significant cardiac disease.",
    "The sample is a phase 3 trial for patients with fever and sepsis, testing the effectiveness of paracetamol and dypirone in reducing symptoms, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 3 trial for opioid-induced constipation, testing the drug n-methylnaltrexone bromide, with inclusion criteria including chronic non-malignant pain and opioid use, and exclusion criteria including chronic constipation and other GI disorders.",
    "This phase 3 trial is testing the efficacy of peg interferon plus ribavirin in treating chronic hepatitis C and HIV infections, with specific inclusion and exclusion criteria for patients.",
    "This phase 3 trial is testing the effectiveness of hydrocodone er for chronic pain associated with various conditions, and patients must meet certain inclusion criteria and not have certain exclusion criteria.",
    "The sample is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of paliperidone palmitate, with inclusion and exclusion criteria related to the patient's diagnosis, medication history, and concurrent diseases.",
    "The sample is a phase 3 clinical trial for Alzheimer's disease, testing the efficacy of bapineuzumab and placebo control drugs, with inclusion and exclusion criteria for patients.",
    "The sample is a phase 3 trial for hypertension testing the efficacy of telmisartan and amlodipine or telmisartan, with inclusion criteria of essential hypertensive patients and exclusion criteria of patients with known or suspected secondary hypertension, recent cardiovascular events, and hepatic and/or renal dysfunction.",
    "The sample is a phase 3 trial for dyslipidemia and coronary heart disease using abt-335, simvastatin, and placebo, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for non-small cell lung carcinoma, testing the efficacy of nexavar (sorafenib, bay43-9006) + carboplatin + paclitaxel and carboplatin plus paclitaxel, with specific eligibility criteria and exclusion criteria.",
    "This is a phase 3 trial for patients with histologically confirmed invasive breast cancer, testing the efficacy of cyclophosphamide, docetaxel, epirubicin hydrochloride, and fluorouracil, with eligibility criteria including HER2-negative disease, ECOG performance status 0-2, and no evidence of metastatic disease.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of aripiprazole+ adt and placebo+ adt in patients who have had inadequate response to one to three adequate antidepressant trials, with inclusion criteria of men and women aged 18-65 years old with non-psychotic episodes of MDD lasting at least 8 weeks.",
    "This phase 3 trial is testing the efficacy of insulin lispro protamine suspension and detemir in treating type 2 diabetes mellitus patients who have been on stable doses of oral antihyperglycemic medications for at least 3 months, with inclusion criteria including a hemoglobin A1c between 7.5% and 10.0% and a BMI between 25 and 45 kg/m2.",
    "The sample is a phase 3 trial for bipolar disorder using the drug lamictal, with inclusion criteria including a diagnosis of bipolar I disorder and exclusion criteria including a history of psychosis or rash related to prior lamictal use.",
    "The sample is a phase 3 trial for venous thrombosis, testing the efficacy of enoxaparin, warfarin, and apixaban, with eligibility criteria including a clinical diagnosis of DVT or PE and exclusion criteria including contraindications for enoxaparin or warfarin, active bleeding or high risk for serious bleeding, short life expectancy, significantly impaired kidney or liver function, and uncontrolled high blood pressure.",
    "This phase 3 trial is testing the efficacy of telcagepant and rizatriptan in treating migraine, with a list of inclusion and exclusion criteria provided.",
    "This is a phase 3 clinical trial for ulcerative colitis testing the efficacy of mesalamin, with inclusion criteria including a documented diagnosis of UC and active UC defined by a modified UC-DAI score of 4-10, while exclusion criteria include previous treatment with a mesalazine dose of > 2.0 g/day and treatment with systemic or rectal steroids within 4 weeks prior to randomization.",
    "This phase 3 trial is testing the efficacy of valproate and placebo in treating Alzheimer's disease in patients who meet specific inclusion and exclusion criteria, including age, MMSE score, and absence of certain medical conditions and medications.",
    "The sample is a phase 3 trial for schizophrenia with bifeprunox, placebo, and quetiapine as drugs, and the inclusion criteria require a primary diagnosis of schizophrenia, clinically significant symptoms, stable medication for 8 weeks, and being in the post-acute maintenance phase of the disease.",
    "This is a phase 3 trial for amyotrophic lateral sclerosis, testing the effectiveness of insulin-like growth factor type 1 and placebo drugs, with eligibility criteria including age, residency, disease history, and medical conditions.",
    "This phase 3 trial investigates the effects of Sativex\u00ae on peripheral neuropathic pain in patients who have participated in a previous GW clinical study, with inclusion criteria including tolerability to the study medication, expected clinical benefit, and compliance with study requirements, while exclusion criteria include significant psychiatric or cardiac disorders, hypersensitivity to cannabinoids, impaired renal or hepatic function, and pregnancy or lactation.",
    "This is a phase 3 trial for patients with heterozygous familial hypercholesterolemia and coronary artery disease, testing the efficacy of mipomersen sodium versus placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for HIV infection, testing the efficacy of efavirenz, tenofovir, and abacavir/lamivudine as antiretroviral drugs, with inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for patients with hyperlipidemia, testing the efficacy of ezetimibe (+) simvastatin, with inclusion criteria being voluntary participation and exclusion criteria including hypersensitivity to active ingredients and severe hepatic insufficiency.",
    "The sample is a phase 3 trial for breast cancer patients with overexpression of HER2 receptor, receiving or scheduled to receive neoadjuvant or adjuvant chemotherapy, and using parenteral chemotherapy, with eligibility criteria including adequate organ function, no prior chemotherapy or radiotherapy, and no significant comorbidities.",
    "This phase 3 trial is testing the efficacy of ropinirole XL in treating Parkinson's disease, with specific inclusion and exclusion criteria for eligible subjects.",
    "The sample is a phase 3 trial for patients with relapsed or refractory indolent non-Hodgkin's lymphoma, testing the efficacy of rituximab and pixantrone, with inclusion and exclusion criteria listed, and the diseases are lymphoma, follicular, mixed-cell, small cleaved-cell, and low-grade.",
    "This phase 3 trial is testing the efficacy of cinacalcet versus placebo in treating secondary hyperparathyroidism in chronic kidney disease patients with specific inclusion and exclusion criteria, and the trial involves patients with different icd-10 codes for the diseases.",
    "The sample is a phase 3 trial for Hodgkin's lymphoma patients who have achieved complete response after autologous stem cell transplant and are at risk for relapse, testing the efficacy of panobinostat and placebo as a treatment option.",
    "The sample is a phase 3 trial for hypertension using losartan potassium for 12 weeks, with inclusion criteria of patients treated with specific medications and specific blood pressure ranges, and exclusion criteria of recent myocardial infarction or stroke.",
    "The sample is a phase 3 trial for breast cancer patients with specific disease characteristics and patient characteristics, testing the effectiveness of cyclophosphamide, epirubicin hydrochloride, and fluorouracil drugs, and eligibility criteria for the trial are listed.",
    "The sample is a phase 3 trial for type 2 diabetes using vildagliptin and gliclazide as drugs, with inclusion criteria based on BMI and blood glucose levels, and exclusion criteria including pregnancy, type 1 diabetes, and significant diabetic complications.",
    "The sample is a phase 3 clinical trial for HIV patients testing the efficacy of Stribild, ATV, ritonavir, and FTC/TDF in reducing plasma HIV-1 RNA levels, with eligibility criteria including no prior use of antiretroviral drugs, sensitivity to the drugs, and normal organ function.",
    "The sample is a phase 3 trial for the contraceptive Skyla (levonorgestrel) in nulliparous or parous females under 18 years old with regular menstrual cycles and suitable uterine conditions, with exclusion criteria including pregnancy, recent delivery or abortion, and uterine anomalies.",
    "This is a phase 3 clinical trial for the treatment of schizophrenia with quetiapine fumarate extended-release, with specific inclusion and exclusion criteria for eligible subjects.",
    "The sample is a phase 3 trial testing the efficacy of ambroxol and placebo in treating acute viral pharyngitis, with eligibility criteria including patients between 18 and 65 years old with severe throat pain and no history of acute viral or bacterial pharyngitis in the past 4 weeks.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of linagliptine and pioglitazone, with inclusion and exclusion criteria including informed consent, withdrawal criteria, birth control, alcohol and drug abuse, and other clinical conditions.",
    "The sample is a phase 3 trial for metastatic colorectal cancer, testing the efficacy of FOLFIRI treatment with drugs including 5 fluorouracil, irinotecan, levo-leucovorin, and placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of ranibizumab in treating macular degeneration, with specific inclusion and exclusion criteria for patients, including age, visual acuity, lesion size, and prior treatments.",
    "The sample is a phase 3 clinical trial for the treatment of macular degeneration using ranibizumab, with inclusion and exclusion criteria based on lesion size, age, and prior treatments.",
    "This phase 3 trial is testing the efficacy of preservative-free tafluprost or vehicle and preservative-free timolol maleate in treating primary open-angle glaucoma, pigmentary glaucoma, capsular glaucoma/pseudoexfoliation, or ocular hypertension, with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for patients with confirmed acute symptomatic proximal deep vein thrombosis (DVT) without symptomatic pulmonary embolism (PE), testing the efficacy of rivaroxaban, unfractionated heparin, and warfarin as drugs, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of nva237, tiotropium, flu/sal, and placebos, with inclusion criteria of moderate to severe COPD and a smoking history of at least 10 pack years, and exclusion criteria of asthma, high blood eosinophil count, concomitant pulmonary disease, lung lobectomy or volume reduction, lung transplantation, \u03b1-1 antitrypsin deficiency, and recent live attenuated vaccinations.",
    "The sample is a phase 3 trial for insomnia, testing the efficacy of zolpidem tartrate sublingual tablet and placebo, with inclusion criteria of adults with a history of sleeplessness and exclusion criteria of allergies to the investigational drug or any conditions/medications that may interfere with study drug evaluation.",
    "The sample is a phase 3 trial for patients with myocardial ischemia and acute coronary syndrome, testing the efficacy of eptifibatide (integrilin) versus placebo in reducing symptoms, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for community-acquired pneumonia, testing the effectiveness of prednisone, with inclusion criteria based on clinical and radiological symptoms of pneumonia and exclusion criteria including corticosteroid therapy, pregnancy or lactation, malignancy, immune-compromised patients, and pre-treatment with macrolide for >24 hours.",
    "The sample is a phase 3 trial for the treatment of retinal vein occlusion using ranibizumab, with specific inclusion and exclusion criteria for participants who have completed 12 months in previous trials.",
    "The sample is a phase 3 trial for extended release niacin in patients with type 2 diabetes, chronic kidney disease, hyperlipidemia, and specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD), testing the efficacy of aclidinium bromide compared to placebo, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for HIV infections using lopinavir/ritonavir as the drug, with specific inclusion and exclusion criteria based on age, HIV status, treatment history, and other medical factors.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the drugs phx1149t and placebo, with inclusion criteria including BMI, HbA1c, and age, and exclusion criteria including currently taking 3 or more oral antidiabetic drugs or insulin, and having type 1 diabetes mellitus.",
    "The sample is a phase 3 trial for type 2 diabetes testing the efficacy of dapagliflozin and placebo-matching dapagliflozin in participants with inadequate glycemic control and uncontrolled hypertension, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for non-small cell lung cancer patients, testing the efficacy of bevacizumab and erlotinib hcl against placebo, with eligibility criteria including confirmed NSCLC, progression after first-line chemotherapy, and ECOG performance status of 0-2.",
    "The sample is a phase 3 clinical trial for generalized anxiety disorder, testing the efficacy of placebo, vortioxetine, and duloxetine, with specific inclusion and exclusion criteria for patients.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of ipragliflozin and placebo, with inclusion criteria including HbA1c value between 7.0 and 10.0%, BMI 20.0 - 45.0 kg/m2, and exclusion criteria including type 1 diabetes mellitus and significant renal, hepatic or cardiovascular diseases.",
    "The sample is a phase 3 trial for non-CF bronchiectasis using azli and placebo drugs, with inclusion and exclusion criteria listed, and the disease is identified by icd-10 codes J47.9, Q33.4, J47.1, and J47.0.",
    "The sample is a phase 3 trial for hepatitis C patients using pegylated interferon alpha2a, with specific eligibility criteria including normal liver function and no chronic liver disease, and exclusion criteria such as co-infection with hepatitis B and alcoholism-related liver disease.",
    "This is a phase 3 clinical trial for the drug paliperidone er in treating autism, with specific inclusion and exclusion criteria listed in the eligibility criteria section.",
    "The sample is a phase 3 trial for essential hypertension, testing the efficacy of azilsartan medoxomil and chlorthalidone and olmesartan medoxomil and hydrochlorothiazide, with eligibility criteria including mean sitting clinic systolic blood pressure between 160 and 190 mm Hg and exclusion criteria including a history of drug or alcohol abuse within the past 2 years.",
    "The sample is a phase 3 trial for hypercholesterolemia, testing the efficacy of various doses of atorvastatin and ezetimibe/simvastatin in patients with cholesterol levels of 130 mg/dL or greater, with inclusion and exclusion criteria based on NCEP ATPIII guidelines.",
    "The sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) testing the efficacy of salmeterol 50mcg/fluticasone propionate 500mcg, with inclusion criteria of FEV1 <60% of predicted normal and baseline FEV1/FVC ratio <70%, and exclusion criteria of other respiratory disorders and requirement for long term oxygen therapy.",
    "The sample is a phase 3 trial for colorectal neoplasms, testing the efficacy of cefmetazole and kanamycin/metronidazole in patients undergoing elective laparoscopic colorectal resection, with specific inclusion and exclusion criteria.",
    "This phase 3 trial focuses on renal transplantation and tests the efficacy of enteric-coated mycophenolate sodium and prednisone as drugs, with inclusion criteria of primary donor kidney transplant and PRA \u2264 20%, and exclusion criteria of multi-organ transplantation or non-compatible donor.",
    "The sample is a phase 3 trial for idiopathic Parkinson's disease using rotigotine as the drug, with inclusion criteria being completion of previous trials and exclusion criteria being ongoing serious adverse events related to study medication.",
    "The sample is a phase 3 trial for patients with non-small cell lung cancer and brain metastases, testing the drug lonafarnib (sarasar) with eligibility criteria including age, performance status, and laboratory values.",
    "The sample is a phase 3 trial for fibromyalgia, testing the efficacy of pregabalin and placebo, with inclusion criteria based on ACR criteria and pain scores, and exclusion criteria for other severe pain conditions, severe depression, and excluded medications.",
    "The sample is a phase 3 trial for psoriasis, testing the efficacy of infliximab and placebo, with specific eligibility criteria including body weight, duration and severity of psoriasis, and previous treatments.",
    "The sample is a phase 3 trial for open-angle glaucoma, testing the drug memantine, with inclusion criteria of glaucoma damage on examination of visual field and optic disc and good visual acuity.",
    "The sample is a phase 3 trial for Parkinson's disease, testing the efficacy of rasagiline mesylate and placebo, with inclusion criteria including confirmed diagnosis of PD and age 35 or older, and exclusion criteria including unstable systemic medical problems or clinically significant malignancy.",
    "The sample is a phase 3 trial for psoriasis patients testing the efficacy of etanercept and placebo drugs, with eligibility criteria including not receiving certain psoriasis medications during the study.",
    "This phase 3 trial is testing the efficacy of brivaracetam, an anti-epileptic drug, in patients with well-characterized epilepsy who have discontinued levetiracetam due to nonpsychotic behavioral side effects, and are currently receiving a minimum of 2 and maximum of 3 anti-epileptic drugs including levetiracetam.",
    "This phase 3 trial will test the efficacy of metformin hcl and colesevelam in treating type 2 diabetes mellitus, hypercholesterolemia, and pre-diabetes, with eligibility criteria including age, HbA1C levels, and LDL-C levels, among others.",
    "This is a phase 3 trial for patients with chronic systolic heart failure, using the drug eplerenone, with inclusion criteria including NYHA functional Class II and participation in the double-blind phase of the EMPHASIS-HF trial.",
    "The sample is a phase 3 trial for patients with mild-to-moderate essential hypertension, testing the efficacy of lcz696 and olmesartan compared to placebo, with eligibility criteria including msSBP levels and exclusion criteria including a history of angioedema or secondary forms of hypertension.",
    "This phase 3 trial is testing the efficacy of 21capecitabine + bevacizumab + oxaliplatin and 1capecitabine + oxaliplatin + bevacizumab + cetuximab in treating advanced colorectal cancer patients who are not amenable to curative surgery and meet certain eligibility criteria.",
    "This phase 3 trial will test the efficacy of razadyne and placebo in treating major depression, bipolar depression, and schizoaffective disorder, with eligibility criteria including DSM-IV diagnosis and age range, while exclusion criteria include various medical conditions and substance use disorders.",
    "The sample is a phase 3 trial for osteoporosis testing the efficacy of placebo and denosumab drugs on women aged 60 to 90 years with a BMD T-Score less than -2.5, and exclusion criteria of BMD T-Score less than -4.0 and severe or more than two moderate vertebral fractures on spinal x-ray at entry.",
    "This phase 3 trial is testing the efficacy of sofosbuvir, peg, and rbv in treating chronic genotype 2 or 3 HCV-infection in patients who are naive to all HCV antiviral treatment(s) and have exclusion criteria such as no history of other clinically significant chronic liver disease or decompensated liver disease.",
    "This phase 3 trial will test the efficacy of Berodual\u00ae via Respimat\u00ae and MDI, as well as placebo, in treating bronchial asthma in patients aged 18-65 who meet specific inclusion criteria, while excluding patients with certain diseases or taking certain medications.",
    "This phase 3 trial is testing the efficacy of zoledronic acid, dexamethasone, thalidomide, vincristine, and adriamycin in treating newly diagnosed multiple myeloma patients with specific eligibility criteria.",
    "This phase 3 trial is testing the safety and efficacy of perampanel in male and female subjects with idiopathic Parkinson's disease who have completed the core efficacy study, with specific inclusion and exclusion criteria, and excludes patients on pergolide or cabergoline.",
    "The sample is a phase 3 trial for juvenile idiopathic arthritis, testing the efficacy of tocilizumab, methotrexate, corticosteroids, and NSAIDs, with specific inclusion and exclusion criteria, and the presence of certain icd-10 codes.",
    "This is a phase 3 trial for patients with essential hypertension, testing the effectiveness of olmesartan, placebo, and lcz696 drugs, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of triamcinolone, a glucocorticoid, in treating perennial allergic rhinitis in children aged 2-5 years with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for allergic rhinitis, testing the efficacy of mometasone furoate nasal spray and placebo nasal spray, with inclusion criteria including a positive skin prick test response to an appropriate seasonal allergen and exclusion criteria including a history of severe local reaction(s) or anaphylaxis to skin testing and participation in any other clinical study.",
    "This phase 3 trial is testing the effectiveness of hypertonic saline and terlipressin and normal saline and norepinephrine in treating septic shock and sepsis-associated hypotension, with specific inclusion and exclusion criteria for patients.",
    "This phase 3 trial is testing the efficacy of Sativex\u00ae and placebo in treating lower limb spasticity in patients with Secondary-Progressive or Primary-Progressive Multiple Sclerosis who have been relapse-free for at least 3 months, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of opc-34712 + adt and placebo + adt in treating major depressive disorder with inadequate response to no more than three adequate antidepressant treatments, with a focus on patients between 18 and 65 years of age.",
    "This phase 3 trial is testing the efficacy of patiromer, a drug used to treat hyperkalemia, in patients with chronic kidney disease and hyperkalemia who are taking ACE inhibitors, ARBs, or aldosterone antagonists, and the trial has specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for megestrol acetate in patients with hepatocellular carcinoma who are not amenable to surgery, with specific eligibility criteria including diagnosis of HCC, ECOG 0-3 performance status, and no prior chemoembolization or systemic chemotherapy for HCC.",
    "This is a phase 3 trial for the treatment of overactive bladder with the drugs ym178, placebo, and tolterodine er, with eligibility criteria including symptoms of overactive bladder for at least 12 weeks, an average frequency of micturition of 8 or more times per 24-hour period, and an average episode of urgency or urge incontinence of one or more times per 24-hours period.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin phosphate, pioglitazone hydrochloride, and metformin, with eligibility criteria including A1c levels and exclusion criteria including previous treatment with certain medications and active liver disease.",
    "This phase 3 trial is testing the efficacy of cisplatin in treating head and neck cancer, mucositis, pain, and radiation toxicity, with eligibility criteria including a histologically proven diagnosis of squamous cell carcinoma and Zubrod Performance Status 0-1.",
    "This is a phase 3 trial for multiple sclerosis, relapsing-remitting, testing the efficacy of natalizumab and placebo, with inclusion criteria including a diagnosis of MS, age between 18 and 50, and a baseline EDSS score between 0.0 and 5.0.",
    "This phase 3 trial is testing the efficacy of aripiprazole as an adjunctive treatment for bipolar disorder mania, with lithium or valproate, and includes inclusion and exclusion criteria such as therapeutic serum levels of lithium or valproate, and exclusion of patients with a diagnosis of delirium, dementia, or other cognitive or psychotic disorders. The trial will also include a placebo and valproate as comparator drugs.",
    "The sample is a phase 3 trial for obesity, testing the drugs taranabant and placebo, with inclusion criteria for obese patients with a BMI between 30-43 kg/m2 and exclusion criteria for serious or unstable medical conditions.",
    "This phase 3 trial is testing the efficacy of bibw 2992 and investigator's choice of chemotherapy in patients with non-small-cell lung carcinoma who have failed treatment with erlotinib or gefitinib, and have received at least one line of cytotoxic chemotherapy, with eligibility criteria including Eastern Cooperative Oncology Group performance Score 0 or 1, and exclusion criteria including pre-existing or current interstitial lung disease and peripheral polyneuropathy of > Grade 2.",
    "The sample is a phase 3 trial for chronic constipation, testing the efficacy of linaclotide and a matching placebo, with inclusion and exclusion criteria listed.",
    "This is a phase 3 clinical trial for Crohn's disease testing the effectiveness of budesonide and mesalazine, with specific inclusion and exclusion criteria for patients.",
    "The sample is a phase 3 trial for osteoporosis with denosumab, placebo, and alendronate sodium hydrate as drugs, and the eligibility criteria includes involutional osteoporosis with prevalent fragility vertebral fractures.",
    "This phase 3 trial is testing the efficacy of olanzapine and paliperidone er in treating patients with schizophrenia who meet specific inclusion criteria, including having a PANSS total score of 60 to 100, while excluding those who have previously been treated with these drugs or have abnormal fasting plasma glucose or triglyceride levels.",
    "This phase 3 trial is testing the efficacy of tivantinib and erlotinib, along with a placebo, in treating non-squamous, non-small-cell lung cancer patients who have received one or two prior lines of systemic anti-cancer therapy, and have measurable disease and documented disease progression following last prior therapy according to Response Evaluation Criteria in Solid Tumors (RECIST) criteria, Version 1.1.",
    "The sample is a phase 3 clinical trial for mesothelioma and lung cancer patients, testing the effectiveness of vorinostat and placebo drugs, with specific eligibility criteria including prior chemotherapy regimens and Karnofsky performance scale status.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of indacaterol, tiotropium, and placebo, with inclusion criteria including a smoking history of at least 10 pack years and post-bronchodilator FEV1 <80% and \u226550% of the predicted normal value, and exclusion criteria including any corticosteroid use for 3 months prior to screening.",
    "This phase 3 trial is testing the efficacy of aripiprazole 5mg and 2mg compared to placebo in treating major depressive disorder in patients who have had an inadequate response to at least one and no more than three adequate antidepressant treatments, with strict inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for acute heart failure, testing the drug tezosentan, with inclusion criteria including dyspnea at rest and elevated BNP or N terminal pro-BNP, and exclusion criteria including ongoing myocardial ischemia and concomitant treatment with cyclosporin A or tacrolimus.",
    "The sample is a phase 3 clinical trial for schizophrenia, testing the efficacy of iloperidone, an active comparator, and placebo, with inclusion criteria of subjects with schizophrenia and exclusion criteria of significant heart, kidney, liver, or gastrointestinal disease or other psychiatric disorders.",
    "The sample is a phase 3 clinical trial for major depressive disorder, testing the efficacy of tc-5214 and placebo in patients with inadequate response to one antidepressant, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for grass pollen-related allergic rhinoconjunctivitis in children aged 5 to 17 years, using 300 ir grass pollen allergen extract tablet and placebo tablet as drugs, with inclusion criteria including sensitization to grass pollen and a total symptom score of at least 12 during the previous pollen season, and exclusion criteria including previous desensitization treatment for grass pollen.",
    "This phase 3 trial is testing the efficacy of mfns and antibiotic versus matching placebo nasal spray plus antibiotic in treating acute bacterial sinusitis, with eligibility criteria including radiographic evidence of sinusitis and exclusion criteria including a history of chronic sinusitis or allergy to corticosteroids or penicillins.",
    "The sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) testing the efficacy of olodaterol and tiotropium inhalers versus placebos, with inclusion and exclusion criteria including age, smoking history, and other medical conditions.",
    "This is a phase 3 trial for gastroesophageal reflux disease, testing the efficacy of sodium alginate double action tablets and placebo, with inclusion criteria based on frequency and severity of heartburn symptoms, and exclusion criteria including other gastrointestinal diseases and recent use of certain medications.",
    "The sample is a phase 3 trial for metastatic melanoma using elesclomol and paclitaxel, with inclusion and exclusion criteria listed, and disease identified by icd-10 codes.",
    "The sample is a phase 3 trial for breast cancer patients with unresectable locally recurrent or metastatic disease, testing the effectiveness of sunitinib malate and taxotere, with inclusion criteria of Her-2 negative tumors and exclusion criteria of contraindication to docetaxel or clinical presentation of inflammatory carcinoma with no other measurable disease.",
    "This phase 3 trial is testing the efficacy of 5fu+l-leucovorin and uft+leucovorin in treating colorectal neoplasms with specific eligibility criteria, including tumor location and stage, age, and organ function.",
    "The sample is a phase 3 trial for ankylosing spondylitis, testing the efficacy of meloxicam suppository, meloxicam tablet, and indomethacin, with inclusion criteria of active ankylosing spondylitis and exclusion criteria of none.",
    "The sample is a phase 3 trial testing the efficacy of tak-438 in treating erosive esophagitis, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the drugs observation, gemcitabine, and erlotinib on patients with stage IV non-small cell lung cancer who meet specific eligibility criteria, including having measurable disease and normal hepatic function, while excluding those with small cell lung cancer, prior therapy with EGFR inhibitor, and other specific conditions.",
    "This phase 3 trial is testing the efficacy of telmisartan and hydrochlorothiazide in treating essential hypertension in patients who meet specific eligibility criteria, while excluding patients with certain medical conditions or taking certain medications.",
    "This phase 3 trial is testing the efficacy of oral treprostinil sustained release tablets in treating pulmonary hypertension, with specific inclusion and exclusion criteria for patients.",
    "The sample is a phase 3 trial for type 1 diabetes mellitus, testing the efficacy of viaject\u2122 and regular human insulin in patients who meet specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of valsartan and irbesartan in treating mild and moderate hypertension in patients undergoing chronic hemodialysis, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes, testing the efficacy of exenatide in patients with specific eligibility criteria, including HbA1c levels and BMI, and exclusion criteria such as recent participation in other studies or use of certain medications.",
    "This phase 3 trial is testing the efficacy of administering ALB or placebo within 5 hours of symptom onset in patients with acute ischemic stroke, with a list of exclusion criteria, and the only drug being tested is saline.",
    "The sample is a phase 3 trial for schizophrenia in Chinese subjects, testing the efficacy of intramuscular ziprasidone mesylate and haloperidol, with inclusion criteria based on ICD-10 criteria for schizophrenia and exclusion criteria including recent use of investigational agents or antipsychotic medication.",
    "This is a phase 3 clinical trial for cystic fibrosis patients with exocrine pancreatic insufficiency, testing the efficacy of Ultrase\u00ae MT20 versus placebo in improving fecal elastase-1 concentration, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for schizophrenia, testing the effectiveness of asenapine and olanzapine, with inclusion criteria including a diagnosis of schizophrenia and persistent negative symptoms, and exclusion criteria including other psychiatric disorders and unstable medical conditions.",
    "The sample is a phase 3 trial for metastatic castration-resistant prostate cancer, testing the efficacy of prednisone, sunitinib, and placebo, with eligibility criteria including confirmed adenocarcinoma of the prostate and prior failure of docetaxel chemotherapy.",
    "The sample is a phase 3 trial for advanced liver cancer patients who have progressed during or after sorafenib treatment, testing the efficacy of everolimus and everolimus placebo, with specific eligibility criteria including radiological confirmation of disease progression and intolerance to sorafenib, and exclusion criteria such as prior therapy with mTOR inhibitors and organ transplantation requiring systemic immunosuppression.",
    "This phase 3 trial is testing the efficacy of armodafinil and placebo in treating major depressive episodes in patients with bipolar I disorder, who are taking certain mood stabilizers, and meet specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of vildagliptin and placebo in patients with type 2 diabetes mellitus who are on stable doses of basal or pre-mixed insulin and metformin, with specific inclusion and exclusion criteria.",
    "This phase 3 trial will test the efficacy of rotigotine and placebo in treating restless legs syndrome in patients with end-stage renal disease, who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This phase 3 trial is testing the efficacy of apf530, dexamethasone, and palonosetron hydrochloride in preventing nausea and vomiting in patients with malignant disease undergoing moderately or highly emetogenic chemotherapy, with specific eligibility criteria for disease and patient characteristics, and prior concurrent therapy.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of insulin lispro protamine suspension and insulin glargine in combination with other oral diabetes medications, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial testing the efficacy of osmotic-release methylphenidate and placebo in treating ADHD and smoking, with specific inclusion and exclusion criteria, and the use of icd-10 codes to identify diseases.",
    "This phase 3 trial is testing the efficacy of apremilast, topical treatments, or phototherapy in treating moderate to severe plaque psoriasis, with strict inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for psoriasis, testing the drugs cp-690,550 and placebo/cp-690,550, with inclusion criteria including a PASI score of 12 or greater and exclusion criteria including non-plaque or drug-induced forms of psoriasis.",
    "The sample is a phase 3 trial for chronic pain associated with OA or LBP, testing the efficacy of tramadol hydrochloride plus acetaminophen and placebo, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of divalproex sodium er and placebo in treating bipolar disorder, with specific inclusion and exclusion criteria for subjects.",
    "The sample is a phase 3 trial for chronic kidney disease with proteinuria, testing the effectiveness of losartan potassium, amlodipine besylate, and enalapril maleate, with inclusion criteria of age 1-17 and exclusion criteria of pregnancy, sensitivity to the drugs, and requiring more than 2 medications to control high blood pressure.",
    "This is a phase 3 clinical trial for asthma patients in China, testing the efficacy of fluticasone propionate inhalation solution and budesonide suspension, with eligibility criteria including a documented clinical history of asthma, reversibility of FEV1, and pre-bronchodilator FEV1% predicted between >=40% and <80%.",
    "This phase 3 trial is testing the efficacy of ezetimibe (+) simvastatin, atorvastatin calcium, and placebo in treating hypercholesterolemia and metabolic syndrome in patients at high risk for coronary heart disease, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for chronic hepatitis C patients, testing the efficacy of irbesartan and placebo, with inclusion criteria including age, liver biopsy results, and past antiviral treatment response, and exclusion criteria including hepatocellular carcinoma, HIV, and cirrhosis.",
    "This phase 3 trial aims to test the efficacy of MCI-196 and placebo in treating hyperphosphatemia in patients with chronic kidney disease undergoing regular dialysis treatment, with eligibility criteria including stable phosphate control using calcium-based phosphate-binding medication only and a negative serum pregnancy test for sexually active females.",
    "The sample is a phase 3 trial testing the efficacy of budesonide and placebo in treating active, mild to moderate ulcerative proctitis and proctosigmoiditis, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of darusentan and darusentan placebo in treating hypertension in subjects who are receiving and adhering to full doses of appropriate guideline-recommended antihypertensive drugs from three different classes of antihypertensive agents, including a diuretic, and meet certain inclusion criteria, while excluding those with certain medical conditions or who have participated in a clinical study involving another investigational drug or device within 4 weeks prior to Screening.",
    "The sample is a phase 3 trial for congestive heart failure, testing the efficacy of candesartan and placebo, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for the treatment of rheumatoid arthritis using the drug CP-690,550, with inclusion criteria being completion of a qualifying study and exclusion criteria being serious medical conditions that could make treatment unsafe. The diseases are specified as rheumatoid arthritis and the icd-10 codes are provided.",
    "The sample is a phase 3 trial for the treatment of pharyngitis using placebo and flurbiprofen, with eligibility criteria including a complaint of sore throat and exclusion criteria including a history of upper gastrointestinal ulcer or chronic analgesic use.",
    "This phase 3 trial aims to evaluate the effectiveness of pilocarpine hydrochloride and placebo in treating dry mouth caused by opioids, with eligibility criteria including age over 16, fluent in English or French, and not having certain medical conditions such as Sjogren's syndrome or acute iritis.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin phosphate (+) metformin hydrochloride and comparing it to pioglitazone, with eligibility criteria including inadequate control and no prior treatment with insulin or oral antihyperglycemic therapy.",
    "This phase 3 trial is testing the efficacy of tipranavir and ritonavir, along with an optimized background regimen, in treating HIV infections in treatment-experienced patients with resistance to more than one protease inhibitor.",
    "The sample is a phase 3 trial for fibromyalgia, testing the efficacy of [s,s]-reboxetine and placebo, with inclusion criteria based on ACR criteria for fibromyalgia and exclusion criteria including other severe pain, autoimmune rheumatic disorder, and major depressive disorder.",
    "The sample is a phase 3 clinical trial for ovarian and fallopian tube cancer patients with measurable disease or relapse, testing the efficacy of pegylated liposomal doxorubicin, carboplatin, and paclitaxel, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for patients with type 1 diabetes mellitus, testing the efficacy of insulin glargine new formulation and insulin glargine (lantus), with eligibility criteria including stable insulin dose and exclusion criteria including severe hypoglycemia and unstable diabetic retinopathy.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of saxagliptin and placebo, with inclusion criteria of drug-naive patients with HbA1c levels between 7.2% and 10.0%, and exclusion criteria of insulin therapy within one year and type 1 diabetes.",
    "The sample is a phase 3 trial for patients with primary open angle glaucoma or ocular hypertension, testing the efficacy of latanoprost 0.005% / timolol 0.5% fixed combination as a replacement for ophthalmic beta-blockers, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus and non-insulin-dependent diabetes, testing the efficacy of sitagliptin, glimepiride, and open-label metformin, with eligibility criteria including age, diagnosis, and stable metformin dose, and exclusion criteria including certain medical conditions and pregnancy.",
    "The sample is a phase 3 trial for major depressive disorder using duloxetine as the drug, with inclusion criteria of being diagnosed with major depressive disorder and exclusion criteria of having a serious medical illness or a history of alcohol or drug dependence or abuse within the past 6 months.",
    "The sample is a phase 3 trial for fibromyalgia, testing the efficacy of pregabalin and placebo, with inclusion criteria based on ACR criteria and a Visual Analog Scale score, and exclusion criteria excluding patients with other musculoskeletal disorders, rheumatic diseases, infections, or untreated endocrine disorders.",
    "The sample is a phase 3 trial for chronic HCV-1b infected patients with non-responder to Interferon plus Ribavirin therapy, testing the efficacy of bms-790052 (daclatasvir) and bms-650032 (asunaprevir) drugs, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with schizophrenia, testing the efficacy of aripiprazole, olanzapine, quetiapine, or risperidone, with inclusion criteria of clinical diagnosis of schizophrenia and poorly controlled symptoms or intolerance to antipsychotic medication, and exclusion criteria of schizoaffective disorder or treatment-resistant patients.",
    "The sample is a phase 3 trial for hypertension using the drug valsartan+amlodipine, with inclusion criteria of successful completion of a core trial and specific blood pressure measurements, and exclusion criteria of previous serious drug-related adverse events and other protocol-defined criteria.",
    "This phase 3 trial is testing the efficacy of vilazodone, a selective serotonin reuptake inhibitor, in treating major depressive disorder, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 clinical trial for previously untreated multiple myeloma patients, testing the efficacy of thalidomide, dexamethasone, and doxil, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for lung transplantation patients, testing the use of everolimus and mycophenolatmofetil as immunosuppressive agents, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for restless legs syndrome, testing the efficacy of pramipexole and levodopa in combination with benserazide, with inclusion criteria including patients diagnosed with idiopathic restless legs syndrome and exclusion criteria including patients with known hypersensitivity or contraindications to the study medications.",
    "This phase 3 trial is testing the efficacy of pazopanib and sunitinib in treating advanced or metastatic renal cell carcinoma with clear-cell component histology, and includes eligibility criteria such as no prior systemic therapy and measurable disease by CT or MRI.",
    "The sample is a phase 3 trial for juvenile idiopathic arthritis, testing infliximab plus methotrexate, combination of dmards, and methotrexate alone, with inclusion criteria including arthritis lasting for at least 6 weeks but not more than 6 months and polyarticular disease with at least 5 active joints with at least 3 joints with pain or tenderness and limitation of motion.",
    "The sample is a phase 3 trial for rheumatoid arthritis patients who have not responded to DMARDs or biological agents, and will test the efficacy of methotrexate and rituximab, with inclusion criteria including a positive rheumatoid factor and exclusion criteria including previous cell-depleting therapy.",
    "The sample is a phase 3 trial for smallpox vaccine cj-50300, with eligibility criteria including being born before 1979, having been vaccinated with smallpox vaccines, and not having immunodeficiency or skin conditions, among others.",
    "This phase 3 trial is testing the efficacy of alogliptin and pioglitazone, along with a placebo, in treating type 2 diabetes mellitus patients who have failed treatment with diet and exercise, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of ranibizumab in treating visual impairment caused by macular edema secondary to retinal vein occlusion, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 clinical trial is testing the efficacy of aflibercept, placebo, docetaxel, and dexamethasone in treating locally advanced or metastatic non-small cell lung cancer patients who have progressed after one prior platinum-based therapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for arthritis, rheumatoid in Japanese patients, testing the efficacy of etanercept and methotrexate, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for schizophrenia with olanzapine and asenapine as drugs, and the eligibility criteria includes completing a short-term trial, meeting demographic and procedural inclusion criteria, and demonstrating compliance with trial medication.",
    "This phase 3 trial is testing the effectiveness of valsartan + amlodipine in treating moderate to severe hypertension, with a list of exclusion criteria including history of allergies, autoimmune diseases, kidney impairment, and more.",
    "This phase 3 trial is testing the efficacy of carboplatin and paclitaxel in treating stage IIIA or IIIB non-small cell lung cancer patients who are considered unresectable or inoperable, with specific eligibility criteria including measurable or evaluable disease, Zubrod Performance Status 0-1, and normal or adequate bone marrow, liver, and kidney function.",
    "The sample is a phase 3 trial for plaque psoriasis, testing the efficacy of methotrexate and placebo to methotrexate, with eligibility criteria including failed response to topical therapy, need for systemic treatment, and stable plaque psoriasis for at least 2 months prior to baseline.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of exenatide and premixed insulin aspart in patients with specific eligibility criteria, including HbA1c between 6.5% and 10.0%, BMI between 25 kg/m^2 and 40 kg/m^2, and exclusion criteria such as type 1 diabetes and previous use of weight loss drugs.",
    "This phase 3 trial is testing the efficacy of liraglutide, a GLP-1 analogue, in treating inadequate glycemic control in patients with type 2 diabetes mellitus who are currently taking metformin, TZD, SU, or any combination of these oral antidiabetic medications, and have a BMI between 20-45 kg/m2, fasting C-peptide >/=0.8 ng/mL, and HbA1c between 7.0% and 10.0%, inclusive.",
    "The sample is a phase 3 trial for melanoma and neoplasm metastasis, testing the drugs pegintron and intron a, with eligibility criteria including histologically proven cutaneous melanoma and absence of clinically detectable regional node metastasis.",
    "The sample is a phase 3 trial for advanced hepatocellular carcinoma testing the efficacy of sorafenib and placebo, with inclusion and exclusion criteria listed, and the diseases are specified as carcinoma, hepatocellular with corresponding icd-10 codes.",
    "This phase 3 trial is testing the efficacy of pn 200 tablets (500 mg naproxen and 20 mg omeprazole) and naproxen 500 mg tablets (pn 200 minus omeprazole) in treating osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis, with eligibility criteria including a history of a documented, uncomplicated gastric or duodenal ulcer within the past 5 years or being 50 years of age and older.",
    "This phase 3 trial is testing the efficacy of fentanyl buccal tablets compared with immediate-release oxycodone for chronic pain associated with various diseases, and requires patients to meet specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for chronic hepatitis C, testing the efficacy of drugs sof, rbv, and placebos, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 3 trial for patients with stage IIIB or IV non-small cell lung cancer, testing the efficacy of tariquidar + vinorelbine versus placebo + vinorelbine, with eligibility criteria including age, performance status, and laboratory values.",
    "The sample is a phase 3 trial for chronic hepatitis B patients with entecavir and pegylated interferon \u03b1-2a sequential treatment group and pegylated interferon \u03b1-2a monotreatment group, testing eligibility criteria for patients with HBeAg positive, HBsAg positive, HBV DNA > 100,000 copies/ml and anti-HBs negative, serum ALT exceeding 2 X ULN but less than 10 X ULN.",
    "The sample is a phase 3 trial for rheumatoid arthritis patients treated with cnto 148, placebo, and methotrexate, with inclusion criteria based on ACR classification and joint count, and exclusion criteria based on hypersensitivity, other diseases, and severe organ dysfunction.",
    "This phase 3 trial is testing the efficacy of mp29-02, azelastine hcl, and fluticasone propionate in treating moderate to severe seasonal allergic rhinitis, with a positive skin test to a prevalent Texas Mountain Cedar allergen as an inclusion criteria, and various exclusion criteria including hypersensitivity to the drugs, respiratory tract infections, and significant pulmonary disease.",
    "This phase 3 trial is testing the effectiveness of hydrochlorothiazide (+) losartan potassium, losartan potassium, and placebos for hypertension in patients aged 6 to 17 years old, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 clinical trial for multiple myeloma patients who have received prior treatment regimens, including chemotherapy, bone marrow transplantation, and biologic therapy, and are eligible based on specific disease and patient characteristics. The trial will test the efficacy of a combination of drugs including cisplatin, cyclophosphamide, dexamethasone, etoposide, and thalidomide.",
    "This phase 3 trial will test the efficacy of tibolone and placebo in reducing vasomotor symptoms in women with surgically treated invasive breast carcinoma and climacteric symptoms, who meet the eligibility criteria, and have no exclusion criteria.",
    "This phase 3 trial is testing the efficacy of three drugs, including placebo and acurox, for pain management in patients undergoing bunionectomy surgery, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for patients with bipolar I disorder, testing the efficacy of cariprazine and placebo, with inclusion and exclusion criteria specified, and icd-10 codes provided for the diseases.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of antidepressant + placebo and antidepressant + aripiprazole in patients who have had an inadequate response to at least one and no more than three antidepressants, with inclusion criteria of men and women aged 18-65 who have experienced a current episode of MDD lasting at least 8 weeks.",
    "This phase 3 trial is testing the efficacy of carboplatin, paclitaxel, and sorafenib tosylate in treating patients with metastatic or unresectable mucosal or cutaneous melanoma, with specific eligibility criteria including prior therapy and performance status.",
    "The sample is a phase 3 trial for the treatment of post-traumatic stress disorder in children using Zoloft (sertraline) and includes eligibility criteria based on age and diagnosis, as well as exclusion criteria related to ongoing trauma and re-exposure risk.",
    "The sample is a phase 3 trial testing the efficacy of liraglutide and placebo in treating obesity in patients with certain co-morbidities, with a list of inclusion and exclusion criteria, and the diseases are metabolism and nutrition disorder and obesity with corresponding icd-10 codes.",
    "The sample is a phase 3 trial for HIV-positive and HCV-positive patients using Kaletra tablets, with eligibility criteria including undetectable viral load, normal AST and ALT levels, and a Karnofsky Score of 70 or greater.",
    "The sample is a phase 3 trial for chronic renal anemia, testing the efficacy of methoxy polyethylene glycol-epoetin beta and epoetin alfa, with inclusion criteria including regular hemodialysis and maintenance therapy with epoetin alfa, and exclusion criteria including recent transfusion of red blood cells and active malignant disease.",
    "This phase 3 trial is testing the efficacy of a combination therapy including metformin, pioglitazone, and alogliptin in inadequately controlled type 2 diabetes mellitus patients with specific eligibility criteria.",
    "This phase 3 trial aims to test the efficacy of lopinavir/ritonavir and lamivudine in preventing mother-to-child transmission of HIV in breastfed infants, with specific inclusion and exclusion criteria for both mother and infant.",
    "The sample is a phase 3 trial for HIV and infectious diseases, testing the efficacy of darunavir and ritonavir drugs, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for high-risk prostate cancer patients using lupron and casodex, with inclusion criteria including PSA levels, CT and bone scan results, and no prior radiation or androgen deprivation therapy.",
    "This phase 3 trial is testing the efficacy of asparaginase, daunorubicin hydrochloride, cytarabine, thioguanine, and etoposide in treating childhood acute myeloid leukemia and other myeloid malignancies, with specific eligibility criteria for patients including diagnosis of myelodysplastic syndromes or acute myeloid leukemia, and meeting certain medical criteria such as shortening fraction and bilirubin levels.",
    "This is a phase 3 trial for rheumatoid arthritis testing the efficacy of mr prednisone and placebo, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for prostate cancer patients with inclusion criteria including baseline testosterone >1.5 ng/mL and a life expectancy of at least 12 months, and the drugs being tested are degarelix, degarelix, and leuprolide 7.5 mg.",
    "This phase 3 trial is testing the efficacy of MP-513, a drug for type 2 diabetes, compared to placebo, in patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for schizophrenia, testing the efficacy of zicronapine and risperidone, with inclusion criteria based on DSM-IV-TR criteria and PANSS score, and exclusion criteria including recent hospitalization, previous treatment with certain antipsychotics, and substance dependence or abuse.",
    "The sample is a phase 3 trial for uncontrolled asthma, testing the efficacy of a fixed combination of budesonide and formoterol and budesonide, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for hypertension using the drug aliskiren, with eligibility criteria including patients over 65 years old and exclusion criteria including severe hypertension and history of secondary form of hypertension.",
    "This phase 3 trial is testing the efficacy of dexamethasone, doxorubicin hydrochloride, valspodar, and vincristine sulfate in treating multiple myeloma and plasma cell neoplasm, with specific eligibility criteria for patients including prior chemotherapy and adequate organ function.",
    "The sample is a phase 3 clinical trial for patients with non-small-cell lung carcinoma who have failed previous chemotherapy and treatment with erlotinib or gefitinib, and will test the efficacy of placebo and bibw 2992 as drugs, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of eslicarbazepine acetate, an antiepileptic drug, in patients over 65 years old with a documented diagnosis of epilepsy and at least 2 partial-onset seizures in the 4 weeks prior to screening, while excluding patients with certain medical conditions and those currently taking oxcarbazepine.",
    "The sample is a phase 3 trial testing the efficacy of Ingavirin and placebo oral capsules in preventing influenza, acute respiratory infections, common cold, flu, and viral infections in participants who have had contact with ill persons during the influenza/other acute viral respiratory disease season, with specific inclusion and exclusion criteria.",
    "This phase 3 trial focuses on overactive bladder and includes the drugs tolterodine er, placebo, and fesoterodine, with eligibility criteria including urinary frequency and urgency, and exclusion criteria including contraindications to fesoterodine and previous urinary retention.",
    "This phase 3 trial is testing the efficacy of anamorelin hcl, a drug that increases appetite, in treating cachexia in patients with non-small cell lung cancer who have involuntary weight loss and a BMI of less than 30 kg/m2.",
    "This is a phase 3 trial for osteoporosis treatment with alendronate, where the eligibility criteria includes non-metastatic adenocarcinoma of the prostate, life expectancy of >12 months, and ECOG performance status 0, 1 or 2, while the exclusion criteria includes bone metastases, hypersensitivity to LHRH, and bilateral hip replacement.",
    "This phase 3 trial is testing the efficacy of baclofen/amitriptyline/ketamine gel in reducing neuropathic pain in patients with various types of cancer who have received neurotoxic chemotherapy, and meet specific eligibility criteria.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of roflumilast and placebo drugs on patients meeting specific inclusion and exclusion criteria, including a history of COPD, FEV1/FVC ratio, and treatment with tiotropium.",
    "The sample is a phase 3 trial for erosive esophagitis using tak-438 and lansoprazole as drugs, with inclusion criteria requiring endoscopically confirmed erosive esophagitis of Grade A to D and exclusion criteria including a history of radiotherapy or cryotherapy of the esophagus.",
    "The sample is a phase 3 trial for type 2 diabetes, testing the efficacy of saxagliptin and metformin against placebo, with inclusion criteria of stable metformin dose and HbA1c between 7.0% and 10.0%.",
    "The sample is a phase 3 trial for renal transplantation patients receiving CsA or tacrolimus, testing the efficacy of sirolimus, tacrolimus, and cyclosporine a, with inclusion criteria of age and Nankivell GFR, and exclusion criteria of recent acute rejection or multiple organ transplants.",
    "The sample is a phase 3 trial for hypertension using the drug valsartan/amlodipine, with inclusion criteria for patients with uncomplicated essential hypertension and exclusion criteria for severe hypertension, history of stroke or heart disease, liver/kidney/pancreas disease, insulin dependent diabetes, and allergies to certain medications.",
    "This is a phase 3 trial for patients with non-small cell lung cancer who have failed 1st line anti-cancer therapy, testing the efficacy of vandetanib and pemetrexed, with eligibility criteria including confirmation of locally advanced or metastatic NSCLC, WHO Performance status 0-2, and measurable lesions according to RECIST criteria.",
    "The sample is a phase 3 trial for prostate cancer patients who have decided to undergo a prostatectomy or brachytherapy, testing the effect of vitamin E on the disease, with eligibility criteria including normal organ and marrow function, and exclusion criteria including metastatic prostate cancer and use of certain medications.",
    "This phase 3 trial is testing the efficacy of quetiapine, an antipsychotic drug, on patients with schizophrenia and schizoaffective disorders who meet specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for breast cancer patients with a tumor size of at least 3 cm, using a combination of cyclophosphamide, epirubicin hydrochloride, gemcitabine hydrochloride, and paclitaxel, with eligibility criteria including no evidence of metastatic disease and negative pregnancy test.",
    "The sample is a phase 3 trial for asthma patients, testing the efficacy of fluticasone furoate/gw642444 and fluticasone furoate inhalation powders, with eligibility criteria including a diagnosis of asthma, maintenance therapy for at least 4 weeks prior to screening, and a best FEV1 of at least 50% of the predicted normal value at screening.",
    "The sample is a phase 3 trial for asthma, testing the efficacy of fluticasone furoate/gw642444 and fluticasone propionate, with inclusion criteria including clinical diagnosis of asthma, reversible FEV1, and currently using moderate to high dose inhaled corticosteroid therapy.",
    "This phase 3 trial is testing the efficacy of prucalopride in treating constipation in patients with a history of constipation and specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for impetigo, testing the efficacy of ozenoxacin placebo, retapamulin 1% ointment, and ozenoxacin 1% cream, with inclusion criteria based on affected area and Total Skin Infection Rating Scale score, and exclusion criteria including systemic signs and symptoms of infection.",
    "The sample is a phase 3 trial for fibromyalgia, testing the efficacy of pregabalin and placebo, with inclusion criteria based on ACR criteria and pain scores, and exclusion criteria based on other severe pain, inflammatory diseases, and severe depression.",
    "This phase 3 trial is testing the efficacy of gw685698/gw642444 and cci18781 in treating asthma in Asian outpatients, with specific inclusion and exclusion criteria, including the requirement of using an ICS for at least 12 weeks prior to Visit 1.",
    "This phase 3 trial is testing chemotherapy and bevacizumab in adult patients with metastatic colorectal cancer who have previously been treated with first-line chemotherapy plus Avastin, and have an Eastern Cooperative Oncology Group (ECOG) performance status <=2.",
    "The sample is a phase 3 trial for osteoporosis, vascular calcification, and inflammation, testing the effect of vitamin K intake on bone mineral density, with exclusion criteria including prior treatment for osteoporosis, hyperparathyroidism, and coronary disease, and the drug being tested is vitamin K.",
    "The sample is a phase 3 trial for patients with chronic hepatitis C, genotype 2 or 3, receiving PEGASYS and Copegus, testing the efficacy of peginterferon alfa-2a and ribavirin, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of lithium or lamotrigine in preventing relapse in patients with bipolar disorder who meet specific inclusion and exclusion criteria, including having had at least one manic episode in the last 5 years.",
    "The sample is a phase 3 trial for prostate cancer patients with metastatic disease and hormone-refractory progression, testing the efficacy of doxorubicin hydrochloride and methylprednisolone, with eligibility criteria including performance status, hematopoietic and hepatic function, and no prior primary cancer.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) with the drugs roflumilast and placebo, and the inclusion criteria includes a history of COPD for at least 12 months and a post-bronchodilator FEV1/FVC ratio \u2264 70%.",
    "The sample is a phase 3 trial for bipolar disorder, testing the efficacy of aripiprazole and placebo, with inclusion criteria for child and adolescent patients with bipolar I disorder, manic or mixed episode with or without psychotic features, and exclusion criteria for certain psychological disorders, serious uncontrolled systemic illness, and significant risk of suicide.",
    "This is a phase 3 trial for chronic pain patients, testing the efficacy of tramadol hydrochloride (hcl) plus acetaminophen (jns013) as a treatment option, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial will test the efficacy of pregabalin and placebo in managing postoperative pain in patients undergoing elective open unilateral inguinal herniorraphy, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of pramipexole extended release and immediate release in treating idiopathic Parkinson's disease, with specific inclusion and exclusion criteria for patients.",
    "The sample is a phase 3 trial for asthma patients, testing the efficacy of budesonide/formoterol and budesonide HFA inhalers, with inclusion criteria of African American patients over 12 years old with moderate to severe asthma and exclusion criteria of systemic corticosteroid use or significant diseases, and the trial will use ICD-10 codes J45.998, J82.83, J45.909, J45.991, J45.20, J45.30, and J45.40 to identify patients with asthma.",
    "The sample is a phase 3 trial for obesity, testing the efficacy of lorcaserin and placebo, with inclusion criteria of BMI 30-45 or BMI 27-29.9 with comorbidities, and exclusion criteria of diabetes, pregnancy, heart valve disease, and serious medical conditions.",
    "The sample is a phase 3 clinical trial for head and neck cancer, testing the efficacy of cisplatin, docetaxel, and 5-fluorouracil, with eligibility criteria including confirmed squamous cell carcinoma, measurable or non-measurable disease, and appropriate for definitive radiotherapy with curative intent.",
    "This phase 3 trial is testing the efficacy of technosphere\u00ae insulin with medtone c inhaler, technosphere \u00aeinsulin with gen2 inhaler, and insulin aspart in combination with a basal insulin for patients with type 1 diabetes mellitus who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for psoriasis with the drugs cp-690,550, and the eligibility criteria includes a PASI score of 12 or greater and a PGA score of 3 or 4, while excluding non-plaque or drug induced forms of psoriasis and uncontrolled significant medical conditions.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of placebo, methylprednisolone, methotrexate, and folic acid or folate in patients who have had inadequate response to methotrexate, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of avelox (moxifloxacin) versus placebo in treating chronic bronchitis in patients over 45 years old with a smoking history of at least 20 pack-years, who have had at least two documented acute exacerbation episodes during the last 12 months, and meet other inclusion criteria.",
    "The sample is a phase 3 trial for hypercholesterolemia patients receiving approved cholesterol-lowering medication, testing the efficacy of mk0653a (ezetimibe [+] simvastatin) and other statin comparators, with inclusion criteria of patients over 18 years old admitted to a hospital for a heart problem, and exclusion criteria of patients with CHF, uncontrolled high blood pressure, poorly controlled blood sugar, impaired kidney function, or HIV.",
    "The sample is a phase 3 trial for adults with ADHD, testing the efficacy of methylphenidate hydrochloride, with inclusion and exclusion criteria listed, including a list of icd-10 codes for ADHD.",
    "This is a phase 3 trial for patients with venous thromboembolism, testing the efficacy of dabigatran etexilate and placebo, with eligibility criteria including confirmed symptomatic PE or proximal DVT of the leg(s) and exclusion criteria including active bleeding or high risk for bleeding.",
    "This phase 3 trial is testing a combination of chemotherapy drugs including rituximab, etoposide, and carboplatin for CD20-positive diffuse large B-cell lymphoma patients who have relapsed after first-line treatment and are eligible for transplant, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of saredutant, placebo, and escitalopram, with inclusion and exclusion criteria based on DSM-IV-TR criteria and other factors.",
    "This phase 3 clinical trial is testing the efficacy of dronedarone and amiodarone in cardioversion and antiarrhythmic treatment for patients with atrial fibrillation who are under oral anticoagulation, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with tumor lysis syndrome, cancer, and hyperuricemia, testing the effectiveness of rasburicase and allopurinol as treatment options, with specific eligibility criteria including ECOG performance status, age, and life expectancy.",
    "This phase 3 trial focuses on the effects of drospirenone/ethinylestradiol/methyltetrahydrofolate and drospirenone/ethinylestradiol (yaz) on healthy women between 18 and 40 requesting oral contraception, with the goal of preventing neural tube defects and contraception, while prohibiting the use of steroidal oral contraceptives or any drug that could alter oral contraception metabolism during the study.",
    "This is a phase 3 clinical trial for primary insomnia, testing the efficacy of eszopiclone and placebo drugs, with eligibility criteria including DSM-IV criteria for primary insomnia, age between 21 and 64, and good health based on physical examination and laboratory values.",
    "The sample is a phase 3 trial for hypercholesterolemia, testing the efficacy of lapaquistat acetate and stable statin therapy versus stable statin therapy alone, with inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the efficacy of droxidopa versus placebo in patients with neurogenic orthostatic hypotension, non-diabetic autonomic neuropathy, multiple system atrophy, and dopamine beta hydroxylase deficiency, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of fostamatinib and placebo, with inclusion criteria including active RA and treatment with certain drugs, and exclusion criteria including pregnancy, liver disease, and previous failure to respond to certain treatments.",
    "This is a phase 3 trial for asthma patients using fluticasone furoate/vilanterol inhalation powder, fluticasone propionate/salmeterol inhalation powder, and placebos, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial testing the efficacy of mk-0524a, er niacin, and placebo in treating hypercholesteremia and hyperlipidemia, with specific eligibility criteria for patients based on their lipid levels and risk factors for coronary heart disease.",
    "This phase 3 trial is testing the efficacy of ranibizumab in treating diabetic macular edema, with inclusion criteria including patients with Type 1 or Type 2 diabetes mellitus and visual impairment due to DME, while exclusion criteria include prior treatment with anti-angiogenic drugs and uncontrolled glaucoma.",
    "This phase 3 trial is testing the efficacy of amg 386 and paclitaxel in treating ovarian, peritoneal, and fallopian tube cancers, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of umeclidinium bromide and fluticasone propionate/salmeterol in treating chronic obstructive pulmonary disease (COPD) in patients who meet specific inclusion criteria, including a history of COPD, smoking history, and dyspnea, while excluding those with certain respiratory and other conditions, allergies, and medication use.",
    "The sample is a phase 3 clinical trial for Crohn's disease using the drug adalimumab, with inclusion criteria of moderate to severe Crohn's disease and failed prior infliximab therapy, and exclusion criteria of previous treatment with adalimumab or being considered an unsuitable candidate.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of bi 10773 and glimepiride compared to placebo, with eligibility criteria including pre-treatment with metformin and HbA1c levels between 7.0% and 10%.",
    "This is a phase 3 trial for kidney transplantation with three different drug treatments (fty720 5 mg + reduced-dose neoral (rdn) + corticosteroids, fty720 2.5 mg + full dose neoral (fdn) + corticosteroids, and mmf 2 g + full-dose neoral (fdn) + corticosteroids) and specific eligibility criteria.",
    "The sample is a phase 3 trial for the treatment of vasomotor symptoms in postmenopausal women using desvenlafaxine succinate sustained release and placebo, with inclusion criteria based on menopausal status and exclusion criteria including history of seizure disorder or major psychiatric disorders.",
    "The sample is a phase 3 trial for patients with high-grade gliomas in first relapse, testing the efficacy of carboplatin, etoposide, isotretinoin, and thiotepa, with eligibility criteria including age under 21 at diagnosis, specific performance status and hematopoietic, hepatic, renal, cardiovascular, and pulmonary requirements, and no prior myeloablative chemotherapy or craniospinal radiotherapy.",
    "This phase 3 trial is testing the effectiveness of sodium oxybate in treating narcolepsy, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the efficacy of casopitant, dexamethasone, ondansetron, and placebo in reducing chemotherapy-induced nausea and vomiting in patients with colorectal cancer receiving oxaliplatin-based therapy, with strict inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for major depressive disorder using escitalopram as the drug, with inclusion and exclusion criteria based on DSM-IV diagnostic criteria and medical history.",
    "This phase 3 trial aims to test the effectiveness of ondansetron and cognitive behavioral therapy versus placebo and cognitive behavioral therapy in treating alcohol dependence, with inclusion criteria such as a DSM-IV diagnosis of alcohol dependence and current alcohol consumption of at least 14 units per week for women and 21 units per week for men, and exclusion criteria such as severe alcohol withdrawal symptoms and use of certain medications.",
    "The sample is a phase 3 trial for embolism, testing the efficacy of certoparin and heparin in hospitalized patients with decreased mobility, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of 50mg qhs and 100mg doses of a drug, along with a placebo, in treating premenopausal women with hypoactive sexual desire disorder (HSDD) and other sexual dysfunctions, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial aims to test the efficacy of carboplatin, glutathione, and paclitaxel in treating various stages of fallopian tube, ovarian, and primary peritoneal cancer, with eligibility criteria including negative pregnancy test, adequate blood counts, and absence of pre-existing peripheral neuropathy.",
    "The sample is a phase 3 clinical trial for patients who have undergone HCT and have biopsy-proven Grade I acute GVHD, testing the effectiveness of etanercept (enbrel) in treating acute graft versus host disease.",
    "This phase 3 trial is testing the efficacy of azilsartan medoxomil/placebo and azilsartan medoxomil - chlorthalidone in treating essential hypertension, with eligibility criteria including mean, trough, sitting, clinic systolic blood pressure and exclusion criteria including a history of hypersensitivity or allergies to angiotensin II receptor blockers (ARB) or thiazide-type diuretics or other sulfonamide-derived compounds.",
    "This is a phase 3 trial for patients with hepatitis C virus who previously failed treatment with peginterferon alfa-2a or peginterferon alfa-2b and ribavirin, and will test the efficacy of asunaprevir, daclatasvir, peg-interferon alfa-2a, and ribavirin; the eligibility criteria includes HCV genotype 1 or 4, HCV RNA \u2265 10,000 IU/mL, and exclusion criteria includes prior treatment of HCV with HCV direct acting antiviral (DAA) and evidence of decompensated liver disease.",
    "The sample is a phase 3 trial for metastatic renal cell cancer, testing the efficacy of bevacizumab, interferon alfa 2a, and placebo, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of exenatide once weekly, sitagliptin, pioglitazone, and placebo in treating type 2 diabetes mellitus in patients with specific eligibility criteria, including a stable treatment regimen of metformin and exclusion criteria such as previous exposure to exenatide once weekly and treatment with certain medications.",
    "The sample is a phase 3 trial for the treatment of esophagitis, reflux and peptic, using dexlansoprazole mr and placebo, with eligibility criteria including previous successful completion of a phase 3 study and exclusion criteria including use of certain medications and inability to comply with study requirements.",
    "The sample is a phase 3 trial for postmenopausal women with osteoporosis risk factors, testing the drug bazedoxifene bza-20, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of amoxicillin pulsatile release multiparticulate sprinkle in treating acute tonsillitis and/or pharyngitis in children aged 6 months to 12 years, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of paliperidone palmitate injection and oral antipsychotics in treating schizophrenia in patients who have been diagnosed for 1-5 years, have a history of hospitalization, and are experiencing an acute schizophrenic episode with a PANSS score between 70 and 120, while also meeting various inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for treatment-naive patients with genotype 1 chronic hepatitis C, using ribavirin, telaprevir, and pegylated interferon alfa-2a, with inclusion criteria including HCV RNA level > 1,000 IU/mL and absence of a mass demonstrated by ultrasound, and exclusion criteria including co-infection with HCV of another genotype, pre-existing psychiatric condition, and history of decompensated liver disease.",
    "The sample is a phase 3 trial testing the efficacy of abt-335 and rosuvastatin calcium in treating dyslipidemia and coronary heart disease, with mixed dyslipidemia patients as the inclusion criteria and unstable medical conditions or medications as the exclusion criteria.",
    "The sample is a phase 3 trial for high-risk prostate cancer patients, testing the efficacy of a combination of drugs including bicalutamide, estramustine phosphate sodium, etoposide, flutamide, paclitaxel, and luteinizing hormone releasing hormone agonist, with eligibility criteria including PSA levels, Gleason score, lymph node status, and patient characteristics such as age and performance status.",
    "This phase 3 trial is testing the efficacy of warfarin, dabigatran dose 1, and dabigatran dose 2 in reducing the risk of stroke in patients with non-valvular atrial fibrillation and additional risk factors, while excluding patients with certain medical conditions and those considered unreliable for follow-up.",
    "The sample is a phase 3 trial for the treatment of opioid-induced constipation, testing the efficacy of nktr-118 and placebo in patients with confirmed OIC and stable maintenance opioid regimen, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of eszopiclone in treating insomnia related to major depressive disorder, with specific inclusion and exclusion criteria, and the use of Hamilton-D-17 scale to measure efficacy.",
    "This phase 3 trial is testing the efficacy of various asthma medications, including mometasone furoate and fluticasone/salmeterol, in patients with a diagnosis of asthma of at least 12 months who have been on a stable regimen of medium or high daily doses of ICS for at least 12 weeks prior to screening, and who meet other eligibility criteria.",
    "The sample is a phase 3 clinical trial for primary insomnia, testing the efficacy of eplivanserin and lormetazepam, with inclusion and exclusion criteria listed, and icd-10 codes provided for the disease.",
    "The sample is a phase 3 trial for patients with non-small cell lung cancer, testing the efficacy of erlotinib, sunitinib, and placebo, with inclusion criteria of prior treatment with no more than 2 chemotherapy regimens and exclusion criteria of prior treatment with certain inhibitors and history of brain metastases.",
    "This phase 3 trial will test the efficacy of Sativex versus placebo in treating neuropathic pain due to distal symmetrical diabetic neuropathy in patients with Type 1 or 2 diabetes mellitus, with specific inclusion and exclusion criteria, and a list of prohibited medications and medical conditions.",
    "This is a phase 3 trial for patients with chronic obstructive pulmonary disease, testing the efficacy of tiotropium and salmeterol compared to placebo, with strict inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for epilepsy with the drug Keppra XR, testing eligibility criteria for subjects with inadequately controlled partial onset epilepsy and experiencing 2 to 40 seizures per 4-week period while being maintained on one or two standard AED(s).",
    "This phase 3 trial is testing the efficacy of alogliptin and pioglitazone, alogliptin, and placebo in treating type 2 diabetes mellitus with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for Alzheimer's disease using galantamine hydrobromide as the drug, with inclusion criteria based on diagnosis and MMSE score, and exclusion criteria including various diseases and conditions.",
    "The sample is a phase 3 trial for heartburn treatment using esomeprazole, with inclusion criteria including experiencing heartburn at least 2 days a week and exclusion criteria including a history of erosive esophagitis or GERD diagnosed by a physician.",
    "The sample is a phase 3 trial for bipolar disorder with asenapine, olanzapine, and placebo as drugs, and the eligibility criteria includes having a DSMIV diagnosis of bipolar I disorder, current episode manic or mixed.",
    "This is a phase 3 trial for patients with primary colonic or rectal carcinoma, testing the efficacy of uft, usel/leucovorin, and krestin, with eligibility criteria including histological stage III, lymph node metastasis positive, and performance status 0 to 2.",
    "The sample is a phase 3 trial for a drug called aleglitazar and placebo in patients with type 2 diabetes mellitus who were hospitalized for an ACS event, with inclusion criteria of adults over 18 years of age and exclusion criteria of an estimated glomerular filtration rate less than 45 mL/min/1.73m2, concomitant treatment with a thiazolidinedione and/or fibrate, triglycerides greater than 400 mg/dL, anaemia, and symptomatic congestive heart failure classified as NYHA class II-IV.",
    "The sample is a phase 3 trial for melanoma testing ipilimumab, placebo, and dacarbazine, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for subjects with type 2 diabetes, testing the efficacy of insulin degludec/liraglutide and insulin degludec, with inclusion criteria including stable daily doses of basal insulin and metformin, and exclusion criteria including treatment with GLP-1 receptor agonists, impaired liver or renal function, and history of chronic pancreatitis or idiopathic acute pancreatitis.",
    "This phase 3 trial is testing the efficacy of aliskiren and placebo in patients with left ventricular systolic dysfunction following an acute myocardial infarction, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for overactive bladder, testing the drug fesoterodine fumarate, with inclusion criteria of micturitions >= 8 per day and urinary urgency episodes >=1 per day, and exclusion criteria including known hypersensitivity to the drug or neurological disease influencing bladder function.",
    "This is a phase 3 trial for the treatment of vasomotor symptoms in generally healthy postmenopausal women, using desvenlafaxine succinate (dvs) sr and placebo, with inclusion criteria of BMI less than or equal to 34 kg/m^2 and exclusion criteria of hypersensitivity to Venlafaxine, myocardial infarction and/or unstable angina within 6 months of screening, and history of seizure disorder.",
    "The sample is a phase 3 trial for diabetic macular edema using ranibizumab as the drug, with inclusion criteria of stable diabetes and visual impairment due to DME, and exclusion criteria of active eye infection or inflammation, history of stroke, renal failure or uncontrolled hypertension.",
    "This phase 3 trial is testing the efficacy of abatacept and methotrexate in treating rheumatoid arthritis in patients who meet specific inclusion and exclusion criteria, including having active clinical synovitis and a positive test result for anticyclic citrullinated peptides 2.",
    "This is a phase 3 trial for patients with prostate cancer, testing the drug leuprolide acetate 22.5 mg depot, gp-pharm sa, with eligibility criteria including males \u226518 years of age with histologically documented prostate carcinoma who might benefit from medical androgen deprivation therapy, and a life expectancy of at least 1 year.",
    "This is a phase 3 trial for bipolar I disorder using aripiprazole and placebo, with inclusion criteria based on DSM-IV-TR criteria and YMRS score, and exclusion criteria including certain medical conditions and recent treatments.",
    "This phase 3 trial is testing the efficacy of pegylated interferon alfa-2a, tenofovir df / emtricitabine combination therapy, and pegifn / tdf / ftc combination therapy in treating chronic hepatitis B and HIV infections, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of docetaxel, doxorubicin, and cyclophosphamide in treating operable breast cancer with specific eligibility criteria, including negative HER2 neu proto-oncogene overexpression and normal cardiac function.",
    "The sample is a phase 3 trial for macular degeneration, testing the efficacy of bevasiranib and ranibizumab, with inclusion criteria including age, visual acuity, and lesion type, and exclusion criteria including prior treatment and intraocular surgery.",
    "The sample is a phase 3 trial for non-Hodgkin's lymphoma using rituximab as a drug, with eligibility criteria including age, disease type, and previous treatment history, and exclusion criteria including other cancers, corticosteroid use, and cardiovascular disease.",
    "The sample is a phase 3 trial for insomnia, using the drug org 50081, with inclusion criteria of completing previous protocols and exclusion criteria of ECG abnormalities, abnormal lab values, adverse events, and non-compliance.",
    "The sample is a phase 3 trial for depression, testing the efficacy of desvenlafaxine (dvs sr) versus placebo in peri- and postmenopausal women with MDD, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to test the efficacy of eplivanserin and placebo in treating primary insomnia in patients who complain of at least one hour of wakefulness after sleep onset for at least 3 nights per week over the preceding month, and have spent at least 6.5 hours and not more than 9.0 hours, in bed, each night, over the preceding two weeks, while excluding patients with certain medical conditions and those who use certain medications.",
    "The sample is a phase 3 trial for dry eye syndrome, testing the efficacy of bromfenac ophthalmic solution A and B compared to a placebo comparator, with inclusion criteria of being 18 years or older and exclusion criteria of having a disease that could interfere with safety or efficacy assessment.",
    "This phase 3 trial is testing the effectiveness of abatacept, a drug used to treat arthritis, in participants who completed two previous Bristol-Myers Squibb studies and meet certain eligibility criteria.",
    "This phase 3 trial is testing the effectiveness of dexamethasone in preventing nausea and vomiting in breast cancer patients receiving non-cisplatin moderately emetogenic chemotherapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for multiple myeloma patients receiving high-dose Melphalan followed by autologous peripheral blood progenitor cell (PBSCT), testing the efficacy of palifermin before only, placebo, and palifermin before and after, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the combination of pegylated interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C virus in adults, with specific eligibility criteria including liver biopsy confirmation, hematological and biochemical criteria, and contraception requirements.",
    "The sample is a phase 3 trial for generalized anxiety disorder, testing the efficacy of pregabalin and placebo in patients who have failed previous GAD treatments, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of various angiotensin II receptor blockers, including azilsartan medoxomil and valsartan, in treating essential hypertension, with strict inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the efficacy of peginterferon alfa-2a plus ribavirin in treating patients with chronic hepatitis C and B who are treatment-na\u00efve or have had treatment failure to previous interferon monotherapy or treatment failure to previous lamivudine therapy.",
    "This phase 3 trial is testing the efficacy of nov-002 injection in combination with paclitaxel and carboplatin for patients with non small cell lung cancer, with eligibility criteria including a diagnosis of Stage IIIb or IV NSCLC, ECOG performance score of 0 or 1, and adequate bone marrow, hepatic, and renal function.",
    "This phase 3 trial is testing the efficacy of zoledronic acid in treating breast cancer patients who are undergoing adjuvant chemotherapy and have a diagnosis of localized breast cancer, with specific eligibility criteria for age, sex, menopausal status, performance status, hematopoietic, hepatic, renal, and other factors. The trial also has specific prior concurrent therapy requirements.",
    "The sample is a phase 3 trial for pain and fracture of neck of femur, testing the efficacy of traumeel s and placebo remedy, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of lopinavir/ritonavir, emtricitabine/tenofovir disoproxil fumarate, and raltegravir in treating HIV infection in participants who have not received prior treatment with an HIV-1 integrase inhibitor, and have met the inclusion and exclusion criteria.",
    "This is a phase 3 trial for asthma patients, testing the efficacy of mometasone furoate/formoterol fumarate combination mdi 200/10 mcg bid, mometasone furoate mdi (mf mdi) 200 mcg, formoterol fumarate 10 mcg, and placebo, with eligibility criteria including a medium daily dose of inhaled glucocorticosteroid for at least 12 weeks and a diagnosis of asthma of at least 12 months' duration.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of liraglutide and insulin compared to placebo, with inclusion criteria including stable insulin therapy and HbA1c between 7.5 and 11.0%, and exclusion criteria including treatment with GLP-1 receptor agonist within 12 weeks prior to screening and known proliferative retinopathy or maculopathy requiring treatment.",
    "This phase 3 trial is testing the efficacy of pramipexole and placebo in treating advanced idiopathic Parkinson's disease, with strict inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with schizophrenia, schizoaffective disorder, or bipolar I disorder and metabolic syndrome, testing the efficacy of switching from olanzapine, risperidone, or quetiapine to aripiprazole, with inclusion and exclusion criteria including specific medical conditions and medication use.",
    "This is a phase 3 clinical trial for chronic hepatitis C, testing the efficacy of albumin interferon alfa-2b, peginterferon alfa-2a, and ribavirin in patients with specific eligibility criteria, including genotype 2/3 infection and no prior interferon treatment.",
    "This phase 3 trial is testing the efficacy of taranabant and placebo in treating obesity, with inclusion criteria based on BMI and obesity-related comorbidities, and exclusion criteria including diabetes mellitis and significant cardiovascular disease.",
    "This is a phase 3 trial for bipolar depression, testing the efficacy of lurasidone and placebo in patients with bipolar I disorder who are currently being treated with lithium or divalproex or willing to begin treatment with them. The eligibility criteria include meeting DSM-IV-TR criteria for bipolar I disorder, having a lifetime history of at least one bipolar manic or mixed manic episode, and being in good physical health. The exclusion criteria include being considered at imminent risk of suicide or injury to self, others, or property, having any chronic organic disease of the CNS (other than Bipolar I Disorder), and having a clinically significant history of alcohol or substance abuse within the past 3 months or alcohol or substance dependence within the past 12 months.",
    "This phase 3 trial is testing the efficacy of pregabalin versus placebo in treating peripheral neuropathic pain syndrome, including diabetic neuropathies and neuralgia, with specific inclusion and exclusion criteria based on diagnosis and pain scores.",
    "The sample is a phase 3 trial for chronic bronchitis, testing the efficacy of moxifloxacin and azithromycin sr, with inclusion criteria including a diagnosis of chronic bronchitis and exacerbations of AECB, and exclusion criteria including recent treatment with systemic antibiotics.",
    "The sample is a phase 3 trial for uterine fibroids and anemia, testing the efficacy of proellex 25 mg, proellex 50 mg, and placebo, with eligibility criteria including anemia and planned surgical interventions for uterine fibroids.",
    "The sample is a phase 3 trial for prostate cancer patients who have failed local treatments and have no metastases, testing the efficacy of a combination of drugs including bicalutamide, docetaxel, and paclitaxel, with eligibility criteria including specific disease characteristics and patient characteristics, and prior concurrent therapy restrictions.",
    "The sample is a phase 3 trial for metastatic prostate cancer using oral satraplatin as the drug, with inclusion criteria including prior chemotherapy and adequate organ function, and exclusion criteria including brain metastases and uncontrolled diabetes.",
    "The sample is a phase 3 trial for patients with coronary heart disease or risk equivalents, and diabetes mellitus, testing the efficacy of torcetrapib/atorvastatin and atorvastatin, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of thalidomide and dexamethasone in treating multiple myeloma patients who have received 1-3 prior lines of treatment and have measurable levels of monoclonal protein in serum or urine.",
    "The sample is a phase 3 trial for metastatic germ cell cancer of the testes, using cisplatin and etoposide, with eligibility criteria including creatinine clearance \u2265 60 mL/min and no prior chemotherapy or radiotherapy.",
    "This phase 3 clinical trial is testing the efficacy of subcutaneous and intravenous abatacept in treating methotrexate inadequate responders with rheumatoid arthritis, and includes eligibility and exclusion criteria for participants.",
    "The sample is a phase 3 trial for juvenile rheumatoid arthritis, testing the efficacy of abatacept and placebo, with inclusion criteria including failed treatment with at least one DMARD and exclusion criteria including presence of infection or history of surgery on more than 5 joints.",
    "This phase 3 trial focuses on patients with coronary artery disease and myocardial infarction, testing the effectiveness of intravenous infusion of saline as a treatment option, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of alogliptin and metformin in treating type 2 diabetes mellitus, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for Alzheimer's disease using memantine er and placebo as drugs, with inclusion criteria including diagnostic evidence of probable Alzheimer's disease and ongoing daily acetylcholinesterase inhibitor therapy, and exclusion criteria including patients with a modified Hachinski Ischemia Score greater than 4 at Screening and patients who have taken memantine within one month of Screening.",
    "The sample is a phase 3 trial for cystic fibrosis patients with Pseudomonas aeruginosa, testing the efficacy of tobramycin inhalation powder and solution for inhalation, with specific eligibility criteria including age, FEV1, and presence of bacteria, and exclusion criteria including recent use of certain medications and pregnancy.",
    "The sample is a phase 3 trial for type 1 and type 2 diabetes patients, testing the effectiveness of technosphere\u00ae insulin inhalation powder compared to usual care, with eligibility criteria including nonsmoking, BMI <42 kg/m2, and normal pulmonary function, and exclusion criteria including significant pulmonary, renal, hepatic, or cardiac disease, and severe complications of diabetes.",
    "This is a phase 3 clinical trial for schizophrenia using ziprasidone as the drug, with inclusion criteria including completion of a previous ziprasidone study and exclusion criteria including acute or chronic heart disease and known hypersensitivity to ziprasidone or lactose.",
    "The sample is a phase 3 trial for multiple sclerosis, testing the efficacy of fampridine-sr versus placebo, with inclusion criteria of confirmed diagnosis and ability to walk, and exclusion criteria including pregnancy, participation in other trials, and previous treatment with 4-aminopyridine.",
    "This phase 3 trial is testing the effectiveness of simvastatin and placebo in treating pneumonia in patients who have been on mechanical ventilation for more than 48 hours, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of a combination of thalidomide and dexamethasone versus placebo and dexamethasone in treating multiple myeloma patients who meet certain eligibility criteria.",
    "The sample is a phase 3 trial for metastatic pancreatic cancer testing the efficacy of dalt\u00e9parine and chemotherapy, with eligibility criteria including confirmed adenocarcinoma, measurable disease, and specific patient characteristics.",
    "This phase 3 trial is testing the effectiveness of valsartan and rosuvastatin in treating hypertension and hyperlipidemia, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for chronic insomnia, testing the efficacy of ramelteon and placebo, with strict inclusion and exclusion criteria, including specific disease and drug history, BMI range, and sleep patterns.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of linagliptin and metformin, with inclusion and exclusion criteria related to renal and hepatic function, and anti-obesity drugs.",
    "The sample is a phase 3 trial for Alzheimer's disease using the drug semagacestat, with inclusion criteria based on NINCDS/ADRDA criteria and completion of previous semagacestat studies, and exclusion criteria based on meeting discontinuation criteria of previous studies.",
    "The sample is a phase 3 trial for metastatic renal cell cancer with clear cell subtype, testing the efficacy of axitinib and sorafenib, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for hypercholesterolemia, testing the efficacy of ezetimibe, atorvastatin, and rosuvastatin, with eligibility criteria including high cardiovascular risk and willingness to maintain a cholesterol lowering diet.",
    "The sample is a phase 3 trial for melanoma and skin cancer patients with regional lymph node metastases, testing the efficacy of cisplatin, dacarbazine, and vinblastine, with eligibility criteria including age, performance status, hematopoietic, hepatic, and renal conditions, and no prior chemotherapy or immunotherapy.",
    "The sample is a phase 3 trial for women with menorrhagia, testing the efficacy of tranexamic acid tablets and placebo tablets, with inclusion criteria of women aged 18-49 with regularly occurring menstrual periods and exclusion criteria of clinically significant disease or abnormalities that may confound the study, history of bilateral oophorectomy or hysterectomy, and hormone therapy.",
    "The sample is a phase 3 trial for patients with critical limb ischemia, peripheral vascular disease, foot ulcers, and rest leg pain, testing the drug remodulin\u00ae (treprostinil sodium) injection, with eligibility criteria of stage III or IV critical limb ischemia due to documented peripheral arterial disease with no planned interventional vascular procedures.",
    "The sample is a phase 3 trial for the drug lurasidone hcl in patients with schizophrenia, with inclusion and exclusion criteria listed, and the disease is identified by its ICD-10 codes.",
    "This phase 3 trial is testing the efficacy of tapentadol, oxycodone, and placebo in treating non-malignant low back pain in patients who have been taking analgesic medications for at least 3 months, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for adolescent patients with schizophrenia or child and adolescent patients with bipolar I disorder, manic or mixed episode, using aripiprazole as the drug, and the eligibility criteria includes exclusion of patients with a significant risk of committing suicide.",
    "This phase 3 clinical trial is testing the efficacy of docetaxel and cisplatin in treating advanced non-small-cell lung cancer patients who meet specific eligibility criteria, including having at least one evaluable tumor lesion and adequate bone marrow and hepatic function.",
    "The sample is a phase 3 trial for HIV patients currently receiving HAART, testing the efficacy of darunavir in simplifying and/or reducing toxicity of the current regimen, with inclusion criteria such as CD4 count and viral load, and exclusion criteria such as no history of virological failure or primary PI mutations.",
    "This phase 3 trial is testing the efficacy of pioglitazone and glimepiride in treating type 2 diabetes mellitus patients with coronary heart disease, who are not taking antidiabetic therapy or are currently treated with monotherapy or combination therapy, and meet specific inclusion criteria, while excluding those with type I diabetes mellitus, uncontrolled hypertension, and other conditions.",
    "The sample is a phase 3 clinical trial for ovarian cancer using carboplatin, gemcitabine, bevacizumab, and placebo, with eligibility criteria including documented ovarian, primary peritoneal, or fallopian tube carcinoma that has recurred and no prior chemotherapy in the recurrent setting.",
    "The sample is a phase 3 trial for type 2 diabetes patients treated with oral antidiabetic drugs, testing the efficacy of liraglutide, glimepiride, and metformin against a placebo, with inclusion criteria including HbA1c levels and BMI, and exclusion criteria including insulin treatment, impaired liver or renal function, and cardiovascular disease, among others.",
    "The sample is a phase 3 trial for chronic hepatitis C with the drugs boceprevir, peginterferon alfa-2b, ribavirin, and erythropoietin, and the eligibility criteria includes having CHC genotype 1 infection, liver biopsy with histology consistent with CHC, and no contraindications for the use of erythropoietin.",
    "The sample is a phase 3 trial for chronic hepatitis B, testing the efficacy of ribavirin and peginterferon alpha 2a, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with relapsed and advanced chronic lymphocytic leukemia, testing the efficacy of fludarabine, cyclophosphamide, and mitoxantrone, with eligibility criteria including ECOG performance status, life expectancy, and prior treatment regimens.",
    "The sample is a phase 3 trial for the drug GW685698X aqueous nasal spray in patients with seasonal allergic rhinitis, with inclusion and exclusion criteria listed, and the disease is identified by the ICD-10 code J30.2.",
    "The sample is a phase 3 trial for anemia, testing the drug epoetin alfa, with inclusion criteria including a confirmed non-myeloid malignancy diagnosis and a baseline hemoglobin value between 11-12 g/dL, and exclusion criteria including uncontrolled hypertension and a history of thrombotic events.",
    "The sample is a phase 3 trial for patients with cyanotic congenital heart disease, testing the efficacy of clopidogrel (sr25990) versus placebo, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of abatacept and placebo, with eligibility criteria including failure of anti-TNF therapy and exclusion criteria including pregnancy, serious medical disease, and history of cancer.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of tocilizumab, placebo, and methotrexate in patients with inadequate response to MTX, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of peginterferon alfa-2a (Pegasys) in treating chronic HBeAg negative hepatitis B, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for venous thromboembolism, testing the efficacy of semuloparin sodium, enoxaparin sodium, and placebo in preventing VTE in patients undergoing major abdominal surgery with additional risk factors for VTE, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of interferon gamma-1b (\"actimmune\") in treating idiopathic pulmonary fibrosis, lung disease, and pulmonary fibrosis, with specific eligibility criteria including FVC and DLCO/TLCO values, disease progression, and diagnostic findings, while excluding patients with certain medical and laboratory conditions and those on certain concomitant therapies.",
    "The sample is a phase 3 trial for gastric cancer patients with HER2-positive tumors, testing the efficacy of trastuzumab, fluorouracil, cisplatin, and capecitabine, with specific eligibility and exclusion criteria.",
    "The sample is a phase 3 trial for kidney transplantation and graft rejection, testing the effectiveness of everolimus, mycophenolic acid, cyclosporine A, basiliximab, and corticosteroids, with specific inclusion and exclusion criteria.",
    "This is a phase 3 clinical trial for patients with relapsed ovarian cancer, testing the efficacy of treosulfan as a third regime study therapy, with specific inclusion and exclusion criteria, and measuring tumor progression through CA-125 levels.",
    "The sample is a phase 3 trial for pancreatic cancer using erlotinib and gemcitabine as drugs, with eligibility criteria including confirmed adenocarcinoma, ECOG performance status 0-3, and adequate hematologic, hepatic, and renal function.",
    "The sample is a phase 3 trial for Chinese postmenopausal women with moderate to severe vasomotor symptoms, testing the efficacy of estradiol/drsp and placebo drugs, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial testing erlotinib hydrochloride in patients with high-risk stage I or stage II-IV ovarian, primary peritoneal, or fallopian tube cancer who have completed first-line therapy within the past 6 weeks and achieved complete response, partial response, or stabilization of disease, and meet certain eligibility criteria.",
    "The sample is a phase 3 trial for postmenopausal osteoporosis, testing the efficacy of risedronate, with inclusion criteria based on age, bone mineral density, and prevalent vertebral body fracture, and exclusion criteria including certain medical conditions and medication use.",
    "This is a phase 3 trial for breast cancer patients with overexpression and/or amplification of HER2, testing the efficacy of lapatinib and paclitaxel, with eligibility criteria including age, performance status, tumor size, and various health parameters.",
    "The sample is a phase 3 trial testing the efficacy of Rozerem and placebo in treating insomnia and obstructive sleep apnea in patients over 60 years old with specific inclusion and exclusion criteria, and the diseases are identified by their ICD-10 codes.",
    "The sample is a phase 3 trial for stroke patients testing the efficacy of candesartan cilexetil and placebo, with inclusion and exclusion criteria based on age, blood pressure, renal and liver function, and other serious or life-threatening diseases.",
    "This phase 3 trial is testing the efficacy of a fixed dose combination of telmisartan+amlodipine and amlodipine in treating essential hypertension that is not adequately controlled, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for asthma patients who smoke, testing the effectiveness of montelukast sodium and other comparators, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for hypertension, testing the effectiveness of aliskiren and ramipril, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is testing the efficacy of dasatinib, a drug used to treat chronic myeloid leukemia and acute lymphoblastic leukemia, in patients who have primary or acquired hematologic resistance to imatinib mesylate or who are intolerant of it. The eligibility criteria include adequate hepatic and renal function, Eastern Cooperative Oncology Group (ECOG) performance status score 0-2, and the use of an adequate method of contraception for women of childbearing potential.",
    "The sample is a phase 3 trial for the treatment of hyperphosphatemia in end stage renal disease patients using ferric citrate, with inclusion criteria such as age over 18 and stable doses of phosphate-binding agents and vitamin D supplementation, and exclusion criteria such as pregnancy, iron allergy, and hemochromatosis.",
    "The sample is a phase 3 trial for Alzheimer's disease, testing the drug rosiglitazone, with inclusion criteria including a clinical diagnosis of probable Alzheimer's disease and MMSE score 10 to 23, and exclusion criteria including a diagnosis of vascular dementia and type I or secondary diabetes mellitus.",
    "The sample is a phase 3 trial for previously untreated multiple myeloma patients, testing the efficacy of dexamethasone and lenalidomide, with eligibility criteria including measurable M-protein levels and specific patient characteristics such as platelet count and creatinine levels.",
    "The sample is a phase 3 trial for metastatic colorectal cancer testing the efficacy of bevacizumab and bevacizumab, erlotinib, with eligibility criteria including measurable lesions, no previous therapy for metastatic disease, and specific laboratory values.",
    "This phase 3 clinical trial is testing the efficacy of Treximet, butalbital-containing combination medications, and placebo in treating migraine disorders and acute migraines, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of loteprednol etabonate and its vehicle in reducing ocular inflammation in subjects undergoing routine cataract surgery, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for lymphoma patients testing the efficacy of bexarotene and methoxypsoralen, with eligibility criteria including confirmed mycosis fungoides, certain performance and hematopoietic statuses, and no prior intolerance to PUVA therapy.",
    "The sample is a phase 3 trial for schizophrenia using risperidone as the drug, with inclusion criteria of meeting DSM-IV criteria for schizophrenia and exclusion criteria of substance dependence and inability to swallow oral tablets.",
    "The sample is a phase 3 trial for vortioxetine and placebo in patients with generalized anxiety disorder, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of GSK1358820 and placebo in treating post-stroke spasticity and cerebrovascular accident, with eligibility criteria including patients with lower limb spasticity who are at least 6 months post-stroke and present with equinus deformity, and exclusion criteria including previous surgical intervention, botulinum toxin therapy, and diagnosis of systemic neuromuscular disorders.",
    "The sample is a phase 3 clinical trial for grass pollen-related allergic rhinoconjunctivitis, testing the efficacy of 300 ir (4m), 300 ir (2m), and placebo drugs, with eligibility criteria including positive SPT and specific IgE values of at least Class 2 for grass pollen allergens.",
    "The sample is a phase 3 trial for chronic hepatitis C genotype 1 infection, testing the efficacy of bi 201335, pegylated interferon-alpha, and ribavirin, with a placebo control, and includes inclusion and exclusion criteria for eligibility.",
    "The sample is a phase 3 trial for patients with Amyotrophic Lateral Sclerosis or multiple sclerosis with Pseudobulbar Affect, testing the efficacy of dextromethorphan hydrobromide and quinidine sulfate compared to placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with histologically confirmed colon carcinoma, using a combination of capecitabine, oxaliplatin, leucovorin (lv), and 5-fluorouracil (5-fu) as adjuvant therapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of saxagliptin, glyburide, metformin, and placebo, with inclusion criteria including inadequate blood sugar control and no major heart, liver, or kidney problems.",
    "This phase 3 trial is testing the efficacy of xyrem, xyrem placebo, modafinil at established dose, and modafinil (placebo) in treating narcolepsy in patients who fulfill the International Classification of Sleep Disorders criteria, while excluding patients with certain medical conditions and substance use disorders.",
    "The sample is a phase 3 trial for genotype 1 hepatitis C infection, testing the efficacy of placebo, tmc435, peginterferon alpha-2a or peginterferon alpha-2b, and ribavirin, with inclusion criteria including no prior treatment for hepatitis C and a recent liver biopsy, and exclusion criteria including HIV infection, non-genotype 1 hepatitis C, and pregnancy.",
    "The sample is a phase 3 trial for chronic myeloid leukemia, testing the effectiveness of bosutinib and imatinib, with inclusion criteria including cytogenetic diagnosis of chronic phase Ph+ CML and exclusion criteria including prior anti-leukemia treatment and prior stem cell transplant.",
    "The sample is a phase 3 trial for infection using omiganan 1% gel and povidone-iodine 10%, with eligibility criteria including new insertion of a noncuffed temporary central venous catheter and exclusion criteria such as prior treatment with certain antibiotics and known bloodstream infection at enrollment.",
    "The sample is a phase 3 trial for childhood acute lymphoblastic leukemia, testing a combination of drugs including doxorubicin hydrochloride, cytarabine, and dexamethasone, with eligibility criteria including initial white blood cells <50,000/ul and newly diagnosed B-precursor acute lymphoblastic leukemia.",
    "The sample is a phase 3 trial for patients with symptomatic atrial fibrillation, testing the effectiveness of omega-3-acid ethyl esters and placebo, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for the treatment of open-angle glaucoma and ocular hypertension using two different drugs, bimatoprost/brimonidine tartrate/timolol ophthalmic solution and fixed combination 0.2% brimonidine tartrate/0.5% timolol ophthalmic solution, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for epilepsy patients with generalized tonic-clonic seizures, testing the effectiveness of levetiracetam, with inclusion and exclusion criteria based on the patient's medical history and diagnosis.",
    "The sample is a phase 3 trial for allergic rhinitis, testing the efficacy of mometasone furoate nasal spray and placebo nasal spray, with inclusion criteria including a positive skin prick test response to an appropriate seasonal allergen and exclusion criteria including a history of severe local reaction(s) or anaphylaxis to skin testing and participation in any other clinical study.",
    "The sample is a phase 3 trial for the drug NKTR-118 and placebo in treating opioid-induced constipation (OIC) in patients with a stable maintenance opioid regimen, with specific inclusion and exclusion criteria for eligibility.",
    "This phase 3 trial is testing the efficacy of glipizide and rosiglitazone maleate in treating type 2 diabetes in patients with atherosclerosis undergoing coronary angiography or PCI, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for moderate to severe scalp psoriasis, testing the efficacy of clobex shampoo 0.05% and placebo, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of cetrorelix acetate, recombinant human choriogonadotropin, and recombinant human follicle stimulating hormone in female subjects with polycystic ovarian syndrome who are suitable for IVF/ICSI, and have met certain eligibility criteria.",
    "The sample is a phase 3 trial for diabetes, testing the efficacy of insulin detemir and insulin aspart in patients who have completed 52 weeks of treatment with insulin detemir in trial NN304-1689, with inclusion criteria including informed consent and exclusion criteria including significant concomitant disease and pregnancy.",
    "The sample is a phase 3 trial for essential hypertension using aliskiren/amlodipine and aliskiren/amlodipine/hctz as drugs, with eligibility criteria including age >= 18 years old and exclusion criteria including severe hypertension and history of myocardial infarction or stroke.",
    "The sample is a phase 3 trial for prostate cancer patients who have completed the FE 200486 CS21 Study, testing the efficacy of degarelix and leuprolide drugs, with inclusion/exclusion criteria, and icd-10 codes listed as C61, D29.1, D40.0, Z15.03, Z80.42, Z85.46, Z12.5.",
    "This is a phase 3 trial for patients with metastatic colorectal cancer, testing the efficacy of capecitabine and bevacizumab as first line treatment, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for multiple myeloma testing the efficacy of thalidomide and placebo, with inclusion criteria being patients in need of treatment and exclusion criteria including previous treatment against multiple myeloma and active cancer of other etiology.",
    "The sample is a phase 3 trial for postmenopausal women with osteoporosis, testing the efficacy of a test group and reference group of drugs, with eligibility criteria including being female over 40 years old and exclusion criteria including a history of malignant cancer.",
    "This phase 3 trial is testing the efficacy of safinamide as an add-on therapy for idiopathic Parkinson's disease in patients who meet specific eligibility criteria, including a stable dose of a single dopamine agonist and no contraindications to MAO B inhibitors.",
    "The sample is a phase 3 trial for non-small cell lung cancer using zoledronic acid, taxotere, and carboplatin as drugs, with eligibility criteria including age, diagnosis, and exclusion criteria including bone metastasis and kidney disease.",
    "This phase 3 trial is testing the efficacy of darunavir and ritonavir in treating patients with HIV-1 who have a viral load greater than 1,000 copies/mL and are stable on HAART, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for the drug amibegron in patients with major depressive disorder, with inclusion and exclusion criteria specified, and the disease is identified by its ICD-10 codes.",
    "The sample is a phase 3 trial for locally advanced and metastatic breast cancer patients who have not responded to aromatase inhibitors, testing the efficacy of fulvestrant and exemestane, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial is testing the effectiveness of velcade, thalidomide, and dexamethasone in treating multiple myeloma, with specific eligibility criteria including confirmed diagnosis, quantifiable M protein levels, and adequate organ function.",
    "This phase 3 trial is testing the efficacy of ustekinumab in treating Crohn's disease, with inclusion criteria including confirmed diagnosis, active disease, and previous non-response or intolerance to other medications, while exclusion criteria include recent bowel resection and pregnancy, and the study will compare the drug to a placebo.",
    "The sample is a phase 3 trial for Alzheimer's disease using memantine hcl as the drug, with inclusion criteria of moderate to severe Alzheimer's disease and stable dose of donepezil for 3 months, and exclusion criteria of other evidence of psychiatric disorders, oncologic diagnosis, and clinically significant gastrointestinal, renal, hepatic, endocrine or cardiovascular disease.",
    "This phase 3 trial is testing the efficacy of ThermoDox and 5% dextrose solution in treating hepatocellular carcinoma in patients who meet specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of ftc/rpv/tdf, pi, rtv, and nrtis in treating HIV-1 infection in patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial testing the efficacy of rivaroxaban, a blood thinner, in preventing venous blood clotting in patients who have undergone elective total hip or knee replacement surgery and are committed to remaining in a subacute unit for the duration of the study. The trial includes patients with arthritis, osteoarthritis of the knee and hip, and thromboembolism, and excludes those with certain medical conditions or taking certain medications.",
    "This phase 3 trial is testing a new formulation of Rebif and interferon beta-1b for relapsing remitting multiple sclerosis (RRMS) and has strict inclusion and exclusion criteria, including no prior interferon beta therapy and no use of certain medications within a certain time frame.",
    "The sample is a phase 3 trial for osteoarthritis, testing the efficacy of naproxcinod and naproxen compared to placebo, with inclusion criteria of chronic NSAID or acetaminophen use and exclusion criteria of uncontrolled hypertension or diabetes, hepatic or renal impairment, and recent participation in another investigational study.",
    "The sample is a phase 3 trial for pain, testing the efficacy of pregabalin and placebo in patients with osteoarthritis, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for skin and soft tissue infections caused by Gram-positive bacteria, testing the efficacy of daptomycin, vancomycin, and teicoplanin, with specific inclusion and exclusion criteria for subjects.",
    "The sample is a phase 3 trial for idiopathic pulmonary fibrosis, testing the efficacy of pirfenidone and placebo drugs, with eligibility criteria including age, lung function, and ability to walk, and exclusion criteria including other medical conditions and withdrawal from other IPF trials.",
    "The sample is a phase 3 trial for patients with primary hypercholesterolemia or mixed dyslipidemia, testing the efficacy of niacin (+) laropiprant and comparing it to simvastatin and atorvastatin calcium, with specified inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with bipolar I disorder, testing the drug cariprazine, with inclusion criteria including confirmation of diagnosis and experiencing a manic or mixed episode within the past 12 months, and exclusion criteria including a diagnosis of an axis I disorder other than bipolar I disorder.",
    "The sample is a phase 3 trial for generalized anxiety disorder using quetiapine fumarate as the drug, with inclusion and exclusion criteria listed, and the disease is identified by its ICD-10 code F41.1.",
    "This phase 3 trial is testing the efficacy of apixaban and acetylsalicylic acid in reducing the risk of stroke in patients with atrial fibrillation and at least one risk factor for stroke, while excluding patients with certain medical conditions or taking certain medications.",
    "This phase 3 trial is testing the effectiveness of rosuvastatin, a lipid-lowering therapy, on primary hypercholesterolemia with CV risk > 20%/10yrs, type 2 diabetes, or a history of CHD or other established atherosclerotic disease, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of docetaxel in treating unresectable non-small cell lung cancer in patients who meet specific eligibility criteria, including age and performance status, and have no prior anaphylactic reaction to any taxane.",
    "This phase 3 trial is testing the effectiveness of melatonin versus placebo in improving anorexia and cachexia in patients with gastrointestinal or lung cancer who have experienced involuntary weight loss, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with schizophrenia or schizoaffective disorder and comorbid depression, testing the efficacy of quetiapine extended release and risperidone, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of paliperidone palmitate, a drug used to treat schizophrenia, on patients who meet specific inclusion criteria, such as having a PANSS total score of 60 to 120 and a documented history of exposure to either a risperidone formulation or a paliperidone formulation.",
    "This phase 3 trial is testing the efficacy of atomoxetine and other standard therapy for ADHD in children aged 6 to 16 years old who are pharmacological na\u00efve and have a diagnosis of ADHD according to DSM IV, confirmed by SADS PL, with normal intelligence, and without a history of bipolar disorder, psychosis, autism spectrum disorder, seizure disorder, significant prior or current medical conditions, alcohol or drug abuse within the past 3 months, or taking any of the excluded medications in the study.",
    "The sample is a phase 3 clinical trial for multiple myeloma patients over 65 years old, testing the efficacy of melphalan/prednisone/velcade and thalidomide/prednisone/velcade, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 3 trial for insulin-na\u00efve type 2 diabetes patients with HbA1c between 7.0-10.0%, testing the efficacy of insulin degludec and insulin glargine in combination with metformin, DPP-4 inhibitor, or alpha-glucosidase-inhibitor, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of retigabine ir, a drug used to treat epilepsy, in patients who have experienced at least 4 partial-onset seizures during an 8-week baseline phase and are receiving a stable dose of one of the following AEDs: carbamazepine/oxcarbazepine, lamotrigine, levetiracetam or valproic acid.",
    "This phase 3 trial is testing the effectiveness of inhaled insulin for treating type 2 diabetes with a list of icd-10 codes and eligibility criteria, including stable doses of drugs for the preceding two months and exclusion of type 1 diabetes and smoking.",
    "This phase 3 trial is testing the efficacy of paliperidone and placebo in treating schizophrenia, with inclusion criteria including a DSM-IV diagnosis of schizophrenia and a PANSS score between 70 and 120, and exclusion criteria including a history of neuroleptic malignant syndrome and treatment with clozapine for treatment refractory or treatment resistant schizophrenia.",
    "The sample is a phase 3 trial for hypertension, testing the efficacy of aliskiren, valsartan, and hydrochlorothiazide, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for pancreatic cancer, testing the efficacy of fluorouracil, gemcitabine hydrochloride, and liposomal cisplatin, with eligibility criteria including confirmed adenocarcinoma of the pancreas and meeting certain patient characteristics.",
    "The sample is a phase 3 trial for kidney transplantation using tacrolimus as the drug, with eligibility criteria including patients between 18 and 60 years of age with end stage kidney disease and exclusion criteria such as high immunological risk and ongoing dosing with corticosteroids.",
    "This phase 3 trial is testing the efficacy of TMC278 and efavirenz in treating HIV-1 infections in patients who have never been treated with a therapeutic HIV vaccine or an ARV drug prior to screening, and have a plasma viral load > 5,000 HIV-1 RNA copies/mL, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for the treatment of venous thrombosis using fondaparinux 2.5mg or placebo, with eligibility criteria including a diagnosis of acute symptomatic superficial thrombophlebitis of the lower limbs at least 5 cm long by compression ultrasound and exclusion criteria including deep vein thrombosis or pulmonary embolism within last 6 months, treatment for cancer during last 6 months, and anticoagulant medication for more than 48 hours prior to inclusion.",
    "The sample is a phase 3 trial for surgically incurable melanoma with a list of drugs including dacarbazine, cp-675,206, and temozolomide, and eligibility criteria including serum LDH level and ECOG performance status.",
    "This phase 3 trial is testing the efficacy of imatinib mesylate in treating gastrointestinal stromal tumor patients who have undergone complete gross resection of a primary GIST within 70 days prior to registration and meet other eligibility criteria.",
    "This phase 3 trial is testing the efficacy of various inhalation powders and salbutamol in treating chronic obstructive pulmonary disease (COPD) in subjects with a history of smoking, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for previously untreated Waldenstr\u00f6m macroglobulinemia, splenic lymphoma with villous lymphocytes, or non-IgM lymphoplasmacytic lymphoma, using chlorambucil and fludarabine phosphate as drugs, with eligibility criteria including performance status, life expectancy, and negative pregnancy test.",
    "This phase 3 trial is testing the effectiveness of folate, vitamin B6, and vitamin B12 in treating Alzheimer's disease, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of vildagliptin, gliclazide, and metformin, with inclusion criteria including stable metformin dose, blood glucose criteria, and BMI range, and exclusion criteria including pregnancy or lactation, type 1 diabetes, significant diabetic or cardiovascular complications, and other protocol-defined criteria.",
    "This phase 3 trial is testing the efficacy of synvisc, bupivicaine, and kenalog injections in treating osteoarthritis in the carpometacarpal joint, with specific inclusion and exclusion criteria for participants.",
    "This is a phase 3 trial for patients with non-small cell lung cancer who have previously received one platinum-containing chemotherapy regimen and no more than two prior systemic anti-cancer therapies. The drug being tested is pemetrexed, and the eligibility criteria include a diagnosis of locally advanced or metastatic NSCLC that is not amenable to curative therapy.",
    "This phase 3 trial is testing the efficacy of prucalopride and placebo in male subjects with chronic constipation, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for lupus nephritis, testing the efficacy of mycophenolate mofetil, cyclophosphamide, and prednisone, with inclusion criteria of adult patients with SLE and lupus nephritis (class III, IV or V) and exclusion criteria of recent cytotoxic drug use, systemic infections, and hepatitis B or C or HIV.",
    "This phase 3 trial will test the efficacy of telmisartan (micardis\u00ae) vs. placebo in treating metabolic syndrome x, with eligibility criteria including abdominal obesity, increased waist circumference, and additional criteria of the metabolic syndrome such as triglycerides >=1.7mmol/L and fasting glucose >=6.1 mmol/L.",
    "This is a phase 3 trial for osteoporosis, testing the efficacy of alendronate and placebo in postmenopausal women or men over 60 years with a history of low trauma vertebral fractures or low bone mineral density, and who have been pretreated with bisphosphonates for at least four years, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for a drug called vi-0521, which is being tested for its effectiveness in treating obesity and type 2 diabetes in patients who meet specific eligibility criteria, including having a BMI of at least 27, certain blood pressure and triglyceride levels, and a waist circumference above a certain threshold.",
    "The sample is a phase 3 trial for patients with unresectable or metastatic melanoma, testing the efficacy of sorafenib, carboplatin/paclitaxel, and placebo, with eligibility criteria including confirmed diagnosis, measurable disease, and previous treatment with DTIC or TMZ.",
    "This phase 3 trial is testing the efficacy of phenoxodiol and carboplatin compared to placebo in treating recurrent or persistent advanced ovarian, fallopian tube, or primary peritoneal carcinoma of epithelial origin, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of NKTR-118 and usual care in treating opioid-induced constipation (OIC) in patients with confirmed OIC and <3 SBMs/week, with inclusion and exclusion criteria specified, and patients randomized to receive NKTR-118 must stop all laxatives and other bowel regimens except bisacodyl as rescue medication.",
    "The sample is a phase 3 trial for type 2 diabetes, testing the efficacy of dapagliflozin and metformin compared to placebo, with eligibility criteria including C-peptide levels and BMI, and exclusion criteria including unstable cardiovascular, renal, hepatic, hematologic, oncologic, endocrine, psychiatric, or rheumatic diseases.",
    "This is a phase 3 clinical trial for the treatment of schizophrenia with paliperidone er, where participants must meet specific inclusion criteria and not have certain exclusion criteria. The trial is focused on participants who have been previously non-acute and have been given an adequate dose of an appropriate oral antipsychotic for an adequate period of time prior to enrollment, but previous treatment is considered unsuccessful due to one or more of the following reasons: lack of effectiveness, lack of tolerability or safety, lack of compliance and/or other reasons to switch to another antipsychotic medication.",
    "The sample is a phase 3 trial for asthma patients, testing the efficacy of vilanterol and salmeterol inhalation powders compared to placebos, with inclusion criteria such as clinical diagnosis of asthma and use of inhaled corticosteroids, and exclusion criteria such as history of life-threatening asthma and allergies to study drugs.",
    "The sample is a phase 3 trial for patients with genotype 1 hepatitis C infection, testing the efficacy of placebo, tmc435, peginterferon alpha-2a, and ribavirin, with inclusion criteria including a recent liver biopsy and the use of effective contraception throughout the study.",
    "This is a phase 3 trial for patients with primary squamous cell carcinoma of the thoracic esophagus, testing the efficacy of neoadjuvant chemotherapy (cisplatin, 5-fluorouracil) with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with atherosclerosis and kidney failure, testing the effectiveness of tacrolimus, mycophenolate mofetil, prednisone, and sirolimus, with eligibility criteria including a history of dialysis or diabetes, and exclusion criteria including malignancy and non-renal organ transplant.",
    "The sample is a phase 3 clinical trial for Chinese patients with type 2 diabetes mellitus, testing the efficacy of glimepiride and metformin hydrochloride combination and glimepiride, with eligibility criteria including inadequate control with metformin and exclusion criteria including HbA1c < 7% or > 10%, and fasting plasma glucose > 250 mg/dL, among others.",
    "This phase 3 trial is testing the efficacy of bg00012 and placebo in treating relapsing-remitting multiple sclerosis, with eligibility criteria including a confirmed diagnosis of RRMS and a baseline EDSS between 0.0 and 5.0, while exclusion criteria include other chronic diseases of the immune system, malignancies, and pregnancy or nursing.",
    "The sample is a phase 3 trial for obesity, testing the efficacy of sibutramine hydrochloride and placebo, with eligibility criteria including BMI and medical history, and exclusion criteria including recent myocardial infarction and hyperthyroidism.",
    "The sample is a phase 3 trial for mild to moderate asthma patients using budesonide/formoterol, with inclusion criteria including confirmed diagnosis and current use of inhaled corticoid-steroid medicine, and exclusion criteria including pregnancy, chronic obstructive pulmonary disease, and use of beta blocker therapy or steroid tablets/injections.",
    "The sample is a phase 3 trial for patients with moderate to severe chronic kidney disease, testing the efficacy of ast-120 and placebo drugs, with eligibility criteria including age, serum creatinine levels, and urinary protein to creatinine ratio.",
    "This phase 3 trial is testing the efficacy of Rebif\u00ae new formulation and placebo in treating relapsing-remitting multiple sclerosis, with inclusion criteria such as having a score of <=5.5 on the Expanded Disability Status Scale and exclusion criteria such as having received monoclonal antibodies or immunosuppressive therapy.",
    "The sample is a phase 3 trial for epilepsy patients with simple or complex partial seizures, testing the efficacy of lacosamide with specific inclusion and exclusion criteria, and the trial includes a list of diseases, icd-10 codes, and drugs.",
    "The sample is a phase 3 trial for cariprazine in patients with schizophrenia, with inclusion criteria including meeting DSM-IV-TR criteria for schizophrenia and normal physical examination, and exclusion criteria including other psychotic disorders; the trial will test the efficacy of cariprazine in treating schizophrenia.",
    "The sample is a phase 3 clinical trial for osteoporosis, testing the efficacy of tibolone and placebo in postmenopausal women with specific inclusion and exclusion criteria, including a BMI of 34 kg/m^2 and screening BMD of the total hip and/or spine equal to or lower than 2.5 SD T-score for subjects without an asymptomatic fracture or equal to or lower than -2.0 SD T-score for subjects with an asymptomatic fracture.",
    "This phase 3 trial is testing the effectiveness of ciclesonide (xrp1526) on patients with persistent bronchial asthma who meet specific inclusion criteria and do not meet any of the exclusion criteria.",
    "The sample is a phase 3 trial testing the efficacy of ospemifene 60 mg and placebo in treating vaginal atrophy and vaginal diseases in naturally or surgically menopausal women with intact uterus and specific vaginal pH and maturation index criteria, with exclusion criteria including endometrial hyperplasia, cancer, abnormal Pap smear, uterine bleeding, current vaginal infection, and use of hormonal medications.",
    "This phase 3 trial is testing the efficacy of docetaxel and doxil in treating locally advanced or metastatic breast cancer in females who have received prior anthracycline therapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for low back pain, testing the efficacy of placebo and buprenorphine transdermal system as drugs, with inclusion criteria of clinical diagnosis of low back pain for 4 weeks or longer and exclusion criteria of current chronic diseases requiring frequent analgesic therapy.",
    "This phase 3 trial is testing the efficacy of insulin glulisine in combination with stable oral antidiabetic therapy for type 2 diabetes mellitus patients with HbA1c \u2265 8.0%, while excluding subjects with insulin use within the previous year, impaired renal function, and other exclusion criteria.",
    "This is a phase 3 trial for breast cancer patients who have undergone breast conserving surgery or modified radical mastectomy plus axillary lymph node dissection, and the study will test the efficacy of carboplatin, carmustine, cisplatin, cyclophosphamide, doxorubicin hydrochloride, paclitaxel, tamoxifen citrate, and thiotepa as treatment options. The eligibility criteria include various medical and demographic factors, and patients must not have received prior chemotherapy or hormonal therapy for breast cancer.",
    "The sample is a phase 3 trial for the drug paliperidone er in patients with schizophrenia, with inclusion criteria based on DSM-IV diagnosis and PANSS score, and exclusion criteria including substance dependence and previous lack of response to risperidone.",
    "This phase 3 trial is testing the efficacy of dexmethylphenidate, mixed amphetamine salts, er, and placebo in treating attention deficit hyperactivity disorder, with inclusion and exclusion criteria outlined.",
    "The sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) testing the efficacy of multiple drugs including gsk573719/gw642444 and tiotropium bromide, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of cobi, rtv, atv, ftc/tdf, and their placebos in treating HIV and HIV infections, with specific eligibility criteria including plasma HIV-1 RNA levels, genotype report, renal and hematologic function, and highly effective contraception methods.",
    "This phase 3 trial is testing the efficacy of ustekinumab in treating psoriatic arthritis, with inclusion criteria including a diagnosis of active PsA and at least 5 tender and 5 swollen joints, and exclusion criteria including a history of using therapeutic agents targeted at reducing IL-12 or IL-23, and a medical history of latent or active granulomatous infection.",
    "This phase 3 trial is testing the efficacy of mometasone furoate/formoterol combination and formoterol mdi compared to placebo in treating moderate to severe chronic obstructive pulmonary disease (COPD) in patients who meet specific eligibility criteria, including having COPD symptoms for at least 24 months and being an ex- or current smoker with a smoking history of at least 10 pack years.",
    "The sample is a phase 3 trial for metastatic breast cancer patients with measurable and/or evaluable disease, using paclitaxel as the drug, and with inclusion criteria such as ECOG performance status 0-2 and normal cardiac function, and exclusion criteria such as peripheral neuropathy > grade 2 and adjuvant taxane-based therapy.",
    "The sample is a phase 3 trial for childhood cancer, aplastic anemia, and metabolic disorders, using heparin and normal saline as drugs, and requiring a single lumen Broviac or double lumen Hickman-type CVC for chemotherapy, blood product support or hematopoietic stem cell transplantation, with exclusion criteria including thrombophilia and bleeding disorder.",
    "This phase 3 trial is testing the efficacy of the drugs cg5503 and placebo in treating painful diabetic peripheral neuropathy in patients with controlled blood glucose levels and who have been taking analgesic medications for at least 3 months prior to screening.",
    "This phase 3 trial is testing the efficacy of peginterferon alfa-2b (pegetron) plus ribavirin (rebetol) in treating chronic hepatitis C patients with genotype 3, who are treatment na\u00efve before current course of therapy and meet specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of paliperidone er, an antipsychotic drug, in treating schizophrenia in patients aged 65 or older with a PANSS score between 70 and 120, who have completed 6 weeks of double-blind treatment or at least 21 days of treatment and discontinued due to lack of efficacy, and who meet other inclusion criteria while excluding those with certain DSM-IV diagnoses or histories of tardive dyskinesia or lack of response to antipsychotics.",
    "The sample is a phase 3 trial for hypertension, testing the efficacy of nebivolol and metoprolol er (tm) in patients with Stage I/II hypertension, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for the treatment of vascular and mixed dementia using donepezil, with inclusion criteria requiring a reliable caregiver and exclusion criteria excluding subjects with primary psychiatric diagnoses other than dementia of the Alzheimer's type or vascular dementia.",
    "This is a phase 3 trial for essential hypertension testing the drugs xoma 985, amlodipine besylate, and perindopril erbumine, with eligibility criteria including hypertension and exclusion criteria such as renal dysfunction and heart failure.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of DVS SR and paroxetine, with eligibility criteria including a HAM D17 total score \u226520 and exclusion criteria including prior treatment with DVS SR and significant suicide risk.",
    "This is a phase 3 trial for the management of moderate to severe malignant or nonmalignant pain using oxycodone hydrochloride controlled-release tablets in patients aged 6 to 17 years who completed the 4-week study drug treatment in study OTR3001 and who will benefit from continuing treatment. The trial has inclusion and exclusion criteria, and the icd-10 codes for the disease are provided.",
    "The sample is a phase 3 trial for ulcerative colitis, testing the efficacy of colal-pred\u00ae and prednisolone, with inclusion criteria of endoscopically confirmed diagnosis and a score of 6-10 on the Disease Activity Index (DAI), and exclusion criteria of previous colonic surgery, other unstable treatments, and certain medical conditions.",
    "This is a phase 3 clinical trial for multiple sclerosis testing the efficacy of teriflunomide and placebo, with inclusion criteria including a well-defined neurological event consistent with demyelination and screening MRI scan with 2 or more T2 lesions at least 3mm in diameter.",
    "The sample is a phase 3 trial for multiple sclerosis testing the efficacy of laquinimod, placebo, and interferon \u03b2-1a (avonex\u00ae) in patients with relapsing-remitting MS, with inclusion and exclusion criteria listed.",
    "This is a phase 3 clinical trial for amyotrophic lateral sclerosis (ALS) patients, testing the efficacy of MCI-186 and placebo of MCI-186, with inclusion criteria based on diagnostic criteria and disease progression, and exclusion criteria including severe complications, pregnancy, and recent participation in other trials.",
    "The sample is a phase 3 trial for small cell lung cancer with extensive disease, testing the efficacy of topotecan + cisplatin and etoposide + carboplatin, with specific eligibility criteria including no prior chemotherapy and adequate organ function.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of rituximab, methotrexate, and methylprednisolone, with specific inclusion and exclusion criteria for patients.",
    "The sample is a phase 3 trial for asthma patients, testing the efficacy of montelukast sodium and placebo, with inclusion and exclusion criteria listed, and icd-10 codes provided for the disease.",
    "The sample is a phase 3 trial for attention deficit hyperactivity disorder (ADHD) with drugs including ldx 30 mg, ldx 50 mg, ldx 70 mg, and placebo, and eligibility criteria including meeting DSM-IV-TR criteria for ADHD, having a baseline ADHD-RS-IV score >=28, and having blood pressure within the 95th percentile for age, gender, and height.",
    "The sample is a phase 3 clinical trial for newly diagnosed multiple myeloma patients, testing the efficacy of lenalidomide and bortezomib/lenalidomide/low dose dex, with eligibility criteria including age, performance status, adequate marrow function, negative pregnancy test, and no prior malignancy.",
    "The sample is a phase 3 trial for non-small cell lung cancer with adenocarcinoma histology, testing the efficacy of gefitinib, carboplatin, and paclitaxel, with specific eligibility criteria for never smokers or light ex-smokers.",
    "This phase 3 trial is testing the efficacy of capecitabine, interferon, and interleukin in treating metastatic renal cell carcinoma, with specific eligibility criteria including confirmed diagnosis, adequate organ function, and written informed consent.",
    "This phase 3 trial is testing the efficacy of ckd-501 0.5mg and pioglitazone 15mg in treating type 2 diabetes mellitus patients who meet specific eligibility criteria, including age, BMI, and C-peptide level, while excluding patients with certain medical histories or conditions.",
    "This phase 3 trial is testing the efficacy of pi-88 versus placebo in patients with primary liver cancer who have undergone curative resection, with key inclusion criteria including histologically-proven hepatocellular carcinoma and Child Pugh classification A or B.",
    "This phase 3 trial is testing the efficacy of zoledronic acid in breast cancer patients who have undergone prior preoperative chemotherapy containing a taxane and an anthracycline, with inclusion criteria including complete resection of primary carcinoma of the breast and histologically detectable tumor residuals, while exclusion criteria include prior treatment with bisphosphonates since breast cancer surgery and concurrent treatment with other experimental drugs or any other anti-cancer therapy.",
    "This phase 3 trial is testing the efficacy of capecitabine, fluorouracil, leucovorin calcium, and oxaliplatin in treating advanced and/or metastatic colorectal adenocarcinoma, with eligibility criteria including measurable disease, WHO performance status 0-2, and various medical exclusions.",
    "The sample is a phase 3 clinical trial for ovarian and peritoneal cancer patients with suboptimal residual disease, testing the efficacy of cisplatin and paclitaxel, with eligibility criteria including specific histologies and patient characteristics, and excluding prior chemotherapy and certain medical conditions.",
    "This phase 3 trial is testing the efficacy of ferric carboxymaltose in treating iron-deficiency anemia in patients with indolent non-Hodgkin's lymphoma, multiple myeloma, or chronic lymphocytic leukemia who have received at least 12 weeks of chemotherapy and meet specific eligibility criteria.",
    "This phase 3 trial is testing the effectiveness of paliperidone palmitate and risperidone in treating schizophrenia, with inclusion criteria including a PANSS score between 60 and 120 and a diagnosis of schizophrenia according to DSM-IV.",
    "This phase 3 trial is testing the efficacy of aliskiren/hydrochlorothiazide and aliskiren in treating Stage II hypertension, with inclusion and exclusion criteria specified, and the presence of hypertension-related diseases and icd-10 codes.",
    "The sample is a phase 3 clinical trial for cervical cancer patients with measurable disease, testing the efficacy of cisplatin, gemcitabine hydrochloride, and paclitaxel, with eligibility criteria including age, performance status, renal function, and prior therapy history.",
    "The sample is a phase 3 trial for bone marrow disease and pain, using drugs fentanyl, emla, l.m.x4, and propofol, with eligibility criteria including age 2-17 and specific diagnoses of acute lymphoblastic leukemia or lymphoblastic lymphoma in remission.",
    "The sample is a phase 3 trial for gastroesophageal reflux disease, testing the efficacy of dexlansoprazole MR and excluding subjects with certain medical conditions or medication use.",
    "The sample is a phase 3 trial for postmenopausal osteoporosis using arzoxifene and raloxifene, with inclusion criteria including osteoporosis, age between 50 and 75, and ability to walk, and exclusion criteria including bone diseases other than osteoporosis, estrogen dependent cancer, and certain heart problems.",
    "This phase 3 trial is testing the efficacy of ly2216684, a noradrenergic agent, in treating major depressive disorder in patients who have had a partial response to an SSRI, with inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This phase 3 trial is testing the drug e2007 on patients with Parkinson's disease who have predictable motor fluctuations of the wearing OFF type, and are taking optimised levodopa therapy, to evaluate its efficacy and safety.",
    "The sample is a phase 3 trial for the treatment of gastroesophageal reflux using esomeprazole, with inclusion criteria of chronic reflux esophagitis or symptomatic GERD and exclusion criteria of certain surgeries, contraindication to the study drug, and pregnancy/lactation/child-bearing potential.",
    "The sample is a phase 3 trial for prostate cancer, testing the efficacy of bicalutamide, goserelin acetate, docetaxel, estramustine phosphate sodium, and acetylsalicylic acid, with eligibility criteria including confirmed adenocarcinoma of the prostate, no suspected metastases, and meeting certain poor prognosis criteria.",
    "The sample is a phase 3 clinical trial for patients with atrial fibrillation, testing the efficacy of dronedarone and placebo, with inclusion and exclusion criteria based on disease history and risk factors.",
    "The sample is a phase 3 trial for type 2 diabetes and hyperlipidemia, testing the efficacy of colesevelam hcl, rosiglitazone maleate, and sitagliptin phosphate, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of rebetol and copegus in treating previously untreated adults with chronic hepatitis C, genotype 1, who have compensated liver disease and meet specific eligibility criteria.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of aclidinium bromide, tiotropium, and placebo drugs, with inclusion criteria of males and females aged \u2265 40 years and current or ex-smokers of \u2265 10 pack-year, and exclusion criteria of history or current diagnosis of asthma, allergic rhinitis, or atopy, respiratory tract infection or acute COPD exacerbation in the last 6 weeks, hospitalization for an acute COPD exacerbation in the last 3 months, and evidence of contraindicated use of anticholinergic drugs.",
    "The sample is a phase 3 trial for impaired glucose tolerance and diabetes, using avandamet (rosiglitazone 2mg/metformin 500mg) bid, with inclusion criteria of Ontario residents aged 18-75 with IGT on OGTT and exclusion criteria including current use of metformin or rosiglitazone, prior use of medication to treat diabetes except gestational diabetes, and liver function studies greater than 2.5x normal.",
    "The sample is a phase 3 trial for Alzheimer's type dementia using galantamine hydrobromide as the drug, with inclusion criteria including severe dementia and progressive worsening of memory, and exclusion criteria including dementia caused by cerebrovascular disease and major sensorimotor impairment.",
    "The sample is a phase 3 trial for the treatment of status epilepticus and convulsions using lorazepam, with specific inclusion and exclusion criteria based on the patient's previous treatment and adverse reactions.",
    "The sample is a phase 3 trial for relapsing-remitting multiple sclerosis, testing the efficacy of interferon beta-1b (betaseron, bay86-5046), with inclusion criteria including completion of a previous study, medical assessment, and negative pregnancy test, and exclusion criteria including severe heart disease, severe depression, and epilepsy not adequately controlled by treatment.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of anagliptin and placebo, with inclusion criteria including uncontrolled blood glucose and exclusion criteria including type 1 diabetes and insulin therapy.",
    "The sample is a phase 3 trial for non-constipation irritable bowel syndrome, testing the efficacy of rifaximin and placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes, testing the efficacy of dapagliflozin and metformin, with eligibility criteria including inadequate glycemic control, drug-naivety, and specific health parameters, while excluding certain medical conditions and recent medication use.",
    "The sample is a phase 3 trial for patients with type 2 diabetes and renal insufficiency, testing the efficacy of bi 10773 and placebo drugs, with eligibility criteria including HbA1c levels and exclusion criteria including liver disease and recent bariatric surgery.",
    "This phase 3 trial is testing the efficacy of eslicarbazepine acetate and placebo in treating painful diabetic neuropathy, with inclusion and exclusion criteria outlined.",
    "This phase 3 trial focuses on patients with breast neoplasms and tests the efficacy of various drug combinations, including doxorubicine + docetaxel sequential, in combination with eligibility criteria such as normal cardiac function and negative pregnancy test.",
    "The sample is a phase 3 clinical trial for head and neck cancer patients, testing the effectiveness of carboplatin, cisplatin, docetaxel, and fluorouracil, with eligibility criteria including confirmed squamous cell carcinoma, specific primary tumor sites, and various medical conditions and exclusions.",
    "This phase 3 trial is testing the effectiveness of nitazoxanide and vancomycin in treating clostridium infections, with eligibility criteria including patients with new onset of disease evidenced by diarrhea and peripheral leukocytosis, and exclusion criteria including patients with other known causes of diarrhea or colitis and history of hypersensitivity to nitazoxanide or vancomycin.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus patients with HbA1c 7.0-10.0% using insulin degludec and insulin glargine, with eligibility criteria including current treatment with specific medications and exclusion criteria including recent use of certain medications and cardiovascular disease.",
    "The sample is a phase 3 clinical trial for the treatment of keratoconjunctivitis sicca and dry eye disease using lifitegrast and placebo, with eligibility criteria including a patient-reported history of dry eye in both eyes and a positive response to the Controlled Adverse Environment model.",
    "The sample is a phase 3 trial for depressive disorder, major, testing the efficacy of duloxetine and placebo, with inclusion and exclusion criteria including age, previous depression episodes, and medical history.",
    "This is a phase 3 clinical trial for gout patients with serum urate level greater than or equal to 8.0 mg/dL, testing the efficacy of febuxostat and allopurinol as urate-lowering drugs, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of lantus, metformin, glyburide, and thiazolidinedione, with inclusion criteria of stable doses of two oral antidiabetic drugs, and exclusion criteria of major cardiovascular events.",
    "This phase 3 trial is testing the efficacy of alogliptin and metformin in treating type 2 diabetes mellitus with inadequate glycemic control, with specific inclusion and exclusion criteria for participants.",
    "This is a phase 3 clinical trial for venous thromboembolism, testing the efficacy of semuloparin sodium and enoxaparin sodium compared to placebo in preventing deep vein thrombosis or pulmonary embolism after elective total hip replacement surgery or revision, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes, testing the efficacy of metformin, sulphonylurea, and saxagliptin, with inclusion criteria of HbA1c >6.5% and \u226410.0%, and exclusion criteria of type 1 diabetes and insulin therapy within one year of enrollment.",
    "This phase 3 trial is testing the efficacy of regorafenib and placebo in treating metastatic colorectal cancer patients who have failed at least two prior treatments, with specific eligibility criteria including histological documentation of adenocarcinoma of the colon or rectum, measurable or non-measurable disease, and Eastern Cooperative Oncology Group (ECOG) Performance Status of 1.",
    "The sample is a phase 3 trial for diabetes mellitus, testing the efficacy of syr-472 and alogliptin 25 mg compared to placebo, with inclusion criteria being outpatient status and signed informed consent, and exclusion criteria being serious cardiac, cerebrovascular, pancreatic, or hematological disease.",
    "This phase 3 trial is testing the efficacy of calcipotriene foam and vehicle foam in treating moderate plaque-type psoriasis on the body and scalp, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing treatment for locally advanced non-squamous lung cancer with the drugs \"treatment\" and eligibility criteria including a positive ALK gene locus and no prior systemic treatment for the disease.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of canagliflozin, metformin, and sulphonylruea against placebo, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for breast cancer patients with specific disease characteristics and patient characteristics, testing the drug tamoxifen citrate as endocrine therapy.",
    "The sample is a phase 3 trial for vildagliptin, a drug used to treat type 2 diabetes, with inclusion criteria including a diagnosis of type 2 diabetes for at least 6 months, meeting blood glucose criteria, and having a BMI in the range of 22-40.",
    "The sample is a phase 3 trial for the treatment of infection using ibuprofen and placebo, with eligibility criteria including fever secondary to uncomplicated acute viral or bacterial infection and otherwise good health.",
    "This is a phase 3 trial for patients with essential hypertension, testing the effectiveness of aliskiren/amlodipine/hydrochlorothiazide, with eligibility criteria including specific blood pressure ranges and exclusion criteria including pregnancy or inability to discontinue prior antihypertensive medications safely.",
    "The sample is a phase 3 trial testing the efficacy of naltrexone sr 32 mg/ bupropion sr 360 mg/ day versus placebo in treating obesity and overweight patients with specific eligibility criteria, including BMI, blood pressure, lipid levels, and psychiatric history.",
    "This phase 3 trial is testing the efficacy of macitentan and placebo in treating symptomatic pulmonary arterial hypertension in patients with confirmed diagnosis and specific inclusion criteria.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of abatacept and placebo in patients who meet specific inclusion criteria, including a clinical diagnosis of rheumatoid arthritis and a Disease Activity Score (DAS)28-C-Reactive Protein (CRP) score between 3.2 and 5.1, while excluding those who have had prior exposure to abatacept or CTLA-4 Ig, received treatment with rituximab, or have received treatment with certain other medications.",
    "This is a phase 3 clinical trial for Alzheimer's disease, testing the efficacy of memantine and placebo pill, with inclusion criteria including dementia diagnosis by DSM-IV, age between 50-95, and conversant in English, and exclusion criteria including history of stroke, Parkinson's disease, major psychiatric disorder, and clinical contraindication to memantine.",
    "This phase 3 trial focuses on renal transplantation and tests the effectiveness of cyclosporine, daclizumab, mycophenoate mofetil, prednisolone, and sirolimus in preventing acute rejection, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for pulmonary arterial hypertension, testing the drug ambrisentan, with inclusion criteria including completion of a previous study and signing an informed consent form, and exclusion criteria including recent use of certain medications and medical conditions that may affect safety or efficacy.",
    "This phase 3 trial is testing the effectiveness of alpha-tocopherol and a sugar pill on Alzheimer's disease and Down syndrome patients, with specific inclusion and exclusion criteria, and the use of ICD-10 codes to identify the diseases.",
    "The sample is a phase 3 trial for postmenopausal women with vaginal atrophy, testing the efficacy of estradiol, 10 mcg, with inclusion criteria including at least one urogenital symptom and exclusion criteria including exposure to exogenous sex steroid hormones within the past 3 months.",
    "This phase 3 trial focuses on patients with candidemia and tests the effectiveness of vfend\u00e2\u00ae i.v., oral, conventional amphotericin b, and diflucan iv, oral drugs, with inclusion criteria being patients with candidemia and exclusion criteria being neutropenia.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of indacaterol and long-acting beta2-agonist drugs, with inclusion criteria based on post-bronchodilator forced expiratory volume and current COPD bronchodilator treatment, and exclusion criteria including a history of asthma and certain cardiovascular comorbid conditions.",
    "The sample is a phase 3 trial for patients with liver cirrhosis and chronic hepatitis C, testing the efficacy of peginterferon alfa-2a and ribavirin, with specific eligibility criteria including age range, liver biopsy results, and exclusion criteria such as neutropenia and thrombocytopenia.",
    "The sample is a phase 3 trial for breast cancer patients with specific disease and patient characteristics, testing the efficacy of cyclophosphamide, epirubicin hydrochloride, fluorouracil, and paclitaxel, with eligibility criteria including no prior chemotherapy or radiation therapy.",
    "This is a phase 3 clinical trial for patients with advanced biliary tract cancer, testing the efficacy of becatecarin and 5-fluorouracil plus leucovorin as treatment options, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial is testing the efficacy of tenofovir/emtricitabine/rilpivirine in treating HIV patients who meet specific eligibility criteria, including having a CD4 cell count >50 cells/mm3 and being on Atripla or Kivexa plus efavirenz for at least 12 weeks, while excluding patients with acute viral hepatitis or chronic hepatitis B and/or C with AST and/or ALT >5 x ULN.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, cardiovascular disease, and hypertension, testing the efficacy of dapagliflozin versus placebo, with inclusion and exclusion criteria specified, and icd-10 codes provided for the diseases.",
    "This phase 3 trial aims to test the efficacy of sitagliptin and glipizide in treating type 2 diabetes and end-stage kidney disease patients on dialysis, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of inhaled treprostinil and placebo inhalation solution in patients with clinically stable pulmonary arterial hypertension, who have been on a stable dose of bosentan or sildenafil for at least three months prior to study start, and meet specific inclusion criteria.",
    "The sample is a phase 3 clinical trial for patients with Crohn's disease, testing the efficacy of mesalazine (mesalamine) as a treatment option, with specific inclusion and exclusion criteria for patient selection.",
    "This phase 3 trial is testing the efficacy of eslicarbazepine acetate 1600 mg and 1200 mg in treating partial epilepsy in patients who meet specific inclusion criteria, including having a medical history of seizures and absence of a structural abnormality, while excluding those with certain seizure types, taking certain medications, or having certain medical conditions.",
    "This phase 3 trial is testing the efficacy of docetaxel and gefitinib in treating recurrent or metastatic head and neck cancer, with eligibility criteria including prior chemotherapy or biologic/targeted therapy regimens, and exclusion criteria including prior therapy with docetaxel and unstable systemic disease.",
    "The sample is a phase 3 trial for primary myelofibrosis and MPN-associated myelofibrosis, testing the efficacy of pomalidomide 0.5 mg compared to placebo, with eligibility criteria including RBC-transfusion-dependence and hemoglobin levels, and exclusion criteria including prior treatment with pomalidomide and laboratory abnormalities.",
    "This phase 3 trial is testing the efficacy of alogliptin and insulin in treating inadequately controlled type 2 diabetes mellitus patients who are currently treated with insulin alone, with or without metformin, and meet specific eligibility criteria.",
    "This phase 3 trial is testing the effectiveness of flibanserin flexible dose in treating sexual dysfunctions, psychological, with specific inclusion and exclusion criteria for eligible patients.",
    "The sample is a phase 3 trial for glaucoma and ocular hypertension, testing the effectiveness of Xalatan and Xalacom in reducing intraocular pressure, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for perennial allergic rhinitis, testing the efficacy of azelastine hydrochloride nasal spray 0.15% and 0.10% compared to placebo, with eligibility criteria including a positive skin prick test to specific allergens and a 12-hour reflective TNSS of at least 6, and exclusion criteria including significant pulmonary disease and hypersensitivity to drugs similar to azelastine.",
    "The sample is a phase 3 trial for psoriasis using adalimumab as the drug, with inclusion and exclusion criteria listed, and the icd-10 codes for psoriasis provided.",
    "The sample is a phase 3 clinical trial for Alzheimer's disease, testing the efficacy of rivastigmine patches (5, 10, and 15 cm^2) and placebos, with inclusion criteria including a diagnosis of probable Alzheimer's disease and a baseline Mini-Mental State Examination score of 10-24, and exclusion criteria including the presence of severe or unstable cardiovascular disease.",
    "The sample is a phase 3 trial for patients with completely resected stage IIIA non-small cell lung cancer, testing the efficacy of carboplatin and paclitaxel, with eligibility criteria including age, performance status, and hematopoietic and renal function.",
    "The sample is a phase 3 trial for patients with acquired bleeding disorder or trauma, testing the efficacy of eptacog alfa (activated) and placebo, with eligibility criteria including evidence of active hemorrhage refractory to blood component therapy and surgical haemostatic procedures.",
    "The sample is a phase 3 clinical trial for bladder cancer testing the drug eflornithine, with eligibility criteria including confirmed low grade TCC of the bladder and no prior systemic chemotherapy or intravesical therapy.",
    "The sample is a phase 3 trial for hyperkalemia, testing the effectiveness of zirconium silicate and placebo in patients with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial testing the efficacy of fentanyl versus placebo in treating postherpetic neuralgia, complex regional pain syndromes, and postoperative pain, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the efficacy of quetiapine fumarate and SSRI/clomipramine in treating obsessive compulsive disorder in patients aged 18 to 65 who have been on at least 12 weeks of treatment, with exclusion criteria including substance abuse or dependence and known intolerance or lack of response to quetiapine.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of sitagliptin and metformin in combination with insulin, with eligibility criteria including age, insulin regimen, and exclusion criteria including recent use of certain medications and medical conditions.",
    "The sample is a phase 3 trial for chronic hepatitis B virus infection, testing the efficacy of entecavir and entecavir + tenofovir in nucleoside- and nucleotide-naive patients with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with myelodysplastic syndrome, testing the efficacy of decitabine at 15 mg/m2 and 20 mg/m2, with eligibility criteria including diagnosis of MDS, ECOG performance status of 0-2, and adequate hepatic and renal function.",
    "The sample is a phase 3 trial for previously untreated primary or secondary acute myeloid leukemia (AML) patients aged 61 to 75, using a combination of cytarabine, etoposide, gemtuzumab ozogamicin, idarubicin, and mitoxantrone hydrochloride, with specific eligibility criteria for disease characteristics, patient characteristics, and prior concurrent therapy.",
    "The sample is a phase 3 trial for Parkinson's disease, testing the efficacy of capsules containing carbidopa, levodopa, and entacapone, with inclusion criteria including age range and specific symptoms, and exclusion criteria including previous use of certain medications and history of brain surgery.",
    "This phase 3 trial is testing the efficacy of 0.15% and 0.1% azelastine hydrochloride and placebo in treating seasonal allergic rhinitis, with eligibility criteria including a 12-hour reflective TNSS of at least 8 and a congestion score of 2 or 3, and exclusion criteria including the presence of any nasal mucosal erosion, nasal ulceration, or nasal septal perforation, and chronic sinusitis.",
    "The sample is a phase 3 trial for seizures, using pregabalin as the drug, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with leukemia or myelodysplastic syndromes, testing the efficacy of cytarabine, daunorubicin hydrochloride, and gemtuzumab ozogamicin, with eligibility criteria including age over 61, WHO performance status 0-2, and no prior induction therapy for AML or myelodysplastic syndromes.",
    "The sample is a phase 3 trial for pulmonary arterial hypertension using bosentan as the drug, with specific inclusion and exclusion criteria for patients who completed the FUTURE 1 study and are between 2 and 12 years old.",
    "This phase 3 trial is testing the effectiveness of two contraceptive drugs, lng-ius and etonorgestrel implant, in healthy females aged 18-35 with regular menstrual cycles and no contraindications, while excluding those with certain medical conditions or using certain contraceptive methods.",
    "The sample is a phase 3 trial for patients with gastric cancer and peritoneal metastasis, testing the efficacy of 5-fu continuous infusion and mtx + 5-fu sequential therapy, with eligibility criteria including histologic confirmation of gastric adenocarcinoma, performance status 2 or less, and no prior treatment for gastric carcinoma except for surgery and adjuvant chemotherapy.",
    "The sample is a phase 3 trial for non hodgkin lymphoma, testing the efficacy of enzastaurin and placebo in patients who have recently completed R-CHOP therapy and achieved remission, with inclusion criteria including IPI score 3,4,5 and exclusion criteria including serious medical conditions and having received therapy other than R-CHOP for lymphoma.",
    "This phase 3 clinical trial is testing the efficacy of intramuscular olanzapine depot and placebo in treating patients with schizophrenia who are experiencing a psychotic episode, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of ly2127399 and methotrexate, with inclusion criteria including a diagnosis of RA, regular use of stable doses of methotrexate, and at least 8 tender and swollen joints, while exclusion criteria include a history of inadequate response to biologic DMARDs and recent surgery on a joint or other major surgery.",
    "The sample is a phase 3 trial for hypercholesterolemia, comparing atorvastatin, ezetimibe, and placebos, with inclusion criteria of LDL-C >100 mg/dL and exclusion criteria of pregnancy, sensitivity to atorvastatin or ezetimibe, and diabetes or coronary heart disease.",
    "This phase 3 clinical trial is testing the efficacy of gemcitabine/carboplatin and gemcitabine/carboplatin plus iniparib in treating newly diagnosed, stage IV squamous cell lung cancer patients who meet specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of umeclidinium bromide, fluticasone propionate/salmeterol, and placebo in treating chronic obstructive pulmonary disease (COPD) in patients who are current or former smokers with a history of \u226510 pack-years, and have a pre and post-albuterol/salbutamol FEV1/FVC ratio of <0.70 and a pre and post-albuterol/salbutamol FEV1 of \u226470% of predicted normal values, among other inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of oxymorphone extended release for the management of moderate to severe chronic non-neuropathic low back pain, with inclusion criteria including a minimum daily dose requirement and exclusion criteria including a history of substance abuse or previous exposure to oxymorphone.",
    "The sample is a phase 3 trial for patients with end-stage, C-peptide-negative, Type 1-diabetic nephropathy who receive a primary simultaneous pancreas/kidney transplant and are treated with either sirolimus or mycophenolate mofetil. The eligibility criteria include age, negative pregnancy test, and signed consent form, while the exclusion criteria include allergies, positive T-cell crossmatch, and substance abuse.",
    "This is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) testing the efficacy of tiotropium at different doses, with specific eligibility criteria and exclusion criteria, including a smoking history of \u226510 pack-years and a post-bronchodilator FEV1 \u2264 70% of predicted normal.",
    "The sample is a phase 3 trial for upper respiratory tract infection using azithromycin sr as the drug, with inclusion criteria of Laryngopharyngitis, Tonsillitis, or Acute Bacterial Rhinosinusitis and exclusion criteria of severe underlying disease, while the icd-10 codes for the disease are also provided.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of canagliflozin and metformin in combination with an SU, with inclusion criteria of HbA1c >=7.0% and <=10.5%, and exclusion criteria including history of diabetic ketoacidosis and severe hypoglycemic episode.",
    "This phase 3 trial is testing the efficacy of tenofovir disoproxil fumarate and adefovir dipivoxil in treating HBeAg positive/negative chronic hepatitis B patients with elevated ALT and HBV DNA levels, who have not received nucleoside or nucleotide treatment, and have not had hepatocellular carcinoma or decompensated liver disease.",
    "This phase 3 trial is testing the efficacy of abacavir/lamivudine, atazanavir, efavirenz, emtricitabine/tenofovir disoproxil fumarate, and ritonavir in treating HIV infections in antiretroviral naive patients with certain laboratory values and negative HBsAg, while also excluding those with major drug resistance-associated mutations or current imprisonment.",
    "This is a phase 3 trial for a contraceptive drug combination of nomac-e2 and drsp-ee in sexually active women who are at risk for pregnancy and not planning to use condoms, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 clinical trial for the drug alfuzosin in Japanese patients with symptomatic prostatic hyperplasia, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of ly2140023, a drug with glutamatergic activity, versus placebo in treating schizophrenia, with inclusion criteria including a diagnosis of schizophrenia, a history of antipsychotic treatment, and recent exacerbation of illness.",
    "This phase 3 trial is testing the efficacy of oral and i.v. palonosetron and dexamethasone in preventing chemotherapy-induced nausea and vomiting in patients with malignant solid tumors receiving cisplatin-based chemotherapy.",
    "The sample is a phase 3 clinical trial for ovarian, fallopian tube, and peritoneal cancers, testing the efficacy of epo906 and doxorubicin, with eligibility criteria including confirmed diagnosis, no more than three chemotherapy regimens, and platinum-based most recent regimen.",
    "This phase 3 trial is testing the efficacy of ciprofloxacin and amoxicillin, as well as i.v. antibiotics, in treating fever, neutropenia, and cancer in patients undergoing chemotherapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for Alzheimer's disease, testing the efficacy of bapineuzumab and placebo control drugs, with inclusion and exclusion criteria for patients, including age, diagnosis, and medical history.",
    "This is a phase 3 trial for kidney transplantation using tacrolimus, mycophenolate mofetil, daclizumab, and steroids, with eligibility criteria including end stage kidney disease and exclusion criteria including HIV positivity and history of malignancy.",
    "The sample is a phase 3 trial for neuralgia and spinal cord injuries, testing the efficacy of placebo and pregabalin as drugs, with specific inclusion and exclusion criteria for subjects.",
    "The sample is a phase 3 trial for glaucoma and ocular hypertension, testing the efficacy of two bimatoprost 0.03% ophthalmic solutions, with inclusion criteria requiring patients to have ocular hypertension or glaucoma in both eyes and requiring IOP-lowering therapy in each eye, and exclusion criteria including active or recurrent eye disease, history of eye surgery or laser within 6 months, chronic use of other eye medications during the study, anticipated wearing of contact lenses during the study, and intermittent use of oral, intramuscular, or intravenous corticosteroids within 21 days.",
    "This phase 3 trial aims to test the efficacy of olmesartan medoxomil, a drug used to treat hypertension, in patients with diabetic nephropathy and type 2 diabetes mellitus, with inclusion criteria including albumin-to-creatinine ratio >= 300 mg/g creatinine and serum creatinine between 1.0 and 2.5 mg/dL, and exclusion criteria including poor glycemic control and history of myocardial infarction or coronary artery bypass grafting within 3 months.",
    "This phase 3 trial is testing the effectiveness of creatine in treating Parkinson's disease, with inclusion criteria including responsiveness to dopaminergic therapy and exclusion criteria including recent use of creatine and other potential causes of parkinsonism.",
    "This phase 3 trial is testing the efficacy of topiramate in treating metabolic syndrome and type 2 diabetes, with inclusion criteria including a BMI of 30 or higher, specific blood glucose and cholesterol levels, and well-controlled diabetes and hypertension, while exclusion criteria include renal insufficiency, pregnancy or lactation, and certain medical conditions, and the drug being tested is topiramate.",
    "The sample is a phase 3 trial for hypercholesterolemia, testing the effectiveness of rosuvastatin and atorvastatin, with specific eligibility criteria including LDL-C levels and exclusion criteria such as statin-induced myopathy and unstable cardiovascular diseases.",
    "The sample is a phase 3 trial for diabetic retinopathy, testing the efficacy of ruboxistaurin and placebo, with inclusion and exclusion criteria based on diabetes and retinopathy status.",
    "The sample is a phase 3 trial for chronic hepatitis C genotype 1, testing the efficacy of boceprevir and ribavirin as treatment options, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for metastatic colorectal cancer testing the efficacy of panitumumab and folfox regimen, with eligibility criteria including diagnosis of metastatic colorectal cancer, measurable lesion, and ECOG performance status of 0, 1, or 2.",
    "The sample is a phase 3 trial for postmenopausal osteoporosis, testing the drugs odanacatib and placebo, with inclusion criteria of women over 65 with low bone mineral density and exclusion criteria of current osteoporosis therapy or hip fracture, and the study will test the ability of extended release nifedipine to decrease the dose of glucocorticoid medication for children with congenital adrenal hyperplasia.",
    "The sample is a phase 3 clinical trial for patients with type 1 diabetes, testing the effectiveness of insulin glulisine, with inclusion criteria of HbA1c 6.5-11.0% and BMI <35 kg/m\u00b2, and exclusion criteria of type 2 diabetes.",
    "The sample is a phase 3 trial for advanced Parkinson's disease, testing the efficacy of levodopa-carbidopa intestinal gel, with inclusion criteria of idiopathic Parkinson's disease and severe motor fluctuations, and exclusion criteria of other parkinsonian syndromes and contraindications to levodopa.",
    "This is a phase 3 trial for patients with locally advanced or metastatic breast cancer with HER2-overexpression, testing the efficacy of capecitabine and trastuzumab as a treatment option for patients who have progressed during or after previous chemotherapy and trastuzumab treatment.",
    "The sample is a phase 3 trial for major depressive disorder (MDD) using extended-release bupropion hydrochloride as the drug, with inclusion criteria including a primary diagnosis of MDD and normal orgasmic function, and exclusion criteria including previous failure to respond to two adequate trials of antidepressants and positive urine test for illicit drug use at screening.",
    "The sample is a phase 3 trial for major depressive disorder in patients over 60 years old, using paroxetine cr as the drug, with specific inclusion and exclusion criteria based on the patient's medical history and treatment.",
    "This phase 3 trial is testing the efficacy of pioglitazone and placebo in treating impaired glucose tolerance and type 2 diabetes, with eligibility criteria including insulin resistance syndrome, family history of diabetes, and gestational diabetes, while exclusion criteria include previous treatment with thiazolidinediones or metformin, cardiovascular disease, and renal disease.",
    "This phase 3 trial is testing the efficacy of lenalidomide and placebo in treating myelodysplastic syndromes with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for acute otitis media, testing the efficacy of xylitol syrup and placebo in children aged 6 months to 5 years with a history of at least three episodes of AOM in the previous 12 months, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of liprotamase versus placebo in patients with cystic fibrosis and exocrine pancreatic insufficiency, with eligibility criteria including a diagnosis of CF, stable respiratory health, and ability to take pancreatic enzyme supplementation.",
    "This phase 3 trial is testing the effectiveness of valsartan and lisinopril in treating mild to moderate hypertension with positive urine spot test and confirmation of microalbuminuria, while excluding patients with renal impairment or abnormal serum potassium values.",
    "This phase 3 trial is testing the efficacy of fluticasone furoate 50mcg, fluticasone propionate 100mcg, and placebo in treating asthma, with inclusion criteria including a pre-bronchodilator FEV1 of at least 60% predicted and FEV1 reversibility of at least 12% and 200ml.",
    "The sample is a phase 3 trial for prostate cancer patients with metastatic, hormone-refractory disease, testing the efficacy of docetaxel and prednisone, with eligibility criteria including age over 18, WHO performance status 0-2, and various hematopoietic, hepatic, renal, cardiovascular, pulmonary, and immunologic requirements.",
    "The sample is a phase 3 trial for kidney transplantation patients with graft rejection, kidney failure, and related diseases, testing the efficacy of cyclosporin or tacrolimus, with specific eligibility criteria and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of duloxetine and placebo in treating major depressive disorder with painful physical symptoms, with specific inclusion and exclusion criteria, and patients must have had at least one previous episode of depression in their medical history.",
    "This phase 3 trial is testing the efficacy of erlotinib and placebo in treating non-small cell lung cancer patients who have undergone surgery, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of vilazodone and placebo, with inclusion and exclusion criteria including age, diagnosis, HAM-D score, and medical history.",
    "The sample is a phase 3 trial for ankylosing spondylitis testing the efficacy of tocilizumab and placebo, with eligibility criteria including inadequate response to previous NSAIDs and TNF antagonist therapy, and exclusion criteria including previous treatment with tocilizumab and active uveitis at baseline.",
    "This phase 3 trial is testing the efficacy of cyclophosphamide, methotrexate, and pegylated liposomal doxorubicin hydrochloride in treating postmenopausal women with hormone receptor-negative breast cancer who are not candidates for endocrine therapy or standard chemotherapy.",
    "The sample is a phase 3 trial for patients with pulmonary hypertension, testing the effectiveness of sildenafil citrate, with inclusion criteria being completion of a 12 week pivotal study and exclusion criteria being patients not included in the pivotal study.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of placebo, czp, and methotrexate in MTX-naive patients with moderate or higher disease activity and poor prognostic factors, while excluding patients with certain medical conditions and prior use of certain medications.",
    "This phase 3 trial is testing the efficacy of gtx-024 and placebo in treating muscle wasting and non small cell lung cancer, with specific eligibility criteria including BMI, cancer stage, and prior chemotherapy regimen.",
    "The sample is a phase 3 trial for newly diagnosed chronic myelogenous leukemia in chronic phase, using drugs such as busulfan, cytarabine, etoposide, hydroxyurea, and idarubicin, with eligibility criteria including age between 15 to 65, no major organ impairment, and not pregnant.",
    "The sample is a phase 3 trial for patients with asthma and lung diseases, testing the effectiveness of esomeprazole and placebo proton pump inhibitor as GERD treatment, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for pediatric patients with partial onset seizures, testing the efficacy of levetiracetam (lev) as a treatment option, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial testing the efficacy of telmisartan and simvastatin in treating hypertension and dyslipidemias, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for plaque psoriasis, testing the efficacy of a placebo drug, with inclusion and exclusion criteria listed, and the value of diseases being 'plaque psoriasis' and drugs being 'placebo'.",
    "The sample is a phase 3 trial for open-angle glaucoma and ocular hypertension, testing the efficacy of brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension, brinzolamide ophthalmic suspension, 1%, and brimonidine tartrate ophthalmic solution, 0.2%, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for hepatitis C virus infection, testing the efficacy of daclatasvir, asunaprevir, ribavirin, and telaprevir, with specific inclusion and exclusion criteria for patients.",
    "The sample is a phase 3 trial for HER2 overexpressing stage IV breast cancer patients, testing the efficacy of trastuzumab, vinorelbine, paclitaxel, and docetaxel, with eligibility criteria including measurable disease, ECOG performance status of 0-2, and various lab values within normal range.",
    "The sample is a phase 3 trial testing the efficacy of pro 2000/5 gel and placebo in preventing HIV infections in sexually active women with diseases such as HIV, gonorrhea, chlamydial infections, and genital herpes, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for the drug renzapride in treating constipation predominant irritable bowel syndrome, with inclusion and exclusion criteria specified, and the icd-10 codes for the disease listed.",
    "The sample is a phase 3 clinical trial for dry eye disease, testing the efficacy of sodium hyaluronate and vehicle as treatments, with eligibility criteria including a documented history of dry eye and exclusion criteria including ocular surgery within the past 4 months and prior participation in a clinical trial of Vismed\u00ae.",
    "The sample is a phase 3 trial for nonorganic insomnia associated with schizophrenia and manic-depressive psychosis, testing the efficacy of zolpidem mr, nitrazepam, and placebo, with inclusion and exclusion criteria related to allergies, cardiac, hepatic, and renal disorders.",
    "This phase 3 trial is testing the effectiveness of Velcade, a drug used to treat multiple myeloma, on patients who meet specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of lpv/r, nucleoside reverse transcriptase inhibitors, peg-ifna 2a, and ribavirin in treating HIV and hepatitis C in patients with certain eligibility criteria, including CD4+ count and genotype, while excluding those with certain liver diseases, heart disease, and psychiatric disorders.",
    "The sample is a phase 3 trial for the drug gw406381 in patients with osteoarthritis of the knee who use pain medication at least 5 days per week, with inclusion and exclusion criteria listed, and the disease is specified as osteoarthritis of the knee and the drug being tested is gw406381.",
    "This is a phase 3 trial for chronic hepatitis C infection testing the efficacy of abt-450/r/abt-267, abt-333, ribavirin, and placebo for ribavirin, with specific inclusion and exclusion criteria.",
    "This phase 3 trial will test the efficacy of gw685698/gw642444 (fluticasone furoate/vilanterol trifenatate) versus placebo in outpatients of Asian ancestry, 12 years of age or older with a diagnosis of asthma, who have been using an ICS for at least 12 weeks prior to Visit 1, and meet other inclusion criteria.",
    "This phase 3 trial is testing the efficacy of nomac-e2 and levonorgestrel and ethinyl estradiol as oral contraceptives for sexually active women at risk for pregnancy with inclusion criteria including age between 18 and 50, BMI between 17 and 29 kg/m^2, and good physical and mental health, while exclusion criteria include contraindications for contraceptive steroids and present or history of alcohol or drug abuse.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of abatacept, placebo, and methotrexate, with inclusion criteria including a diagnosis of RA within 2 years, CRP >= 4.5 mg/L, and positive rheumatoid factor or anti-CCP antibody, and exclusion criteria including a history of cancer within 5 years and active tuberculosis.",
    "The sample is a phase 3 trial for patients with colorectal cancer, testing the drug rofecoxib, with eligibility criteria including confirmed colorectal carcinoma, resected primary tumor, and no prior adverse reaction to NSAIDs.",
    "The sample is a phase 3 trial for macular edema resulting from retinal vein occlusion, testing the efficacy of 700 \u00b5g and 350 \u00b5g dexamethasone, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of rosuvastatin, a statin medication, in reducing the risk of stroke in patients with any degree of stenosis on the relevant artery of atherothrombotic origin appearing on DWI through MRA or CTA.",
    "This phase 3 trial is testing the efficacy of lacosamide, an antiepileptic drug, in combination with levetiracetam and a sodium channel blocking antiepileptic drug for the treatment of epilepsy with partial-onset seizures, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 1 diabetes, testing the efficacy of diapep277 and placebo, with inclusion criteria including a recent diagnosis of type 1 diabetes, insulin dependency, and presence of diabetes-related autoantibodies, and exclusion criteria including pregnancy, significant diseases, and immune deficiency or use of immuno-suppressive or cytotoxic drugs.",
    "The sample is a phase 3 trial for bipolar disorder using risperidone as the drug, with inclusion criteria including a primary diagnosis of bipolar I disorder and exclusion criteria including a history of substance dependence and poor antimanic response to risperidone.",
    "The sample is a phase 3 trial for patients with hypercholesterolemia or dyslipidemia, testing the effectiveness of pitavastatin and simvastatin, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of oxycodone, placebo, and tapentadol in treating osteoarthritis and pain in patients who meet specific inclusion criteria, including a baseline pain score of 5 or greater, while excluding patients with certain medical histories or conditions.",
    "The sample is a phase 3 trial for HIV infections testing the efficacy of mk-0518, efavirenz, truvada, and placebos, with inclusion criteria of being HIV positive and ART naive, and exclusion criteria of previous ART use and resistance to certain drugs.",
    "This phase 3 trial is testing the efficacy of ketoprofen in diractin\u00ae, celecoxib, and placebo for treating osteoarthritis of the knee in patients who meet specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of carboplatin, etoposide, and ifosfamide in treating aggressive B-cell non-Hodgkin's lymphoma that has failed prior chemotherapy, with eligibility criteria including CD20 antigen expression and no clinical evidence of CNS involvement by lymphoma.",
    "The sample is a phase 3 clinical trial for patients with liver metastases secondary to cutaneous or ocular melanoma, testing the efficacy of melphalan, regional chemotherapy, and systemic chemotherapy, with eligibility criteria including measurable disease by CT scan and/or MRI, ECOG performance status 0-2, and various laboratory values within normal limits.",
    "The sample is a phase 3 trial testing darbepoetin alfa and placebo on patients with heart failure, anemia, cardiovascular disease, ventricular dysfunction, and congestive heart failure, with specific inclusion and exclusion criteria based on hemoglobin levels, left ventricular ejection fraction, and other factors.",
    "The sample is a phase 3 trial for ADHD treatment using methylphenidate hydrochloride extended release capsules, with inclusion criteria including ADHD diagnosis and age between 6 and 18, and exclusion criteria including IQ less than 80, chronic medical illnesses, and hypersensitivity to methylphenidate.",
    "The sample is a phase 3 clinical trial for osteoarthritis, testing the efficacy of meloxicam test capsules and placebo capsules, with inclusion criteria including a primary diagnosis of functional class I-III OA of the hip or knee and chronic use of nonsteroidal anti-inflammatory drugs (NDAIDs) and/or acetaminophen for OA pain, and exclusion criteria including a history of allergic reaction or clinically significant intolerance to acetaminophen, aspirin, or any NSAIDs, including meloxicam.",
    "The sample is a phase 3 trial for bipolar disorder, testing the efficacy of ziprasidone oral capsules and placebo oral capsules, with inclusion criteria of DSM-IV criteria for Bipolar I disorder (manic or mixed) and exclusion criteria of imminent risk of suicide or homicide and any history of serious or unstable medical illness, including risk for QT prolongation.",
    "This phase 3 trial is testing the efficacy of flutiform\u00ae in treating mild to moderate reversible asthma in children between 4-12 years of age, with inclusion criteria including a documented reversibility of \u2265 15% in FEV1 during the screening phase and exclusion criteria including a history of systemic (injectable) corticosteroid medication within 1 month before the Screening Visit.",
    "The sample is a phase 3 trial for migraine patients using topiramate, with inclusion criteria including a diagnosis of migraine and successful completion of a previous study, and exclusion criteria including abnormal liver tests and pregnancy or breastfeeding.",
    "This phase 3 trial is testing the efficacy of gemcitabine/eloxatin and carboplatin/paclitaxel in treating newly diagnosed non-small-cell lung carcinoma patients who are chemo or systemic therapy naive, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for ADHD with the drugs being tested being jns001 and placebo, and the eligibility criteria including meeting DSM-IV-TR criteria for ADHD and being healthy based on physical examination and laboratory tests.",
    "The sample is a phase 3 trial for kidney transplant patients with end-stage renal disease or kidney transplantation, using cyclosporine, sirolimus, and tacrolimus, with eligibility criteria including stable kidney function and exclusion criteria including allergy to sirolimus and pregnancy.",
    "The sample is a phase 3 trial for breast cancer patients with HER2 positivity, testing the efficacy of chemotherapy and trastuzumab (Herceptin\u00ae), with eligibility criteria including no prior history of cerebrovascular disease or neurological disorder including seizures, and no prior cranial radiotherapy or neurosurgery.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of tocilizumab and methotrexate, with inclusion criteria based on disease duration, activity score, joint count, and positive RF and/or anti-CCP, and exclusion criteria including previous treatment with tocilizumab or biologic agent, and functional class IV.",
    "The sample is a phase 3 trial for patients with type 1 diabetes mellitus, testing the efficacy of ly2963016, lantus, and insulin lispro, with inclusion criteria including duration of diabetes greater than or equal to one year, HbA1c less than or equal to 11.0%, and BMI less than or equal to 35 kg/m\u00b2, and exclusion criteria including significant renal, cardiac, gastrointestinal or liver disease, and active cancer or cancer within the past 5 years.",
    "This phase 3 trial is testing the efficacy of pramipexole in treating idiopathic restless legs syndrome, with inclusion criteria including a diagnosis of RLS and a total score larger than 15 on the IRLS, and exclusion criteria including premenopausal women who are pregnant or possibly pregnant, patients with diabetes mellitus requiring insulin therapy, and patients with other sleep disorders.",
    "The sample is a phase 3 trial for breast cancer patients with bone metastasis, testing the efficacy of zoledronic acid and placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of donepezil hydrochloride and placebo in treating brain tumors and metastatic disease, with eligibility criteria including prior radiation treatment and stable disease, while exclusion criteria include hypersensitivity to donepezil and current use of certain medications.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of tiotropium and olodaterol, along with a placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of naltrexone and bupropion in treating obesity and overweight patients with specific eligibility criteria, including BMI, blood pressure, and psychiatric history.",
    "This phase 3 trial is testing the efficacy of peg 3350 plus electrolytes and prucalopride in treating chronic constipation in female patients aged 18 to 75 years who have not been satisfied with laxatives in the past and meet specific inclusion criteria, while excluding patients with certain medical conditions or who have taken certain medications.",
    "The sample is a phase 3 trial for dutasteride and its placebo in treating benign prostatic hyperplasia, with inclusion and exclusion criteria including clinical diagnosis of BPH, prostate volume >=30cm(3), and exclusion of history of prostate cancer, hepatic impairment, and use of certain drugs.",
    "This phase 3 trial is testing the effectiveness of aprepitant and placebo in reducing chemotherapy-induced nausea and vomiting in children and adolescents with malignancy, who are receiving highly emetogenic chemotherapy for the first time, and have a weight between 15-65 kg, with a confirmed diagnosis of malignancy and a list of specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for the treatment of common cold symptoms using xylometazoline, with eligibility criteria including age over 18 and moderate symptoms for less than 36 hours, and exclusion criteria including recent use of antibiotics and sinusitis.",
    "This phase 3 trial is testing the efficacy of bevacizumab, capecitabine, cisplatin, placebo, and 5-fluorouracil in treating patients with inoperable, locally advanced, or metastatic adenocarcinoma of the stomach or gastro-oesophageal junction, with specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of methylnaltrexone and placebo in treating opioid-induced constipation in patients with chronic non-malignant pain who have been taking opioids for at least a month and have no history of chronic constipation, with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for breast cancer patients, testing the efficacy of docetaxel and epirubicin drugs, with eligibility criteria including tumor characteristics and absence of local or metastatic disease.",
    "The sample is a phase 3 trial for psoriasis, testing the effectiveness of etanercept and clobetasol propionate foam, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for kidney stones, testing the effectiveness of silodosin and tamsulosin, with inclusion and exclusion criteria listed, and icd-10 codes provided.",
    "This phase 3 trial is testing the efficacy of rosiglitazone, a drug used to treat type 2 diabetes, in patients with coexisting vascular disease or hypertension, and evidence of at least one atheromatous plaque causing narrowing of internal carotid artery between 10 and 95%.",
    "This is a phase 3 trial for chronic pain patients, testing the efficacy of hydrocodone er and placebo, with inclusion criteria including pain intensity score of 5 or more, and exclusion criteria including history of substance abuse and active malignancy.",
    "The sample is a phase 3 trial for fibromyalgia using the drug savella, with inclusion criteria including a pain score of \u226510 on Gracely scale and exclusion criteria including uncontrolled hypertension and significant cardiovascular disease.",
    "This phase 3 trial is testing the efficacy of mercaptopurine, methotrexate, and tretinoin in treating previously untreated low- or intermediate-risk acute promyelocytic leukemia patients with confirmed PML-RAR\u03b1 fusion gene positivity, who have not had recurrent disease and meet specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of rapid acting intramuscular olanzapine and isotonic sodium chloride solution in treating schizophrenia patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This phase 3 trial is testing the efficacy of ribavirin in treating acute hepatitis C virus in patients aged 18-65 with normal or elevated serum alanine transferase levels, with specific inclusion and exclusion criteria related to liver function, pregnancy, psychiatric and neurologic disease, and other severe illnesses.",
    "The sample is a phase 3 trial for patients with renal failure, testing the efficacy of 10mg rosuvastatin and placebo, with inclusion and exclusion criteria specified.",
    "This is a phase 3 trial for HIV-1 patients with specific inclusion and exclusion criteria, testing the efficacy of maraviroc, emtricitabine/tenofovir, darunavir/ritonavir, and placebos for these drugs.",
    "This phase 3 trial is testing the effectiveness of imiquimod, a drug, in treating nodular or superficial primary basal cell skin carcinoma in patients of any age without bleeding disorder, morphoeic histology, or life-threatening disease, who are not pregnant or nursing, have negative pregnancy test, and are available for study follow-up for up to 3 years.",
    "This phase 3 trial is testing the drug sunitinib malate in patients with stage IIIB or IV non-small cell lung cancer who have received one chemotherapy regimen and achieved a complete response, partial response, or stable disease, and have no evidence of disease progression, with specific eligibility criteria including performance status, cardiac function, and laboratory values.",
    "This phase 3 trial is testing the effectiveness of pitavastatin in treating hypercholesterolemia and dyslipidemias in patients over 65 years old who have completed a previous study, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for chronic migraine patients using topiramate as the drug, with inclusion criteria including successful completion of a previous study and good health, and exclusion criteria including pregnancy and non-compliance with study medication.",
    "The sample is a phase 3 trial for ulcerative colitis testing the efficacy of tacrolimus and placebo in steroid-resistant or dependent patients with moderate to severe disease activity, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD), testing the efficacy of aclidinium bromide compared to placebo, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for insulin detemir and insulin aspart in insulin detemir naive patients with type 1 diabetes and HbA1c lesser than or equal to 11.0%, with exclusion criteria of significant concomitant diseases. The trial includes patients with diabetes and diabetes mellitus, type 1, and the icd-10 codes associated with these diseases.",
    "This phase 3 trial is testing the efficacy of zoledronic acid and placebo in treating osteoporosis in patients with multiple sclerosis who meet specific eligibility criteria, including having a bone mineral density T-score of less than or equal to -2.0 and more than or equal to -4.0, and no recent immunomodulatory treatment for MS.",
    "The sample is a phase 3 trial for glaucoma and ocular hypertension, testing the efficacy of three different ophthalmic solutions (0.2% brimonidine/0.5% timolol fixed combination, concurrent brimonidine 0.2% and timolol 0.5%, and brimonidine 0.2%) with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of smc021 oral calcitonin and placebo in postmenopausal women with osteoporosis, with specific inclusion and exclusion criteria based on BMD T-score and vertebral fractures.",
    "The sample is a phase 3 trial for contraception using norethindrone acetate/ethinyl estradiol in healthy women with regular cycles and at risk for pregnancy, with exclusion criteria including contraindications for hormonal contraception and BMI > 35.",
    "This is a phase 3 clinical trial for patients with B-cell chronic lymphocytic leukemia (CLL) using cyclophosphamide and fludarabine as drugs, with specific eligibility criteria including Binet classification stages B or C, Del 17 p (FISH) negative, and Matutes score 4 or 5.",
    "This phase 3 trial is testing the efficacy of various drug combinations, including ondansetron, ibuprofen, paracetamol and metoclopramide, codeine phosphate, ibuprofen, paracetamol, in treating HIV patients who have reported GI upset and constitutional side-effects, and meet certain eligibility criteria.",
    "This phase 3 trial is testing the effectiveness of levetiracetam, carbamazepine controlled release, and valproate extended release in treating epilepsy, with specific inclusion and exclusion criteria for subjects.",
    "This is a phase 3 clinical trial for patients with schizophrenia, testing the effectiveness of paliperidone palmitate, with inclusion criteria including meeting DSM-IV criteria for schizophrenia, being non-acute, and having been given an adequate dose of antipsychotic medication prior to enrollment.",
    "The sample is a phase 3 trial for patients with advanced Parkinson's disease, testing the drug istradefylline (kw-6002) and requiring patients to meet specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for post-menopausal osteoporosis, testing the efficacy of ibandronate (Bonviva/Boniva) with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of methotrexate, ocrelizumab, and placebo, with inclusion and exclusion criteria listed, and the icd-10 codes for the disease provided.",
    "This phase 3 trial is testing the efficacy of dexlansoprazole and lansoprazole in treating erosive esophagitis in patients who meet specific inclusion criteria and do not have certain exclusion criteria, such as a positive CLO test for H. pylori or a history of Zollinger-Ellison syndrome.",
    "This phase 3 trial aims to test the efficacy of the contraceptive gel C31G and nonoxynol-9 in healthy women at risk for pregnancy, with inclusion criteria including age range, negative pregnancy test, and willingness to use the study product as the primary method of contraception, while exclusion criteria include allergy to spermicides or N-9, history of infertility, and clinically significant abnormal vaginal bleeding or spotting.",
    "The sample is a phase 3 trial for moderate to severe plaque-type psoriasis, testing the efficacy of infliximab and methotrexate, with eligibility criteria including a minimum PASI score and negative TB test results.",
    "The sample is a phase 3 trial for breast cancer patients with high risk of recurrence, testing the efficacy of capecitabine and docetaxel, with eligibility criteria including histologically confirmed invasive breast cancer and exclusion criteria such as presence of distant metastases and abnormal laboratory values.",
    "The sample is a phase 3 clinical trial for Alzheimer's disease, testing the drug atorvastatin, with inclusion criteria based on diagnostic evidence and MMSE score, and exclusion criteria for other types of dementia or conditions that may increase risk or decrease data reliability.",
    "This phase 3 trial is testing the efficacy of nexavar (sorafenib, bay43-9006) versus placebo in treating hepatocellular carcinoma in patients who have undergone surgical resection or local ablation with curative intent, and meet specific eligibility criteria.",
    "This is a phase 3 trial for patients with type 2 diabetes mellitus, testing the drug muraglitazar, with inclusion criteria including stable metformin therapy, HbA1c levels, fasting c-peptide levels, BMI, and serum triglycerides.",
    "This is a phase 3 trial for gastrointestinal stromal tumors using the drug nilotinib, with inclusion criteria including radiological confirmation of disease progression during imatinib and sunitinib therapy or intolerance to those drugs, and exclusion criteria including previous treatment with nilotinib or any other drug in this class or other targeted therapy.",
    "This phase 3 trial is testing the efficacy of imatinib, a drug used to treat chronic myeloid leukemia, in patients who have not responded to other treatments and meet specific eligibility criteria.",
    "The sample is a phase 3 trial for poorly controlled type 2 diabetes mellitus patients on insulin or insulin and metformin, testing the efficacy of sitagliptin phosphate compared to placebo, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing bg00002, interferon beta-1a, and glatiramer acetate in patients with relapsing remitting multiple sclerosis who have had disease activity within 12 months prior to screening while on therapy, and have a documented Expanded Disability Status Scale (EDSS) score between 0.0 and 5.5, inclusive.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of escitalopram and placebo, with inclusion and exclusion criteria based on DSM-IV-TR diagnostic criteria and medical history.",
    "This is a phase 3 clinical trial for patients with ovarian or primary peritoneal carcinoma, testing the effectiveness of interferon gamma-1b, with eligibility criteria including histologically confirmed epithelial ovarian or primary peritoneal carcinoma, FIGO Stage III or IV disease, and adequate bone marrow, hepatic, renal, and neurologic function.",
    "The sample is a phase 3 trial for chronic myeloid leukemia testing the efficacy of dasatinib and imatinib, with eligibility criteria including age, disease stage, and performance status, and exclusion criteria including cardiovascular disease and prior treatment with certain medications.",
    "The sample is a phase 3 trial for vildagliptin, a drug used to treat type 2 diabetes, with eligibility criteria including a diagnosis of T2DM, no prior treatment with oral antidiabetic agents for at least 12 weeks, and a BMI between 22-35 kg/m2.",
    "The sample is a phase 3 clinical trial for type 2 diabetes mellitus, testing the efficacy of lixisenatide and metformin, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for major depressive disorder with inadequate response to one antidepressant, testing the efficacy of tc-5214 compared to placebo, with inclusion criteria of outpatient status and exclusion criteria of bipolar disorder, psychotic disorder, and history of suicide attempts, among others.",
    "The sample is a phase 3 clinical trial for ulcerative colitis, testing the efficacy of mesalamine once-daily and twice-daily, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of tipranavir and ritonavir in combination with other agents for HIV-1 infected patients with resistance to more than one PI, and with chronic hepatitis C Virus or hepatitis B infection.",
    "This phase 3 trial is testing the efficacy of policosanol, a lipid-lowering drug, on patients with hypercholesterolemia and combined hyperlipidemia, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of agomelatine and placebo, with inclusion criteria including a diagnosis of MDD and certain scores on HAM-D17 and CGI-Severity scales, and exclusion criteria including a history of bipolar disorder, substance or alcohol abuse, and concomitant psychotropic medication.",
    "This is a phase 3 trial for non-small cell lung cancer patients who have progressed while on or following a first-line chemotherapy regimen, testing the efficacy of asa404 and docetaxel compared to placebo, with eligibility criteria including confirmed histology, age \u2265 18 years old, WHO Performance Status of 0-2, and central laboratory values within the range, among others.",
    "This phase 3 trial is testing the long-term extension administration of GSK1325760A, a drug for pulmonary arterial hypertension and hypertension, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for metastatic colorectal cancer testing the efficacy of bevacizumab and capecitabine in patients over 70 years old with measurable metastatic lesions, and excluding those with prior chemotherapeutic treatment or adjuvant anti-VEGF treatment, and with clinically significant cardiovascular disease or current use of aspirin or NSAIDs.",
    "The sample is a phase 3 trial for patients with esophagitis, reflux and peptic, testing the efficacy of dexlansoprazole mr and placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial testing the efficacy of er niacin/laropiprant, simvastatin, and ezetimibe/simvastatin in treating cardiovascular disease, peripheral arterial disease, diabetes mellitus, and coronary heart disease, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for colorectal cancer patients who have undergone curative radical resection, testing the efficacy of celecoxib, fluorouracil, and leucovorin calcium, with eligibility criteria including various medical conditions and restrictions on concurrent medication and participation in other clinical studies.",
    "This phase 3 trial is testing the efficacy of insulin degludec, placebo, and liraglutide in treating type 2 diabetes patients who are insulin na\u00efve and currently taking metformin or metformin in combination with other glucose-lowering agents, with specific HbA1c levels, while excluding those with certain medical conditions or recent history of malignant neoplasms.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of vildagliptin and thiazolidinedione (tzd) drugs, with eligibility criteria including stable metformin dose, age range of 18-80 years, BMI range of 22-40 kg/m2, HbA1c range of 7.0 to 10%, and FPG <270 mg/dL (15 mmol/L).",
    "The sample is a phase 3 trial for bipolar disorder, testing the efficacy of asenapine, olanzapine, and placebo, with inclusion criteria requiring a DSM-IV diagnosis of bipolar I disorder, and exclusion criteria excluding participants with unstable medical conditions, clinically significant laboratory abnormalities, or rapid cycling, and those with any other psychiatric disorder as a primary diagnosis.",
    "The sample is a phase 3 trial for patients with stage III adenocarcinoma of the colon, testing the efficacy of a combination of drugs including irinotecan hydrochloride, oxaliplatin, leucovorin calcium, fluorouracil, and locally directed therapy, with strict eligibility criteria including no prior chemotherapy or radiotherapy for colon cancer, and no concurrent biologic or targeted agents.",
    "The sample is a phase 3 trial for dyslipidemia and kidney disease patients, testing the effectiveness of abt-335 plus rosuvastatin and rosuvastatin drugs, with specific eligibility criteria including laboratory results and exclusion criteria such as certain medical conditions and medications.",
    "The sample is a phase 3 trial for patients with irritable bowel syndrome with constipation or chronic constipation, testing the effectiveness of linaclotide, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for colorectal cancer using capecitabine and oxaliplatin, with eligibility criteria including confirmed adenocarcinoma of the rectum, accessible tumor location, and specific patient characteristics such as age and hematopoietic levels.",
    "This phase 3 trial is testing the efficacy of ranibizumab injection in treating macular edema and retinal vein occlusion, with strict inclusion and exclusion criteria, and sham injection as a control group.",
    "The sample is a phase 3 clinical trial for Crohn's disease, testing the efficacy of methotrexate and placebo as treatments, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for patients with chronic obstructive pulmonary disease, testing the efficacy of tiotropium and olodaterol, with strict inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for prostate cancer using drugs zd4054 and placebo, with inclusion criteria including confirmed diagnosis of prostate cancer and increasing PSA, and exclusion criteria including previous chemotherapy treatment and heart failure.",
    "The sample is a phase 3 trial for patients with severe sepsis, testing the efficacy of drotrecogin alfa (activated) versus placebo, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the combination of pegylated interferon alfa-2b and rebetol for patients who have undergone liver transplantation and have chronic hepatitis C or liver cirrhosis, with specific eligibility criteria, including age, liver function, and immunosuppression status.",
    "This phase 3 trial is testing the efficacy of tamsulosin hydrochloride/solifenacin succinate fixed dose combination in treating lower urinary tract symptoms and benign prostatic hyperplasia, with inclusion criteria of completion of 12 weeks double-blind treatment in a previous study and exclusion criteria of any significant PVR volume (>150 mL).",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the drugs ly2127399 and placebo q4w and q2w, with eligibility criteria including a diagnosis of RA, previous treatment with biologic TNF-\u03b1 inhibitor therapy, and regular use of at least 1 conventional DMARD.",
    "This phase 3 trial is testing the efficacy of rituximab and methotrexate in treating moderate to severe active rheumatoid arthritis in patients who have had inadequate response to previous treatments, with a list of inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for the treatment of painful diabetic neuropathy, testing the efficacy of duloxetine compared to placebo, with inclusion criteria including confirmed diagnosis of Type 1 or Type 2 diabetes mellitus, stable glycemic control, and a score of at least 4 on the Brief Pain Inventory (BPI) 24-hour average pain item at Screening.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of olodaterol (bi 1744) and placebo in patients with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for venous thrombosis using Arixtra (fondaparinux sodium) as a drug, with inclusion and exclusion criteria for patients undergoing open laparotomy gynecologic surgery.",
    "The sample is a phase 3 trial for safinamide in patients with idiopathic Parkinson's disease, where the inclusion criteria includes patients with less than 5 years of diagnosis and a stable dose of a single dopamine agonist, and the exclusion criteria includes patients with medical conditions that would interfere with the study evaluations, substance abuse, history of psychosis, depression, evidence of dementia or cognitive dysfunction, end of dose wearing-off, female patients of childbearing potential, and patients who have previously received safinamide.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of insulin glargine, insulin lispro protamine suspension, and insulin lispro in combination with metformin and at least one other oral antihyperglycemic medication, with eligibility criteria including HbA1c levels, BMI, and willingness to follow the protocol.",
    "The sample is a phase 3 clinical trial for ulcerative colitis, testing the efficacy of Asacol 400 mg in children aged 5-17 with mildly-to-moderately active UC, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of arixtra alone in treating cancer patients with acute, radiographically confirmed, de novo Deep Vein Thrombosis (DVT) or Pulmonary Embolism (PE) and no past medical history of a prior thrombus or known thrombophilia, while excluding patients with contraindications such as severe renal impairment, bleeding disorders, and brain metastasis.",
    "This phase 3 trial is testing the efficacy of fesoterodine and placebo in treating overactive bladder symptoms with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for hypercholesterolemia and hyperlipidemia using laropiprant/niacin and placebo drugs, with inclusion and exclusion criteria for patients between 18 and 70 years of age.",
    "The sample is a phase 3 trial for patients with moderate to severe COPD, testing the efficacy of nva237 and tiotropium, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of repaglinide and metformin combination tablet and rosiglitazone and metformin combination tablet, with inclusion criteria of HbA1c between 7.5-11.0% on monotherapy or 7.0-10.0% on dual therapy and BMI maximum 45 kg/m2, and exclusion criteria of severe heart disease and pregnancy.",
    "The sample is a phase 3 trial for HIV infection, testing the efficacy of tenofovir df and lopinavir/ritonavir with 2 nucleoside rtis, with inclusion criteria of being HIV positive, over 18 years of age, having HIV RNA> 400 copies/mL, any CD 4 cell count, antiretroviral na\u00efve, and no acute illness.",
    "This phase 3 trial is testing the efficacy of GSK573719/GW642444 and its individual components in treating chronic obstructive pulmonary disease (COPD) in patients with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial testing the efficacy of nebivolol and valsartan, as well as other drugs, in treating stage 1 and stage 2 hypertension with specific inclusion and exclusion criteria, and the trial includes a list of diseases and their corresponding ICD-10 codes.",
    "This phase 3 trial is testing the efficacy of dolutegravir in ART-experienced, INI-experienced, DTG na\u00efve patients with virological failure on raltegravir or elvitegravir regimen and genotypic resistance to RAL or ELV, who have documented resistance to at least one drug from each of two or more of any approved classes of ART other than integrase inhibitors, and are able to receive at least one fully active drug as part of the OBR from Day 8, with the goal of treating HIV infections.",
    "The sample is a phase 3 trial for subjects with a history of osteoarthritis, rheumatoid arthritis, or ankylosing spondylitis who require daily NSAID therapy and have a history of a documented, uncomplicated gastric or duodenal ulcer, testing the efficacy of pn400 (vimovo) and pn 400 (vimovo) as drugs, with eligibility criteria and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with esophageal metaplasia, testing the efficacy of ranitidine and pantoprazole as treatment, with specific inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the effectiveness of cytarabine, idarubicin, all-trans retinoic acid, mitoxantrone, and etoposid in treating newly diagnosed acute myeloid leukemia in patients over 60 years old, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of extended-release guanfacine hydrochloride and atomoxetine hydrochloride, along with a placebo comparator, in treating attention deficit hyperactivity disorder in children aged 6-17 years who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This phase 3 trial is testing the efficacy of ofatumumab and ibrutinib in treating relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 clinical trial for the treatment of allergic rhinoconjunctivitis with a list of drugs including loratadine, olopatadine, mometasone furoate, and prednisone, and eligibility criteria including age, positive skin prick test response, and normal safety laboratory tests and vital signs.",
    "This phase 3 trial is testing the efficacy of tiotropium and olodaterol in patients with chronic obstructive pulmonary disease who meet specific eligibility criteria.",
    "This is a phase 3 trial for schizophrenia, testing the effectiveness of paliperidone extended release and aripiprazole in participants who meet certain criteria, including having a PANSS score between 60 and 120, and excluding those with substance dependence or a history of certain neurological disorders.",
    "This phase 3 trial aims to test the efficacy of pafuramidine maleate and trimethoprim-sulfamethoxazole in treating HIV patients with pneumonia caused by Pneumocystis jiroveci, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of lisdexamfetamine dimesylate and atomoxetine hydrochloride in treating attention-deficit/hyperactivity disorder in children aged 6-17 who have had an inadequate response to methylphenidate treatment, with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for mood disorders using quetiapine as a drug, with specific inclusion and exclusion criteria based on DSM-IV diagnosis and medical conditions.",
    "This phase 3 trial will test the efficacy of toremifene citrate in preventing fractures in men with prostate cancer who are on androgen deprivation therapy and have low bone mineral density.",
    "The sample is a phase 3 trial for asthma patients, testing the efficacy of fluticasone furoate/vilanterol inhalation powder, fluticasone furoate inhalation powder, and placebo, with inclusion criteria including age, FEV1, and corticosteroid use, and exclusion criteria including history of life-threatening asthma, respiratory infection, and smoking history.",
    "This phase 3 trial is testing the efficacy of alogliptin and glyburide in treating type 2 diabetes mellitus with specific eligibility criteria, including a BMI between 23-45 kg/m2 and a fasting C-peptide concentration greater than or equal to 0.8 ng/mL.",
    "The sample is a phase 3 trial for patients with myocardial infarction, testing the efficacy of abciximab and its placebo, with inclusion and exclusion criteria listed.",
    "This is a phase 3 trial for asthma patients using mometasone furoate/formoterol and fluticasone propionate/salmeterol, with inclusion criteria including a diagnosis of asthma for at least 12 months, a stable regimen of inhaled glucocorticosteroids, and a history of asthma-related unscheduled visits to a physician or emergency room.",
    "The sample is a phase 3 trial for patients with refractory epilepsy and seizures, testing the efficacy of retigabine and placebo drugs, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing cytarabine plus daunorubicin for previously-untreated acute myeloid leukemia in patients aged 15-65 with adequate organ function and performance status, while excluding patients with certain genetic mutations or prior chemotherapy, and requiring informed consent.",
    "The sample is a phase 3 trial for premenopausal women with estrogen receptor positive breast cancer, testing the efficacy of tamoxifen, anastrazole (arimidex), and goserelin acetate (zoladex) as treatments, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of hzt-501 and ibuprofen in patients with peptic ulcer disease who require daily NSAID administration, with specific inclusion and exclusion criteria outlined.",
    "This phase 3 trial focuses on kidney transplantation and the use of tacrolimus as a drug, with eligibility criteria including age and compatibility with the donor, and exclusion criteria including immunological high risk and significant liver disease.",
    "This phase 3 trial is testing the efficacy of d-cycloserine and placebo in treating autistic disorder in children aged 3 to 12 years with a confirmed diagnosis and an ABC lethargy subscale score of 13 or greater, while excluding those with certain medical and psychiatric conditions, and requiring females of childbearing potential to use birth control during the study.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of tocilizumab, placebo, and methotrexate, with inclusion criteria including age, disease duration, and stable medication doses, and exclusion criteria including surgery history and inadequate response to anti-TNF agents.",
    "The sample is a phase 3 trial for glaucoma patients, testing the efficacy of dorzolamide hydrochloride (+) timolol maleate and comparing it to timolol maleate and dorzolamide hydrochloride, with inclusion criteria of glaucoma and ocular hypertension and exclusion criteria of recent ocular surgery and contradiction to timolol and dorzolamide.",
    "The sample is a phase 3 trial for lenvatinib and placebo in patients with 131 I-refractory/resistant thyroid cancer, with inclusion and exclusion criteria for eligibility, and an additional OOL lenvatinib treatment period for eligible participants.",
    "This phase 3 trial is testing the efficacy of docetaxel, a chemotherapy drug, in combination with ramucirumab, a VEGF inhibitor, for the treatment of metastatic or locally-recurrent and inoperable breast cancer in female patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of vildagliptin and placebo, with inclusion criteria including confirmed diagnosis of T2DM, stable doses of insulin and metformin, HbA1c of 7.5 to 11.0%, and BMI of 22 to 40 kg/m2.",
    "This phase 3 trial will test the efficacy of moxifloxacin and piperacillin/tazobactam & amoxicillin/clavulanic acid in treating bacterial skin and skin structure infections caused by abscess, wound infection, diabetic foot, ulcer, and infected ischemic ulcers with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 1 diabetes mellitus, testing the effectiveness of insulin degludec, insulin detemir, and insulin aspart, with inclusion criteria including ongoing daily treatment with insulin for at least 3 months prior to screening and a maximum HbA1c of 11%.",
    "The sample is a phase 3 trial for patients with malignant bone disease and moderate to severe pain, testing the effectiveness of ibandronate and zoledronic acid, with specific inclusion and exclusion criteria.",
    "This is a phase 3 clinical trial for early rheumatoid arthritis, testing the effectiveness of methotrexate as a treatment option, with specific inclusion and exclusion criteria for eligible subjects.",
    "This is a phase 3 clinical trial for type 2 diabetes mellitus patients with inclusion criteria including HbA1c of 7.1% to 11.0%, BMI of 25 kg/m2 to 45 kg/m2, and stable body weight, and the drugs being tested are exenatide once weekly and insulin glargine.",
    "The sample is a phase 3 trial for patients with operable primary invasive breast cancer, testing the efficacy of bevacizumab and standard adjuvant chemotherapy, with inclusion criteria including triple negative confirmation and exclusion criteria including previous breast cancer history and clinically significant cardiovascular disease.",
    "This phase 3 trial is testing the efficacy of intravitreal ranibizumab and photodynamic therapy in treating choroidal neovascularization and age-related macular degeneration, with specific inclusion and exclusion criteria for patients.",
    "The sample is a phase 3 trial for patients with HIV and chronic hepatitis C, testing the efficacy of ribavirin and HIV antiretroviral therapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for acute myeloid leukemia, testing the efficacy of tipifarnib, zarnestra, and r115777 in patients who are not medically fit for combination induction chemotherapy, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of indacaterol 300 \u03bcg and placebo in male and female adults aged \u2265 40 years with moderate to severe chronic obstructive pulmonary disease (COPD) and a smoking history of at least 20 pack years, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of mycophenolate mofetil in reducing cardiovascular risk factors in kidney transplant recipients who are at least 6 months post-surgery and have at least one established cardiovascular risk factor.",
    "The sample is a phase 3 trial for psoriasis vulgaris, testing the efficacy of calcipotriol plus hydrocortisone ointment vehicle, tacalcitol ointment, and calcipotriol plus hydrocortisone ointment, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with type 2 diabetes and obesity, testing the efficacy of bi 10773 and placebo drugs in combination with insulin and metformin, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes patients receiving TZD monotherapy, testing the efficacy of saxagliptin, pioglitazone, rosiglitazone, and metformin, with inclusion and exclusion criteria based on HbA1c, BMI, and C-peptide levels.",
    "This phase 3 trial is testing the efficacy of eribulin mesylate and capecitabine in female patients with metastatic breast cancer who have received up to three prior chemotherapy regimens, and no more than two prior regimens for advanced and/or metastatic disease, and meet other eligibility criteria.",
    "This phase 3 clinical trial is testing the efficacy of zonisamide and placebo in treating partial seizures refractory to current anti-epilepsy drug therapy, with eligibility criteria including at least 4 partial seizures per month and exclusion criteria including history of zonisamide administration and sensitivity to sulfonamide medications.",
    "This phase 3 trial is testing the drug triptorelin pamoate 11.25mg on patients with locally advanced or metastatic prostate cancer who are suitable for androgen deprivation therapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of sitagliptin and metformin compared to placebo, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of GSK548470 and ETV in treating chronic hepatitis B in patients who meet specific eligibility criteria, including having a positive serum HBsAg for at least 6 months and no prior therapy for over 6 months in the past.",
    "This phase 3 trial is testing the effectiveness of azilsartan medoxomil and olmesartan, along with a placebo, in treating essential hypertension with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for chronic noncancer pain, testing the efficacy of oros hydromorphone hcl and oxycodone, with inclusion and exclusion criteria specified, and disease identified as pain with corresponding icd-10 codes.",
    "This phase 3 trial is testing the efficacy of carboplatin, cisplatin, paclitaxel, and topotecan hydrochloride in treating stage IIB-IV ovarian epithelial, primary peritoneal, or fallopian tube cancer patients who meet specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of tiotropium+olodaterol (low and high dose) versus placebo in patients with chronic obstructive pulmonary disease who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for the treatment of intra-abdominal infections using metronidazole and ceftriaxone sodium, with inclusion criteria including diagnosis of the infection and ability to obtain a specimen for bacteriological efficacy assessment.",
    "The sample is a phase 3 trial for chronic low back pain, testing the effectiveness of duloxetine and placebo, with inclusion and exclusion criteria including age, medical history, and previous exposure to duloxetine.",
    "The sample is a phase 3 trial for metastatic colorectal cancer, testing the efficacy of bevacizumab, irinotecan, leucovorin, and fluorouracil, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase 3 trial for atopic dermatitis, testing the efficacy of v0034cr01b and desonide 0.1% cream, with inclusion criteria of objective SCORAD < 15 and xerosis score > = 2, and exclusion criteria of acute or severe form of atopic dermatitis.",
    "The sample is a phase 3 trial for psoriasis vulgaris using calcipotriol plus hydrocortisone, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for primary insomnia, with vec-162 20 mg and 50 mg and placebo as drugs, and the eligibility criteria includes a diagnosis of primary insomnia, habitual bedtime between 9:00 pm and 1:00 am, and no history of certain sleep disorders or drug/alcohol abuse.",
    "This phase 3 trial will test the efficacy of lamotrigine versus placebo in treating binge eating disorder and obesity, with eligibility criteria including meeting DSM-IV-TR criteria for BED and having a BMI > 30 kg/m2.",
    "The sample is a phase 3 trial for mixed dyslipidemia and coronary heart disease using abt-335, atorvastatin, and placebo, with eligibility criteria including adequate birth control methods and adherence to the AHA diet.",
    "The sample is a phase 3 trial testing the efficacy of vorapaxar and placebo in patients with a history of atherosclerosis involving various systems, with a list of diseases and their corresponding icd-10 codes provided, and eligibility criteria including exclusion criteria, while the drugs and diseases are listed in the respective columns.",
    "The sample is a phase 3 trial for generalized anxiety disorder, testing the effectiveness of quetiapine fumarate and paroxetine, with inclusion and exclusion criteria listed.",
    "This is a phase 3 trial for schizophrenia testing the efficacy of paliperidone palmitate and placebo, with inclusion criteria including meeting diagnostic criteria for schizophrenia, having a PANSS score of 60-120, and having a history of exposure to either a risperidone or paliperidone formulation.",
    "The sample is a phase 3 trial for acute stroke and cerebral infarction, testing the efficacy of citicoline versus placebo in patients meeting specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of cinitapride and domperidone in treating mild to moderate functional dyspepsia, with exclusion criteria including patients with gastroesophageal reflux, a history of gastric or duodenal ulcer, and known allergy to cinitapride.",
    "The sample is a phase 3 trial testing the effectiveness of rosuvastatin in reducing elevated high-sensitivity c-reactive protein levels in men over 50 and women over 60 with low to normal levels of LDL cholesterol, and the exclusion criteria includes a history of cardiovascular or cerebrovascular events, active liver disease, diabetes mellitus, uncontrolled hypertension or hypothyroidism, history of certain malignancies, chronic inflammatory conditions, and history of alcohol or drug abuse.",
    "The sample is a phase 3 trial testing the efficacy of ralfinamide, a drug used to treat neuropathic pain, on patients with chronic neuropathic low back pain caused by compression radiculopathy or post-traumatic/post-surgical lumbar radiculopathy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for chronic plaque psoriasis, testing the efficacy of cyclosporine a microemulsion and placebo, with inclusion and exclusion criteria including disease remission, abnormal renal and liver function, and history of malignancy.",
    "This is a phase 3 trial for infertility, testing the efficacy of triptorelin acetate and NaCl %0.9 in women undergoing embryo transfer following controlled ovarian hyperstimulation with a fixed GnRH antagonist protocol, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to test the efficacy of saccharomyces boulardii versus placebo in preventing antibiotic-associated diarrhea and clostridium difficile in hospitalized adult patients receiving systemic antibiotic treatment, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial testing the efficacy of dalbavancin and vancomycin/linezolid in treating abscess, wound infection, surgical site infection, and cellulitis caused by Gram-positive bacteria, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial testing the efficacy of oral glycopyrrolate liquid in reducing drooling in patients with cerebral palsy, neurological conditions, mental retardation, and sialorrhea, with inclusion and exclusion criteria outlined.",
    "This phase 3 trial will test the effectiveness of dutasteride (avodart) compared to placebo in treating benign prostatic hyperplasia in males over 50 years old who meet specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of dapagliflozin and placebo in treating type 2 diabetes mellitus, with inclusion criteria including A1C levels between 7.0 and 10.0%, C-peptide levels \u2265 1.0 ng/mL, and BMI \u2264 45 kg/m\u00b2.",
    "This phase 3 trial is testing the effectiveness of ac regimen, cyclophosphamide, doxorubicin hydrochloride, and paclitaxel in treating breast cancer patients with 0-3 positive axillary lymph nodes, and eligibility criteria includes negative tumor margins and no previous anthracycline chemotherapy.",
    "This phase 3 trial is testing the efficacy of Dymista nasal spray and fluticasone propionate nasal spray in treating allergic rhinitis in children aged 4 to 12 years, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for acromegaly, testing the efficacy of c2l-oct-01 pr and octreotide acetate prolonged release drugs, with specific inclusion and exclusion criteria for subjects.",
    "The sample is a phase 3 trial for fibromyalgia, testing the efficacy of xyrem\u00ae and placebo, with inclusion criteria based on ACR diagnostic criteria and exclusion criteria based on rheumatic disease or other disorders that may compromise reliable representation of subjective symptoms.",
    "This is a phase 3 trial for attention deficit hyperactivity disorder (ADHD) patients who have positive response to methylphenidate therapy and will be treated with either placebo, oros (methylphenidate hcl), or ritalin (methylphenidate) for three weeks, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for the treatment of hepatitis C with telaprevir and ribavirin, with inclusion criteria such as genotype 1 chronic hepatitis C and exclusion criteria such as contraindications to Pegasys\u00ae or Copegus\u00ae therapy, and the trial will test the ability of extended release nifedipine to decrease the dose of glucocorticoid medication for the treatment of congenital adrenal hyperplasia in children.",
    "This is a phase 3 trial for major depressive disorder, testing the drug desvenlafaxine succinate, with inclusion criteria for outpatients who completed a previous short-term study and exclusion criteria for clinically important abnormalities and significant risk of suicide.",
    "The sample is a phase 3 trial for cytomegalovirus infections, testing the efficacy of valganciclovir as a treatment option, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with mania or bipolar disorder, testing the efficacy of quetiapine fumarate and lithium, with inclusion criteria of a YMRS total score of at least 20 and exclusion criteria of known intolerance or lack of response to the drugs.",
    "This phase 3 trial is testing the efficacy of hydroxyurea in reducing transfusional iron overload in pediatric patients with severe forms of sickle cell anemia who have experienced a primary stroke, with inclusion criteria including age range of 5.0-18.9 years, transfusional iron overload, and adequate monthly erythrocyte transfusions, and exclusion criteria including inability to receive or tolerate chronic red blood cell transfusion therapy, inability to take or tolerate daily oral hydroxyurea, and abnormal laboratory values at initial evaluation.",
    "The sample is a phase 3 trial for erosive esophagitis, testing the efficacy and safety of lafutidine, famotidine, and omeprazole, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of MCI-196, a phosphate binder, in treating chronic kidney disease and hyperphosphatemia, with inclusion and exclusion criteria for eligible participants.",
    "The sample is a phase 3 trial for bipolar disorder and depression, testing the efficacy of ziprasidone and placebo, with inclusion criteria requiring therapeutic dose of lithium, valproate or lamotrigine for at least 4 weeks prior to randomization.",
    "This phase 3 trial is testing the efficacy of bortezomib in patients with multiple myeloma who require second-, third-, or fourth-line therapy due to disease progression, and have measurable disease and meet certain eligibility criteria.",
    "The sample is a phase 3 trial for prostate cancer patients with eligibility criteria including PSA relapse or incurable disease, and the use of antiandrogen therapy and releasing hormone agonist therapy as drugs.",
    "This is a phase 3 trial for female patients with histologically proven, core-biopsied, invasive breast cancer of any clinical and/or radiological T-stage (except for T4d), testing the efficacy of epirubicin, docetaxel, capecitabine, and trastuzumab, with eligibility criteria including age 18-70 years, WHO performance status \u2264 2, and normal cardiac function confirmed by LVEF (echocardiography or Muga scan).",
    "The sample is a phase 3 trial for patients with type 2 diabetes and moderate or severe renal impairment, testing the efficacy of vildagliptin and placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with cystic fibrosis and a first or early lower respiratory tract infection with Pseudomonas aeruginosa, testing the efficacy of tobramycin solution for inhalation 300 mg as a treatment option, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for cancer pain management, testing the efficacy of oxycodone cr and r331333, with inclusion criteria including documented clinical diagnosis of cancer and chronic malignant tumor-related cancer pain, and exclusion criteria including uncontrolled/clinically significant arrhythmia and history of alcohol and/or drug abuse.",
    "This phase 3 trial is testing the efficacy of bardoxolone methyl (20mg) in patients with chronic renal insufficiency and type 2 diabetes who are taking ACE inhibitors and/or ARBs, with inclusion criteria including a screening eGFR of 15.0-30.0 mL/min/1.73 m2 and mean systolic blood pressure \u2264 160 mmHg and \u2265 105 mmHg.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of valsartan and nateglinide combinations, with inclusion criteria of impaired glucose tolerance and age-dependent risk factors, and exclusion criteria of frank diabetes.",
    "This phase 3 trial is testing the efficacy of ezetimibe and various statins in managing hypercholesterolemia in patients of South Asian descent with a diagnosis of primary hypercholesterolemia and who are defined as being \"high risk\" with a diagnosis of CAD or diabetes, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of budesonide/formoterol (symbicort) pmdi and formoterol turbuhaler, with inclusion criteria including a COPD diagnosis, smoking history, and recent exacerbations, and exclusion criteria including asthma, allergic rhinitis, and significant comorbidities.",
    "The sample is a phase 3 trial for hyperlipidemia using fenofibrate/simvastatin and simvastatin drugs, with inclusion criteria of mixed dyslipidemia and exclusion criteria of hypersensitivity to the drugs, pregnancy or lactation, contra-indication to the drugs, and unstable or severe cardiac disease.",
    "The sample is a phase 3 trial for non-small cell lung cancer patients who have received induction therapy with specific chemotherapeutic doublets, and will test the efficacy of pemetrexed and placebo as maintenance therapy.",
    "The sample is a phase 3 trial for pharyngitis, testing the efficacy of placebo, flurbiprofen, and acetaminophen 650mg, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of clobetasone butyrate 0.05% cream and vehicle cream on eczema patients with specific inclusion and exclusion criteria, including a body surface area involvement of less than or equal to 10% and a score greater than or equal to 3 on the investigators global assessment of eczema severity.",
    "This phase 3 trial is testing dabrafenib and trametinib, along with a placebo, on patients with BRAF V600E/K mutation-positive cutaneous melanoma that is either Stage IIIC or Stage IV, and who have not received prior treatment with a BRAF or MEK inhibitor.",
    "This phase 3 trial is testing the efficacy of telmisartan+amlodipine and amlodipine in treating essential hypertension in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "The sample is a phase 3 clinical trial for the treatment of common cold and pharyngitis using acetylsalicylic acid (aspirin complex, baye4465) + pseudoephedrine, acetylsalicylic acid (aspirin, baye4465), pseudoephedrine, or placebo, with specific eligibility and exclusion criteria.",
    "This is a phase 3 trial for multiple sclerosis patients, testing the efficacy of rnf and placebo drugs, with eligibility criteria including a new neurological abnormality, clinically silent lesions on MRI, and EDSS 0-5.0, while exclusion criteria include a history of MS, use of other MS drugs, and autoimmune disease.",
    "This phase 3 trial is testing the efficacy of celecoxib, a nonsteroidal anti-inflammatory drug, in treating symptomatic osteoarthritis of the hip in subjects aged 50 or older who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This phase 3 trial is testing the efficacy of brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension, brinzolamide 1% ophthalmic suspension, and brimonidine tartrate 0.2% ophthalmic solution in treating open-angle glaucoma and ocular hypertension in patients who are insufficiently controlled on monotherapy or are currently on multiple IOP-lowering medications, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for osteoporosis using bazedoxifene acetate as the drug, with inclusion criteria for postmenopausal women with osteoporosis and exclusion criteria for certain diseases and history of venous thromboembolic events.",
    "The sample is a phase 3 trial for heavy menstrual bleeding, testing the effectiveness of levosert-20 and mirena, with eligibility criteria including non-pregnant, non-lactating non-menopausal females at least 18 years of age and exclusion criteria including abnormal liver function, renal insufficiency, and known or suspected pregnancy.",
    "This phase 3 trial is testing the effectiveness of gefitinib, a drug used to treat lung cancer, on patients with adenocarcinoma of the lung who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for chronic low back pain, testing the efficacy of duloxetine and placebo, with inclusion criteria of male/female outpatients 18 years of age and exclusion criteria including major depressive disorder and daily narcotics use.",
    "The sample is a phase 3 trial for hypertension using candesartan cilexetil and hydrochlorothiazide as drugs, with eligibility criteria including primary hypertension and mean sitting DBP 90-114 mmHg, and exclusion criteria including secondary or malignant hypertension, myocardial infarction, stroke, and chronic liver disease.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of canagliflozin and sitagliptin against placebo, with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for colorectal cancer patients who have undergone curative surgery, and the study will test the efficacy of capecitabine, 5-fluorouracil (5-fu), leucovorin calcium, and oxaliplatin as well as eligibility criteria for the trial.",
    "This phase 3 trial is testing the drug lapatinib on female patients with metastatic breast cancer who have progressed on prior therapies, and have documented amplification of the ErbB2 gene or overexpression of the ErbB2 protein, with eligibility criteria including measurable lesions and adequate organ function.",
    "The sample is a phase 3 trial for cystic fibrosis patients receiving pancrelipase delayed release or placebo, with inclusion criteria including confirmed CF diagnosis and PEI, and exclusion criteria including ileus or acute abdomen and history of fibrosing colonopathy.",
    "This phase 3 trial is testing the efficacy of double-blind placebo and double-blind or open label PR OROS methylphenidate in treating attention deficit disorder with hyperactivity in patients who have completed a previous study and meet certain inclusion criteria, while excluding patients with certain psychiatric conditions or allergies to methylphenidate.",
    "The sample is a phase 3 trial for breast cancer patients with HER2/c-neu overexpression, testing the efficacy of a combination of drugs including docetaxel, trastuzumab, epirubicin, cyclophosphamide, 5-fluoruracil, and granulocyte-colony stimulating growth factor, with specific eligibility criteria for inclusion and exclusion.",
    "This phase 3 trial is testing the efficacy of ranibizumab in treating visual impairment caused by macular edema following branch retinal vein occlusion, with specific inclusion and exclusion criteria, and the diseases and icd-10 codes listed include visual impairment, macular edema, and branch retinal vein occlusion.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) using formoterol fumarate inhalation solution as a drug, with inclusion criteria of COPD diagnosis and smoking history, and exclusion criteria of asthma or other significant conditions.",
    "The sample is a phase 3 trial for premenopausal women with breast cancer or osteoporosis, testing the efficacy of risedronate sodium, with eligibility criteria including age, performance status, and contraindications such as hypercalcemia and previous bisphosphonate treatment.",
    "The sample is a phase 3 trial for relapsed or progressed non-Hodgkin's lymphoma patients who responded to Galiximab in combination with Rituximab, with eligibility criteria including bidimensionally measurable disease and acceptable hematologic, hepatic, and renal function.",
    "The sample is a phase 3 trial for the treatment of partial epilepsies and partial onset seizures using lacosamide, with inclusion criteria being eligible subjects who participated in SP925 and exclusion criteria being receiving any study drug or experimental device other than lacosamide, meeting withdrawal criteria for parent study SP925, and experiencing ongoing serious adverse event.",
    "The sample is a phase 3 trial for HIV/AIDS patients, testing the efficacy of enfuvirtide, emtricitabine/tenofovir, and lopinavir or efavirenz, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for kidney transplantation using tacrolimus as the drug, with inclusion criteria for patients receiving a kidney transplant from a cadaveric or living non HLA identical donor between 5 and 65 years of age, and exclusion criteria for patients with a high immunological risk or cold ischaemia time of the donor kidney >30 hours.",
    "The sample is a phase 3 trial for chronic hepatitis C patients, testing the efficacy of ribavirin, placebo, and boceprevir, with specific eligibility and exclusion criteria.",
    "The sample is a phase 3 trial for paricalcitol in Chinese patients with chronic kidney disease on hemodialysis, with inclusion criteria based on intact parathyroid hormone, serum calcium, and calcium-phosphorus product levels, and exclusion criteria including history of drug or alcohol abuse and poor compliance with diet, medication, or hemodialysis.",
    "The sample is a phase 3 trial for osteoarthritis treatment with two drugs, mk0663 and etoricoxib, and a comparator drug, celecoxib, with inclusion criteria of osteoarthritis of the knee or hip and exclusion criteria of known allergy to the study drugs.",
    "The sample is a phase 3 trial for myocardial infarction, testing the efficacy of enoxaparin, tenecteplase, and clopidogrel, with inclusion criteria of age 18 or older, onset of symptoms less than 3 hours prior to randomization, and informed consent received, and exclusion criteria related to bleeding events and the inability to evaluate the study primary endpoint.",
    "This phase 3 trial is testing the efficacy of fixed dose combination of telmisartan+amlodipine and amlodipine in treating essential hypertension that is not adequately controlled with amlodipine monotherapy, with inclusion and exclusion criteria specified.",
    "This is a phase 3 trial for the treatment of schizophrenia, schizoaffective disorders, and psychotic disorders using quetiapine ir, with inclusion criteria for men and women aged 18 to 65 years and exclusion criteria for significant and unstable conditions of heart, circulation, blood, liver, kidney, malignancies, diabetes, history of fits or fainting, resistance to antipsychotic medication, current alcohol/drug abuse, and pregnant/breastfeeding women.",
    "This is a phase 3 trial for the drug flibanserin to treat sexual dysfunctions in women, with specific inclusion and exclusion criteria, and a list of relevant icd-10 codes.",
    "This phase 3 trial is testing the efficacy of ranibizumab in treating age-related macular degeneration, with patients meeting specific inclusion and exclusion criteria, and receiving one of three different dosages of the drug.",
    "This phase 3 clinical trial is testing the effectiveness of insulin glulisine / insulin glargine and insulin glulisin / insulin detemir in treating type 1 diabetes mellitus with specific eligibility criteria, including a concentration of C-peptide < 0.1 nmol//l and a fasting blood glucose of >= 1.26 g/l, and exclusion criteria such as recent history of severe hypoglycaemia and altered hepatic function.",
    "The sample is a phase 3 trial for asthma with a list of icd-10 codes, testing the efficacy of budesonide/formoterol, fluticasone/salmeterol, and albuterol as maintenance therapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for insomnia, testing the efficacy of esmirtazapine and placebo, with inclusion and exclusion criteria related to medical and psychiatric illness, sleep disorders, and substance abuse.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of bi 10773 and placebo drugs in combination with pioglitazone or metformin, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for schizophrenia, testing the efficacy of asenapine and placebo, with inclusion criteria including a primary diagnosis of schizophrenia and exclusion criteria including concurrent psychiatric disorders other than schizophrenia.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of pioglitazone, placebo, and rivoglitazone hcl, with inclusion criteria including A1C > 7% and non-fasting C-peptide > 0.5ng/mL.",
    "The sample is a phase 3 trial for fibromyalgia, testing the efficacy of pregabalin and placebo, with inclusion criteria requiring patients to have fibromyalgia and exclusion criteria excluding patients with other painful conditions.",
    "The sample is a phase 3 trial for essential hypertension, testing the efficacy and safety of olmesartan medoxomil, amlodipine, and hydrochlorothiazide, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of elvitegravir, raltegravir, and a background regimen in treating HIV infection in patients with documented resistance or prior experience with two or more classes of antiretroviral agents, with eligibility criteria including normal ECG, adequate renal and hematologic function, and negative pregnancy test.",
    "This phase 3 trial will test the effectiveness of ramosetron and granisetron in preventing vomiting and nausea in cancer patients undergoing chemotherapy, with specific eligibility criteria including age, performance status, and exclusion criteria such as recent radiotherapy or concurrent diseases that may cause vomiting.",
    "The sample is a phase 3 trial for patients with myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms, testing the drug decitabine, with eligibility criteria including age over 60, bone marrow blast count, and no prior intensive chemotherapy.",
    "The sample is a phase 3 trial for dyslipidemias and coronary heart disease using drugs abt-335, placebo, atorvastatin, and ezetimibe, with inclusion criteria based on mixed dyslipidemia and exclusion criteria for unstable medical conditions and certain medications.",
    "The sample is a phase 3 clinical trial for psoriasis vulgaris, testing the efficacy of LEO 80185 gel and tacalcitol ointment, with eligibility criteria including a minimum PASI score and exclusion criteria such as recent systemic treatment with biological or other therapies, and skin disorders on the treatment area.",
    "The sample is a phase 3 trial for atopic dermatitis, testing the efficacy of tacrolimus ointment and placebo ointment, with inclusion criteria of patients aged 16 or older with a Rajka/Langeland score of at least 3, and exclusion criteria of patients with genetic epidermal barrier defects or clinically significant skin infections on the affected area.",
    "This phase 3 trial is testing the efficacy of netupitant and palonosetron, palonosetron, and dexamethasone in preventing chemotherapy-induced nausea and vomiting in patients with solid malignant tumors receiving anthracycline and cyclophosphamide containing moderately emetogenic chemotherapy.",
    "The sample is a phase 3 trial for melanoma patients with measurable disease, testing the efficacy of dacarbazine plus genasense and dacarbazine plus placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of vortioxetine and placebo, with inclusion and exclusion criteria, and randomisation criteria for patients in remission.",
    "The sample is a phase 3 clinical trial for chronic prostatitis with chronic pelvic pain syndrome and prostatitis, testing the effectiveness of botulinum toxin type A compared to placebo, with specific eligibility and exclusion criteria.",
    "The sample is a phase 3 trial for diabetic macular edema, testing the efficacy of intravitreal aflibercept injection (iai; eylea\u00ae; bay86-5321) with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for venous thromboembolism, testing the efficacy of enoxaparin sodium, semuloparin sodium, and placebo in preventing deep vein thrombosis or pulmonary embolism in patients undergoing standard surgery for fracture of the upper third of the femur, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of paliperidone er in treating schizophrenia in participants who have previously been treated with Risperdal, Zyprexa or Seroquel and have had unsatisfactory results, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for bladder cancer using mitomycin c as the drug, with eligibility criteria including confirmed solitary primary or recurrent papillary transitional cell carcinoma of the bladder, negative urine cytology, and no prior history of T1 G3 tumors or muscle invasive tumors, among others.",
    "The sample is a phase 3 trial for advanced or metastatic soft tissue sarcoma, testing the efficacy of doxorubicin hydrochloride and ifosfamide, with eligibility criteria including measurable disease with evidence of progression in prior 6 weeks and no symptomatic or known CNS metastases.",
    "The sample is a phase 3 trial for chronic hepatitis C infection using peginterferon alfa-2a as the drug, with eligibility criteria including quantifiable HCV RNA, compensated liver disease without cirrhosis, and negative pregnancy test, among others.",
    "This phase 3 trial is testing the efficacy of insulin degludec and insulin glargine in insulin-na\u00efve subjects with type 2 diabetes and HbA1c levels between 7.0-10.0%, who are currently on metformin monotherapy or metformin in combination with other drugs, and have a BMI below or equal to 45.0 kg/m^2, while excluding those with certain medical conditions and recent use of specific medications.",
    "The sample is a phase 3 trial for advanced metastatic kidney cancer using fluorouracil as a drug, with eligibility criteria including confirmed renal cell carcinoma, measurable disease, and specific hematopoietic and cardiovascular requirements.",
    "The sample is a phase 3 trial for postmenopausal osteoporosis, testing the efficacy of alendronate and denosumab (amg 162) in improving bone mineral density, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the efficacy of Rebif new formulation in combination with prophylactic or PRN ibuprofen for relapsing multiple sclerosis patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for exercise-induced asthma in children aged 6-14, testing the efficacy of montelukast sodium, salmeterol xinafoate, and fluticasone propionate, with matching placebos, and the inclusion and exclusion criteria for the trial.",
    "The sample is a phase 3 trial for essential hypertension, testing the efficacy of olmesartan medoxomil and amlodipine, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of tapentadol extended release and morphine sulphate controlled release in treating chronic malignant tumor-related pain in opioid-na\u00efve or dissatisfied patients, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of saredutant succinate in treating major depressive disorder, with inclusion criteria including a confirmed diagnosis of MDD and a minimum MADRS score of 22, while exclusion criteria include a history of failure to respond to treatment with paroxetine or other antidepressant medications.",
    "The sample is a phase 3 trial for allergic rhinitis, testing the efficacy of bdp and placebo drugs, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for schizoaffective disorder, testing the efficacy of paliperidone palmitate and placebo, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for HIV infections testing the efficacy of nevirapine ir and nevirapine xr drugs with specific eligibility and exclusion criteria.",
    "The sample is a phase 3 trial for patients with mantle cell lymphoma who have received prior therapies and are refractory to at least 1 regimen, testing the efficacy of temsirolimus and investigator's choice drugs, with eligibility criteria including confirmation of MCL and exclusion criteria including active CNS metastases.",
    "The sample is a phase 3 trial for major depressive disorder using duloxetine as the drug, with inclusion criteria of being diagnosed with major depressive disorder and exclusion criteria of having a history of alcohol or drug dependence or abuse within the past 6 months.",
    "The sample is a phase 3 trial for patients with hypercholesterolemia and coronary heart disease, testing the effectiveness of rosuvastatin, ezetimibe, and simvastatin in reducing cholesterol levels, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for breast cancer patients, testing the efficacy of a combination of drugs including docetaxel, epirubicin, cyclophosphamide, 5-fluoruracil, and granulocyte-colony stimulating growth factor, with specific eligibility criteria for patients.",
    "This phase 3 trial is testing the efficacy of suvorexant high and low dose compared to placebo in treating primary insomnia, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the efficacy of indacaterol and tiotropium compared to placebo in treating moderate to severe chronic obstructive pulmonary disease (COPD) in patients with a smoking history of at least 10 pack years and specific lung function criteria.",
    "The sample is a phase 3 trial testing the efficacy of risperidone in treating various behavioral disorders, including oppositional defiant disorder and bipolar disorder, with specific inclusion and exclusion criteria, while the drugs column lists only risperidone.",
    "The sample is a phase 3 trial for severe persistent asthma using omalizumab and placebo, with specific inclusion and exclusion criteria, and the presence of non-atopic asthma.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the drug kad-1229, with inclusion criteria of inadequate glycemic control and HbA1c range of \u2265 6.5 to < 9%, and exclusion criteria of type 1 diabetes mellitus and serious complications.",
    "This is a phase 3 trial for rheumatoid arthritis using adalimumab as the drug, with specific inclusion and exclusion criteria for eligible subjects.",
    "The sample is a phase 3 clinical trial for multiple myeloma patients who have received at least three cycles of initial systemic therapy and are within 2-10 months of initiation of the initial therapy, and the trial will test the efficacy of thalidomide and dexamethasone as drugs, with eligibility criteria including meeting the Durie and Salmon criteria for initial diagnosis of MM and having adequate organ function.",
    "The sample is a phase 3 clinical trial for diabetes mellitus, testing the effectiveness of insulin glulisine, lispro, and insulin glargine, with inclusion criteria of type 1 or type 2 diabetic patients with HbA1c levels between 6.5% and 11.0%, and exclusion criteria of pregnant women.",
    "This phase 3 trial is testing the drug E2007 on male or female patients with Parkinson's disease who have completed a previous study and meet certain eligibility criteria, while excluding patients with certain medical conditions or taking certain medications.",
    "This phase 3 trial is testing the efficacy of unfractionated heparin in treating submassive pulmonary embolism, with specific inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of cyclophosphamide, docetaxel, and doxorubicin in treating breast cancer patients who meet specific eligibility criteria, including having undergone prior mastectomy or lumpectomy, and having no metastatic disease, while also meeting various patient characteristics such as having a life expectancy of at least 10 years and no grade 2 or greater peripheral neuropathy.",
    "This is a phase 3 clinical trial for male osteoporosis, testing the efficacy of ibandronate and placebo drugs, with inclusion and exclusion criteria including age, bone density, medical history, and previous treatments.",
    "The sample is a phase 3 trial for acute gouty arthritis, testing the effectiveness of indomethacin and celecoxib, with inclusion criteria based on ACR criteria for acute arthritis of primary gout and exclusion criteria including acute polyarticular gout involving greater than 4 joints or chronic gout.",
    "The sample is a phase 3 clinical trial for bipolar disorder, testing the efficacy of aripiprazole, with inclusion criteria of clinical diagnosis of bipolar I disorder, manic or mixed episode, and exclusion criteria of first manic or mixed episode, allergy or intolerance to lithium and valproate or aripiprazole, and previous participation in a clinical trial with aripiprazole.",
    "The sample is a phase 3 trial for advanced, incurable squamous cell carcinoma of the head and neck, testing the efficacy of methotrexate and paclitaxel in patients who are ineligible for cisplatin-based therapy due to various reasons, with specific eligibility criteria for patients' disease characteristics, patient characteristics, and prior concurrent therapy.",
    "This phase 3 trial is testing the efficacy of vortioxetine and placebo in treating major depressive disorder, with strict inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for open-angle glaucoma and ocular hypertension, testing the effectiveness of brinzolamide and dorzolamide eye drops, with eligibility criteria including age and diagnosis, and exclusion criteria including pregnancy.",
    "The sample is a phase 3 clinical trial for major depressive disorder, testing the efficacy of ly2216684 and placebo in combination with an SSRI, with specific inclusion and exclusion criteria, and using pre-defined psychiatric scales to assess diagnosis of depression, disease severity, and response to SSRI treatment.",
    "This phase 3 trial is testing the effectiveness of budesonide, a drug used to treat ulcerative colitis, on patients who have completed a previous study and are not in clinical remission, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of placebo in treating ankylosing spondylitis in adult patients who have had an inadequate response or are intolerant to previous non-steroidal anti-inflammatory drugs, and have withdrawn from traditional disease-modifying anti-rheumatic drugs for at least 4 weeks prior to baseline, with exclusion criteria including a history of severe allergic reactions to monoclonal antibodies and body weight over 150 kg.",
    "This phase 3 trial is testing the efficacy of amantadine in treating chronic hepatitis C, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with confirmed acute symptomatic pulmonary embolism, testing the efficacy of rivaroxaban, unfractionated heparin, and warfarin as treatments, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes, testing the efficacy of dapagliflozin and thiazolidinedione (pioglitazone) in controlling glycemic levels, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of ranibizumab and sham injection in treating diabetic macular edema in patients with diabetes mellitus, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for ocular hypertension and open-angle glaucoma, testing the efficacy of timolol/fdc/placebo/tafluprost, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is testing the efficacy of wal801cl dry syrup and ketotifen fumarate dry syrup in treating moderate to severe perennial allergic rhinitis in children aged 15 or younger, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of alo-02, an opioid analgesic, versus placebo in treating moderate-to-severe chronic low back pain, with a focus on patients who require continuous around-the-clock opioid analgesic for an extended period of time, and have refrained from taking other opioid and non-opioid medications during the study. The trial includes patients with chronic pain, low back pain, and analgesia, and the icd-10 codes for these diseases are also provided. The eligibility criteria and exclusion criteria are also listed.",
    "The sample is a phase 3 trial for HIV-1 positive adults testing the efficacy of lopinavir/ritonavir with nucleoside reverse transcriptase inhibitors, with inclusion criteria including <7 days of prior antiretroviral therapy and plasma HIV-1 RNA levels >= 1,000 copies/mL, and exclusion criteria including abnormal laboratory results such as HBsAg presence and ALT or AST >= 3.0 x ULN.",
    "The sample is a phase 3 trial for asthma patients with inclusion criteria such as a diagnosed history of asthma for at least 6 months, FEV1 >70% of predicted normal value, and positive skin prick test to pollen, animal dander or house dust mite, and the trial will test the effectiveness of formoterol and budesonide/formoterol.",
    "The sample is a phase 3 trial testing the effectiveness of doripenem, an antibiotic, in treating complicated lower urinary tract infections or pyelonephritis, with a list of relevant icd-10 codes and eligibility criteria provided.",
    "The sample is a phase 3 trial for patients with cystic fibrosis and chronic pseudomonas aeruginosa infection, testing the efficacy of liposomal amikacin for inhalation and tobramycin inhalation solution, with specific eligibility criteria for inclusion and exclusion.",
    "This phase 3 trial is testing the efficacy of ee20/drsp and ethinylestradiol/desogestrel in reducing hormone withdrawal symptoms in healthy female subjects using low-dose oral contraceptives, who suffer from at least two of the symptoms, including headache, pelvic pain, and bloating, and meet the inclusion criteria, while excluding those with a history of thrombotic/thromboembolic events, migraine with focal neurological symptoms, diabetes mellitus with vascular involvement, obesity, moderate to severe hypertension, pancreatitis, severe hepatic disease, jaundice and/or pruritus related to cholestasis, severe renal insufficiency or acute renal failure, liver tumors, or known or suspected sex-steroid influenced malignancies or premalignant disease.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin, liraglutide, glimepiride, and metformin, with eligibility criteria including stable metformin monotherapy and exclusion criteria including impaired liver or kidney function, history of malignancy, and contraindications to the drugs being tested.",
    "This phase 3 trial is testing the efficacy of fluvastatin and standard therapy in patients with chronic nephropathy, proteinuria, and hypertension, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for non-small-cell lung carcinoma using the drug zd6474 (vandetanib) with eligibility criteria including patients who have exhausted standard cancer treatments, and exclusion criteria including recent chemotherapy or significant cardiovascular events.",
    "The sample is a phase 3 clinical trial for Parkinson's disease patients who are being treated with carbidopa/levodopa/entacapone (CLE) and have predictable \"off\" periods, and the trial will test the efficacy of ipx066 and CLE drugs.",
    "The sample is a phase 3 trial for patients with chronic obstructive airways disease, testing the efficacy of salmeterol/fluticasone propionate 50/500mcg diskus, with inclusion criteria of reduced lung function and a smoking history of at least 10 pack-years, and exclusion criteria of any other serious disease and a chest X-ray to eliminate a diagnosis other than COPD.",
    "The sample is a phase 3 trial for systemic lupus erythematosus, testing the efficacy of belimumab at two different doses and including eligibility criteria such as clinical diagnosis of SLE, active disease, and autoantibody positivity.",
    "The sample is a phase 3 trial for mixed dyslipidemia using fenofibrate/simvastatin and simvastatin drugs to treat cardiovascular diseases with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of frovatriptan 2.5 mg in treating menstrual associated migraine (MAM) in females aged 15 years and over with a documented history of migraine, and who meet specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for fibromyalgia using Xyrem\u00ae as the drug, with inclusion criteria requiring completion of previous studies and ability to take the drug for approximately 9-1/2 months, and exclusion criteria including early termination or adverse events related to the drug in previous studies.",
    "The sample is a phase 3 trial for major depressive disorder using risperidone as the drug, with inclusion criteria including a sub-optimal response to an antidepressant and exclusion criteria including the presence of other serious medical illnesses.",
    "The sample is a phase 3 trial for rheumatoid arthritis, testing the efficacy of golimumab and methotrexate compared to placebo, with specific eligibility criteria including a minimum dose of methotrexate and exclusion criteria for hypersensitivity to golimumab or history of certain infections.",
    "The sample is a phase 3 trial for patients with atrial fibrillation and atrial flutter, testing the effectiveness of warfarin and apixaban as well as eligibility criteria including age, previous stroke, and hypertension.",
    "The sample is a phase 3 trial for schizophrenia and schizoaffective disorder, testing the efficacy of d-serine and placebo drugs, with inclusion criteria being a diagnosis of either disorder and exclusion criteria being pregnancy or lactation.",
    "This phase 3 trial is testing the efficacy of qva149, nva237, tiotropium, and salbutamol/albuterol in treating severe to very severe chronic obstructive pulmonary disease (COPD) in patients aged \u226540 years with a smoking history of at least 10 pack years and a post-bronchodilator FEV1 <50% of the predicted normal value, who have had at least 1 COPD exacerbation in the previous 12 months, and meet other inclusion criteria.",
    "The sample is a phase 3 trial for osteoporosis testing zoledronic acid, alendronate, and calcium/vitamin D, with eligibility criteria including low bone mineral density in postmenopausal women and exclusion criteria including previous use of certain medications.",
    "The sample is a phase 3 trial for gout patients, testing the efficacy of febuxostat and allopurinol, with inclusion criteria including thiazide diuretic therapy and serum urate level less than 8.0 mg/dL, and exclusion criteria including intolerance of allopurinol.",
    "This phase 3 trial is testing the efficacy of gefitinib, a drug, in treating bladder cancer patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for patients with moderate to severe community acquired pneumonia, testing the efficacy of ampicillin sodium/sulbactam sodium as a treatment, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with non-valvular atrial fibrillation, testing the efficacy of idrabiotaparinux sodium, warfarin, and avidin, with inclusion criteria based on previous ischemic stroke, TIA, or systemic embolism, and at least two risk factors, while exclusion criteria include active bleeding, uncontrolled hypertension, and pregnancy or childbearing potential without proper contraceptive measures.",
    "This phase 3 trial is testing the efficacy of sorafenib tosylate and sunitinib malate in treating patients with primary-intact renal cell carcinoma eligible for nephrectomy with curative intent, with specific eligibility criteria including tumor size and absence of distant metastases.",
    "The sample is a phase 3 trial testing the efficacy of cellulose sulfate vaginal gel as a microbicide for preventing HIV infections, gonorrhea, and chlamydia infections in women with multiple male sexual partners, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of a combination of drugs, including 62.5/25mcg, 62.5mcg, 25mcg, and placebo, in treating chronic obstructive pulmonary disease (COPD) in patients who meet specific inclusion criteria, such as a diagnosis of COPD, a history of cigarette smoking, and a post-bronchodilator FEV1/FVC of <0.7.",
    "This phase 3 trial is testing the efficacy of bilastine and cetirizine compared to placebo in treating perennial allergic rhinitis in patients aged 12 to 70 years with positive skin prick test for at least one of the following perennial allergens, and with exclusion criteria including non-allergic rhinitis, negative skin prick test, and severe concomitant disease.",
    "The sample is a phase 3 trial for restless legs syndrome, testing the drug ropinirole, with inclusion criteria including a diagnosis of RLS and written informed consent, and exclusion criteria including other primary sleep disorders or movement disorders.",
    "This phase 3 trial is testing the efficacy of carboplatin, cisplatin, doxorubicin hydrochloride, methotrexate, paclitaxel, and vinblastine sulfate in treating bladder and urethral cancer patients who have undergone radical cystectomy and pelvic lymph node dissection, with specific eligibility criteria for disease and patient characteristics.",
    "The sample is a phase 3 trial for hypertension using the drug aliskiren/hctz, with inclusion criteria of patients with hypertension and exclusion criteria of severe hypertension and previous or current diagnosis of heart failure.",
    "The sample is a phase 3 trial for polycythemia vera, testing the efficacy and safety of hydroxyurea, with inclusion criteria including new or old diagnosis of PV and willingness to comply with study requirements, and exclusion criteria including significant liver or renal disease and history of substance or alcohol abuse.",
    "This is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) testing the efficacy of GSK573719/GW642444, GSK573719, and placebo, with inclusion criteria including age 40 or older, COPD diagnosis, and at least 10 pack-year smoking history, and exclusion criteria including current diagnosis of asthma, other respiratory disorders other than COPD, and use of certain medications within a certain timeframe.",
    "This phase 3 trial is testing the effectiveness of quetiapine sr in treating anxiety disorders, with inclusion criteria of patients aged 18-65 with a diagnosis of GAD according to DSM-IV criteria, and exclusion criteria of patients with depressive symptoms, while diseases are anxiety disorders and icd-10 codes are provided.",
    "The sample is a phase 3 trial for patients with secondary hyperparathyroidism and hemodialysis, testing the effectiveness of paricalcitol and maxacalcitol drugs on reducing iPTH levels, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for patients who have participated in previous studies with FK506E, testing its efficacy in heart, liver, and kidney transplantation, with inclusion and exclusion criteria listed, and FK506E being the drug of interest.",
    "The sample is a phase 3 trial for patients with coronary disease and left ventricular dysfunction, testing the efficacy of ivabradine versus placebo, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for metastatic prostate cancer, testing antiandrogen therapy, docetaxel, and goserelin acetate, with eligibility criteria including confirmed prostate adenocarcinoma, measurable or evaluable disease, and specific hematopoietic, hepatic, renal, and cardiovascular requirements.",
    "This is a phase 3 clinical trial for the treatment of schizophrenia using paliperidone palmitate, with inclusion criteria including a DSM-IV diagnosis of schizophrenia and a total PANSS score of 70 to 120, and exclusion criteria including a history of treatment resistance and pregnancy.",
    "This phase 3 trial is testing the efficacy of multiple daily injections of insulin glulisine, insulin lispro, insulin glargine, and NPH insulin in children with type 1 diabetes mellitus who have been on uninterrupted insulin therapy for at least 1 year and have a glycated hemoglobin level between \u2265 6.0 and \u226411.0 %.",
    "The sample is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) testing the efficacy of tiotropium and placebo drugs, with inclusion and exclusion criteria listed.",
    "This is a phase 3 trial for chronic myelogenous leukemia using peginterferon alfa-2a as the drug, with specific inclusion and exclusion criteria based on previous participation in related studies.",
    "The sample is a phase 3 trial for patients with soft tissue sarcoma, testing the efficacy of doxorubicin hydrochloride and ifosfamide, with eligibility criteria including confirmed diagnosis, measurable lesion with clinical evidence of progression, and specific patient characteristics such as age and performance status.",
    "This phase 3 trial is testing the efficacy of oxaliplatin + 5-fluorouracil/leucovorin and doxorubicin in treating unresectable hepatocellular carcinoma patients who have not received previous palliative systemic chemotherapy for metastatic disease and meet specific eligibility criteria.",
    "The sample is a phase 3 trial for the treatment of generalized anxiety disorder using vortioxetine and placebo, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for pulmonary hypertension using bosentan as the drug, with inclusion criteria of patients who completed protocol AC-052-366 and exclusion criteria of major protocol violations, pregnancy, or breastfeeding.",
    "This phase 3 trial is testing the efficacy of valsartan and amlodipine in treating moderate essential hypertension, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for breast cancer patients who have not responded to anti-estrogen hormonal treatment, and will test the drug fulvestrant, with inclusion criteria including positive estrogen receptor hormone sensitivity and postmenopausal status.",
    "This phase 3 trial is testing the efficacy of alogliptin and pioglitazone in treating type 2 diabetes mellitus with specific eligibility criteria, including a BMI between 23-45 kg/m2 and a fasting C-peptide concentration greater than or equal to 0.8 ng per mL.",
    "The sample is a phase 3 trial for chronic hepatitis C infection, testing the efficacy of abt-450/r/abt-267, abt-333, and ribavirin, with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for metastatic breast cancer patients, testing the efficacy of placebo, celecoxib, and exemestane drugs, with eligibility criteria including female patients aged over 18 years with histologically proven breast cancer, measurable lesion, and adequate biological values.",
    "The sample is a phase 3 trial testing the efficacy of capecitabine and celecoxib in combination with placebo for patients with metastatic colorectal or breast cancer, with eligibility criteria including adequate organ and bone marrow function, controlled brain metastasis, and no history of allergies to certain medications.",
    "This phase 3 trial is testing the efficacy of tiotropium inhalation solution in patients with asthma who are symptomatic despite low doses of inhaled corticosteroids, with a list of inclusion and exclusion criteria, and a list of drugs and icd-10 codes used.",
    "The sample is a phase 3 trial for major depressive disorder using escitalopram as the drug, with inclusion and exclusion criteria based on DSM-IV diagnostic criteria and medical history.",
    "This is a phase 3 trial for patients with schizophrenia, testing the effectiveness of risperdal consta and paliperidone palmitate, with inclusion criteria including a PANSS score between 60 and 120 and a diagnosis of schizophrenia for at least 1 year, and exclusion criteria including a history of treatment resistance and significant risk of suicidal or violent behavior.",
    "The sample is a phase 3 trial for newly diagnosed B-precursor acute lymphoblastic leukemia, testing a combination of drugs including cyclophosphamide, cytarabine, and doxorubicin hydrochloride, with eligibility criteria including age and white blood cell count, and prior concurrent therapy restrictions.",
    "The sample is a phase 3 trial for patients with CD20 and CD22-positive, follicular lymphoma, testing the efficacy of inotuzumab ozogamicin, rituximab, cyclophosphamide, vincristine, prednisone/prednisolone, mitoxantrone, fludarabine, and dexamethasone, with specific eligibility criteria for enrollment.",
    "The sample is a phase 3 trial for schizophrenia and schizoaffective disorder, testing the effectiveness of asenapine and olanzapine, with inclusion criteria being the presence of either disorder and signed informed consent, and exclusion criteria being uncontrolled medical conditions or other primary psychiatric disorders.",
    "The sample is a phase 3 trial for rheumatoid arthritis using rituximab as a drug, with inclusion criteria including inadequate response to anti-TNF treatment and stable methotrexate use, and exclusion criteria including previous treatment with MabThera and concurrent use of other DMARDs.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of linagliptin as an add-on therapy to metformin, with specific inclusion and exclusion criteria, and the trial will test the ability of the drug to lower HbA1c levels.",
    "This is a phase 3 trial for female patients with locally recurrent or metastatic breast cancer who have received at least two prior chemotherapeutic regimens, testing the efficacy of E7389 and physician's choice drugs, with eligibility criteria including resolution of toxicities, adequate organ function, and willingness to comply with the study protocol.",
    "The sample is a phase 3 trial for prostate cancer using orteronel, prednisone, and placebo drugs, with eligibility criteria including confirmed diagnosis of prostate adenocarcinoma, radiograph-documented metastatic disease, and prior chemotherapy treatment.",
    "The sample is a phase 3 trial testing the effectiveness of olmesartan medoxomil, losartan, and furosemide oral tablets in treating essential hypertension and renal impairment, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for colorectal cancer patients with specific eligibility criteria, testing the efficacy of fluorouracil, leucovorin calcium, and levamisole hydrochloride as treatment options.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of indacaterol 150 \u03bcg and placebo, with inclusion criteria including age over 40, a 20 pack-year smoking history, and post-bronchodilator forced expiratory volume in 1 second (FEV1) \u2265 30% and < 80% predicted FEV1/FVC, while exclusion criteria include history of asthma, prior exposure to indacaterol, active cancer or history of cancer, and concomitant pulmonary disease.",
    "This phase 3 trial is testing the efficacy of benzydamine hydrochloride 0.15% oral rinse in preventing oral and/or oropharyngeal mucositis in patients with high risk of developing it due to radiation to head and neck areas, who are scheduled to receive a continuous course of conventional or hyperfractionated external beam radiation for cancer of the head and neck region, and have at least two oral tissue sites planned to receive a total radiation dose of 5500 cGy or higher, given in a single daily fraction of 180 to 220 cGy or twice daily fractions of 110 to 150 cGy.",
    "This is a phase 3 trial for HIV infections testing the efficacy of atazanavir/ritonavir and LPV/r in immediate and delayed/optional switch groups, respectively, with inclusion criteria such as HIV positive, non-HDL higher than 160 mg/dL, and CD4 of at least 50 cells/mL, and exclusion criteria such as use of lipid-lowering agents.",
    "This phase 3 trial is testing the efficacy of hydroxychloroquine versus placebo in treating primary Sj\u00f6gren's syndrome, with specific inclusion and exclusion criteria for patients, and the trial will involve patients who have not previously been treated with hydroxychloroquine.",
    "This is a phase 3 trial for major depressive disorder, testing the efficacy of saredutant and placebo drugs, with specific inclusion and exclusion criteria for patients.",
    "The sample is a phase 3 trial for chronic plaque psoriasis, testing the efficacy of calcipotriol/betamethasone ointment and placebo, with eligibility criteria including failed response to at least two systemic therapies and exclusion criteria including previous exposure to adalimumab and pregnancy.",
    "This phase 3 trial is testing the efficacy of Sofosbuvir and Ribavirin in treating chronic genotype 2 or 3 Hepatitis C infection, with eligibility criteria including HCV RNA > 10,000 IU/mL and treatment-naive or experienced patients, while exclusion criteria include prior use of any other inhibitor of the HCV NS5B Polymerase and history of any other clinically significant chronic liver disease.",
    "The sample is a phase 3 trial for attention deficit hyperactivity disorder, testing the efficacy of atomoxetine hydrochloride and placebo, with inclusion and exclusion criteria based on DSM-IV-TR\u2122 criteria and comorbidities, respectively.",
    "This phase 3 trial is testing the efficacy of lamotrigine, a drug used to treat mood disorders, in an orally disintegrating tablet form for patients who have difficulty swallowing the compressed tablet form.",
    "This phase 3 trial is testing the efficacy of apremilast 20mg and 30mg compared to placebo in treating psoriatic arthritis, with strict inclusion and exclusion criteria including laboratory values and prior treatments.",
    "This phase 3 trial is testing the efficacy of ftc/tdf + efv or lpv/r +t20 and ftc/tdf + efv or lpv/r in treating chronic HIV-1 infection with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for rheumatoid arthritis using certolizumab pegol as a drug, with inclusion criteria of moderate to severe RA and failed DMARDs, and exclusion criteria of concomitant diseases, while the diseases are identified by icd-10 codes.",
    "The sample is a phase 3 trial for severe sepsis, testing the efficacy of eritoran tetrasodium and placebo, with inclusion and exclusion criteria including age, confirmed infection, organ dysfunction, and medical history.",
    "The sample is a phase 3 trial for epilepsy patients with tonic-clonic seizures, using levetiracetam as the drug, and with specific inclusion and exclusion criteria based on previous trials and the need for additional antiepileptic drugs.",
    "The sample is a phase 3 trial for metastatic colorectal cancer using panitumumab and folfiri, with eligibility criteria including a diagnosis of mCRC, radiologically documented disease progression, and adequate hematologic, renal, and hepatic functions.",
    "This phase 3 trial is testing the efficacy of preservative-free tafluprost and comparator timolol in treating open-angle glaucoma and ocular hypertension, with specific inclusion and exclusion criteria for patients.",
    "The sample is a phase 3 trial for HIV patients with plasma HIV-1 RNA levels \u2265 5,000 copies/mL, testing the efficacy of Stribild and Atripla drugs, with eligibility criteria including normal ECG, adequate renal and hematologic function, and highly effective contraception methods, while exclusion criteria include a new AIDS-defining condition, drug treatment for hepatitis C, and history of malignancy within the past 5 years.",
    "The sample is a phase 3 trial for Parkinson's disease, testing the efficacy of KW-6500 and its placebo on patients who meet specific inclusion criteria, while excluding patients with certain illnesses, mental diseases, and those taking certain medications.",
    "This phase 3 trial is testing the efficacy of rotigotine and placebo in treating advanced Parkinson's disease, with eligibility criteria including a stable dose of L-dopa and clinical symptoms of gastrointestinal dysfunction.",
    "The sample is a phase 3 trial for metastatic colorectal cancer using 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin, with eligibility criteria including bidimensionally measurable disease, adequate hematologic and liver function, and no previous chemotherapy other than adjuvant or concomitant chemoradiotherapy.",
    "This phase 3 trial is testing the effectiveness of escitalopram, an SSRI, on chronic schizophrenia patients with a PANSS score of 50 or above, who are on stable doses of antipsychotic medications for at least one month before the study entry, and are clinically stable and free of any additional axis I diagnosis or significant medical illnesses before enrollment into the study.",
    "This phase 3 trial is testing the efficacy of velcade, administered by subcutaneous injection or intravenous infusion, in treating relapsed or progressing multiple myeloma patients who have not previously received velcade, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) patients, testing the efficacy of roflumilast and placebo drugs, with inclusion and exclusion criteria based on exacerbation history and lung function.",
    "This is a phase 3 clinical trial for schizophrenia, testing the efficacy of lurasidone, olanzapine, and placebo comparator, with inclusion criteria including meeting DSM-IV criteria for schizophrenia and being off prior antipsychotic medication, and exclusion criteria including history of alcohol or drug abuse/dependence within the last 6 months.",
    "This phase 3 trial is testing the efficacy of netupitant and palonosetron, aprepitant, palonosetron, and dexamethasone in preventing chemotherapy-induced nausea and vomiting in patients with malignant tumors who are naive to cytotoxic chemotherapy and have an ECOG Performance Status of 0, 1, or 2.",
    "The sample is a phase 3 trial for children with asthma, testing the effectiveness of budesonide/formoterol pmdi 40/2.25ug + spacer and budesonide/formoterol pmdi 40/2.25 ug, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for perennial allergic rhinitis using ciclesonide hfa 160 \u03bcg as the drug, with eligibility criteria including completion of a previous study, good health, and negative pregnancy test for females, while exclusion criteria include pregnancy, nasal pathology, and any condition that would prevent completion of the study.",
    "This phase 3 trial is testing the efficacy of zoledronic acid in postmenopausal women with early breast cancer who have not received prior aromatase inhibitor treatment, and have been treated with tamoxifen for 2.5-3.5 years, with the goal of preventing bone loss and fractures.",
    "This phase 3 trial is testing the efficacy of bia 9-1067, placebo, levodopa, carbidopa, and benserazide in treating Parkinson's disease patients who have been diagnosed for at least 3 years and have signs of \"wearing-off\" phenomenon despite optimal anti-PD therapy.",
    "This phase 3 trial is testing the efficacy of fentanyl sublingual spray and placebo in treating breakthrough cancer pain in opioid-tolerant patients with a diagnosis of cancer, who have experienced persistent pain related to the cancer or its treatment of moderate or lesser intensity in the 24 hours prior to assessment, and have 1 to 4 breakthrough cancer pain episodes per day usually at least partially controlled by supplemental medication of at least 5 mg immediate-release morphine or an equivalent short-acting opioid.",
    "This phase 3 trial focuses on prostate cancer and tests the effectiveness of flutamide, zoladex, and lupron in treating patients who meet specific eligibility criteria, including having locally confined adenocarcinoma of the prostate and a Karnofsky performance status of at least 70.",
    "This is a phase 3 trial for relapsing-remitting multiple sclerosis, testing the efficacy of cladribine and placebo, with eligibility criteria including completion of randomized treatment course and normal hematologic parameters, and exclusion criteria including use of certain medications and treatments.",
    "The sample is a phase 3 trial for patients with pulmonary hypertension caused by primary PAH, associated with connective tissue disease or following surgical repair of a congenital heart lesion, testing the drug sildenafil citrate, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of ciclesonide and mometasone, two INCS drugs, in treating perennial allergic rhinitis, with eligibility criteria including a documented history of PAR and a positive skin-prick test for allergens.",
    "The sample is a phase 3 trial for patients with aggressive non-Hodgkin's lymphoma, testing the efficacy of cisplatin, cytarabine, dexamethasone, and gemcitabine hydrochloride, with eligibility criteria including age 16-65, ECOG 0-3 performance status, and no uncontrolled CNS involvement by lymphoma.",
    "The sample is a phase 3 trial for anemia patients with inclusion and exclusion criteria, testing the efficacy of ferric carboxymaltose and standard medical care, with a list of icd-10 codes and eligibility criteria for patients.",
    "The sample is a phase 3 trial for patients with essential diastolic hypertension, testing the efficacy of valsartan/amlodipine and valsartan in reducing blood pressure, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for aggressive non-Hodgkin's lymphoma, testing a combination of drugs including chop regimen, cyclophosphamide, and doxorubicin hydrochloride, with eligibility criteria including age between 18 to 60, ECOG 0-4, and no prior chemotherapy for NHL.",
    "This phase 3 trial is testing the efficacy of asacol 800 mg and asacol 400 mg in treating moderately active ulcerative colitis in patients between 18 and 75 years old, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for breast cancer patients undergoing myelosuppressive chemotherapy, testing the efficacy of ep2006 and filgrastim in treating chemotherapy-associated neutropenia, with inclusion criteria including histologically proven breast cancer and exclusion criteria including previous or concurrent malignancy, and estimated life expectancy of more than six months.",
    "This phase 3 trial is testing the efficacy of paliperidone palmitate and placebo in treating schizophrenia, with inclusion criteria including a diagnosis of schizophrenia, a PANSS score between 70 and 120, and a BMI greater than 17.0 kg/m2.",
    "The sample is a phase 3 trial for bipolar disorder using aripiprazole and placebo as drugs, with inclusion criteria for patients aged 4-9 years who meet DSM-IV criteria for bipolar disorder and exclusion criteria for patients with certain medical or neurological conditions, allergies to aripiprazole, or who are taking certain psychotropic agents.",
    "This phase 3 trial is testing the efficacy of paliperidone palmitate and placebo in treating schizophrenia in patients who meet specific inclusion criteria, including having a PANSS score of <120 and a DSM-IV-TM diagnosis of schizophrenia for at least 1 year before screening.",
    "This phase 3 trial is testing the efficacy of lamotrigine extended-release and placebo in treating epilepsy with tonic-clonic seizures, with specific inclusion and exclusion criteria for participants.",
    "This is a phase 3 clinical trial for patients with multiple myeloma, testing the effectiveness of bortezomib as a treatment option. The eligibility criteria includes having undergone ASCT as part of primary therapy and not having prior exposure to bortezomib, while exclusion criteria includes having neuropathy greater than grade 2 and having a history of hypotension.",
    "This is a phase 3 clinical trial for fibromyalgia patients with stable depression, testing the efficacy of pregabalin and placebo, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for bipolar disorder, testing the efficacy of quetiapine fumarate or valproate, with inclusion criteria of DSM-IV diagnosis for bipolar I or II disorder and exclusion criteria of substance or alcohol dependence, pregnancy, schizophrenia, and suicidal or aggressive behavior.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of tocilizumab and permitted DMARDs, with inclusion criteria of adult patients with active rheumatoid arthritis and exclusion criteria of previous treatment with tocilizumab or unsuccessful treatment with a biologic agent.",
    "The sample is a phase 3 trial for bipolar disorder and depression, testing the efficacy of seroquel (quetiapine fumarate) tablets, with inclusion criteria of written informed consent, bipolar disorder with most recent episode depressed, and outpatient status, and exclusion criteria of current Axis I disorder other than bipolar disorder within 6 months of screening and current episode of depression exceeding 12 months or less than 4 weeks.",
    "The sample is a phase 3 trial for multiple types of cancer, testing the effectiveness of doxorubicin hydrochloride and ifosfamide as treatment options, with eligibility criteria including histologically proven soft tissue sarcoma with pulmonary metastases and patient characteristics such as age, performance status, and no prior or concurrent other primary malignancy except adequately treated carcinoma in situ of the cervix or basal cell carcinoma.",
    "The sample is a phase 3 trial for patients with cystic fibrosis and exocrine pancreatic insufficiency, testing the efficacy of pancrease mt 10.5 or mt 21 versus placebo, with eligibility criteria including abnormal COA-fat and fecal elastase results, and stable diet and dose of pancreatic enzyme supplementation.",
    "This phase 3 trial is testing the efficacy of 0.15% and 0.1% azelastine hydrochloride and placebo in treating perennial allergic rhinitis in patients with a 2-year history of PAR and positive skin test to cockroach, dust mite, mold or cat/dog dander, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the combination therapy of alogliptin and a rapid-acting insulin secretagogue in patients with type 2 diabetes mellitus who are eligible for combination therapy, and have been receiving basic diabetes treatment with a stable dosage regimen of a rapid-acting insulin secretagogue for at least 10 weeks prior to the start of the observation period, and meet other inclusion criteria, while excluding patients with certain medical conditions or taking certain medications.",
    "The sample is a phase 3 trial for epilepsy, testing the effectiveness of topiramate and phenytoin in patients with new-onset or relapsed epilepsy, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of aripiprazole depot and placebo depot in treating schizophrenia, with inclusion and exclusion criteria outlined, and icd-10 codes provided for the disease.",
    "This phase 3 trial is testing the efficacy of insulin degludec, insulin aspart, and liraglutide in treating diabetes mellitus type 2, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial testing the effectiveness of ramipril and ramipril-telmisartan in treating hypertension, type 2 diabetes, and albuminuria, with specific eligibility and exclusion criteria listed.",
    "The sample is a phase 3 trial for asthma patients, testing the effectiveness of montelukast sodium and aminophylline hydrate, with eligibility criteria including adult participants with acute asthma attacks and exclusion criteria including smoking habits and other severe diseases.",
    "The sample is a phase 3 trial for patients with ovarian, peritoneal, or fallopian tube cancer, testing the efficacy of carboplatin and cisplatin, with eligibility criteria including tumor size and patient characteristics such as performance status and hematopoietic function.",
    "The sample is a phase 3 trial for rheumatoid arthritis using rituximab, with inclusion criteria based on previous participation in ML19070 and exclusion criteria including concurrent treatment with certain drugs, and the trial will test the ability of the drug to re-treat patients with DAS28 >2.6 after week 24.",
    "This phase 3 trial is testing the efficacy of fluticasone furoate 50mcg and placebo in treating asthma, with inclusion criteria such as a pre-bronchodilator FEV1 of at least 60% predicted and exclusion criteria such as a history of life-threatening asthma exacerbation within the past 10 years.",
    "The sample is a phase 3 trial for chronic hepatitis C, testing daily infergen and ribavirin for up to 48 weeks, with specific inclusion and exclusion criteria for patient enrollment.",
    "This phase 3 trial is testing the efficacy of docetaxel and leuprolide acetate in treating prostate cancer patients who meet specific eligibility criteria, including having a predicted probability of 5-year freedom from progression \u2264 60% and no evidence of metastasis on bone-scan, chest x-ray, and abdominal CT scan.",
    "This phase 3 trial is testing the efficacy of memantine in treating patients with obsessive-compulsive disorder or generalized anxiety disorder who meet specific inclusion criteria and do not have any exclusion criteria.",
    "The sample is a phase 3 trial for metastatic colorectal cancer with EGFR-positive tumors, testing the combination of oxaliplatin, leucovorin, and 5-fluorouracil, with eligibility criteria including prior irinotecan treatment and exclusion criteria such as prior oxaliplatin therapy and known DPD deficiency.",
    "This phase 3 trial will test the efficacy of bevacizumab, placebo, and chemotherapy in treating metastatic breast cancer patients who meet specific eligibility criteria.",
    "The sample is a phase 3 clinical trial for Alzheimer's disease, testing the drug galantamine hbr, with inclusion criteria including a diagnosis of mild to moderate probable AD and an MMSE score of 10-24, and exclusion criteria including neurodegenerative disorders such as Parkinson's disease and evidence of multi-infarct dementia or clinically active cerebrovascular disease.",
    "This phase 3 trial is testing the effectiveness of olmesartan, an AT II inhibitor, in patients with documented paroxysmal atrial fibrillation and excludes patients with various cardiac and renal conditions, as well as those on certain medications or with drug intolerance.",
    "This phase 3 trial is testing the efficacy of act-129968, placebo, and cetirizine in treating seasonal allergic rhinitis associated with mountain cedar pollen, with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for chronic pain patients treated with hydrocodone bitartrate, with eligibility criteria including opioid use for at least 3 months and an average daily dose of at least 30 mg, and exclusion criteria including uncontrolled blood pressure and BMI over 45 kg/m2.",
    "The sample is a phase 3 trial for schizophrenia, testing the efficacy of asenapine and haloperidol, with inclusion criteria of acute exacerbation of schizophrenia and exclusion criteria of uncontrolled medical conditions or other psychiatric disorders.",
    "This phase 3 trial is testing the effectiveness of lamictal, an anti-epileptic drug, in treating newly diagnosed or recurrent epilepsy in patients who meet specific inclusion criteria and do not have certain exclusion criteria.",
    "This phase 3 trial is testing the efficacy of 10% metronidazole ointment for treating Crohn's disease with anorectal involvement, with eligibility criteria including a PCDAI of 5 or above and stable concomitant medication, while exclusion criteria include recent surgery or perianal abscess, allergy to metronidazole, and recent participation in an experimental drug study.",
    "The sample is a phase 3 trial for hypercholesterolemia using atorvastatin and ezetimibe, with inclusion criteria of LDL-C >70 mg/dL and exclusion criteria of pregnancy or sensitivity/intolerance to the drugs.",
    "This phase 3 trial is testing the drug lapatinib in women with ErbB2-overexpressing invasive carcinoma of the breast who have undergone excision of tumor and received neoadjuvant or adjuvant chemotherapy containing either an anthracycline or a taxane, and meet certain eligibility criteria.",
    "The sample is a phase 3 trial for Alzheimer's disease using rivastigmine transdermal patch as the drug, with inclusion criteria of completing the double-blind treatment phase without significant protocol violations.",
    "The sample is a phase 3 trial for renal cell carcinoma with metastases, testing the drugs interferon-alfa and su011248, with inclusion criteria of clear cell histology and measurable disease, and exclusion criteria of prior systemic therapy or brain metastases.",
    "This phase 3 trial is testing erlotinib and carboplatin/gemcitabine/docetaxel/cisplatin in patients with non-small cell lung cancer with specific genetic mutations, and includes eligibility criteria such as age, performance status, and adequate organ function.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of pelubiprofen and celebrex, with inclusion criteria for patients taking NSAIDs and belonging to ACR functional class 1, 2, or 3, and exclusion criteria for patients belonging to ACR functional class 4 or with hypersensitivity or bleeding disorders.",
    "The sample is a phase 3 trial for lenalidomide in patients with anemia due to low or intermediate-1 risk Myelodysplastic Syndrome (MDS) who are resistant to erythropoiesis stimulating agents (ESAs) or have a blood erythropoietin level > 500 mU/mL, and have other eligibility criteria, while excluding those with certain medical conditions or prior treatments.",
    "The sample is a phase 3 clinical trial for low-grade Non-Hodgkin's lymphoma patients, testing the efficacy of cyclophosphamide, fludarabine phosphate, vincristine sulfate, and prednisone, with eligibility criteria including specific disease stages, measurable disease parameters, and lab values.",
    "The sample is a phase 3 trial for non-small cell lung cancer patients who have received 1 or 2 chemotherapy treatments and are now being tested with icotinib and gefitinib drugs, while excluding those who have previously used EGFR-TKI or antibody to EGFR.",
    "The sample is a phase 3 trial for patients with hypercholesterolemia and hyperlipidemia, testing the efficacy of niacin and laropiprant, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of exenatide versus placebo in treating type 2 diabetes mellitus, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for type 2 diabetes, testing the efficacy of human insulin inhalation powder and injectable insulin, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for generalized anxiety disorder (GAD) testing the efficacy of duloxetine and venlafaxine compared to placebo, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the effectiveness of ezetimibe (+) simvastatin in treating hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia, with eligibility criteria based on specific cholesterol and triglyceride levels.",
    "This phase 3 trial is testing the effectiveness of gemtuzumab ozogamicin, cytosine arabinoside, and daunomycin in treating acute myeloid leukemia in patients aged 18-60 with a Zubrod performance status of 0-3, and who have not received prior systemic chemotherapy.",
    "This phase 3 trial is testing the efficacy of circadin and placebo circadin in treating primary insomnia in patients aged 18-80 years who meet specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of sulfonylurea mono-therapy and placebo, with inclusion criteria of HbA1c value between 7.0 and 9.5% and BMI between 20.0 and 45.0 kg/m2, and exclusion criteria of type 1 diabetes mellitus, serum creatinine > upper limit of normal, proteinuria, dysuria and/or urinary tract infection, significant renal, hepatic or cardiovascular diseases, and severe gastrointestinal diseases.",
    "This phase 3 trial is testing the efficacy of quetiapine, an antipsychotic drug, in treating acute depressive episodes in adolescents with bipolar I disorder who meet specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for patients with essential hypertension, testing the efficacy of valsartan/amlodipine and amlodipine, with strict inclusion and exclusion criteria, including contraindications to the drugs and other medical conditions, and requiring written informed consent.",
    "This phase 3 trial is testing the efficacy of a combination product (sumatriptan succinate / naproxen sodium) versus placebo for the treatment of migraine disorders in subjects who have recently discontinued the use of certain triptans due to nonresponse or intolerable adverse events.",
    "This phase 3 trial is testing the efficacy of cediranib, a VEGF inhibitor, in treating relapsed epithelial ovarian carcinoma, with specific eligibility criteria including age, disease history, performance status, and organ function.",
    "This phase 3 trial is testing the efficacy of aripiprazole and placebo in treating serious behavioral problems in children with autistic disorder, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes, testing the efficacy of dapagliflozin, glipizide, and metformin hydrochloride, with inclusion criteria of HbA1c >6.5% and </=10% and exclusion criteria of type 1 diabetes, insulin therapy within one year of enrollment, and renal failure or dysfunction.",
    "The sample is a phase 3 trial for head and neck cancer using cisplatin as the drug, with eligibility criteria including histologically confirmed squamous cell carcinoma and specific patient characteristics such as age, performance status, and hematopoietic, hepatic, renal, and cardiovascular health.",
    "The sample is a phase 3 trial for asthma patients using budesonide/formoterol turbuhaler versus conventional best asthma therapy, with inclusion criteria of a diagnosis of asthma and prescribed daily use of glucocorticosteroids at a dose > 320 mcg/day for at least 3 months prior to Visit 1, and exclusion criteria of smoking history > 10 pack-years, recent asthma exacerbation, and any significant disease or disorder that may jeopardize patient safety.",
    "This phase 3 trial is testing the efficacy of MCI-196 and placebo in treating chronic kidney disease, dialysis, hyperphosphatemia, and dyslipidemia, with eligibility criteria including stable phosphate control and a negative pregnancy test for female subjects.",
    "This phase 3 trial is testing the efficacy of atazanavir+ritonavir and lopinavir+ritonavir in treating HIV infections in patients who have failed NNRTI-containing HAART regimens, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of lurasidone, an antipsychotic drug, versus a matching placebo in treating schizophrenia, with strict inclusion and exclusion criteria for subjects.",
    "The sample is a phase 3 trial for depression, testing the efficacy of desvenlafaxine sr, desipramine, and paroxetine, with inclusion criteria for healthy nonsmokers between 18 to 55 years of age and exclusion criteria for various medical conditions and alcohol consumption.",
    "This is a phase 3 trial for juvenile rheumatoid arthritis, testing the effectiveness of etanercept and placebo, with inclusion and exclusion criteria listed, and the icd-10 codes for the disease provided.",
    "The sample is a phase 3 trial for patients with type 2 diabetes and high blood sugar, testing the drug dapagliflozin, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for small cell lung cancer, testing the efficacy of amrubicin hydrochloride and etoposide-cisplatin combined chemotherapy, with inclusion criteria including extensive disease and no prior chemotherapy regimen.",
    "The sample is a phase 3 trial for obesity and dyslipidemia, testing the effectiveness of atorvastatin compared to a sugar pill, with eligibility criteria including abnormal triglyceride and HDL-C levels, and exclusion criteria including untreated abnormal thyroid function and diabetes.",
    "The sample is a phase 3 trial for major depressive disorder (MDD) using agomelatine and placebo as drugs, with inclusion criteria based on DSM-IV criteria, HAM-D17 and CGI-Severity scores, and exclusion criteria including history of bipolar disorder, substance or alcohol abuse, and concomitant psychotropic medication.",
    "This phase 3 trial is testing the efficacy of the drugs nva237 and placebo in treating moderate to severe chronic obstructive pulmonary disease (COPD) in patients aged 40 years or older with a smoking history of at least 10 pack years, and with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of insulin glargine, metformin, taspoglutide, and taspoglutide, with specific eligibility criteria including stable metformin and sulfonylurea treatment, HbA1c levels, and fasting C-peptide levels.",
    "The sample is a phase 3 trial for women with locally advanced or metastatic breast cancer, testing the efficacy of temsirolimus and letrozole, with eligibility criteria including postmenopausal status and exclusion criteria including extensive visceral disease and prior radiation therapy to the site of measurable disease.",
    "This phase 3 trial will test the efficacy of tak-438 and placebo in treating non-erosive gastroesophageal reflux disease, with eligibility criteria including confirmed endoscopy results and repeated acid reflux symptoms, while exclusion criteria include esophagus-related complications and acute gastritis.",
    "The sample is a phase 3 trial testing the efficacy of topiramate in treating alcohol dependence and borderline personality disorder, with inclusion and exclusion criteria listed, and icd-10 codes provided for the diseases.",
    "The sample is a phase 3 trial for hypoactive sexual desire disorder, testing the effectiveness of testosterone gel and placebo gel, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the efficacy of iloprost and placebo in treating pulmonary arterial hypertension in patients with specific inclusion and exclusion criteria, including idiopathic or familial pulmonary arterial hypertension, HIV-associated pulmonary hypertension, and NYHA functional class II to IV, while excluding patients with pulmonary arterial hypertension related to conditions not specified in the inclusion criteria, pulmonary arterial hypertension associated with significant venous or capillary involvement, and other contraindications to iloprost or its excipients.",
    "The sample is a phase 3 trial for hypercholesterolemia using atorvastatin as the drug, with specific inclusion and exclusion criteria based on age, triglyceride and LDL-C levels, and previous statin use.",
    "This is a phase 3 trial for extended-release guanfacine hydrochloride in treating attention-deficit/hyperactivity disorder in children aged 6-17 years, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of technosphere insulin and an active comparator in treating type 1 diabetes, with inclusion criteria such as a clinical diagnosis of type 1 diabetes for at least 1 year and a BMI less than or equal to 35kg/m2, and exclusion criteria such as evidence of severe complications of diabetes and aminotransferase and/or alanine aminotransferase > than 3 times the upper limit of normal.",
    "This phase 3 trial is testing the efficacy of tiotropium respimat\u00ae inhaler and placebo respimat\u00ae inhaler in patients with cystic fibrosis who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for cardiovascular diseases using atorvastatin as the drug, with inclusion criteria of subjects with measurable carotid plaque and exclusion criteria of subjects with high LDL-cholesterol, currently on high dose statin, or contraindications for MRI or statin therapy.",
    "The sample is a phase 3 trial for restless legs syndrome, testing xp13512 (gen) as a treatment, with inclusion criteria requiring completion of specific previous studies and exclusion criteria for non-compliance.",
    "The sample is a phase 3 trial for congestive heart failure, testing the efficacy of candesartan and placebo, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for the drug marimastat in patients with non-small cell lung cancer who have had minimal residual disease after prior therapy, with eligibility criteria including age, performance status, and medical history.",
    "The sample is a phase 3 trial for type 1 diabetes patients planning to become pregnant or already pregnant, testing the efficacy of insulin detemir, nph insulin, and insulin aspart, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of tiotropium plus salmeterol, tiotropium, and salmeterol in patients with chronic obstructive pulmonary disease (COPD) who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This phase 3 trial is testing the efficacy of various budesonide drugs and a placebo in treating mild to moderate ulcerative colitis in patients who meet specific inclusion criteria and do not meet any of the exclusion criteria.",
    "The sample is a phase 3 trial for generalized anxiety disorder (GAD) testing the efficacy of duloxetine, venlafaxine, and placebo, with inclusion and exclusion criteria based on DSM-IV Axis I diagnosis, and the icd-10 codes for GAD are listed as F41.1, F41.9, F40.9, F43.22, F41.0, F93.0, and F12.980.",
    "This phase 3 trial is testing the efficacy of FTC/RPV/TDF and EFV/FTC/TDF in treating HIV-1 infection, with eligibility criteria including plasma HIV-1 RNA levels, genotype report, and normal ECG, hepatic, hematologic, and renal function, while exclusion criteria include ongoing therapy with contraindicated drugs or herbal/natural supplements, immunosuppressant therapies or chemotherapeutic agents, and other clinical conditions that would make the participant unsuitable for the study.",
    "This phase 3 trial aims to test the efficacy of sitagliptin and placebo in treating type 2 diabetes with postprandial lipemia, with inclusion criteria such as stable doses of metformin and exclusion criteria such as cardiovascular disease and alcohol or drug abuse.",
    "The sample is a phase 3 trial for patients with decompensated chronic hepatitis B related cirrhosis, testing the efficacy of telbivudine, lamivudine, and placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of capecitabine and gemcitabine hydrochloride in treating locally advanced, unresectable, or metastatic extrahepatic bile duct cancer, gallbladder cancer, and liver cancer, with specific eligibility criteria for patients' disease characteristics and patient characteristics.",
    "The sample is a phase 3 trial for patients with atrial fibrillation, testing the effectiveness of candesartan, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy and safety of olmesartan medoxomil and hydrochlorothiazide tablets in treating moderate to severe essential hypertension in European patients, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for the treatment of benign prostatic hyperplasia using a combination of finasteride and alfuzosin, with specific eligibility and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with nausea and neoplasms, testing the effectiveness of olanzapine and haldol in treating significant nausea/vomiting that has failed previous treatments, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for the treatment of esophagitis, reflux and peptic, using dexlansoprazole mr and placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for non-insulin-dependent diabetes mellitus, testing the drug rosiglitazone, with eligibility criteria including co-existing vascular disease and at least 6 months of statin or fibrate therapy.",
    "This phase 3 trial is testing the efficacy of telmisartan and losartan in treating mild to moderate hypertension, with specific inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of sulodexide and placebo in treating diabetic nephropathy in patients with type 2 diabetes, microalbuminuria, and controlled blood pressure, while excluding patients with certain medical conditions and medication regimens.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin phosphate (+) metformin hydrochloride and metformin, with inclusion criteria including age, Hb1Ac levels, and previous AHA use, and exclusion criteria including type 1 diabetes mellitus or history of ketoacidosis.",
    "The sample is a phase 3 trial testing the efficacy of flibanserin, a drug used to treat sexual dysfunction, in premenopausal women with HSDD, and includes eligibility criteria and exclusion criteria.",
    "This phase 3 trial focuses on major depressive disorder and tests the efficacy of agomelatine and placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of rivaroxaban and enoxaparin in preventing venous thromboembolism in patients undergoing elective TKR, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for the treatment of perennial allergic rhinitis using the drugs gw685698x and mometasone furoate, with inclusion criteria requiring a positive allergen test and exclusion criteria including certain medication use and serious medical problems.",
    "This phase 3 trial is testing the efficacy of megadose oral methylprednisolone and IV methylprednisolone in treating acute symptomatic exacerbation of relapsing multiple sclerosis in patients between the ages of 18 and 50 with an EDSS score between 2 and 6.5, and who meet other inclusion criteria, while excluding patients who have received systemic corticosteroid use within one month of the index episode at screening, prior use of immunosuppressive treatments within 90 days of index episode, or who are pregnant or breastfeeding.",
    "This phase 3 trial is testing the efficacy of dapagliflozin and placebo in treating type 2 diabetes with inadequate glycemic control and uncontrolled hypertension, with eligibility criteria including stable doses of oral antidiabetic agents and ACEI or ARB, and exclusion criteria including severe uncontrolled diabetes and serious cardiovascular, renal, hepatic, hematological, oncological, endocrine, psychiatric, or rheumatic diseases.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of ly2189265, insulin glargine, sulfonylureas, and biguanide, with inclusion criteria including stable drug dose and qualifying HbA1c value, and exclusion criteria including previous GLP-1 analog treatment and current insulin treatment.",
    "This is a phase 3 trial for obesity using rimonabant and placebo as drugs, with inclusion criteria of BMI > 25 kg/m\u00b2 and exclusion criteria including absence of stable weight, presence of diabetes, and abnormal TSH level.",
    "This phase 3 trial is testing the effectiveness of insulin lispro and insulin aspart in patients with type 1 diabetes, who have been on continuous subcutaneous insulin infusion therapy for at least 6 months, and have met certain inclusion criteria, while excluding those with impaired renal function, legal blindness, and other exclusion criteria.",
    "This phase 3 trial is testing the efficacy of budesonide mmx\u00ae, placebo, and 5-asa in treating active mild or moderate ulcerative colitis in patients who have not responded to oral 5-ASA therapy, with strict inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of flutiform, seretide, and flixotide in children aged 5 to <12 years old with moderate to severe persistent reversible asthma, who have inadequate asthma control on an ICS alone or controlled asthma on an ICS-LABA combination, and have demonstrated satisfactory technique in the use of the pMDI and spacer device.",
    "This phase 3 trial is testing the efficacy of MCI-196 and placebo in treating chronic kidney disease, dialysis, and hyperphosphatemia, with eligibility criteria including stable phosphate control and regular dialysis treatment.",
    "The sample is a phase 3 trial for HIV-infected pregnant women, testing the efficacy of abacavir sulfate, lamivudine, and zidovudine, lamivudine/zidovudine, and lopinavir/ritonavir, with eligibility criteria including viral load and CD4 count requirements, and exclusion criteria including major birth defects in infants and intention to breastfeed.",
    "The sample is a phase 3 trial for uncontrolled or partly controlled asthma patients, testing the efficacy of meptin swinghaler and berotec, with inclusion criteria including pulmonary function test and exclusion criteria including recent hospitalization or use of corticosteroids, and the trial will assess the safety and efficacy of the drugs in treating asthma.",
    "The sample is a phase 3 trial for chronic hepatitis C virus, testing the drugs ldv/sof and rbv, with inclusion criteria including age over 18 and HCV treatment-naive, and exclusion criteria including presence of cirrhosis and co-infection with HIV or hepatitis B virus.",
    "The sample is a phase 3 trial for sleep disorder, testing the efficacy of trazodone and sentra pm in comparison to placebo, with inclusion criteria of patients with non-restorative sleep and exclusion criteria of previous use of GABAdone, SentraPM or trazadone, and subjects with implanted pacemakers or other implanted electrical devices.",
    "The sample is a phase 3 trial for bipolar disorder using lamotrigine as the drug, with inclusion criteria including a diagnosis of Bipolar I Disorder and currently depressed for minimum of the previous 8 weeks, and exclusion criteria including a history of non-response to antidepressant treatment and clinical history of substance dependence in the past year or abuse within the 4 weeks prior to study entry.",
    "This is a phase 3 trial for urinary bladder overactivity, testing the efficacy of mirabegron and tolterodine compared to placebo, with specific inclusion and exclusion criteria for subjects.",
    "The sample is a phase 3 trial for type 2 diabetes patients using sulfonylurea, liraglutide, and diet/exercise therapy, with inclusion criteria of HbA1c between 7.0% and 10.0% and BMI less than 35 kg/m2, and exclusion criteria of recent insulin treatment, interference with glucose level drugs, serious medical conditions, and pregnancy/breastfeeding, targeting diabetes and diabetes mellitus type 2.",
    "This is a phase 3 clinical trial for aneurysmal subarachnoid hemorrhage, testing the efficacy of clazosentan and placebo, with specific inclusion and exclusion criteria for patient eligibility.",
    "This phase 3 trial is testing the efficacy of alogliptin, a drug used to treat type 2 diabetes mellitus, in patients who have failed previous treatment with diet and exercise, and are receiving no current antidiabetic therapy.",
    "This phase 3 trial is testing the efficacy of cetuximab, 5-fu, irinotecan, leucovorin, and oxaliplatin in treating locally advanced or metastatic colorectal cancer, with eligibility criteria including no prior treatment for advanced or metastatic colorectal cancer, age \u2265 18 years, and CTC (ECOG) performance status of 0-1.",
    "This phase 3 trial is testing the efficacy of pramipexol extended release and immediate release compared to placebo in treating advanced idiopathic Parkinson's disease with motor fluctuations, and patients must meet specific inclusion criteria and not have any exclusion criteria.",
    "The sample is a phase 3 trial for patients with a history of gastrointestinal events related to NSAID therapy, testing the efficacy of pn400 (vimovo) and diclofenac/misoprostol in preventing gastric ulcers, with eligibility criteria including a negative H. pylori test and exclusion criteria including a history of hypersensitivity to esomeprazole or NSAIDs.",
    "This phase 3 trial is testing the effectiveness of lamotrigine, an anticonvulsant drug, in treating persistent positive symptoms of schizophrenia in patients who have been taking specific atypical antipsychotics for at least 3 months and have a stable dose, while excluding those with certain medical disorders or taking certain medications.",
    "This phase 3 trial will investigate the effectiveness of tiotropium and salmeterol in treating chronic obstructive pulmonary disease, with patients meeting eligibility criteria yet to be determined.",
    "This phase 3 trial is testing the efficacy of ipx056 and encapsulated baclofen in treating multiple sclerosis patients with spasticity, and includes eligibility criteria such as EDSS rating between 3.0-8.0 and a negative urine drug screen at screening visit.",
    "This is a phase 3 clinical trial for patients with multiple myeloma receiving high-dose chemotherapy and autologous peripheral stem cell transplantation, testing the efficacy of emend and placebo drugs, with specific inclusion and exclusion criteria.",
    "This phase 3 trial focuses on major depressive disorder and tests the efficacy of agomelatine and placebo, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with relapsing-remitting multiple sclerosis, testing the efficacy of interferon beta-1b and copaxone, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for HIV infection using cellulose sulfate gel (6%) as a drug, with inclusion criteria of being at least 18 years old, having an average of at least three vaginal sex acts per week, at least three different partners in the last three months, and being HIV negative, while exclusion criteria include pregnancy, allergy to latex or spermicides, and intravenous drug use.",
    "The sample is a phase 3 trial for the treatment of vaginal atrophy with drugs including ospemifene and a nonhormonal vaginal lubricant, with eligibility criteria including postmenopausal status and vaginal pH greater than 5.0, and exclusion criteria including abnormal endometrial pathology and current vaginal infection.",
    "This phase 3 trial is testing the efficacy of tapentadol and oxycodone compared to placebo in managing moderate to severe pain following bunionectomy surgery, with inclusion and exclusion criteria specified. The trial involves patients with arthralgia, bunion, hallux valgus, and pain, and the icd-10 codes associated with these diseases.",
    "The sample is a phase 3 trial for symptomatic neurogenic orthostatic hypotension, non-diabetic neuropathy, primary autonomic failure, and dopamine beta hydroxylase deficiency, testing the efficacy of droxidopa compared to placebo, with patient inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the effectiveness of valganciclovir and ganciclovir in preventing CMV disease in patients following allogeneic stem cell transplantation, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of apremilast in treating psoriatic arthritis, with inclusion criteria including a diagnosis of PsA, inadequate response to DMARDs, and \u2265 3 swollen and tender joints, while exclusion criteria include pregnancy or breastfeeding, allergy to investigational product, and therapeutic failure on > 3 agents for PsA or > 1 biologic TNF blocker.",
    "The sample is a phase 3 trial for obesity, testing the efficacy of lorcaserin and placebo, with inclusion criteria of BMI 30-45 kg/m2 and comorbid conditions, and exclusion criteria of pregnancy, diabetes, heart valve disease, and serious medical conditions.",
    "The sample is a phase 3 trial for migraine patients testing the efficacy of mk0974 and placebo, with inclusion and exclusion criteria listed, and the icd-10 codes for migraine provided.",
    "This phase 3 trial is testing the efficacy of retaspimycin hydrochloride and placebo in treating gastrointestinal stromal tumors, with eligibility criteria including confirmed metastatic and/or unresectable GIST, measurable disease on CT or MRI, and documented radiographic progression or intolerance to imatinib and sunitinib.",
    "The sample is a phase 3 trial for schizoaffective disorder and psychotic disorder, testing the efficacy of paliperidone er and placebo, with inclusion criteria including a DSM-IV diagnosis and a PANSS score of >= 60, and exclusion criteria including treatment with clozapine within 6 months of randomization and pregnancy.",
    "The sample is a phase 3 trial for bacterial infections, testing the efficacy of ceftaroline, vancomycin plus aztreonam, and placebo, with eligibility criteria including SSSI and exclusion criteria including prior treatment with antimicrobials or failure of vancomycin or aztreonam therapy.",
    "This phase 3 trial is testing the effectiveness of certolizumab pegol, a drug used to treat rheumatoid arthritis, in patients who meet specific eligibility criteria, including having a diagnosis of adult-onset RA and having received treatment with MTX for at least 6 months prior to the baseline visit.",
    "This phase 3 trial is testing the efficacy of oravescent fentanyl, an opioid medication, in treating chronic pain associated with various conditions, and requires patients to meet specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for the treatment of perennial allergic rhinitis, using the drugs ff and placebo, with inclusion criteria of a PAR diagnosis and literacy, and exclusion criteria of significant medical conditions, corticosteroid use, and exposure to investigational drugs.",
    "The sample is a phase 3 trial for hypoactive sexual desire disorder in postmenopausal women, testing the efficacy of testosterone and placebo, with inclusion criteria including low sexual desire causing distress and exclusion criteria excluding any confounding conditions.",
    "This is a phase 3 clinical trial for attention deficit disorder with hyperactivity, testing the efficacy of neutral salts of dextroamphetamine sulfate, usp, amphetamine sulphate, usp, d-amphetamine saccharate, d, l-amphetamine aspartate monohydrate, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for new diagnosed multiple myeloma patients with treatment demanding disease, using pamidronate as the drug, and with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of busulphan plus cyclophosphamide and busulphan plus fludarabine in patients aged 40-65 with acute myeloid leukemia (AML) in complete remission, who have an HLA compatible sibling or unrelated donor, and meet other eligibility criteria.",
    "This phase 3 trial is testing the efficacy of vortioxetine in treating recurrent major depressive episodes in patients who have completed a prior study, with specific inclusion and exclusion criteria, and the use of adequate contraception is required for sexually active females.",
    "This phase 3 trial is testing the efficacy of aripiprazole im depot, an antipsychotic medication, in treating schizophrenia in subjects who require chronic treatment, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of bibw 2992, trastuzumab, and vinorelbine in treating HER2-overexpression breast cancer that has progressed on one prior trastuzumab treatment, with eligibility criteria including measurable lesions and an ECOG score of 0 or 1.",
    "This phase 3 trial is testing the efficacy of sunitinib and sorafenib in treating metastatic renal cell carcinoma, with eligibility criteria including age, performance status, and laboratory requirements.",
    "The sample is a phase 3 trial for restless legs syndrome using the drug rotigotine, with inclusion criteria of idiopathic restless legs syndrome and exclusion criteria including ongoing serious adverse events from SP792 and medical or psychiatric conditions that could compromise participation.",
    "This phase 3 trial is testing the efficacy of entecavir and telbivudine in treating HBeAg-positive chronic hepatitis B patients, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for bipolar I disorder with alcohol dependence, testing the effectiveness of quetiapine fumarate, lithium, and divalproex, with inclusion criteria of outpatient status and recent history of heavy drinking, and exclusion criteria of unstable medical illness and recent antipsychotic use.",
    "The sample is a phase 3 trial for pulmonary hypertension using the drug sitaxentan, with eligibility criteria including completion of a previous study and exclusion criteria related to hypertension and hypotension.",
    "The sample is a phase 3 trial for epilepsy with lamotrigine extended-release as the drug, and the inclusion criteria require a confident diagnosis of epilepsy and currently being on LAMICTAL and up to 2 concomitant AEDs.",
    "The sample is a phase 3 trial for ocular inflammation using 0.5% loteprednol etabonate ophthalmic ointment and its vehicle, with inclusion criteria of potential postoperative pinholed Snellen VA of at least 20/200 in the study eye and exclusion criteria of concurrent ocular therapy with certain medications or hypersensitivity to the study drugs.",
    "This phase 3 trial is testing the efficacy of canagliflozin and placebo in patients with type 2 diabetes and renal insufficiency who are not on or are on monotherapy or combination therapy, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for seasonal allergic rhinitis and hay fever, using beclomethasone dipropionate and placebo nasal aerosol, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial testing the efficacy of loteprednol etabonate and its vehicle in reducing inflammation and pain in patients undergoing cataract surgery, with inclusion and exclusion criteria specified.",
    "This phase 3 trial is testing the efficacy of exenatide once weekly, metformin, sitagliptin, and pioglitazone in treating type 2 diabetes mellitus patients who are treated with diet and exercise alone, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with type 2 diabetes, testing the efficacy of vildagliptin and metformin, with inclusion criteria including age, BMI, and HbA1c range, and exclusion criteria including history of type 1 diabetes and treatment with insulin or other oral antidiabetic agents.",
    "The sample is a phase 3 trial for type 2 diabetes, testing saxagliptin, metformin (blinded), metformin (open-label), and placebo, with inclusion criteria including drug-naive patients with HbA1c between 6.0% and 8.0%, and exclusion criteria including recent cardiac or cerebrovascular events and elevated serum creatinine.",
    "This phase 3 trial is testing the efficacy of intravitreal aflibercept injection in treating foveal center-involved macular edema secondary to branch retinal vein occlusion, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the effectiveness of Truvada, a drug used for HIV prevention, on individuals at higher risk of becoming HIV infected, with specific eligibility criteria including age, health status, and medication history.",
    "The sample is a phase 3 trial for HIV patients, testing the switch from tenofovir to abacavir, with inclusion criteria such as undetectable plasma HIV-1 RNA and exclusion criteria such as intolerance to abacavir or therapy with biphosphonates.",
    "The sample is a phase 3 clinical trial for acute bacterial sinusitis, testing the efficacy of moxifloxacin and placebo drugs, with inclusion and exclusion criteria based on clinical and radiographic symptoms.",
    "The sample is a phase 3 trial for gastroesophageal reflux disease, testing the efficacy of 10 mg ilaprazole and 40mg esomeprazole, with eligibility criteria including age, symptoms, and documented erosive esophagitis, and exclusion criteria including other diseases, recent use of proton pump inhibitors, and hypersensitivity to the drugs.",
    "This phase 3 trial is testing the efficacy of gsk573719/vi and placebo in treating chronic obstructive pulmonary disease (COPD) in patients who meet specific inclusion criteria, including a post-albuterol/salbutamol FEV1/FVC ratio of <0.70 and a post-albuterol/salbutamol FEV1 of less than or equal to 70% of predicted normal values, and excluding those with asthma, alpha-1 antitrypsin deficiency, active lung infections, and other significant respiratory conditions, among other exclusion criteria.",
    "This phase 3 trial is testing the efficacy of teduglutide in treating short bowel syndrome, with a list of inclusion and exclusion criteria, and three different drugs being tested including a placebo.",
    "The sample is a phase 3 trial for asthma with a list of icd-10 codes, and the drugs being tested are budesonide/formoterol, fluticasone/salmeterol, and albuterol, with eligibility criteria including age, diagnosis of asthma, and use of inhaled corticosteroids.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of multiple drugs including indacaterol and glycopyrronium, glycopyrronium, indacaterol, tiotropium, and placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of docetaxel, vinorelbine, carboplatin, and gemcitabine in treating stage IV or IIIB non-small cell lung cancer patients with measurable or evaluable disease, who have undergone biopsy and meet certain eligibility criteria.",
    "This phase 3 trial is testing the drug mk0557 on obese individuals with specific body mass index requirements to determine its effectiveness in treating obesity, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for breast cancer patients with specific eligibility criteria, including the use of fenretinide and tamoxifen citrate as drugs, and the presence of certain icd-10 codes.",
    "This is a phase 3 trial for heart failure patients requiring intravenous therapy, testing the effectiveness of nesiritide and placebo, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with schizophrenia or schizoaffective disorder, testing the efficacy of risperidone long-acting injectable drugs at stable doses, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of cytarabine and laromustine in treating acute myeloid leukemia in patients who have relapsed after achieving a first complete response, with specific eligibility criteria for patient characteristics and prior concurrent therapy.",
    "This phase 3 trial is testing the effectiveness of various doses of amlodipine/atorvastatin combination drugs in treating hypertension and hypercholesterolemia in patients who meet specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for pain, testing the efficacy of buprenorphine, fentanyl, and placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of alogliptin and pioglitazone in treating inadequate glycemic control in patients with type 2 diabetes mellitus who are on metformin, with specific inclusion and exclusion criteria.",
    "This phase 3 trial will test the efficacy of 5-mg desloratadine versus placebo in treating allergic rhinitis, with specific inclusion and exclusion criteria for subjects, and a list of icd-10 codes and allergens used for diagnosis.",
    "The sample is a phase 3 trial for otitis media and negative middle ear pressure, testing the effectiveness of triamcinolone acetonide nasal spray versus placebo, with inclusion criteria of patients aged 0-18 years and exclusion criteria including chronic infectious otitis media and immunodeficiency.",
    "The sample is a phase 3 clinical trial testing the efficacy of Sofosbuvir and Ribavirin in treating chronic hepatitis C and HIV-1 co-infection, with specific inclusion and exclusion criteria, and requires liver imaging in cirrhotic patients.",
    "This phase 3 trial is testing the efficacy of busulfan, cyclophosphamide, cytarabine, gemtuzumab ozogamicin, and daunorubicin in treating acute myeloid leukemia (AML) in patients aged 16 to 60 with specific cytogenetic abnormalities, while excluding those with certain other types of leukemia or prior biologic or cytotoxic chemotherapy, and requiring a sibling donor match for allogeneic transplantation.",
    "The sample is a phase 3 trial for patients with severe motor fluctuations in idiopathic Parkinson's disease, testing the efficacy of levodopa-carbidopa intestinal gel, with inclusion criteria including completion of previous protocols and exclusion criteria including medically relevant abnormal findings, with the disease being dyskinesias, Parkinson's disease, and severe motor fluctuations, and the drug being levodopa-carbidopa intestinal gel.",
    "This phase 3 trial is testing the efficacy of taxotere and pemetrexed in treating non-squamous cell type non-small cell lung cancer (NSCLC) with measurable lesions, and includes eligibility criteria such as ECOG performance status 0-2 and exclusion criteria such as hypersensitivity to taxane and EGFR mutation.",
    "The sample is a phase 3 trial for hypoactive sexual desire disorder, testing the effectiveness of testosterone gel and placebo gel, with specific inclusion and exclusion criteria for participants.",
    "The sample is a phase 3 trial for rheumatoid arthritis testing the efficacy of golimumab with eligibility criteria including a diagnosis of RA, active RA, and being methotrexate-na\u00efve, while exclusion criteria include no prior treatment with biologic anti-TNF drugs and no history of chronic or recurrent infectious disease. The drugs being tested are placebo injections, placebo capsules, and methotrexate capsules.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of various drugs including placebo, canagliflozin, sitagliptin, metformin, and pioglitazone, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of thiotepa, cyclophosphamide, tacrolimus, methotrexate, and sirolimus in treating various types of childhood acute lymphoblastic leukemia in remission, graft versus host disease, and high risk de novo ALL in CR1, with specific eligibility criteria for patients.",
    "The sample is a phase 3 trial for restless legs syndrome (RLS) using ropinirole extended release (XR) as the drug, with inclusion criteria based on RLS diagnosis and disturbed sleep, and exclusion criteria including secondary RLS and inability to tolerate dopamine agonists or antagonists.",
    "The sample is a phase 3 trial for obesity, comparing taranabant and placebo, with inclusion criteria of BMI between 30-43 kg/m2 and exclusion criteria including history of major psychiatric disorder, seizures, high blood pressure, high fasting blood glucose, and high triglycerides.",
    "The sample is a phase 3 trial for hepatitis B with the drugs entecavir and adefovir, and the eligibility criteria includes a Child-Pugh score of at least 7 and HBV viremia, but excludes patients with ALT levels greater than 15x ULN and coinfection with HIV/HCV/HDV.",
    "The sample is a phase 3 trial for patients with bipolar disorder, testing the efficacy of paliperidone er, with inclusion criteria including a history of manic or mixed episodes, use of lithium or valproate, and a YMRS score of at least 20, and exclusion criteria including rapid cycling, drug use, and benzodiazepine use.",
    "This phase 3 trial is testing the efficacy of dorzolamide hydrochloride (+) timolol maleate and prostaglandin in treating glaucoma and ocular hypertension, with specific inclusion and exclusion criteria for patients.",
    "The sample is a phase 3 trial for non-small cell lung cancer, testing the efficacy of dacomitinib, erlotinib, and placebos, with specific inclusion and exclusion criteria for patients.",
    "The sample is a phase 3 trial for Parkinson's disease using ropinirole XL, with inclusion criteria including a diagnosis of idiopathic Parkinson's disease and completion of either Study 167 or Study 164, and exclusion criteria including the presence of uncontrolled psychiatric, hematological, renal, hepatic, endocrinological, neurological, cardiovascular disease or active malignancy, dizziness or fainting due to orthostatic hypotension on standing, significant sleep disorder, and drug abuse or alcoholism.",
    "This phase 3 trial is testing the efficacy of tenofovir disoproxil fumarate (tdf) versus placebo in treating chronic hepatitis B virus (HBV) infection in adolescents aged 12-17, with inclusion criteria including documented chronic HBV infection, HBV DNA > 100,000 copies/mL, and ALT > 2 \u00d7 upper limit of normal, while exclusion criteria include significant renal or bone disease, ongoing therapy with nephrotoxic agents, and known hypersensitivity to the study drugs.",
    "This is a phase 3 clinical trial for the drug adalimumab in treating active ulcerative colitis with a Mayo score of 6 to 12 points and endoscopy subscore of 2 to 3 points, despite concurrent treatment with at least 1 of the following (oral corticosteroids or immunosuppressants or both).",
    "This phase 3 trial is testing the effectiveness of carvedilol controlled release and immediate release in treating stable, chronic, mild to severe congestive heart failure with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for newly diagnosed acute myeloid leukemia (AML) patients, testing the efficacy of a combination of drugs including asparaginase, cytarabine, daunorubicin hydrochloride, etoposide, gemtuzumab ozogamicin, and mitoxantrone hydrochloride, with eligibility criteria including bone marrow blast percentage and karyotypic abnormalities.",
    "This phase 3 trial is testing the effectiveness of ldv/sof and rbv drugs in treating chronic hepatitis C virus in patients who have previously failed a nonstructural protein (NS)3/4A protease inhibitor plus pegylated interferon (PEG)/RBV regimen, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of desmopressin and placebo in treating nocturia in females, with strict inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for the drug ropinirole in treating moderate to severe idiopathic restless legs syndrome, with inclusion and exclusion criteria including specific disease diagnosis, severity of symptoms, and medication history.",
    "The sample is a phase 3 trial for patients with stage III or IV NSCLC, testing the efficacy of pegylated rhg-csf and placebo in preventing neutropenia and febrile neutropenia, with inclusion and exclusion criteria listed.",
    "This phase 3 trial aims to investigate the effect of vitamin D3 supplementation on type II diabetics with vitamin D deficiency, using vitamin D3 2000 iu, vitamin D3 5000 iu, and placebo, with inclusion criteria including stable glycemic control and current HA1c between 6.5 and 8%.",
    "The sample is a phase 3 trial for advanced Parkinson's disease, testing the efficacy of levodopa carbidopa intestinal gel, levodopa-carbidopa oral tablets, and their placebos, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for asthma patients, testing the effectiveness of salmeterol and beclomethasone hfa, with inclusion criteria based on FEV1 and methacholine PC20, and exclusion criteria including smoking history and life-threatening asthma, while also requiring genotype eligibility.",
    "This phase 3 trial is testing the efficacy of extended-release guanfacine hydrochloride and placebo in treating attention deficit disorder in children aged 6-17 years who meet DSM-IV-TR criteria for primary diagnosis of ADHD and have a minimum ADHD-RS-IV total score of 32 at enrollment/visit 2, with various inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of entecavir in preventing hepatitis B recurrence in patients receiving orthotopic liver transplant due to chronic HBV infection, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for patients with relapsed or progressive follicular B-NHL, testing the efficacy of bortezomib + rituximab and rituximab, with eligibility criteria including measurable tumor mass and prior response to rituximab.",
    "The sample is a phase 3 clinical trial for patients with chronic obstructive pulmonary disease (COPD) testing the efficacy of zileuton and placebo drugs, with inclusion and exclusion criteria listed, and the diseases are specified with their corresponding ICD-10 codes.",
    "The sample is a phase 3 trial for hypertension, testing the efficacy of l50/h12.5/a5 and l50/h12.5 drugs compared to placebo, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the efficacy of rituximab, mycophenolate mofetil, methylprednisolone, and other drugs in treating lupus nephritis, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the efficacy of rifampicin and placebo in treating multiple system atrophy, with eligibility criteria including a diagnosis of MSA-P or MSA-C, normal cognition, and exclusion criteria including use of certain medications and medical conditions that may affect the study results.",
    "This phase 3 trial is testing the efficacy of risedronate and teriparatide in treating osteoporosis in males, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of gemcitabine hydrochloride and sorafenib tosylate in treating locally advanced or metastatic pancreatic cancer patients who meet specific eligibility criteria.",
    "The sample is a phase 3 trial for cervical dystonia, testing the efficacy of placebo as a treatment option, with inclusion and exclusion criteria listed, and the icd-10 codes for the disease provided.",
    "This phase 3 trial is testing the efficacy of tariquidar + paclitaxel/carboplatin versus placebo + paclitaxel/carboplatin in treating stage IIIB and IV non-small cell lung cancer, with eligibility criteria including a WHO performance status of 1 or 0 and life expectancy of greater than 3 months.",
    "This phase 3 trial is testing the efficacy of boceprevir and ribavirin in treating chronic hepatitis C in participants who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This phase 3 trial is testing the efficacy of prolonged release methylphenidate and placebo in treating ADHD, with inclusion criteria including a confirmed diagnosis of ADHD and a CAARS score of at least 24, and exclusion criteria including a known non-response to methylphenidate and any clinically unstable psychiatric condition.",
    "This phase 3 trial is testing the efficacy of telcagepant potassium 150 mg, telcagepant potassium 300 mg, and zolmitriptan 5 mg, as well as their placebos, in treating migraine in patients who meet certain inclusion criteria and do not meet any exclusion criteria.",
    "The sample is a phase 3 trial for HIV infection, testing the efficacy of mk0518 (raltegravir) and comparators kaletra\u2122 (lopinavir (+) ritonavir) and placebo, with eligibility criteria including being HIV positive and having documented HIV RNA <50 copies/mL for at least 3 months while on a KALETRA based regimen.",
    "The sample is a phase 3 trial for HIV infection, testing the efficacy of different comparator drugs including raltegravir and lopinavir (+) ritonavir, with specific inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 clinical trial for allergic rhinitis, testing the efficacy of fluticasone furoate nasal spray versus placebo, with inclusion and exclusion criteria based on medical history, symptoms, and skin prick tests.",
    "This phase 3 trial is testing the efficacy of mycophenolate mofetil and placebo in treating newly diagnosed chronic-graft-versus host disease in patients who have undergone prior transplantation, with specific eligibility criteria for patient characteristics and prior concurrent therapy.",
    "This phase 3 clinical trial is testing lc15-0444 and placebo in patients with type 2 diabetes mellitus who meet specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for breast cancer patients with T2-3, N0-1, M0, using drugs such as herceptin, taxol, fluorouracil, cytoxan, and epirubicin, and eligibility criteria including Her-2/neu positivity, normal cardiac ejection fraction, and adequate bone marrow, liver, and renal function.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of sitagliptin phosphate and other comparators, with eligibility criteria including being on diet/exercise therapy and pioglitazone as monotherapy.",
    "This phase 3 trial is testing the efficacy of bia 9-1067, entacapone, placebo, levodopa, carbidopa, and benserazide in treating Parkinson's disease patients who meet specific inclusion criteria, while excluding those with certain medical conditions or who are taking certain medications.",
    "This phase 3 trial is testing the efficacy of ly2189265, liraglutide, and metformin in treating type 2 diabetes in patients who are not optimally controlled on diet and exercise and a stable dose of metformin, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for hypertension, testing the efficacy of telmisartan and amlodipine combination therapy and telmisartan alone, with eligibility criteria including age, blood pressure levels, and exclusion criteria including history of cardiac events and hypersensitivity to certain drugs.",
    "This phase 3 trial is testing the efficacy of donepezil and vitamin E in treating Alzheimer's disease in patients who meet specific eligibility criteria, including memory complaints and difficulties, abnormal memory function, and a Mini-Mental Exam score between 24 and 30.",
    "The sample is a phase 3 trial for hormone refractory prostate cancer with bone metastases, testing the efficacy of radium-223 dichloride, placebo, and best standard of care, with eligibility criteria including confirmed adenocarcinoma of the prostate, hormone refractory disease, and multiple skeletal metastases.",
    "This phase 3 trial is testing the efficacy of oral and IV casopitant, ondansetron hydrochloride, and oral dexamethasone in reducing chemotherapy-induced nausea and vomiting in patients with malignant solid tumors receiving cisplatin-based chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This is a phase 3 trial for active rheumatoid arthritis, testing the efficacy of abatacept and placebo in participants who have been treated with methotrexate for at least 3 months and meet specific inclusion criteria.",
    "This phase 3 trial is testing the efficacy of sitagliptin phosphate, pioglitazone, glimepiride or gliclazide, and metformin in treating type 2 diabetes mellitus with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial testing the efficacy of risperidone in treating bipolar disorder and anxiety disorder, with specific eligibility criteria and exclusion criteria listed.",
    "This phase 3 trial focuses on breast neoplasms and tests the efficacy of fec-docgemzar and fec-doc adjuvant chemotherapy, as well as zoledronic acid, while also outlining specific eligibility criteria for participants.",
    "This phase 3 trial is testing the effectiveness of clobazam at different doses and a placebo in treating Lennox-Gastaut syndrome (LGS) in children under 11 years old, with a list of inclusion and exclusion criteria, and a list of diseases and ICD-10 codes associated with LGS.",
    "The sample is a phase 3 trial for type 2 diabetes, testing the drugs nexium and placebo, with eligibility criteria including age, HbA1c levels, and exclusion criteria including kidney and liver disease, heart failure, and drug interactions.",
    "This phase 3 trial is testing the efficacy of ambrisentan, an endothelin receptor antagonist, in treating pulmonary hypertension associated with various etiologies, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of insulin degludec and insulin glargine in combination with oral anti-diabetic drugs for type 2 diabetes mellitus patients with HbA1c levels between 7.0-11.0% and BMI below or equal to 40.0 kg/m^2, while excluding patients with cancer, recent cardiovascular disease, uncontrolled hypertension, and pregnancy.",
    "This phase 3 trial is testing the efficacy of preladenant and rasagiline in treating idiopathic Parkinson's disease in patients who meet specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of pemetrexed, cisplatin, and gefitinib in treating non-small cell lung cancer in East Asian participants who are light ex-smokers or never-smokers and have not received prior systemic therapy for lung cancer. The eligibility criteria include having a non-squamous histology, an ECOG performance status of 0 or 1, and no clinically active interstitial lung disease. The exclusion criteria include known EGFR mutation status and clinically significant third-space fluid collections.",
    "The sample is a phase 3 trial for metastatic melanoma testing the efficacy of tasisulam-sodium and paclitaxel, with specific eligibility criteria including previous treatment history and exclusion criteria such as CNS metastasis and hypersensitivity to paclitaxel or Cremophor EL.",
    "This phase 3 trial is testing the efficacy of tiotropium and olodaterol, as well as their individual components, in treating chronic obstructive pulmonary disease (COPD) in patients over 40 years old with a smoking history of more than 10 pack years, and includes a list of exclusion criteria.",
    "This phase 3 trial is testing the efficacy of amg 706, placebo, paclitaxel, and carboplatin in treating non-small cell lung cancer patients with specific eligibility criteria.",
    "The sample is a phase 3 trial for epilepsy using the drug lacosamide, with inclusion criteria of a diagnosis of epilepsy and completion of a double blind trial, and exclusion criteria of taking other investigational drugs and meeting withdrawal criteria from the double blind trial.",
    "The sample is a phase 3 trial for colorectal cancer patients who have undergone curative resection, with eligibility criteria including performance status, hematopoietic, hepatic, renal, and cardiovascular requirements, and the drugs being tested are folfox and cetuximab.",
    "The sample is a phase 3 clinical trial for previously untreated chronic lymphocytic leukemia (CLL) using obinutuzumab, rituximab, and chlorambucil, with eligibility criteria including CD20+ B-Cell CLL and a Total Cumulative Illness Rating Scale (CIRS) > 6 and/or creatinine clearance < 70 ml/min.",
    "This phase 3 trial aims to test the efficacy of mycophenolate mofetil and mycofenolate mofetil (mmf) compared to placebo in treating interstitial cystitis and painful bladder syndrome in participants who have failed at least 24 weeks of active treatment with a minimum of 3 standard forms of therapy, and have met other inclusion and exclusion criteria.",
    "This is a phase 3 trial for breast neoplasms testing the efficacy of epirubicin, cyclophosphamide and docetaxel and docetaxel, cyclophosphamide in patients meeting specific eligibility criteria.",
    "The sample is a phase 3 clinical trial for the treatment of Restless Legs Syndrome using pramipexole and placebo, with eligibility criteria including a diagnosis of IRLS, RLS rating scale for severity total score >15, and exclusion criteria including previous pharmacologically therapy of RLS and clinical significant hepatic disease.",
    "The sample is a phase 3 trial for melanoma patients with three different types of melanoma, testing the efficacy of three drugs (allovectin-7, allovectin-7/dacarbazine, and dacarbazine) with specific eligibility criteria including no prior chemotherapy and at least one measurable tumor.",
    "The sample is a phase 3 trial for acute coronary syndrome, testing the effectiveness of rosuvastatin and atorvastatin, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with ovarian cancer or peritoneal cavity cancer, testing the efficacy of carboplatin and pegylated liposomal doxorubicin hydrochloride, with eligibility criteria including disease progression or recurrence after platinum-based chemotherapy and specific patient characteristics such as hematopoietic and cardiovascular health.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of Symbicort Turbuhaler and any available COPD treatment, with inclusion criteria including a clinical diagnosis of COPD and documented COPD symptoms for more than 2 years, and exclusion criteria including a history of asthma and relevant cardiovascular disorders.",
    "The sample is a phase 3 trial for patients with high-risk prostate cancer who have undergone radical prostatectomy, testing the efficacy of docetaxel, with eligibility criteria including negative lymph nodes, preoperative PSA \u2265 10.0 ng/mL, and no prior hormonal therapy or chemotherapy.",
    "This phase 3 trial is testing the efficacy of aripiprazole and placebo in treating non-institutionalized patients with Alzheimer's disease who have symptoms of delusions or hallucinations, and have completed the 10-week acute phase; the study also includes inclusion and exclusion criteria for patient eligibility.",
    "The sample is a phase 3 trial for hypertension, testing the efficacy of a combination of amlodipine and olmesartan medoxomil, with eligibility criteria including age, blood pressure levels, and exclusion criteria including history of stroke or heart disease.",
    "This phase 3 trial is testing the efficacy of calcium gluconate, magnesium sulfate, and oxaliplatin in treating chemotherapeutic agent toxicity, colorectal cancer, neuropathy, and neurotoxicity, with eligibility criteria including confirmed adenocarcinoma of the colon or rectum and undergoing curative resection.",
    "This is a phase 3 trial for the treatment of relapsing-remitting multiple sclerosis with natalizumab and placebo, with inclusion criteria such as a diagnosis of MS, age between 18 and 55, and a baseline EDSS score between 0.0 and 5.0, and exclusion criteria such as primary progressive, secondary progressive, or progressive relapsing MS, and abnormal lab results.",
    "This phase 3 trial is testing the efficacy of low and high dose ampion and placebo in treating moderate to moderately-severe osteoarthritis of the knee, with eligibility criteria including age, ambulatory ability, and symptomatic knee pain, while exclusion criteria include certain medical conditions and medications.",
    "This phase 3 trial is testing the efficacy of tiotropium respimat\u00ae and salmeterol hfa mdi in treating asthma, with inclusion criteria including confirmed diagnosis of asthma, stable dose of inhaled corticosteroids, and symptomatic patients with pre-bronchodilator FEV1 between 60% and 90% of predicted normal.",
    "This phase 3 trial is testing the efficacy of ranolazine versus placebo in treatment-na\u00efve patients with type 2 diabetes mellitus, with specific inclusion and exclusion criteria, and a list of prohibited medications.",
    "The sample is a phase 3 clinical trial for metastatic prostate cancer patients, testing the efficacy of aflibercept, docetaxel, and prednisone/prednisolone, with inclusion criteria including histologically-confirmed prostate adenocarcinoma and exclusion criteria including prior treatment with VEGF inhibitors or ECOG performance status >2.",
    "The sample is a phase 3 trial for diabetic retinopathy and diabetic macular edema, testing the efficacy of intravitreal triamcinolone acetonide, with eligibility criteria including age, diabetes diagnosis, and study eye inclusion criteria such as retinal thickening and visual acuity.",
    "This phase 3 trial is testing the efficacy of prasugrel and clopidogrel in patients with acute STEMI undergoing planned percutaneous coronary intervention, with specific inclusion and exclusion criteria listed.",
    "This is a phase 3 trial for the drug flibanserin to treat sexual dysfunctions in premenopausal women with HSDD, with eligibility criteria including regular menstrual periods, minimum cut-off scores on questionnaires, and a stable, monogamous, heterosexual relationship.",
    "This phase 3 trial is testing the efficacy of intravenous carbamazepine (iv cbz) in treating epilepsy in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) testing the efficacy of fluticasone furoate/vilanterol and tiotropium bromide, with inclusion criteria including a clinical history of COPD, post-albuterol spirometry criteria, and a history of diagnosed cardiovascular disease or risk factors, while exclusion criteria include a current diagnosis of asthma, other respiratory disorders, and abnormal clinically significant findings in liver chemistry, biochemical, or haematology tests.",
    "This is a phase 3 trial for patients with stomach cancer or neoplasm metastasis, testing the efficacy of ECC and FOLFIRI drugs, with eligibility criteria including age, tumor type, and general health status.",
    "This is a phase 3 trial for patients with locally advanced or metastatic thyroid cancer, testing the efficacy of XL184 and placebo drugs, with eligibility criteria including age, performance status, disease progression, and organ function, and exclusion criteria including prior treatment, brain metastases, and pregnancy.",
    "The sample is a phase 3 trial for bipolar disorder, testing the efficacy of risperdal consta and placebo, with inclusion and exclusion criteria listed, and icd-10 codes provided for the disease.",
    "This is a phase 3 trial for non-small cell lung cancer patients who are medically inoperable or unresectable, and the treatment involves cisplatin and gemcitabine hydrochloride, with eligibility criteria including ECOG 0 or 1 performance status and no prior chemotherapy.",
    "The sample is a phase 3 trial for congestive heart failure, testing the efficacy of candesartan and placebo, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with rheumatoid arthritis, testing the efficacy of golimumab (a drug) compared to placebo, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of pemetrexed and carboplatin in treating newly diagnosed non-small cell lung carcinoma patients with specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of niacin extended release and lovastatin tablets in treating intermittent claudication and peripheral vascular disease in patients with specific eligibility criteria, including age, LDL-C and triglyceride levels, and absence of certain medical conditions.",
    "The sample is a phase 3 trial for open-angle glaucoma and ocular hypertension, testing the efficacy of travoprost ophthalmic solution 0.004% with sofzia\u00ae preservative system (travatan z\u00ae) and latanoprost ophthalmic solution 0.005% (xalatan\u00ae) in controlling intraocular pressure, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of metformin, bi 10773, and placebos in combination with various oral antidiabetic drugs, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of mometasone furoate/formoterol combination and mometasone furoate mdi in treating asthma in patients who have been using a high dose of inhaled glucocorticosteroid for at least 12 weeks and have experienced at least one severe exacerbation requiring a course of oral glucocorticosteroid 2 to 12 months prior to screening.",
    "This phase 3 trial is testing the efficacy of ponatinib and imatinib in treating chronic myeloid leukemia patients who meet specific eligibility criteria.",
    "This phase 3 trial is testing the efficacy of golimumab, methotrexate, and placebos in treating rheumatoid arthritis in patients who have inadequate disease control despite treatment with etanercept or adalimumab, and have received a stable dose of methotrexate for at least 4 consecutive weeks, while meeting other inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for major depressive disorder, testing the efficacy of sr58611a and escitalopram compared to placebo, with inclusion criteria of MADRS total score >= 30 and exclusion criteria including current or lifetime history of bipolar disorder, psychotic disorder, panic disorder, and antisocial personality disorder.",
    "The sample is a phase 3 trial for chronic hepatitis C, testing the combination of pegylated interferon alfa-2b and ribavirin, with specific inclusion and exclusion criteria, and requiring contraception for women of childbearing potential and male partners.",
    "This phase 3 trial is testing the drug aegr-733 for treating homozygous familial hypercholesterolemia in patients who meet specific eligibility criteria, including a diagnosis of functional homozygous FH and stable concurrent lipid lowering medication/apheresis for at least 6 weeks before the baseline visit.",
    "This phase 3 trial is testing the efficacy of clevidipine, a calcium channel blocker, in reducing systolic blood pressure in patients with intracerebral hemorrhage and hypertension, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of gemcitabine and placebo in treating superficial transitional cell carcinoma of the bladder, with inclusion and exclusion criteria outlined.",
    "The sample is a phase 3 trial for essential hypertension, testing the efficacy and safety of olmesartan medoxomil/hydrochlorothiazide tablets, with inclusion criteria of European adults with moderate to severe hypertension and exclusion criteria including pregnancy, serious disorders, and clinically significant abnormal laboratory values.",
    "This is a phase 3 clinical trial for schizophrenia patients, testing the efficacy of aripiprazole depot and oral tablets compared to placebo, with strict inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of tiotropium respimat low and high dose compared to placebo respimat in treating asthma in patients between 12 and 17 years old who have been on maintenance treatment with inhaled corticosteroids, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for patients with moderate to severe chronic obstructive pulmonary disease (COPD), testing the efficacy of qva149, tiotropium, and formoterol against placebos, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for patients with non-small cell lung cancer and brain metastases, testing the efficacy of erlotinib hydrochloride and temozolomide, with eligibility criteria including specific tumor size and location, performance status, and various laboratory values.",
    "The sample is a phase 3 trial for plaque psoriasis with the drug being tested being a placebo, and the eligibility criteria including a diagnosis of psoriasis for 6 months, BSA 10%, PASI 12 or above, and PGA 3 or above.",
    "This phase 3 trial is testing the efficacy of methylphenidate hydrochloride extended release capsules versus placebo in treating attention deficit hyperactivity disorder (ADHD) in children aged 6 to 12, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of rosiglitazone extended release 2mg and 8mg in treating mild to moderate Alzheimer's disease in subjects aged 50-90 who have been on stable acetylcholinesterase inhibitor therapy for at least 2 months, with a list of inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for migraine disorders, testing the efficacy of map0004 and placebo drugs, with inclusion criteria of age and history of episodic migraine, and exclusion criteria of allergies or contraindications to study drugs or major medical conditions.",
    "This phase 3 trial is testing the efficacy and safety of nva237 and placebo in patients with stable, symptomatic Chronic Obstructive Pulmonary Disease (COPD) with airflow obstruction of level 2 and 3, and with inclusion and exclusion criteria defined in the protocol.",
    "This phase 3 trial is testing the efficacy of fingolimod and interferon \u03b2-1a in treating multiple sclerosis in patients aged 18-55 with a relapsing-remitting disease course and an EDSS score of 0-5.5, while excluding patients with other chronic diseases of the immune system, malignancies, acute pulmonary disease, cardiac failure, pregnant or nursing women, and patients who cannot tolerate treatment with an interferon.",
    "This phase 3 trial is testing the efficacy of insulin degludec/insulin aspart and insulin glargine in insulin-na\u00efve subjects with type 2 diabetes mellitus who have been treated with metformin and at least one other oral antidiabetic drug for at least 3 months before trial start, with a glycosylated haemoglobin (HbA1c) between 7.5 - 11.0% (both inclusive) and a body mass index (BMI) no higher than 40.0 kg/m^2, while excluding those with cardiovascular disease diagnosed within 6 months before trial start and those who have taken glucagon like peptide-1 (GLP-1) receptor agonists and/or thiazolidinedione(s) within the last 3 months prior to trial start.",
    "This phase 3 trial is testing the efficacy of corifollitropin alfa and progesterone in females undergoing in vitro fertilization, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 1 diabetes mellitus using rhgad65 and placebo drugs, with eligibility criteria including recent diagnosis, elevated GAD65 antibodies, and exclusion criteria including treatment with immunosuppressants or other anti-diabetic medications.",
    "The sample is a phase 3 trial for patients with type 1 diabetes, testing the efficacy of insulin degludec, insulin glargine, and insulin aspart, with inclusion criteria including HbA1c maximum 10.0% and BMI below or equal to 35.0 kg/m^2, and exclusion criteria including cardiovascular disease and uncontrolled severe hypertension.",
    "The sample is a phase 3 trial for gastroesophageal reflux disease (GERD) testing the effectiveness of pantoprazole and placebo in infants aged 28 days to 11 months with a weight between 2.5 kg and 15 kg, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for type 2 diabetes and high blood sugar, testing the efficacy of dapagliflozin and placebo, with inclusion criteria of age and diagnosis, and exclusion criteria of type 1 diabetes, high FPG, renal or hepatic disease, and significant cardiovascular history.",
    "This phase 3 trial is testing the efficacy of cetuximab and cisplatin in treating squamous cell carcinoma of the oropharynx, hypopharynx, or larynx, with specific eligibility criteria including stage III or IV disease and adequate bone marrow and hepatic function.",
    "This phase 3 trial aims to test the efficacy of liraglutide versus placebo in treating obesity and obstructive sleep apnoea in patients with certain eligibility criteria, including a BMI of 30 or above, and exclusion criteria such as a history of diabetes or chronic pancreatitis.",
    "The sample is a phase 3 clinical trial for chronic constipation, testing the efficacy of linaclotide and placebo, with inclusion and exclusion criteria based on bowel movement frequency and other symptoms, and medical history, respectively.",
    "This phase 3 trial is testing the efficacy of vildagliptin and placebo in patients with type 2 diabetes mellitus, with inclusion criteria including age \u2265 70 years, confirmed diagnosis of T2DM, HbA1c of \u2265 7% and \u226410.0%, and BMI in the range of 19-45kg/m2, and exclusion criteria including FPG \u2265 270 mg/dL, previous or current participation in any vildagliptin clinical study, and history of hypersensitivity to DPP-4 inhibitors.",
    "This phase 3 trial is testing the efficacy of cetuximab, capecitabine, and cisplatin in treating unresectable advanced or metastatic gastric cancer with specific eligibility criteria, including confirmed adenocarcinoma and measurable lesions, while excluding patients with certain medical conditions or prior treatments.",
    "This phase 3 trial is testing the efficacy of umeclidinium bromide/vilanterol, fluticasone propionate/salmeterol, and placebo in treating chronic obstructive pulmonary disease (COPD) in patients who are current or former smokers with a history of >=10 pack-years, and have a pre and post-salbutamol FEV1/FVC ratio of <0.70 and a post-salbutamol FEV1 of >=30% and <=70% of predicted normal values calculated using NHANES III reference equations.",
    "The sample is a phase 3 trial for women with a history of stage 0-II breast cancer and menopausal symptoms, testing the drug norethindrone acetate, with eligibility criteria including hormone receptor status and no prior or concurrent chemotherapy or radiotherapy.",
    "The sample is a phase 3 trial for attention deficit hyperactivity disorder (ADHD) using atomoxetine as the drug, with inclusion criteria of age, ADHD diagnosis, and normal intelligence, and exclusion criteria of weight, other psychiatric diagnoses, suicidal risk, severe allergies, and recent alcohol or drug abuse.",
    "The sample is a phase 3 trial testing the efficacy of ezetimibe + simvastatin, simvastatin, and placebo in treating hypercholesterolemia and atherosclerosis, with specific inclusion and exclusion criteria for participants.",
    "This is a phase 3 clinical trial for patients with non-ST-segment elevation Acute Coronary Syndrome, testing the efficacy of otamixaban, ufh, and eptifibatide, with eligibility criteria including ischemic symptoms, elevated cardiac biomarkers, and planned coronary angiography.",
    "This phase 3 trial is testing the efficacy of hydromorphone hcl, oxycodone hcl cr, and placebo in managing moderate to severe cancer pain in participants who require between 40 mg and 184 mg of oral morphine or morphine equivalents every 24 hours, and who are not expected to start a course of chemotherapy, radiotherapy, targeted cancer therapy, hormone therapy or diphosphates therapy after enrolment into the study.",
    "The sample is a phase 3 trial for breakthrough pain and cancer patients, testing the efficacy of fentanyl ethypharm as a treatment, with specific inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with depression, HIV infections, and hepatitis C, testing the efficacy of citalopram and placebos, with eligibility criteria including chronic HCV infection and exclusion criteria including prior suicide attempt or active depression.",
    "This phase 3 trial is testing preladenant, rasagiline, and placebo as adjunct therapy for Parkinson's disease patients taking L-dopa, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 clinical trial for infertility, testing the efficacy of corifollitropin alfa, recfsh, gonadatropin releasing hormone antagonist, human chorion gonadatropin, and placebos, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the efficacy of odanacatib and placebo for odanacatib in treating osteoporosis in males between 40 and 95 years of age, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for glaucoma, testing the effectiveness of timolol and latanoprost, with inclusion criteria including a diagnosis of glaucoma and IOP of 22 mmHg or above, and exclusion criteria including prior cyclodestructive procedures and ocular trauma or surgery within 3 months of the baseline visit.",
    "The sample is a phase 3 trial for the drug Lu AA21004 in patients with major depressive disorder who have completed a preceding study, with inclusion and exclusion criteria listed, and the drug and disease values provided.",
    "The sample is a phase 3 trial for chronic obstructive pulmonary disease (COPD) testing the efficacy of glycopyrronium bromide compared to placebo, with specific inclusion and exclusion criteria based on smoking history, lung function, and comorbid conditions.",
    "The sample is a phase 3 trial for depression, testing the efficacy of escitalopram, placebo, peginterferon alfa-2a, and ribavirin, with specific inclusion and exclusion criteria for participants.",
    "This phase 3 trial is testing the efficacy of apremilast in treating psoriatic arthritis, with inclusion criteria including a diagnosis of PSA, inadequate response to DMARDs, and \u2265 3 swollen and tender joints, and the drugs being tested include apremilast and placebo.",
    "The sample is a phase 3 trial for chronic hepatitis C patients with genotype 1, using daclatasvir, peg-interferon alfa-2a, and ribavirin as drugs, and the eligibility criteria includes HCV RNA viral load of \u226510,000 IU/mL at screening and liver biopsy obtained \u226436 months prior to first treatment for compensated cirrhotics.",
    "This phase 3 trial is testing the efficacy of a combination of pi, rtv, ftc/tdf, and stribild in treating acquired immunodeficiency syndrome and HIV infections, with strict inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for myelodysplastic syndromes and anemia, testing the efficacy of epoetin alfa and placebo, with specific eligibility criteria including no prior use of erythropoietin stimulating agents and exclusion of anemia caused by factors other than MDS.",
    "This phase 3 trial is testing the efficacy of bemiparin and placebo in preventing thrombosis in cancer patients with a CVC, who meet certain eligibility criteria and do not have any exclusion criteria, and have a platelet count above 30,000/mm3, and have given their informed consent to participate in the study.",
    "The sample is a phase 3 trial for patients with hypertension and stroke, testing the drug cilnidipine, with inclusion criteria of ischemic stroke patients with hypertension and exclusion criteria of cardioembolic stroke patients, severe hypertensive patients, and secondary hypertensive patients.",
    "The sample is a phase 3 trial for major depressive disorder using bupropion xl as the drug, with inclusion and exclusion criteria listed, and icd-10 codes provided for the disease.",
    "This phase 3 trial is testing the efficacy of hcrf and placebo hcrf drugs in treating brain edema and brain tumor patients who have steroid-associated side effects and require dexamethasone, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for the treatment of moderate to severe atopic dermatitis using tacrolimus ointment, with eligibility criteria including age range, previous medication use, and written informed consent.",
    "This phase 3 trial is testing the efficacy of rolofylline and placebo in treating heart failure patients with impaired renal function, with a list of exclusion criteria including acute contrast induced nephropathy, ongoing IV therapy for heart failure with certain agents, and various medical conditions such as severe pulmonary disease and brain tumors.",
    "This is a phase 3 trial for patients with moderate to severe COPD, testing the efficacy of qva149 and tiotropium, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for venous thromboembolism prevention in patients undergoing elective total knee replacement, with drugs including rivaroxaban, enoxaparin, and placebos, and eligibility criteria including age and absence of bleeding risk.",
    "The sample is a phase 3 trial for patients with atrial fibrillation or lung cancer, testing the drug amiodarone, with eligibility criteria including resectable lung nodules or mass and exclusion criteria including allergy to amiodarone and documented atrial fibrillation within the past 12 months.",
    "The sample is a phase 3 trial for chronic low back pain using OROS hydromorphone slow release as the drug, with inclusion criteria requiring patients to have completed short-term Study DO-127 and requiring at least 8 mg of the drug every 24 hours, and exclusion criteria including intolerance or hypersensitivity to hydromorphone, pregnancy or breastfeeding, significant CNS disorder, and risk for serious decreases in blood pressure upon taking an opioid analgesic.",
    "The sample is a phase 3 trial for type 2 diabetes mellitus, testing the efficacy of sitagliptin and metformin against placebo, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of Prograf-xl and Prograf, along with mycophenolate mofetil, in liver transplant recipients, with inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "The sample is a phase 3 trial for relapsing multiple sclerosis, testing the drug fty720, with inclusion criteria of age 18-65 and exclusion criteria including certain immune, heart, and lung conditions, as well as patients on certain medications.",
    "This phase 3 trial is testing the efficacy of lapaquistat acetate and current lipid-lowering treatment in patients with homozygous FH and a stable, approved lipid-lowering drug regimen, with specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of tegafur-gimeracil-oteracil potassium and tegafur-uracil in treating stage III or IV squamous cell carcinoma of the head and neck, with eligibility criteria including completed definitive treatment within the past 3 months and ECOG performance status 0-1.",
    "This phase 3 trial is testing the drug carboxyamidotriazole for patients with stage III or IV non-small cell lung cancer who have had one prior chemotherapy regimen, and have met certain eligibility criteria.",
    "The sample is a phase 3 trial for schizophrenia with the drugs asenapine and olanzapine, and the eligibility criteria includes having completed a previous trial and having an acceptable degree of compliance, while excluding those with unstable medical conditions or noncompliance.",
    "This phase 3 trial is testing the efficacy of fluocinolone acetonide for diabetic macular edema, with inclusion criteria including age over 18, diagnosis of diabetes mellitus, and best corrected visual acuity of 19-68 letters.",
    "The sample is a phase 3 trial for malignant mesothelioma using doxorubicin hydrochloride and ranpirnase as drugs, with eligibility criteria including confirmed mesothelioma, measurable or evaluable disease, and specific patient characteristics such as ECOG 0-1 performance status and normal creatinine levels.",
    "The sample is a phase 3 trial for cystic fibrosis patients, testing the efficacy of mp-376 (levofloxacin solution for inhalation) compared to placebo, with inclusion criteria including confirmed diagnosis of cystic fibrosis and positive sputum culture for P. aeruginosa, and exclusion criteria including use of any nebulized or systemic antibiotics within 28 days prior to baseline.",
    "The sample is a phase 3 trial for patients with schizophrenia or schizoaffective disorder, testing the effectiveness of ziprasidone as an antipsychotic medication, with specific inclusion and exclusion criteria based on prior treatment and risk factors.",
    "The sample is a phase 3 trial for neuropathic pain, testing the effectiveness of pregabalin, with inclusion criteria of Chinese outpatients aged 18 to 75 with a score greater than 40 mm on the visual log scale of SF-MPQ, and exclusion criteria of neurologic disorders unrelated to neuropathic pain and serum creatinine clearance greater than 60 ml/min.",
    "This phase 3 trial is testing the efficacy of fluticasone propionate inhalation solution, oral prednisone, and salbutamol in treating asthma in Chinese pediatric and adolescent subjects, with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for non-small cell lung cancer patients who have received one prior platinum-based chemotherapy regimen and are current cigarette smokers, testing the drug erlotinib (Tarceva) and requiring patients to meet specific inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of insulin degludec/liraglutide versus placebo in subjects with type 2 diabetes mellitus who are on a stable daily dose of sulphonylurea with or without metformin, and have a BMI below or equal to 40 kg/m^2, while excluding those with certain medical conditions or previous treatments.",
    "The sample is a phase 3 trial for pancreatic cancer patients who have undergone complete resection, with eligibility criteria including age, performance status, and no evidence of metastases, and the trial will test the efficacy of fluorouracil, gemcitabine hydrochloride, and leucovorin calcium as treatment options.",
    "This is a phase 3 clinical trial for chronic constipation, testing the efficacy of prucalopride versus placebo, with inclusion and exclusion criteria specified, and the use of ICD-10 codes to identify the disease.",
    "The sample is a phase 3 trial for patients with essential hypertension, testing the effectiveness of nifedipine (adalat, baya1040) in reducing blood pressure, with inclusion and exclusion criteria listed.",
    "This phase 3 trial is testing the efficacy of dasatinib and imatinib in treating Chronic Phase Philadelphia chromosome positive (CP Ph+) CML patients who have failed to achieve CCyR after 3-18 months of therapy with imatinib 400 mg, and the eligibility criteria includes being able to tolerate chronic administration of imatinib at the highest dose, having ECOG PS 0-2, and having adequate hepatic and renal function.",
    "The sample is a phase 3 trial testing the effectiveness of aspirin and warfarin in reducing the risk of stroke and heart disease in patients with low cardiac EF and a Modified Rankin score <=4, who are taking ACE inhibitors or angiotensin II receptor blockers, and meet other eligibility criteria. The trial includes patients with a recent stroke or TIA within twelve months and chronic CHF patients (NYHA I-IV) who are stable and ambulatory at the time of discharge. The trial excludes patients with certain cardiac sources of embolism, cyanotic congenital heart disease, decompensated heart failure, recent cardiac surgery, angioplasty, or MI, contraindications to the use of warfarin or aspirin, and other comorbid conditions.",
    "The sample is a phase 3 trial testing the use of aspirin in patients with thrombocytopenia and myocardial infarction, with specific inclusion and exclusion criteria, while the schema includes columns for phase, diseases, icd codes, drugs, and eligibility criteria.",
    "This is a phase 3 trial for patients with chronic obstructive pulmonary disease (COPD) testing the efficacy of aclidinium bromide/formoterol fumarate and aclidinium bromide monotherapy compared to placebo, with inclusion and exclusion criteria including smoking history, FEV1/FVC ratio, and cardiovascular and respiratory conditions.",
    "This is a phase 3 trial for metastatic colorectal cancer testing the efficacy of regorafenib and placebo, with eligibility criteria including documented adenocarcinoma of the colon or rectum, progression during or within 3 months following the last administration of approved standard therapies, and an ECOG Performance Status of </= 1.",
    "The sample is a phase 3 trial for type 2 diabetes testing the efficacy of technosphere insulin and powder in patients who meet specific eligibility criteria, including HbA1c levels, BMI, and current diabetes treatment, while excluding patients with certain medical conditions and previous insulin use.",
    "The sample is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of rosiglitazone, sulfonylurea, and metformin, with inclusion and exclusion criteria related to glucose-lowering therapy, blood pressure, and insulin use.",
    "This phase 3 trial is testing the efficacy of paliperidone er and placebo in treating schizophrenia, with inclusion criteria including meeting DSM-IV criteria for schizophrenia, having had at least 1 adequate treatment with an antipsychotic before, and having a PANSS score between 60 and 120, while exclusion criteria include having a known or suspected history of seizure disorder, or neuroleptic malignant syndrome, encephalopathic syndrome, tardive dyskinesia, or insulin dependent diabetes mellitus.",
    "This is a phase 3 trial for patients with psoriatic arthritis, testing the efficacy of onercept and placebo drugs, with eligibility criteria including having plaque psoriasis for at least 12 months, covering at least 10% of total body surface area, and a PASI score of 12.0 or more.",
    "This phase 3 trial is testing the efficacy of fluticasone furoate and fluticasone propionate/salmeterol in treating chronic obstructive pulmonary disease (COPD) in patients with specific inclusion and exclusion criteria, including a history of COPD, a post-albuterol spirometry criteria, and no history of severe milk protein allergy, alcohol or drug abuse, or pregnancy/lactation.",
    "The sample is a phase 3 trial for locally advanced or metastatic pancreatic cancer patients who failed one prior gemcitabine-containing chemotherapy regimen, and the study will test the efficacy of fluorouracil and irofulven as treatment options.",
    "The sample is a phase 3 trial for breast cancer patients with specific disease and patient characteristics, testing a combination of drugs including aromatase inhibition therapy, cyclophosphamide, docetaxel, doxorubicin hydrochloride, epirubicin hydrochloride, fluorouracil, paclitaxel, releasing hormone agonist therapy, and tamoxifen citrate, with eligibility criteria including node positivity or negativity and certain tumor characteristics.",
    "The sample is a phase 3 trial for HIV infection using half-boosted and full-boosted fosamprenavir, with inclusion criteria of HIV-1 infection and written consent, and exclusion criteria of pregnancy, breastfeeding, active AIDS condition, pancreatitis, poor kidney function, clinically relevant hepatitis, medication interactions, allergy to study drugs, and other criteria to be evaluated by the physician.",
    "This phase 3 trial is testing the efficacy of armodafinil and placebo in treating major depressive episodes in patients with bipolar I disorder who are taking specific mood stabilizers, and have had no more than 6 mood episodes in the last year, with a list of inclusion and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of candesartan cilexetil (atacand) in treating hypertension in children between 10-40 kg with specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for perennial allergic rhinitis, testing the efficacy of various ciclesonide nasal sprays and placebos, with eligibility criteria including a history of PAR and sensitivity to allergens, and exclusion criteria including respiratory disorders and hypersensitivity to corticosteroids.",
    "This is a phase 3 clinical trial for gout patients with serum urate level >= 8.0 mg/dL, testing the efficacy of febuxostat and allopurinol, with specific inclusion and exclusion criteria.",
    "This phase 3 clinical trial is testing the efficacy of technosphere\u00ae insulin inhalation powder and 70% insulin aspart protamine suspension and 30% insulin aspart injection (rdna origin) in treating type 2 diabetes mellitus with specific inclusion and exclusion criteria.",
    "This is a phase 3 trial for patients with type 2 diabetes mellitus, testing the efficacy of lixisenatide, sulfonylurea, and metformin in controlling blood glucose levels, with a list of exclusion criteria including various medical conditions and medication use.",
    "The sample is a phase 3 trial for asthma patients, testing the efficacy of flutiform and symbicort turbohaler drugs, with eligibility criteria including age, asthma severity, and reversibility of FEV1, and exclusion criteria including recent hospitalization for asthma and use of certain medications.",
    "The sample is a phase 3 trial for hypertension, testing the efficacy of amlodipine in patients with high blood pressure, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 trial for Parkinson's disease using the drug parcopa, with inclusion criteria of stable Parkinson's disease and exclusion criteria of idiopathic PD with Hoehn and Yahr state II or III.",
    "The sample is a phase 3 trial for postmenopausal women with vulvar and vaginal atrophy, testing the drug ospemifene 60mg oral tablet, with inclusion and exclusion criteria specified.",
    "The sample is a phase 3 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of insulin human/insuman comb 25 and insulin human/novolin\u00ae 30r, with specific inclusion and exclusion criteria.",
    "This phase 3 trial aims to evaluate the efficacy of ezetimibe and simvastatin combination therapy in patients with hypercholesterolemia, type 2 diabetes mellitus, and coronary disease, who are currently taking simvastatin 20 mg daily, and have LDL-C concentration between 2.6 mmol/L and 4.1 mmol/L, and triglyceride concentrations of <3.99 mmol/L, while adhering to specific inclusion and exclusion criteria.",
    "The sample is a phase 3 trial for osteoarthritis knee pain, testing the efficacy of duloxetine and placebo, with inclusion and exclusion criteria listed.",
    "The sample is a phase 3 trial for patients with ovarian and peritoneal neoplasms, testing the efficacy of a combination of drugs including paclitaxel, carboplatin, and bibf 1120, with eligibility criteria including histologically confirmed cancer, ECOG performance status 0-2, and exclusion criteria including prior systemic therapy for ovarian cancer and contraindications for therapy with paclitaxel or carboplatin.",
    "This phase 3 trial is testing the effectiveness of amlodipine/losartan and amlodipine in treating hypertension, with specific eligibility and exclusion criteria.",
    "This phase 3 trial is testing the efficacy of prograf and lcp-tacro in preventing renal allograft rejection in patients with renal failure, with eligibility criteria including negative cross match test and compatible blood type, while exclusion criteria include history of malignancies and treatment with certain drugs within 3 months prior to enrollment.",
    "The sample is a phase 3 trial testing the efficacy of vortioxetine and escitalopram compared to placebo in treating treatment-emergent sexual dysfunction in patients with major depressive disorder who are currently being treated with selective serotonin reuptake inhibitor (SSRI) monotherapy, and the eligibility criteria includes age, stability, and CGI-S score.",
    "This phase 3 trial is testing the efficacy of capecitabine, perifosine, and placebo in treating advanced colorectal cancer patients who have failed previous therapies, and have not been previously exposed to capecitabine in the metastatic colorectal cancer setting, with inclusion and exclusion criteria specified."
]